id	sid	tid	token	lemma	pos
cord-308095-mehmk49a	1	1	key	key	JJ
cord-308095-mehmk49a	1	2	:	:	:
cord-308095-mehmk49a	1	3	cord-308095-mehmk49a	cord-308095-mehmk49a	CD
cord-308095-mehmk49a	1	4	authors	author	NNS
cord-308095-mehmk49a	1	5	:	:	:
cord-308095-mehmk49a	1	6	Marks	Marks	NNP
cord-308095-mehmk49a	1	7	,	,	,
cord-308095-mehmk49a	1	8	Jonathan	Jonathan	NNP
cord-308095-mehmk49a	1	9	H.	H.	NNP
cord-308095-mehmk49a	1	10	title	title	NN
cord-308095-mehmk49a	1	11	:	:	:
cord-308095-mehmk49a	1	12	Lessons	lesson	NNS
cord-308095-mehmk49a	1	13	from	from	IN
cord-308095-mehmk49a	1	14	Corporate	corporate	JJ
cord-308095-mehmk49a	1	15	Influence	influence	NN
cord-308095-mehmk49a	1	16	in	in	IN
cord-308095-mehmk49a	1	17	the	the	DT
cord-308095-mehmk49a	1	18	Opioid	opioid	JJ
cord-308095-mehmk49a	1	19	Epidemic	epidemic	NN
cord-308095-mehmk49a	1	20	:	:	:
cord-308095-mehmk49a	2	1	Toward	toward	IN
cord-308095-mehmk49a	2	2	a	a	DT
cord-308095-mehmk49a	2	3	Norm	norm	NN
cord-308095-mehmk49a	2	4	of	of	IN
cord-308095-mehmk49a	2	5	Separation	separation	NN
cord-308095-mehmk49a	2	6	date	date	NN
cord-308095-mehmk49a	2	7	:	:	:
cord-308095-mehmk49a	2	8	2020	2020	CD
cord-308095-mehmk49a	2	9	-	-	HYPH
cord-308095-mehmk49a	2	10	07	07	CD
cord-308095-mehmk49a	2	11	-	-	SYM
cord-308095-mehmk49a	2	12	13	13	CD
cord-308095-mehmk49a	2	13	journal	journal	NN
cord-308095-mehmk49a	2	14	:	:	:
cord-308095-mehmk49a	3	1	J	J	NNP
cord-308095-mehmk49a	3	2	Bioeth	Bioeth	NNP
cord-308095-mehmk49a	3	3	Inq	Inq	NNP
cord-308095-mehmk49a	3	4	DOI	DOI	NNP
cord-308095-mehmk49a	3	5	:	:	:
cord-308095-mehmk49a	3	6	10.1007	10.1007	CD
cord-308095-mehmk49a	3	7	/	/	SYM
cord-308095-mehmk49a	3	8	s11673	s11673	CD
cord-308095-mehmk49a	3	9	-	-	HYPH
cord-308095-mehmk49a	3	10	020	020	CD
cord-308095-mehmk49a	3	11	-	-	HYPH
cord-308095-mehmk49a	3	12	09982-x	09982-x	ADD
cord-308095-mehmk49a	4	1	sha	sha	NNP
cord-308095-mehmk49a	4	2	:	:	:
cord-308095-mehmk49a	5	1	63203024645efcbc1ef944a16bc8fca77753fbec	63203024645efcbc1ef944a16bc8fca77753fbec	CD
cord-308095-mehmk49a	5	2	doc_id	doc_id	CD
cord-308095-mehmk49a	5	3	:	:	:
cord-308095-mehmk49a	5	4	308095	308095	CD
cord-308095-mehmk49a	5	5	cord_uid	cord_uid	NNS
cord-308095-mehmk49a	5	6	:	:	:
cord-308095-mehmk49a	5	7	mehmk49a	mehmk49a	.
cord-308095-mehmk49a	6	1	There	there	EX
cord-308095-mehmk49a	6	2	is	be	VBZ
cord-308095-mehmk49a	6	3	overwhelming	overwhelming	JJ
cord-308095-mehmk49a	6	4	evidence	evidence	NN
cord-308095-mehmk49a	6	5	that	that	IN
cord-308095-mehmk49a	6	6	the	the	DT
cord-308095-mehmk49a	6	7	opioid	opioid	JJ
cord-308095-mehmk49a	6	8	crisis	crisis	NN
cord-308095-mehmk49a	6	9	—	—	:
cord-308095-mehmk49a	6	10	which	which	WDT
cord-308095-mehmk49a	6	11	has	have	VBZ
cord-308095-mehmk49a	6	12	cost	cost	VBN
cord-308095-mehmk49a	6	13	hundreds	hundred	NNS
cord-308095-mehmk49a	6	14	of	of	IN
cord-308095-mehmk49a	6	15	thousands	thousand	NNS
cord-308095-mehmk49a	6	16	of	of	IN
cord-308095-mehmk49a	6	17	lives	life	NNS
cord-308095-mehmk49a	6	18	and	and	CC
cord-308095-mehmk49a	6	19	trillions	trillion	NNS
cord-308095-mehmk49a	6	20	of	of	IN
cord-308095-mehmk49a	6	21	dollars	dollar	NNS
cord-308095-mehmk49a	6	22	(	(	-LRB-
cord-308095-mehmk49a	6	23	and	and	CC
cord-308095-mehmk49a	6	24	counting)—has	counting)—has	NNP
cord-308095-mehmk49a	6	25	been	be	VBN
cord-308095-mehmk49a	6	26	created	create	VBN
cord-308095-mehmk49a	6	27	or	or	CC
cord-308095-mehmk49a	6	28	exacerbated	exacerbate	VBN
cord-308095-mehmk49a	6	29	by	by	IN
cord-308095-mehmk49a	6	30	webs	web	NNS
cord-308095-mehmk49a	6	31	of	of	IN
cord-308095-mehmk49a	6	32	influence	influence	NN
cord-308095-mehmk49a	6	33	woven	weave	VBN
cord-308095-mehmk49a	6	34	by	by	IN
cord-308095-mehmk49a	6	35	several	several	JJ
cord-308095-mehmk49a	6	36	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	6	37	companies	company	NNS
cord-308095-mehmk49a	6	38	.	.	.
cord-308095-mehmk49a	7	1	These	these	DT
cord-308095-mehmk49a	7	2	webs	web	NNS
cord-308095-mehmk49a	7	3	involve	involve	VBP
cord-308095-mehmk49a	7	4	health	health	NN
cord-308095-mehmk49a	7	5	professionals	professional	NNS
cord-308095-mehmk49a	7	6	,	,	,
cord-308095-mehmk49a	7	7	patient	patient	JJ
cord-308095-mehmk49a	7	8	advocacy	advocacy	NN
cord-308095-mehmk49a	7	9	groups	group	NNS
cord-308095-mehmk49a	7	10	,	,	,
cord-308095-mehmk49a	7	11	medical	medical	JJ
cord-308095-mehmk49a	7	12	professional	professional	JJ
cord-308095-mehmk49a	7	13	societies	society	NNS
cord-308095-mehmk49a	7	14	,	,	,
cord-308095-mehmk49a	7	15	research	research	NN
cord-308095-mehmk49a	7	16	universities	university	NNS
cord-308095-mehmk49a	7	17	,	,	,
cord-308095-mehmk49a	7	18	teaching	teach	VBG
cord-308095-mehmk49a	7	19	hospitals	hospital	NNS
cord-308095-mehmk49a	7	20	,	,	,
cord-308095-mehmk49a	7	21	public	public	JJ
cord-308095-mehmk49a	7	22	health	health	NN
cord-308095-mehmk49a	7	23	agencies	agency	NNS
cord-308095-mehmk49a	7	24	,	,	,
cord-308095-mehmk49a	7	25	policymakers	policymaker	NNS
cord-308095-mehmk49a	7	26	,	,	,
cord-308095-mehmk49a	7	27	and	and	CC
cord-308095-mehmk49a	7	28	legislators	legislator	NNS
cord-308095-mehmk49a	7	29	.	.	.
cord-308095-mehmk49a	8	1	Opioid	opioid	JJ
cord-308095-mehmk49a	8	2	companies	company	NNS
cord-308095-mehmk49a	8	3	built	build	VBD
cord-308095-mehmk49a	8	4	these	these	DT
cord-308095-mehmk49a	8	5	webs	web	NNS
cord-308095-mehmk49a	8	6	as	as	IN
cord-308095-mehmk49a	8	7	part	part	NN
cord-308095-mehmk49a	8	8	of	of	IN
cord-308095-mehmk49a	8	9	corporate	corporate	JJ
cord-308095-mehmk49a	8	10	strategies	strategy	NNS
cord-308095-mehmk49a	8	11	of	of	IN
cord-308095-mehmk49a	8	12	influence	influence	NN
cord-308095-mehmk49a	8	13	that	that	WDT
cord-308095-mehmk49a	8	14	were	be	VBD
cord-308095-mehmk49a	8	15	designed	design	VBN
cord-308095-mehmk49a	8	16	to	to	TO
cord-308095-mehmk49a	8	17	expand	expand	VB
cord-308095-mehmk49a	8	18	the	the	DT
cord-308095-mehmk49a	8	19	opioid	opioid	JJ
cord-308095-mehmk49a	8	20	market	market	NN
cord-308095-mehmk49a	8	21	from	from	IN
cord-308095-mehmk49a	8	22	cancer	cancer	NN
cord-308095-mehmk49a	8	23	patients	patient	NNS
cord-308095-mehmk49a	8	24	to	to	IN
cord-308095-mehmk49a	8	25	larger	large	JJR
cord-308095-mehmk49a	8	26	groups	group	NNS
cord-308095-mehmk49a	8	27	of	of	IN
cord-308095-mehmk49a	8	28	patients	patient	NNS
cord-308095-mehmk49a	8	29	with	with	IN
cord-308095-mehmk49a	8	30	acute	acute	JJ
cord-308095-mehmk49a	8	31	or	or	CC
cord-308095-mehmk49a	8	32	chronic	chronic	JJ
cord-308095-mehmk49a	8	33	pain	pain	NN
cord-308095-mehmk49a	8	34	,	,	,
cord-308095-mehmk49a	8	35	to	to	TO
cord-308095-mehmk49a	8	36	increase	increase	VB
cord-308095-mehmk49a	8	37	dosage	dosage	NN
cord-308095-mehmk49a	8	38	as	as	RB
cord-308095-mehmk49a	8	39	well	well	RB
cord-308095-mehmk49a	8	40	as	as	IN
cord-308095-mehmk49a	8	41	opioid	opioid	JJ
cord-308095-mehmk49a	8	42	use	use	NN
cord-308095-mehmk49a	8	43	,	,	,
cord-308095-mehmk49a	8	44	to	to	TO
cord-308095-mehmk49a	8	45	downplay	downplay	VB
cord-308095-mehmk49a	8	46	the	the	DT
cord-308095-mehmk49a	8	47	risks	risk	NNS
cord-308095-mehmk49a	8	48	of	of	IN
cord-308095-mehmk49a	8	49	addiction	addiction	NN
cord-308095-mehmk49a	8	50	and	and	CC
cord-308095-mehmk49a	8	51	abuse	abuse	NN
cord-308095-mehmk49a	8	52	,	,	,
cord-308095-mehmk49a	8	53	and	and	CC
cord-308095-mehmk49a	8	54	to	to	TO
cord-308095-mehmk49a	8	55	characterize	characterize	VB
cord-308095-mehmk49a	8	56	physicians	physician	NNS
cord-308095-mehmk49a	8	57	’	’	POS
cord-308095-mehmk49a	8	58	concerns	concern	NNS
cord-308095-mehmk49a	8	59	about	about	IN
cord-308095-mehmk49a	8	60	the	the	DT
cord-308095-mehmk49a	8	61	addiction	addiction	NN
cord-308095-mehmk49a	8	62	and	and	CC
cord-308095-mehmk49a	8	63	abuse	abuse	NN
cord-308095-mehmk49a	8	64	risks	risk	NNS
cord-308095-mehmk49a	8	65	as	as	IN
cord-308095-mehmk49a	8	66	“	"	``
cord-308095-mehmk49a	8	67	opiophobia	opiophobia	NNP
cord-308095-mehmk49a	8	68	.	.	.
cord-308095-mehmk49a	8	69	”	"	''
cord-308095-mehmk49a	9	1	In	in	IN
cord-308095-mehmk49a	9	2	the	the	DT
cord-308095-mehmk49a	9	3	face	face	NN
cord-308095-mehmk49a	9	4	of	of	IN
cord-308095-mehmk49a	9	5	these	these	DT
cord-308095-mehmk49a	9	6	pervasive	pervasive	JJ
cord-308095-mehmk49a	9	7	strategies	strategy	NNS
cord-308095-mehmk49a	9	8	,	,	,
cord-308095-mehmk49a	9	9	conflict	conflict	NN
cord-308095-mehmk49a	9	10	of	of	IN
cord-308095-mehmk49a	9	11	interest	interest	NN
cord-308095-mehmk49a	9	12	policies	policy	NNS
cord-308095-mehmk49a	9	13	have	have	VBP
cord-308095-mehmk49a	9	14	proven	prove	VBN
cord-308095-mehmk49a	9	15	insufficient	insufficient	JJ
cord-308095-mehmk49a	9	16	for	for	IN
cord-308095-mehmk49a	9	17	addressing	address	VBG
cord-308095-mehmk49a	9	18	corporate	corporate	JJ
cord-308095-mehmk49a	9	19	influence	influence	NN
cord-308095-mehmk49a	9	20	in	in	IN
cord-308095-mehmk49a	9	21	medical	medical	JJ
cord-308095-mehmk49a	9	22	practice	practice	NN
cord-308095-mehmk49a	9	23	,	,	,
cord-308095-mehmk49a	9	24	medical	medical	JJ
cord-308095-mehmk49a	9	25	research	research	NN
cord-308095-mehmk49a	9	26	,	,	,
cord-308095-mehmk49a	9	27	and	and	CC
cord-308095-mehmk49a	9	28	public	public	JJ
cord-308095-mehmk49a	9	29	health	health	NN
cord-308095-mehmk49a	9	30	policy	policy	NN
cord-308095-mehmk49a	9	31	.	.	.
cord-308095-mehmk49a	10	1	Governments	government	NNS
cord-308095-mehmk49a	10	2	,	,	,
cord-308095-mehmk49a	10	3	the	the	DT
cord-308095-mehmk49a	10	4	academy	academy	NN
cord-308095-mehmk49a	10	5	,	,	,
cord-308095-mehmk49a	10	6	and	and	CC
cord-308095-mehmk49a	10	7	civil	civil	JJ
cord-308095-mehmk49a	10	8	society	society	NN
cord-308095-mehmk49a	10	9	need	need	VBP
cord-308095-mehmk49a	10	10	to	to	TO
cord-308095-mehmk49a	10	11	develop	develop	VB
cord-308095-mehmk49a	10	12	counterstrategies	counterstrategie	NNS
cord-308095-mehmk49a	10	13	to	to	TO
cord-308095-mehmk49a	10	14	insulate	insulate	VB
cord-308095-mehmk49a	10	15	themselves	-PRON-	PRP
cord-308095-mehmk49a	10	16	from	from	IN
cord-308095-mehmk49a	10	17	corporate	corporate	JJ
cord-308095-mehmk49a	10	18	influence	influence	NN
cord-308095-mehmk49a	10	19	and	and	CC
cord-308095-mehmk49a	10	20	to	to	TO
cord-308095-mehmk49a	10	21	preserve	preserve	VB
cord-308095-mehmk49a	10	22	their	-PRON-	PRP$
cord-308095-mehmk49a	10	23	integrity	integrity	NN
cord-308095-mehmk49a	10	24	and	and	CC
cord-308095-mehmk49a	10	25	public	public	JJ
cord-308095-mehmk49a	10	26	trust	trust	NN
cord-308095-mehmk49a	10	27	.	.	.
cord-308095-mehmk49a	11	1	These	these	DT
cord-308095-mehmk49a	11	2	strategies	strategy	NNS
cord-308095-mehmk49a	11	3	require	require	VBP
cord-308095-mehmk49a	11	4	a	a	DT
cord-308095-mehmk49a	11	5	paradigm	paradigm	NN
cord-308095-mehmk49a	11	6	shift	shift	NN
cord-308095-mehmk49a	11	7	—	—	:
cord-308095-mehmk49a	11	8	from	from	IN
cord-308095-mehmk49a	11	9	partnerships	partnership	NNS
cord-308095-mehmk49a	11	10	with	with	IN
cord-308095-mehmk49a	11	11	the	the	DT
cord-308095-mehmk49a	11	12	private	private	JJ
cord-308095-mehmk49a	11	13	sector	sector	NN
cord-308095-mehmk49a	11	14	,	,	,
cord-308095-mehmk49a	11	15	which	which	WDT
cord-308095-mehmk49a	11	16	are	be	VBP
cord-308095-mehmk49a	11	17	ordinarily	ordinarily	RB
cord-308095-mehmk49a	11	18	vehicles	vehicle	NNS
cord-308095-mehmk49a	11	19	for	for	IN
cord-308095-mehmk49a	11	20	corporate	corporate	JJ
cord-308095-mehmk49a	11	21	influence	influence	NN
cord-308095-mehmk49a	11	22	,	,	,
cord-308095-mehmk49a	11	23	to	to	IN
cord-308095-mehmk49a	11	24	a	a	DT
cord-308095-mehmk49a	11	25	norm	norm	NN
cord-308095-mehmk49a	11	26	of	of	IN
cord-308095-mehmk49a	11	27	separation	separation	NN
cord-308095-mehmk49a	11	28	.	.	.
cord-308095-mehmk49a	12	1	The	the	DT
cord-308095-mehmk49a	12	2	opioid	opioid	JJ
cord-308095-mehmk49a	12	3	epidemic	epidemic	NN
cord-308095-mehmk49a	12	4	has	have	VBZ
cord-308095-mehmk49a	12	5	claimed	claim	VBN
cord-308095-mehmk49a	12	6	the	the	DT
cord-308095-mehmk49a	12	7	lives	life	NNS
cord-308095-mehmk49a	12	8	of	of	IN
cord-308095-mehmk49a	12	9	more	more	JJR
cord-308095-mehmk49a	12	10	than	than	IN
cord-308095-mehmk49a	12	11	400,000	400,000	CD
cord-308095-mehmk49a	12	12	Americans	Americans	NNPS
cord-308095-mehmk49a	12	13	in	in	IN
cord-308095-mehmk49a	12	14	the	the	DT
cord-308095-mehmk49a	12	15	last	last	JJ
cord-308095-mehmk49a	12	16	two	two	CD
cord-308095-mehmk49a	12	17	decades	decade	NNS
cord-308095-mehmk49a	12	18	(	(	-LRB-
cord-308095-mehmk49a	12	19	CDC	CDC	NNP
cord-308095-mehmk49a	12	20	2019a	2019a	CD
cord-308095-mehmk49a	12	21	)	)	-RRB-
cord-308095-mehmk49a	12	22	.	.	.
cord-308095-mehmk49a	13	1	It	-PRON-	PRP
cord-308095-mehmk49a	13	2	has	have	VBZ
cord-308095-mehmk49a	13	3	devastated	devastate	VBN
cord-308095-mehmk49a	13	4	families	family	NNS
cord-308095-mehmk49a	13	5	,	,	,
cord-308095-mehmk49a	13	6	destroyed	destroy	VBD
cord-308095-mehmk49a	13	7	entire	entire	JJ
cord-308095-mehmk49a	13	8	communities	community	NNS
cord-308095-mehmk49a	13	9	,	,	,
cord-308095-mehmk49a	13	10	and	and	CC
cord-308095-mehmk49a	13	11	drained	drain	VBD
cord-308095-mehmk49a	13	12	the	the	DT
cord-308095-mehmk49a	13	13	resources	resource	NNS
cord-308095-mehmk49a	13	14	of	of	IN
cord-308095-mehmk49a	13	15	social	social	JJ
cord-308095-mehmk49a	13	16	services	service	NNS
cord-308095-mehmk49a	13	17	.	.	.
cord-308095-mehmk49a	14	1	Opioid	opioid	JJ
cord-308095-mehmk49a	14	2	addiction	addiction	NN
cord-308095-mehmk49a	14	3	and	and	CC
cord-308095-mehmk49a	14	4	deaths	death	NNS
cord-308095-mehmk49a	14	5	impose	impose	VBP
cord-308095-mehmk49a	14	6	societal	societal	JJ
cord-308095-mehmk49a	14	7	costs	cost	NNS
cord-308095-mehmk49a	14	8	that	that	WDT
cord-308095-mehmk49a	14	9	,	,	,
cord-308095-mehmk49a	14	10	in	in	IN
cord-308095-mehmk49a	14	11	the	the	DT
cord-308095-mehmk49a	14	12	United	United	NNP
cord-308095-mehmk49a	14	13	States	States	NNP
cord-308095-mehmk49a	14	14	alone	alone	RB
cord-308095-mehmk49a	14	15	,	,	,
cord-308095-mehmk49a	14	16	are	be	VBP
cord-308095-mehmk49a	14	17	now	now	RB
cord-308095-mehmk49a	14	18	measured	measure	VBN
cord-308095-mehmk49a	14	19	in	in	IN
cord-308095-mehmk49a	14	20	the	the	DT
cord-308095-mehmk49a	14	21	trillions	trillion	NNS
cord-308095-mehmk49a	14	22	of	of	IN
cord-308095-mehmk49a	14	23	dollars	dollar	NNS
cord-308095-mehmk49a	14	24	(	(	-LRB-
cord-308095-mehmk49a	14	25	CEA	CEA	NNP
cord-308095-mehmk49a	14	26	2017	2017	CD
cord-308095-mehmk49a	14	27	(	(	-LRB-
cord-308095-mehmk49a	14	28	CEA	CEA	NNP
cord-308095-mehmk49a	14	29	,	,	,
cord-308095-mehmk49a	14	30	2019	2019	CD
cord-308095-mehmk49a	14	31	,	,	,
cord-308095-mehmk49a	14	32	with	with	IN
cord-308095-mehmk49a	14	33	many	many	JJ
cord-308095-mehmk49a	14	34	of	of	IN
cord-308095-mehmk49a	14	35	these	these	DT
cord-308095-mehmk49a	14	36	costs	cost	NNS
cord-308095-mehmk49a	14	37	falling	fall	VBG
cord-308095-mehmk49a	14	38	on	on	IN
cord-308095-mehmk49a	14	39	underfunded	underfunded	JJ
cord-308095-mehmk49a	14	40	local	local	JJ
cord-308095-mehmk49a	14	41	and	and	CC
cord-308095-mehmk49a	14	42	state	state	NN
cord-308095-mehmk49a	14	43	government	government	NN
cord-308095-mehmk49a	14	44	agencies	agency	NNS
cord-308095-mehmk49a	14	45	.	.	.
cord-308095-mehmk49a	15	1	In	in	IN
cord-308095-mehmk49a	15	2	recent	recent	JJ
cord-308095-mehmk49a	15	3	months	month	NNS
cord-308095-mehmk49a	15	4	,	,	,
cord-308095-mehmk49a	15	5	much	much	JJ
cord-308095-mehmk49a	15	6	evidence	evidence	NN
cord-308095-mehmk49a	15	7	has	have	VBZ
cord-308095-mehmk49a	15	8	emerged	emerge	VBN
cord-308095-mehmk49a	15	9	demonstrating	demonstrate	VBG
cord-308095-mehmk49a	15	10	the	the	DT
cord-308095-mehmk49a	15	11	ways	way	NNS
cord-308095-mehmk49a	15	12	in	in	IN
cord-308095-mehmk49a	15	13	which	which	WDT
cord-308095-mehmk49a	15	14	opioid	opioid	JJ
cord-308095-mehmk49a	15	15	companies	company	NNS
cord-308095-mehmk49a	15	16	'	'	POS
cord-308095-mehmk49a	15	17	strategies	strategy	NNS
cord-308095-mehmk49a	15	18	of	of	IN
cord-308095-mehmk49a	15	19	influence	influence	NN
cord-308095-mehmk49a	15	20	fuelled	fuel	VBD
cord-308095-mehmk49a	15	21	the	the	DT
cord-308095-mehmk49a	15	22	crisis	crisis	NN
cord-308095-mehmk49a	15	23	.	.	.
cord-308095-mehmk49a	16	1	Companies	company	NNS
cord-308095-mehmk49a	16	2	built	build	VBD
cord-308095-mehmk49a	16	3	relationships	relationship	NNS
cord-308095-mehmk49a	16	4	with	with	IN
cord-308095-mehmk49a	16	5	a	a	DT
cord-308095-mehmk49a	16	6	variety	variety	NN
cord-308095-mehmk49a	16	7	of	of	IN
cord-308095-mehmk49a	16	8	individuals	individual	NNS
cord-308095-mehmk49a	16	9	and	and	CC
cord-308095-mehmk49a	16	10	institutions	institution	NNS
cord-308095-mehmk49a	16	11	:	:	:
cord-308095-mehmk49a	16	12	physicians	physician	NNS
cord-308095-mehmk49a	16	13	,	,	,
cord-308095-mehmk49a	16	14	professional	professional	JJ
cord-308095-mehmk49a	16	15	societies	society	NNS
cord-308095-mehmk49a	16	16	,	,	,
cord-308095-mehmk49a	16	17	patient	patient	JJ
cord-308095-mehmk49a	16	18	advocacy	advocacy	NN
cord-308095-mehmk49a	16	19	organizations	organization	NNS
cord-308095-mehmk49a	16	20	,	,	,
cord-308095-mehmk49a	16	21	research	research	NN
cord-308095-mehmk49a	16	22	universities	university	NNS
cord-308095-mehmk49a	16	23	,	,	,
cord-308095-mehmk49a	16	24	public	public	JJ
cord-308095-mehmk49a	16	25	health	health	NN
cord-308095-mehmk49a	16	26	agencies	agency	NNS
cord-308095-mehmk49a	16	27	,	,	,
cord-308095-mehmk49a	16	28	and	and	CC
cord-308095-mehmk49a	16	29	legislators	legislator	NNS
cord-308095-mehmk49a	16	30	.	.	.
cord-308095-mehmk49a	17	1	Although	although	IN
cord-308095-mehmk49a	17	2	the	the	DT
cord-308095-mehmk49a	17	3	impact	impact	NN
cord-308095-mehmk49a	17	4	of	of	IN
cord-308095-mehmk49a	17	5	these	these	DT
cord-308095-mehmk49a	17	6	strategies	strategy	NNS
cord-308095-mehmk49a	17	7	has	have	VBZ
cord-308095-mehmk49a	17	8	been	be	VBN
cord-308095-mehmk49a	17	9	most	most	RBS
cord-308095-mehmk49a	17	10	closely	closely	RB
cord-308095-mehmk49a	17	11	observed	observe	VBN
cord-308095-mehmk49a	17	12	in	in	IN
cord-308095-mehmk49a	17	13	North	North	NNP
cord-308095-mehmk49a	17	14	America	America	NNP
cord-308095-mehmk49a	17	15	,	,	,
cord-308095-mehmk49a	17	16	their	-PRON-	PRP$
cord-308095-mehmk49a	17	17	reach	reach	NN
cord-308095-mehmk49a	17	18	is	be	VBZ
cord-308095-mehmk49a	17	19	international	international	JJ
cord-308095-mehmk49a	17	20	.	.	.
cord-308095-mehmk49a	18	1	Previous	previous	JJ
cord-308095-mehmk49a	18	2	analyses	analysis	NNS
cord-308095-mehmk49a	18	3	of	of	IN
cord-308095-mehmk49a	18	4	corporate	corporate	JJ
cord-308095-mehmk49a	18	5	influence	influence	NN
cord-308095-mehmk49a	18	6	in	in	IN
cord-308095-mehmk49a	18	7	the	the	DT
cord-308095-mehmk49a	18	8	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	18	9	sector	sector	NN
cord-308095-mehmk49a	18	10	make	make	VBP
cord-308095-mehmk49a	18	11	clear	clear	JJ
cord-308095-mehmk49a	18	12	that	that	IN
cord-308095-mehmk49a	18	13	the	the	DT
cord-308095-mehmk49a	18	14	opioid	opioid	JJ
cord-308095-mehmk49a	18	15	companies	company	NNS
cord-308095-mehmk49a	18	16	'	'	POS
cord-308095-mehmk49a	18	17	strategies	strategy	NNS
cord-308095-mehmk49a	18	18	are	be	VBP
cord-308095-mehmk49a	18	19	not	not	RB
cord-308095-mehmk49a	18	20	entirely	entirely	RB
cord-308095-mehmk49a	18	21	novel	novel	JJ
cord-308095-mehmk49a	18	22	(	(	-LRB-
cord-308095-mehmk49a	18	23	see	see	VB
cord-308095-mehmk49a	18	24	,	,	,
cord-308095-mehmk49a	18	25	e.g.	e.g.	RB
cord-308095-mehmk49a	18	26	,	,	,
cord-308095-mehmk49a	18	27	Applbaum	Applbaum	NNP
cord-308095-mehmk49a	18	28	2009	2009	CD
cord-308095-mehmk49a	18	29	)	)	-RRB-
cord-308095-mehmk49a	18	30	.	.	.
cord-308095-mehmk49a	19	1	Some	some	DT
cord-308095-mehmk49a	19	2	of	of	IN
cord-308095-mehmk49a	19	3	the	the	DT
cord-308095-mehmk49a	19	4	leading	lead	VBG
cord-308095-mehmk49a	19	5	case	case	NN
cord-308095-mehmk49a	19	6	studies	study	NNS
cord-308095-mehmk49a	19	7	should	should	MD
cord-308095-mehmk49a	19	8	have	have	VB
cord-308095-mehmk49a	19	9	been	be	VBN
cord-308095-mehmk49a	19	10	cautionary	cautionary	JJ
cord-308095-mehmk49a	19	11	tales	tale	NNS
cord-308095-mehmk49a	19	12	because	because	IN
cord-308095-mehmk49a	19	13	they	-PRON-	PRP
cord-308095-mehmk49a	19	14	also	also	RB
cord-308095-mehmk49a	19	15	involved	involve	VBD
cord-308095-mehmk49a	19	16	prescription	prescription	NN
cord-308095-mehmk49a	19	17	medicines	medicine	NNS
cord-308095-mehmk49a	19	18	for	for	IN
cord-308095-mehmk49a	19	19	the	the	DT
cord-308095-mehmk49a	19	20	treatment	treatment	NN
cord-308095-mehmk49a	19	21	of	of	IN
cord-308095-mehmk49a	19	22	pain	pain	NN
cord-308095-mehmk49a	19	23	(	(	-LRB-
cord-308095-mehmk49a	19	24	see	see	UH
cord-308095-mehmk49a	19	25	,	,	,
cord-308095-mehmk49a	19	26	e.g.	e.g.	RB
cord-308095-mehmk49a	19	27	,	,	,
cord-308095-mehmk49a	19	28	Steinman	Steinman	NNP
cord-308095-mehmk49a	19	29	et	et	NNP
cord-308095-mehmk49a	19	30	al	al	NNP
cord-308095-mehmk49a	19	31	.	.	.
cord-308095-mehmk49a	19	32	2006	2006	CD
cord-308095-mehmk49a	19	33	;	;	:
cord-308095-mehmk49a	19	34	Ross	Ross	NNP
cord-308095-mehmk49a	19	35	et	et	NNP
cord-308095-mehmk49a	19	36	al	al	NNP
cord-308095-mehmk49a	19	37	.	.	NNP
cord-308095-mehmk49a	19	38	2008	2008	CD
cord-308095-mehmk49a	19	39	)	)	-RRB-
cord-308095-mehmk49a	19	40	.	.	.
cord-308095-mehmk49a	20	1	A	a	DT
cord-308095-mehmk49a	20	2	number	number	NN
cord-308095-mehmk49a	20	3	of	of	IN
cord-308095-mehmk49a	20	4	corporate	corporate	JJ
cord-308095-mehmk49a	20	5	strategies	strategy	NNS
cord-308095-mehmk49a	20	6	were	be	VBD
cord-308095-mehmk49a	20	7	honed	hone	VBN
cord-308095-mehmk49a	20	8	within	within	IN
cord-308095-mehmk49a	20	9	the	the	DT
cord-308095-mehmk49a	20	10	drug	drug	NN
cord-308095-mehmk49a	20	11	and	and	CC
cord-308095-mehmk49a	20	12	medical	medical	JJ
cord-308095-mehmk49a	20	13	device	device	NN
cord-308095-mehmk49a	20	14	sector	sector	NN
cord-308095-mehmk49a	20	15	-	-	,
cord-308095-mehmk49a	20	16	for	for	IN
cord-308095-mehmk49a	20	17	example	example	NN
cord-308095-mehmk49a	20	18	,	,	,
cord-308095-mehmk49a	20	19	hiring	hire	VBG
cord-308095-mehmk49a	20	20	"	"	``
cord-308095-mehmk49a	20	21	medical	medical	JJ
cord-308095-mehmk49a	20	22	education	education	NN
cord-308095-mehmk49a	20	23	and	and	CC
cord-308095-mehmk49a	20	24	communication	communication	NN
cord-308095-mehmk49a	20	25	companies	company	NNS
cord-308095-mehmk49a	20	26	"	"	''
cord-308095-mehmk49a	20	27	(	(	-LRB-
cord-308095-mehmk49a	20	28	or	or	CC
cord-308095-mehmk49a	20	29	MECCs	mecc	NNS
cord-308095-mehmk49a	20	30	)	)	-RRB-
cord-308095-mehmk49a	20	31	to	to	TO
cord-308095-mehmk49a	20	32	shape	shape	VB
cord-308095-mehmk49a	20	33	the	the	DT
cord-308095-mehmk49a	20	34	evidence	evidence	NN
cord-308095-mehmk49a	20	35	required	require	VBN
cord-308095-mehmk49a	20	36	for	for	IN
cord-308095-mehmk49a	20	37	the	the	DT
cord-308095-mehmk49a	20	38	approval	approval	NN
cord-308095-mehmk49a	20	39	and	and	CC
cord-308095-mehmk49a	20	40	promotion	promotion	NN
cord-308095-mehmk49a	20	41	of	of	IN
cord-308095-mehmk49a	20	42	new	new	JJ
cord-308095-mehmk49a	20	43	products	product	NNS
cord-308095-mehmk49a	20	44	and	and	CC
cord-308095-mehmk49a	20	45	recruiting	recruit	VBG
cord-308095-mehmk49a	20	46	physicians	physician	NNS
cord-308095-mehmk49a	20	47	as	as	IN
cord-308095-mehmk49a	20	48	"	"	``
cord-308095-mehmk49a	20	49	key	key	JJ
cord-308095-mehmk49a	20	50	opinion	opinion	NN
cord-308095-mehmk49a	20	51	leaders	leader	NNS
cord-308095-mehmk49a	20	52	"	"	''
cord-308095-mehmk49a	20	53	(	(	-LRB-
cord-308095-mehmk49a	20	54	KOLs	KOLs	NNP
cord-308095-mehmk49a	20	55	)	)	-RRB-
cord-308095-mehmk49a	20	56	,	,	,
cord-308095-mehmk49a	20	57	a	a	DT
cord-308095-mehmk49a	20	58	title	title	NN
cord-308095-mehmk49a	20	59	designed	design	VBN
cord-308095-mehmk49a	20	60	to	to	TO
cord-308095-mehmk49a	20	61	be	be	VB
cord-308095-mehmk49a	20	62	psychologically	psychologically	RB
cord-308095-mehmk49a	20	63	rewarding	rewarding	JJ
cord-308095-mehmk49a	20	64	,	,	,
cord-308095-mehmk49a	20	65	and	and	CC
cord-308095-mehmk49a	20	66	paying	pay	VBG
cord-308095-mehmk49a	20	67	them	-PRON-	PRP
cord-308095-mehmk49a	20	68	to	to	TO
cord-308095-mehmk49a	20	69	deliver	deliver	VB
cord-308095-mehmk49a	20	70	scripted	script	VBN
cord-308095-mehmk49a	20	71	promotional	promotional	JJ
cord-308095-mehmk49a	20	72	presentations	presentation	NNS
cord-308095-mehmk49a	20	73	to	to	IN
cord-308095-mehmk49a	20	74	their	-PRON-	PRP$
cord-308095-mehmk49a	20	75	peers	peer	NNS
cord-308095-mehmk49a	20	76	(	(	-LRB-
cord-308095-mehmk49a	20	77	Sismondo	Sismondo	NNP
cord-308095-mehmk49a	20	78	2018	2018	CD
cord-308095-mehmk49a	20	79	;	;	:
cord-308095-mehmk49a	20	80	Sah	Sah	NNP
cord-308095-mehmk49a	20	81	and	and	CC
cord-308095-mehmk49a	20	82	Fugh	Fugh	NNP
cord-308095-mehmk49a	20	83	-	-	HYPH
cord-308095-mehmk49a	20	84	Berman	Berman	NNP
cord-308095-mehmk49a	20	85	2013	2013	CD
cord-308095-mehmk49a	20	86	)	)	-RRB-
cord-308095-mehmk49a	20	87	.	.	.
cord-308095-mehmk49a	21	1	But	but	CC
cord-308095-mehmk49a	21	2	many	many	JJ
cord-308095-mehmk49a	21	3	strategies	strategy	NNS
cord-308095-mehmk49a	21	4	were	be	VBD
cord-308095-mehmk49a	21	5	developed	develop	VBN
cord-308095-mehmk49a	21	6	with	with	IN
cord-308095-mehmk49a	21	7	the	the	DT
cord-308095-mehmk49a	21	8	advice	advice	NN
cord-308095-mehmk49a	21	9	and	and	CC
cord-308095-mehmk49a	21	10	guidance	guidance	NN
cord-308095-mehmk49a	21	11	of	of	IN
cord-308095-mehmk49a	21	12	the	the	DT
cord-308095-mehmk49a	21	13	kinds	kind	NNS
cord-308095-mehmk49a	21	14	of	of	IN
cord-308095-mehmk49a	21	15	entities	entity	NNS
cord-308095-mehmk49a	21	16	-	-	:
cord-308095-mehmk49a	21	17	public	public	JJ
cord-308095-mehmk49a	21	18	relations	relation	NNS
cord-308095-mehmk49a	21	19	,	,	,
cord-308095-mehmk49a	21	20	management	management	NN
cord-308095-mehmk49a	21	21	consultancy	consultancy	NN
cord-308095-mehmk49a	21	22	,	,	,
cord-308095-mehmk49a	21	23	and	and	CC
cord-308095-mehmk49a	22	1	crisis	crisis	NN
cord-308095-mehmk49a	22	2	management	management	NN
cord-308095-mehmk49a	22	3	firmsthat	firmsthat	NNP
cord-308095-mehmk49a	22	4	were	be	VBD
cord-308095-mehmk49a	22	5	previously	previously	RB
cord-308095-mehmk49a	22	6	hired	hire	VBN
cord-308095-mehmk49a	22	7	by	by	IN
cord-308095-mehmk49a	22	8	tobacco	tobacco	NN
cord-308095-mehmk49a	22	9	companies	company	NNS
cord-308095-mehmk49a	22	10	and	and	CC
cord-308095-mehmk49a	22	11	other	other	JJ
cord-308095-mehmk49a	22	12	industries	industry	NNS
cord-308095-mehmk49a	22	13	to	to	TO
cord-308095-mehmk49a	22	14	cast	cast	VB
cord-308095-mehmk49a	22	15	doubt	doubt	NN
cord-308095-mehmk49a	22	16	on	on	IN
cord-308095-mehmk49a	22	17	the	the	DT
cord-308095-mehmk49a	22	18	harms	harm	NNS
cord-308095-mehmk49a	22	19	caused	cause	VBN
cord-308095-mehmk49a	22	20	by	by	IN
cord-308095-mehmk49a	22	21	their	-PRON-	PRP$
cord-308095-mehmk49a	22	22	products	product	NNS
cord-308095-mehmk49a	22	23	or	or	CC
cord-308095-mehmk49a	22	24	commercial	commercial	JJ
cord-308095-mehmk49a	22	25	practices	practice	NNS
cord-308095-mehmk49a	22	26	(	(	-LRB-
cord-308095-mehmk49a	22	27	see	see	VB
cord-308095-mehmk49a	22	28	,	,	,
cord-308095-mehmk49a	22	29	e.g.	e.g.	RB
cord-308095-mehmk49a	22	30	,	,	,
cord-308095-mehmk49a	22	31	Michaels	Michaels	NNP
cord-308095-mehmk49a	22	32	2008	2008	CD
cord-308095-mehmk49a	22	33	;	;	:
cord-308095-mehmk49a	22	34	Armstrong	Armstrong	NNP
cord-308095-mehmk49a	22	35	2019	2019	CD
cord-308095-mehmk49a	22	36	;	;	:
cord-308095-mehmk49a	22	37	Michaels	Michaels	NNP
cord-308095-mehmk49a	22	38	2020	2020	CD
cord-308095-mehmk49a	22	39	)	)	-RRB-
cord-308095-mehmk49a	22	40	.	.	.
cord-308095-mehmk49a	23	1	These	these	DT
cord-308095-mehmk49a	23	2	strategies	strategy	NNS
cord-308095-mehmk49a	23	3	are	be	VBP
cord-308095-mehmk49a	23	4	both	both	DT
cord-308095-mehmk49a	23	5	extensive	extensive	JJ
cord-308095-mehmk49a	23	6	and	and	CC
cord-308095-mehmk49a	23	7	comprehensive	comprehensive	JJ
cord-308095-mehmk49a	23	8	,	,	,
cord-308095-mehmk49a	23	9	involving	involve	VBG
cord-308095-mehmk49a	23	10	webs	web	NNS
cord-308095-mehmk49a	23	11	or	or	CC
cord-308095-mehmk49a	23	12	networks	network	NNS
cord-308095-mehmk49a	23	13	of	of	IN
cord-308095-mehmk49a	23	14	relationships	relationship	NNS
cord-308095-mehmk49a	23	15	with	with	IN
cord-308095-mehmk49a	23	16	government	government	NN
cord-308095-mehmk49a	23	17	,	,	,
cord-308095-mehmk49a	23	18	the	the	DT
cord-308095-mehmk49a	23	19	academy	academy	NN
cord-308095-mehmk49a	23	20	,	,	,
cord-308095-mehmk49a	23	21	and	and	CC
cord-308095-mehmk49a	23	22	civil	civil	JJ
cord-308095-mehmk49a	23	23	society	society	NN
cord-308095-mehmk49a	23	24	(	(	-LRB-
cord-308095-mehmk49a	23	25	Marks	Marks	NNP
cord-308095-mehmk49a	23	26	2019a	2019a	CD
cord-308095-mehmk49a	23	27	)	)	-RRB-
cord-308095-mehmk49a	23	28	.	.	.
cord-308095-mehmk49a	24	1	Although	although	IN
cord-308095-mehmk49a	24	2	relationships	relationship	NNS
cord-308095-mehmk49a	24	3	are	be	VBP
cord-308095-mehmk49a	24	4	widespread	widespread	JJ
cord-308095-mehmk49a	24	5	at	at	IN
cord-308095-mehmk49a	24	6	institutional	institutional	JJ
cord-308095-mehmk49a	24	7	levels	level	NNS
cord-308095-mehmk49a	24	8	,	,	,
cord-308095-mehmk49a	24	9	media	medium	NNS
cord-308095-mehmk49a	24	10	attention	attention	NN
cord-308095-mehmk49a	24	11	tends	tend	VBZ
cord-308095-mehmk49a	24	12	to	to	TO
cord-308095-mehmk49a	24	13	focus	focus	VB
cord-308095-mehmk49a	24	14	on	on	IN
cord-308095-mehmk49a	24	15	individualsmost	individualsmost	NN
cord-308095-mehmk49a	24	16	commonly	commonly	RB
cord-308095-mehmk49a	24	17	,	,	,
cord-308095-mehmk49a	24	18	excoriating	excoriate	VBG
cord-308095-mehmk49a	24	19	doctors	doctor	NNS
cord-308095-mehmk49a	24	20	and	and	CC
cord-308095-mehmk49a	24	21	researchers	researcher	NNS
cord-308095-mehmk49a	24	22	for	for	IN
cord-308095-mehmk49a	24	23	failing	fail	VBG
cord-308095-mehmk49a	24	24	to	to	TO
cord-308095-mehmk49a	24	25	disclose	disclose	VB
cord-308095-mehmk49a	24	26	that	that	IN
cord-308095-mehmk49a	24	27	they	-PRON-	PRP
cord-308095-mehmk49a	24	28	have	have	VBP
cord-308095-mehmk49a	24	29	industry	industry	NN
cord-308095-mehmk49a	24	30	-	-	HYPH
cord-308095-mehmk49a	24	31	related	relate	VBN
cord-308095-mehmk49a	24	32	financial	financial	JJ
cord-308095-mehmk49a	24	33	conflicts	conflict	NNS
cord-308095-mehmk49a	24	34	of	of	IN
cord-308095-mehmk49a	24	35	interest	interest	NN
cord-308095-mehmk49a	24	36	.	.	.
cord-308095-mehmk49a	25	1	The	the	DT
cord-308095-mehmk49a	25	2	focus	focus	NN
cord-308095-mehmk49a	25	3	on	on	IN
cord-308095-mehmk49a	25	4	"	"	``
cord-308095-mehmk49a	25	5	naming	name	VBG
cord-308095-mehmk49a	25	6	and	and	CC
cord-308095-mehmk49a	25	7	shaming	shame	VBG
cord-308095-mehmk49a	25	8	"	"	``
cord-308095-mehmk49a	25	9	individuals	individual	NNS
cord-308095-mehmk49a	25	10	,	,	,
cord-308095-mehmk49a	25	11	even	even	RB
cord-308095-mehmk49a	25	12	when	when	WRB
cord-308095-mehmk49a	25	13	warranted	warrant	VBN
cord-308095-mehmk49a	25	14	,	,	,
cord-308095-mehmk49a	25	15	threatens	threaten	VBZ
cord-308095-mehmk49a	25	16	to	to	TO
cord-308095-mehmk49a	25	17	downplay	downplay	VB
cord-308095-mehmk49a	25	18	or	or	CC
cord-308095-mehmk49a	25	19	ignore	ignore	VB
cord-308095-mehmk49a	25	20	a	a	DT
cord-308095-mehmk49a	25	21	systemic	systemic	JJ
cord-308095-mehmk49a	25	22	problem	problem	NN
cord-308095-mehmk49a	25	23	:	:	:
cord-308095-mehmk49a	25	24	institutional	institutional	JJ
cord-308095-mehmk49a	25	25	and	and	CC
cord-308095-mehmk49a	25	26	societal	societal	JJ
cord-308095-mehmk49a	25	27	cultures	culture	NNS
cord-308095-mehmk49a	25	28	and	and	CC
cord-308095-mehmk49a	25	29	practices	practice	NNS
cord-308095-mehmk49a	25	30	that	that	WDT
cord-308095-mehmk49a	25	31	embrace	embrace	VBP
cord-308095-mehmk49a	25	32	partnership	partnership	NN
cord-308095-mehmk49a	25	33	with	with	IN
cord-308095-mehmk49a	25	34	industry	industry	NN
cord-308095-mehmk49a	25	35	and	and	CC
cord-308095-mehmk49a	25	36	,	,	,
cord-308095-mehmk49a	25	37	wittingly	wittingly	RB
cord-308095-mehmk49a	25	38	or	or	CC
cord-308095-mehmk49a	25	39	unwittingly	unwittingly	RB
cord-308095-mehmk49a	25	40	,	,	,
cord-308095-mehmk49a	25	41	promote	promote	VB
cord-308095-mehmk49a	25	42	companies	company	NNS
cord-308095-mehmk49a	25	43	'	'	POS
cord-308095-mehmk49a	25	44	products	product	NNS
cord-308095-mehmk49a	25	45	,	,	,
cord-308095-mehmk49a	25	46	increase	increase	VB
cord-308095-mehmk49a	25	47	brand	brand	NN
cord-308095-mehmk49a	25	48	loyalty	loyalty	NN
cord-308095-mehmk49a	25	49	,	,	,
cord-308095-mehmk49a	25	50	burnish	burnish	VB
cord-308095-mehmk49a	25	51	corporate	corporate	JJ
cord-308095-mehmk49a	25	52	reputations	reputation	NNS
cord-308095-mehmk49a	25	53	,	,	,
cord-308095-mehmk49a	25	54	defuse	defuse	VB
cord-308095-mehmk49a	25	55	support	support	NN
cord-308095-mehmk49a	25	56	for	for	IN
cord-308095-mehmk49a	25	57	the	the	DT
cord-308095-mehmk49a	25	58	regulation	regulation	NN
cord-308095-mehmk49a	25	59	of	of	IN
cord-308095-mehmk49a	25	60	companies	company	NNS
cord-308095-mehmk49a	25	61	'	'	POS
cord-308095-mehmk49a	25	62	products	product	NNS
cord-308095-mehmk49a	25	63	and	and	CC
cord-308095-mehmk49a	25	64	marketing	marketing	NN
cord-308095-mehmk49a	25	65	practices	practice	NNS
cord-308095-mehmk49a	25	66	,	,	,
cord-308095-mehmk49a	25	67	and	and	CC
cord-308095-mehmk49a	25	68	reinforce	reinforce	VB
cord-308095-mehmk49a	25	69	the	the	DT
cord-308095-mehmk49a	25	70	framing	framing	NN
cord-308095-mehmk49a	25	71	of	of	IN
cord-308095-mehmk49a	25	72	public	public	JJ
cord-308095-mehmk49a	25	73	health	health	NN
cord-308095-mehmk49a	25	74	problems	problem	NNS
cord-308095-mehmk49a	25	75	and	and	CC
cord-308095-mehmk49a	25	76	their	-PRON-	PRP$
cord-308095-mehmk49a	25	77	solutions	solution	NNS
cord-308095-mehmk49a	25	78	in	in	IN
cord-308095-mehmk49a	25	79	ways	way	NNS
cord-308095-mehmk49a	25	80	that	that	WDT
cord-308095-mehmk49a	25	81	are	be	VBP
cord-308095-mehmk49a	25	82	least	least	RBS
cord-308095-mehmk49a	25	83	threatening	threaten	VBG
cord-308095-mehmk49a	25	84	to	to	IN
cord-308095-mehmk49a	25	85	the	the	DT
cord-308095-mehmk49a	25	86	commercial	commercial	JJ
cord-308095-mehmk49a	25	87	interests	interest	NNS
cord-308095-mehmk49a	25	88	of	of	IN
cord-308095-mehmk49a	25	89	those	those	DT
cord-308095-mehmk49a	25	90	companies	company	NNS
cord-308095-mehmk49a	25	91	(	(	-LRB-
cord-308095-mehmk49a	25	92	Marks	Marks	NNP
cord-308095-mehmk49a	25	93	2019a	2019a	CD
cord-308095-mehmk49a	25	94	)	)	-RRB-
cord-308095-mehmk49a	25	95	.	.	.
cord-308095-mehmk49a	26	1	Nowhere	nowhere	RB
cord-308095-mehmk49a	26	2	is	be	VBZ
cord-308095-mehmk49a	26	3	this	this	DT
cord-308095-mehmk49a	26	4	more	more	RBR
cord-308095-mehmk49a	26	5	evident	evident	JJ
cord-308095-mehmk49a	26	6	than	than	IN
cord-308095-mehmk49a	26	7	in	in	IN
cord-308095-mehmk49a	26	8	the	the	DT
cord-308095-mehmk49a	26	9	origins	origin	NNS
cord-308095-mehmk49a	26	10	of	of	IN
cord-308095-mehmk49a	26	11	and	and	CC
cord-308095-mehmk49a	26	12	responses	response	NNS
cord-308095-mehmk49a	26	13	to	to	IN
cord-308095-mehmk49a	26	14	the	the	DT
cord-308095-mehmk49a	26	15	opioid	opioid	JJ
cord-308095-mehmk49a	26	16	crisis	crisis	NN
cord-308095-mehmk49a	26	17	,	,	,
cord-308095-mehmk49a	26	18	where	where	WRB
cord-308095-mehmk49a	26	19	collaborative	collaborative	JJ
cord-308095-mehmk49a	26	20	efforts	effort	NNS
cord-308095-mehmk49a	26	21	to	to	TO
cord-308095-mehmk49a	26	22	address	address	VB
cord-308095-mehmk49a	26	23	pain	pain	NN
cord-308095-mehmk49a	26	24	management	management	NN
cord-308095-mehmk49a	26	25	-	-	:
cord-308095-mehmk49a	26	26	an	an	DT
cord-308095-mehmk49a	26	27	important	important	JJ
cord-308095-mehmk49a	26	28	and	and	CC
cord-308095-mehmk49a	26	29	historically	historically	RB
cord-308095-mehmk49a	26	30	neglected	neglect	VBN
cord-308095-mehmk49a	26	31	problem	problem	NN
cord-308095-mehmk49a	26	32	in	in	IN
cord-308095-mehmk49a	26	33	medicine	medicine	NN
cord-308095-mehmk49a	26	34	and	and	CC
cord-308095-mehmk49a	26	35	public	public	JJ
cord-308095-mehmk49a	26	36	health	health	NN
cord-308095-mehmk49a	26	37	-	-	,
cord-308095-mehmk49a	26	38	have	have	VBP
cord-308095-mehmk49a	26	39	profoundly	profoundly	RB
cord-308095-mehmk49a	26	40	exacerbated	exacerbate	VBN
cord-308095-mehmk49a	26	41	another	another	DT
cord-308095-mehmk49a	26	42	major	major	JJ
cord-308095-mehmk49a	26	43	public	public	JJ
cord-308095-mehmk49a	26	44	health	health	NN
cord-308095-mehmk49a	26	45	challenge	challenge	NN
cord-308095-mehmk49a	26	46	,	,	,
cord-308095-mehmk49a	26	47	addiction	addiction	NN
cord-308095-mehmk49a	26	48	(	(	-LRB-
cord-308095-mehmk49a	26	49	see	see	VB
cord-308095-mehmk49a	26	50	,	,	,
cord-308095-mehmk49a	26	51	e.g.	e.g.	RB
cord-308095-mehmk49a	26	52	,	,	,
cord-308095-mehmk49a	26	53	Meier	Meier	NNP
cord-308095-mehmk49a	26	54	2018	2018	CD
cord-308095-mehmk49a	26	55	;	;	:
cord-308095-mehmk49a	26	56	Macy	Macy	NNP
cord-308095-mehmk49a	26	57	2018	2018	CD
cord-308095-mehmk49a	26	58	;	;	:
cord-308095-mehmk49a	26	59	McGreal	McGreal	NNP
cord-308095-mehmk49a	26	60	2018	2018	CD
cord-308095-mehmk49a	26	61	)	)	-RRB-
cord-308095-mehmk49a	26	62	.	.	.
cord-308095-mehmk49a	27	1	Opioid	opioid	JJ
cord-308095-mehmk49a	27	2	companies	company	NNS
cord-308095-mehmk49a	27	3	'	'	POS
cord-308095-mehmk49a	27	4	strategies	strategy	NNS
cord-308095-mehmk49a	27	5	were	be	VBD
cord-308095-mehmk49a	27	6	designed	design	VBN
cord-308095-mehmk49a	27	7	to	to	TO
cord-308095-mehmk49a	27	8	expand	expand	VB
cord-308095-mehmk49a	27	9	the	the	DT
cord-308095-mehmk49a	27	10	prescribing	prescribing	NN
cord-308095-mehmk49a	27	11	of	of	IN
cord-308095-mehmk49a	27	12	opioids	opioid	NNS
cord-308095-mehmk49a	27	13	from	from	IN
cord-308095-mehmk49a	27	14	terminal	terminal	JJ
cord-308095-mehmk49a	27	15	cancer	cancer	NN
cord-308095-mehmk49a	27	16	patients	patient	NNS
cord-308095-mehmk49a	27	17	to	to	IN
cord-308095-mehmk49a	27	18	a	a	DT
cord-308095-mehmk49a	27	19	larger	large	JJR
cord-308095-mehmk49a	27	20	and	and	CC
cord-308095-mehmk49a	27	21	more	more	JJR
cord-308095-mehmk49a	27	22	lucrative	lucrative	JJ
cord-308095-mehmk49a	27	23	population	population	NN
cord-308095-mehmk49a	27	24	:	:	:
cord-308095-mehmk49a	27	25	patients	patient	NNS
cord-308095-mehmk49a	27	26	with	with	IN
cord-308095-mehmk49a	27	27	non	non	JJ
cord-308095-mehmk49a	27	28	-	-	JJ
cord-308095-mehmk49a	27	29	cancer	cancer	NN
cord-308095-mehmk49a	27	30	-	-	HYPH
cord-308095-mehmk49a	27	31	related	relate	VBN
cord-308095-mehmk49a	27	32	acute	acute	JJ
cord-308095-mehmk49a	27	33	and	and	CC
cord-308095-mehmk49a	27	34	chronic	chronic	JJ
cord-308095-mehmk49a	27	35	paindespite	paindespite	NN
cord-308095-mehmk49a	27	36	lack	lack	NN
cord-308095-mehmk49a	27	37	of	of	IN
cord-308095-mehmk49a	27	38	evidence	evidence	NN
cord-308095-mehmk49a	27	39	of	of	IN
cord-308095-mehmk49a	27	40	efficacy	efficacy	NN
cord-308095-mehmk49a	27	41	in	in	IN
cord-308095-mehmk49a	27	42	relation	relation	NN
cord-308095-mehmk49a	27	43	to	to	IN
cord-308095-mehmk49a	27	44	the	the	DT
cord-308095-mehmk49a	27	45	latter	latter	JJ
cord-308095-mehmk49a	27	46	.	.	.
cord-308095-mehmk49a	28	1	Companies	company	NNS
cord-308095-mehmk49a	28	2	promoted	promote	VBD
cord-308095-mehmk49a	28	3	-	-	:
cord-308095-mehmk49a	28	4	some	some	DT
cord-308095-mehmk49a	28	5	would	would	MD
cord-308095-mehmk49a	28	6	say	say	VB
cord-308095-mehmk49a	28	7	pushed	push	VBN
cord-308095-mehmk49a	28	8	-	-	HYPH
cord-308095-mehmk49a	28	9	higher	high	JJR
cord-308095-mehmk49a	28	10	doses	dose	NNS
cord-308095-mehmk49a	28	11	of	of	IN
cord-308095-mehmk49a	28	12	opioids	opioid	NNS
cord-308095-mehmk49a	28	13	in	in	IN
cord-308095-mehmk49a	28	14	order	order	NN
cord-308095-mehmk49a	28	15	to	to	TO
cord-308095-mehmk49a	28	16	increase	increase	VB
cord-308095-mehmk49a	28	17	profits	profit	NNS
cord-308095-mehmk49a	28	18	further	further	RB
cord-308095-mehmk49a	28	19	,	,	,
cord-308095-mehmk49a	28	20	while	while	IN
cord-308095-mehmk49a	28	21	downplaying	downplay	VBG
cord-308095-mehmk49a	28	22	the	the	DT
cord-308095-mehmk49a	28	23	risks	risk	NNS
cord-308095-mehmk49a	28	24	of	of	IN
cord-308095-mehmk49a	28	25	addiction	addiction	NN
cord-308095-mehmk49a	28	26	and	and	CC
cord-308095-mehmk49a	28	27	abuse	abuse	NN
cord-308095-mehmk49a	28	28	.	.	.
cord-308095-mehmk49a	29	1	In	in	IN
cord-308095-mehmk49a	29	2	addition	addition	NN
cord-308095-mehmk49a	29	3	,	,	,
cord-308095-mehmk49a	29	4	companies	company	NNS
cord-308095-mehmk49a	29	5	framed	frame	VBD
cord-308095-mehmk49a	29	6	both	both	DT
cord-308095-mehmk49a	29	7	doctors	doctor	NNS
cord-308095-mehmk49a	29	8	and	and	CC
cord-308095-mehmk49a	29	9	patients	patient	NNS
cord-308095-mehmk49a	29	10	as	as	IN
cord-308095-mehmk49a	29	11	the	the	DT
cord-308095-mehmk49a	29	12	problem	problem	NN
cord-308095-mehmk49a	29	13	.	.	.
cord-308095-mehmk49a	30	1	Physicians	physician	NNS
cord-308095-mehmk49a	30	2	who	who	WP
cord-308095-mehmk49a	30	3	had	have	VBD
cord-308095-mehmk49a	30	4	legitimate	legitimate	JJ
cord-308095-mehmk49a	30	5	concerns	concern	NNS
cord-308095-mehmk49a	30	6	about	about	IN
cord-308095-mehmk49a	30	7	the	the	DT
cord-308095-mehmk49a	30	8	addictive	addictive	JJ
cord-308095-mehmk49a	30	9	properties	property	NNS
cord-308095-mehmk49a	30	10	of	of	IN
cord-308095-mehmk49a	30	11	opioids	opioid	NNS
cord-308095-mehmk49a	30	12	were	be	VBD
cord-308095-mehmk49a	30	13	characterized	characterize	VBN
cord-308095-mehmk49a	30	14	as	as	IN
cord-308095-mehmk49a	30	15	having	have	VBG
cord-308095-mehmk49a	30	16	"	"	``
cord-308095-mehmk49a	30	17	opiophobia	opiophobia	NNP
cord-308095-mehmk49a	30	18	.	.	.
cord-308095-mehmk49a	31	1	"	"	``
cord-308095-mehmk49a	31	2	This	this	DT
cord-308095-mehmk49a	31	3	term	term	NN
cord-308095-mehmk49a	31	4	,	,	,
cord-308095-mehmk49a	31	5	coined	coin	VBN
cord-308095-mehmk49a	31	6	by	by	IN
cord-308095-mehmk49a	31	7	Purdue	Purdue	NNP
cord-308095-mehmk49a	31	8	Pharma	Pharma	NNP
cord-308095-mehmk49a	31	9	,	,	,
cord-308095-mehmk49a	31	10	the	the	DT
cord-308095-mehmk49a	31	11	manufacturer	manufacturer	NN
cord-308095-mehmk49a	31	12	of	of	IN
cord-308095-mehmk49a	31	13	arguably	arguably	RB
cord-308095-mehmk49a	31	14	the	the	DT
cord-308095-mehmk49a	31	15	most	most	RBS
cord-308095-mehmk49a	31	16	well	well	RB
cord-308095-mehmk49a	31	17	-	-	HYPH
cord-308095-mehmk49a	31	18	known	know	VBN
cord-308095-mehmk49a	31	19	prescription	prescription	NN
cord-308095-mehmk49a	31	20	opioid	opioid	NN
cord-308095-mehmk49a	31	21	,	,	,
cord-308095-mehmk49a	31	22	OxyContin	OxyContin	NNP
cord-308095-mehmk49a	31	23	,	,	,
cord-308095-mehmk49a	31	24	later	later	RB
cord-308095-mehmk49a	31	25	found	find	VBD
cord-308095-mehmk49a	31	26	its	-PRON-	PRP$
cord-308095-mehmk49a	31	27	way	way	NN
cord-308095-mehmk49a	31	28	into	into	IN
cord-308095-mehmk49a	31	29	guidelines	guideline	NNS
cord-308095-mehmk49a	31	30	of	of	IN
cord-308095-mehmk49a	31	31	the	the	DT
cord-308095-mehmk49a	31	32	World	World	NNP
cord-308095-mehmk49a	31	33	Health	Health	NNP
cord-308095-mehmk49a	31	34	Organization	Organization	NNP
cord-308095-mehmk49a	31	35	(	(	-LRB-
cord-308095-mehmk49a	31	36	WHO	who	WP
cord-308095-mehmk49a	31	37	)	)	-RRB-
cord-308095-mehmk49a	32	1	(	(	-LRB-
cord-308095-mehmk49a	32	2	Clark	Clark	NNP
cord-308095-mehmk49a	32	3	and	and	CC
cord-308095-mehmk49a	32	4	Rogers	Rogers	NNP
cord-308095-mehmk49a	32	5	2019	2019	CD
cord-308095-mehmk49a	32	6	)	)	-RRB-
cord-308095-mehmk49a	32	7	.	.	.
cord-308095-mehmk49a	33	1	These	these	DT
cord-308095-mehmk49a	33	2	guidelines	guideline	NNS
cord-308095-mehmk49a	33	3	remained	remain	VBD
cord-308095-mehmk49a	33	4	in	in	IN
cord-308095-mehmk49a	33	5	effect	effect	NN
cord-308095-mehmk49a	33	6	for	for	IN
cord-308095-mehmk49a	33	7	the	the	DT
cord-308095-mehmk49a	33	8	better	well	JJR
cord-308095-mehmk49a	33	9	part	part	NN
cord-308095-mehmk49a	33	10	of	of	IN
cord-308095-mehmk49a	33	11	a	a	DT
cord-308095-mehmk49a	33	12	decade	decade	NN
cord-308095-mehmk49a	33	13	until	until	IN
cord-308095-mehmk49a	33	14	they	-PRON-	PRP
cord-308095-mehmk49a	33	15	were	be	VBD
cord-308095-mehmk49a	33	16	"	"	``
cord-308095-mehmk49a	33	17	discontinued	discontinue	VBN
cord-308095-mehmk49a	33	18	"	"	''
cord-308095-mehmk49a	33	19	by	by	IN
cord-308095-mehmk49a	33	20	the	the	DT
cord-308095-mehmk49a	33	21	WHO	WHO	NNP
cord-308095-mehmk49a	33	22	in	in	IN
cord-308095-mehmk49a	33	23	June	June	NNP
cord-308095-mehmk49a	33	24	2019	2019	CD
cord-308095-mehmk49a	33	25	in	in	IN
cord-308095-mehmk49a	33	26	the	the	DT
cord-308095-mehmk49a	33	27	wake	wake	NN
cord-308095-mehmk49a	33	28	of	of	IN
cord-308095-mehmk49a	33	29	revelations	revelation	NNS
cord-308095-mehmk49a	33	30	of	of	IN
cord-308095-mehmk49a	33	31	corporate	corporate	JJ
cord-308095-mehmk49a	33	32	influence	influence	NN
cord-308095-mehmk49a	33	33	(	(	-LRB-
cord-308095-mehmk49a	33	34	WHO	who	WP
cord-308095-mehmk49a	33	35	2019	2019	CD
cord-308095-mehmk49a	33	36	)	)	-RRB-
cord-308095-mehmk49a	33	37	.	.	.
cord-308095-mehmk49a	34	1	Patients	patient	NNS
cord-308095-mehmk49a	34	2	who	who	WP
cord-308095-mehmk49a	34	3	became	become	VBD
cord-308095-mehmk49a	34	4	addicted	addicted	JJ
cord-308095-mehmk49a	34	5	were	be	VBD
cord-308095-mehmk49a	34	6	,	,	,
cord-308095-mehmk49a	34	7	of	of	IN
cord-308095-mehmk49a	34	8	course	course	NN
cord-308095-mehmk49a	34	9	,	,	,
cord-308095-mehmk49a	34	10	not	not	RB
cord-308095-mehmk49a	34	11	characterized	characterize	VBN
cord-308095-mehmk49a	34	12	as	as	IN
cord-308095-mehmk49a	34	13	victims	victim	NNS
cord-308095-mehmk49a	34	14	of	of	IN
cord-308095-mehmk49a	34	15	an	an	DT
cord-308095-mehmk49a	34	16	aggressive	aggressive	JJ
cord-308095-mehmk49a	34	17	marketing	marketing	NN
cord-308095-mehmk49a	34	18	and	and	CC
cord-308095-mehmk49a	34	19	public	public	JJ
cord-308095-mehmk49a	34	20	relations	relation	NNS
cord-308095-mehmk49a	34	21	strategy	strategy	NN
cord-308095-mehmk49a	34	22	.	.	.
cord-308095-mehmk49a	35	1	When	when	WRB
cord-308095-mehmk49a	35	2	Richard	Richard	NNP
cord-308095-mehmk49a	35	3	Sackler	Sackler	NNP
cord-308095-mehmk49a	35	4	was	be	VBD
cord-308095-mehmk49a	35	5	president	president	NN
cord-308095-mehmk49a	35	6	of	of	IN
cord-308095-mehmk49a	35	7	Purdue	Purdue	NNP
cord-308095-mehmk49a	35	8	Pharma	Pharma	NNP
cord-308095-mehmk49a	35	9	in	in	IN
cord-308095-mehmk49a	35	10	2001	2001	CD
cord-308095-mehmk49a	35	11	,	,	,
cord-308095-mehmk49a	35	12	he	-PRON-	PRP
cord-308095-mehmk49a	35	13	urged	urge	VBD
cord-308095-mehmk49a	35	14	colleagues	colleague	NNS
cord-308095-mehmk49a	35	15	to	to	TO
cord-308095-mehmk49a	35	16	blame	blame	VB
cord-308095-mehmk49a	35	17	and	and	CC
cord-308095-mehmk49a	35	18	"	"	``
cord-308095-mehmk49a	35	19	hammer	hammer	VB
cord-308095-mehmk49a	35	20	"	"	''
cord-308095-mehmk49a	35	21	patients	patient	NNS
cord-308095-mehmk49a	35	22	,	,	,
cord-308095-mehmk49a	35	23	describing	describe	VBG
cord-308095-mehmk49a	35	24	them	-PRON-	PRP
cord-308095-mehmk49a	35	25	contemptuously	contemptuously	RB
cord-308095-mehmk49a	35	26	as	as	IN
cord-308095-mehmk49a	35	27	"	"	``
cord-308095-mehmk49a	35	28	abusers	abuser	NNS
cord-308095-mehmk49a	35	29	,	,	,
cord-308095-mehmk49a	35	30	"	"	''
cord-308095-mehmk49a	35	31	"	"	``
cord-308095-mehmk49a	35	32	culprits	culprit	NNS
cord-308095-mehmk49a	35	33	,	,	,
cord-308095-mehmk49a	35	34	"	"	''
cord-308095-mehmk49a	35	35	and	and	CC
cord-308095-mehmk49a	35	36	"	"	``
cord-308095-mehmk49a	35	37	reckless	reckless	JJ
cord-308095-mehmk49a	35	38	criminals	criminal	NNS
cord-308095-mehmk49a	35	39	"	"	''
cord-308095-mehmk49a	35	40	(	(	-LRB-
cord-308095-mehmk49a	35	41	Zezima	Zezima	NNP
cord-308095-mehmk49a	35	42	and	and	CC
cord-308095-mehmk49a	35	43	Bernstein	Bernstein	NNP
cord-308095-mehmk49a	35	44	2019	2019	CD
cord-308095-mehmk49a	35	45	)	)	-RRB-
cord-308095-mehmk49a	35	46	.	.	.
cord-308095-mehmk49a	36	1	Most	Most	JJS
cord-308095-mehmk49a	36	2	of	of	IN
cord-308095-mehmk49a	36	3	the	the	DT
cord-308095-mehmk49a	36	4	media	medium	NNS
cord-308095-mehmk49a	36	5	attention	attention	NN
cord-308095-mehmk49a	36	6	has	have	VBZ
cord-308095-mehmk49a	36	7	focused	focus	VBN
cord-308095-mehmk49a	36	8	on	on	IN
cord-308095-mehmk49a	36	9	Purdue	Purdue	NNP
cord-308095-mehmk49a	36	10	Pharma	Pharma	NNP
cord-308095-mehmk49a	36	11	-	-	:
cord-308095-mehmk49a	36	12	and	and	CC
cord-308095-mehmk49a	36	13	on	on	IN
cord-308095-mehmk49a	36	14	members	member	NNS
cord-308095-mehmk49a	36	15	of	of	IN
cord-308095-mehmk49a	36	16	the	the	DT
cord-308095-mehmk49a	36	17	Sackler	Sackler	NNP
cord-308095-mehmk49a	36	18	family	family	NN
cord-308095-mehmk49a	36	19	who	who	WP
cord-308095-mehmk49a	36	20	are	be	VBP
cord-308095-mehmk49a	36	21	major	major	JJ
cord-308095-mehmk49a	36	22	shareholders	shareholder	NNS
cord-308095-mehmk49a	36	23	.	.	.
cord-308095-mehmk49a	37	1	1	1	LS
cord-308095-mehmk49a	38	1	However	however	RB
cord-308095-mehmk49a	38	2	,	,	,
cord-308095-mehmk49a	38	3	it	-PRON-	PRP
cord-308095-mehmk49a	38	4	is	be	VBZ
cord-308095-mehmk49a	38	5	important	important	JJ
cord-308095-mehmk49a	38	6	to	to	TO
cord-308095-mehmk49a	38	7	keep	keep	VB
cord-308095-mehmk49a	38	8	in	in	IN
cord-308095-mehmk49a	38	9	mind	mind	NN
cord-308095-mehmk49a	38	10	that	that	IN
cord-308095-mehmk49a	38	11	this	this	DT
cord-308095-mehmk49a	38	12	company	company	NN
cord-308095-mehmk49a	38	13	was	be	VBD
cord-308095-mehmk49a	38	14	only	only	RB
cord-308095-mehmk49a	38	15	one	one	CD
cord-308095-mehmk49a	38	16	of	of	IN
cord-308095-mehmk49a	38	17	several	several	JJ
cord-308095-mehmk49a	38	18	drug	drug	NN
cord-308095-mehmk49a	38	19	companies	company	NNS
cord-308095-mehmk49a	38	20	that	that	WDT
cord-308095-mehmk49a	38	21	promoted	promote	VBD
cord-308095-mehmk49a	38	22	their	-PRON-	PRP$
cord-308095-mehmk49a	38	23	opioids	opioid	NNS
cord-308095-mehmk49a	38	24	by	by	IN
cord-308095-mehmk49a	38	25	building	build	VBG
cord-308095-mehmk49a	38	26	webs	web	NNS
cord-308095-mehmk49a	38	27	of	of	IN
cord-308095-mehmk49a	38	28	relationships	relationship	NNS
cord-308095-mehmk49a	38	29	with	with	IN
cord-308095-mehmk49a	38	30	a	a	DT
cord-308095-mehmk49a	38	31	variety	variety	NN
cord-308095-mehmk49a	38	32	of	of	IN
cord-308095-mehmk49a	38	33	public	public	JJ
cord-308095-mehmk49a	38	34	health	health	NN
cord-308095-mehmk49a	38	35	agencies	agency	NNS
cord-308095-mehmk49a	38	36	,	,	,
cord-308095-mehmk49a	38	37	academic	academic	JJ
cord-308095-mehmk49a	38	38	institutions	institution	NNS
cord-308095-mehmk49a	38	39	,	,	,
cord-308095-mehmk49a	38	40	and	and	CC
cord-308095-mehmk49a	38	41	public	public	JJ
cord-308095-mehmk49a	38	42	health	health	NN
cord-308095-mehmk49a	38	43	NGOs	NGOs	NNPS
cord-308095-mehmk49a	38	44	,	,	,
cord-308095-mehmk49a	38	45	as	as	RB
cord-308095-mehmk49a	38	46	well	well	RB
cord-308095-mehmk49a	38	47	as	as	IN
cord-308095-mehmk49a	38	48	thousands	thousand	NNS
cord-308095-mehmk49a	38	49	of	of	IN
cord-308095-mehmk49a	38	50	individual	individual	JJ
cord-308095-mehmk49a	38	51	health	health	NN
cord-308095-mehmk49a	38	52	professionals	professional	NNS
cord-308095-mehmk49a	38	53	.	.	.
cord-308095-mehmk49a	39	1	A	a	DT
cord-308095-mehmk49a	39	2	recent	recent	JJ
cord-308095-mehmk49a	39	3	trial	trial	NN
cord-308095-mehmk49a	39	4	in	in	IN
cord-308095-mehmk49a	39	5	Oklahoma	Oklahoma	NNP
cord-308095-mehmk49a	39	6	shed	shed	VBN
cord-308095-mehmk49a	39	7	light	light	NN
cord-308095-mehmk49a	39	8	on	on	IN
cord-308095-mehmk49a	39	9	the	the	DT
cord-308095-mehmk49a	39	10	activities	activity	NNS
cord-308095-mehmk49a	39	11	of	of	IN
cord-308095-mehmk49a	39	12	Johnson	Johnson	NNP
cord-308095-mehmk49a	39	13	&	&	CC
cord-308095-mehmk49a	39	14	Johnson	Johnson	NNP
cord-308095-mehmk49a	39	15	,	,	,
cord-308095-mehmk49a	39	16	a	a	DT
cord-308095-mehmk49a	39	17	family	family	NN
cord-308095-mehmk49a	39	18	of	of	IN
cord-308095-mehmk49a	39	19	companies	company	NNS
cord-308095-mehmk49a	39	20	that	that	WDT
cord-308095-mehmk49a	39	21	has	have	VBZ
cord-308095-mehmk49a	39	22	not	not	RB
cord-308095-mehmk49a	39	23	only	only	RB
cord-308095-mehmk49a	39	24	sold	sell	VBN
cord-308095-mehmk49a	39	25	its	-PRON-	PRP$
cord-308095-mehmk49a	39	26	own	own	JJ
cord-308095-mehmk49a	39	27	opioids	opioid	NNS
cord-308095-mehmk49a	39	28	but	but	CC
cord-308095-mehmk49a	39	29	also	also	RB
cord-308095-mehmk49a	39	30	supplied	supply	VBD
cord-308095-mehmk49a	39	31	the	the	DT
cord-308095-mehmk49a	39	32	active	active	JJ
cord-308095-mehmk49a	39	33	ingredients	ingredient	NNS
cord-308095-mehmk49a	39	34	to	to	IN
cord-308095-mehmk49a	39	35	several	several	JJ
cord-308095-mehmk49a	39	36	other	other	JJ
cord-308095-mehmk49a	39	37	opioid	opioid	JJ
cord-308095-mehmk49a	39	38	companies	company	NNS
cord-308095-mehmk49a	39	39	,	,	,
cord-308095-mehmk49a	39	40	including	include	VBG
cord-308095-mehmk49a	39	41	Purdue	Purdue	NNP
cord-308095-mehmk49a	39	42	Pharma	Pharma	NNP
cord-308095-mehmk49a	39	43	(	(	-LRB-
cord-308095-mehmk49a	39	44	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	39	45	2019a	2019a	CD
cord-308095-mehmk49a	39	46	(	(	-LRB-
cord-308095-mehmk49a	39	47	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	39	48	,	,	,
cord-308095-mehmk49a	39	49	2019b	2019b	CD
cord-308095-mehmk49a	39	50	.	.	.
cord-308095-mehmk49a	40	1	For	for	IN
cord-308095-mehmk49a	40	2	that	that	DT
cord-308095-mehmk49a	40	3	reason	reason	NN
cord-308095-mehmk49a	40	4	,	,	,
cord-308095-mehmk49a	40	5	Johnson	Johnson	NNP
cord-308095-mehmk49a	40	6	&	&	CC
cord-308095-mehmk49a	40	7	Johnson	Johnson	NNP
cord-308095-mehmk49a	40	8	had	have	VBD
cord-308095-mehmk49a	40	9	an	an	DT
cord-308095-mehmk49a	40	10	additional	additional	JJ
cord-308095-mehmk49a	40	11	incentive	incentive	NN
cord-308095-mehmk49a	40	12	to	to	TO
cord-308095-mehmk49a	40	13	engage	engage	VB
cord-308095-mehmk49a	40	14	(	(	-LRB-
cord-308095-mehmk49a	40	15	and	and	CC
cord-308095-mehmk49a	40	16	did	do	VBD
cord-308095-mehmk49a	40	17	engage	engage	VB
cord-308095-mehmk49a	40	18	)	)	-RRB-
cord-308095-mehmk49a	40	19	in	in	IN
cord-308095-mehmk49a	40	20	the	the	DT
cord-308095-mehmk49a	40	21	unbranded	unbranded	JJ
cord-308095-mehmk49a	40	22	promotion	promotion	NN
cord-308095-mehmk49a	40	23	of	of	IN
cord-308095-mehmk49a	40	24	opioids	opioid	NNS
cord-308095-mehmk49a	40	25	.	.	.
cord-308095-mehmk49a	41	1	The	the	DT
cord-308095-mehmk49a	41	2	criminal	criminal	JJ
cord-308095-mehmk49a	41	3	trial	trial	NN
cord-308095-mehmk49a	41	4	of	of	IN
cord-308095-mehmk49a	41	5	the	the	DT
cord-308095-mehmk49a	41	6	former	former	JJ
cord-308095-mehmk49a	41	7	executives	executive	NNS
cord-308095-mehmk49a	41	8	of	of	IN
cord-308095-mehmk49a	41	9	another	another	DT
cord-308095-mehmk49a	41	10	company	company	NN
cord-308095-mehmk49a	41	11	,	,	,
cord-308095-mehmk49a	41	12	Insys	Insys	NNP
cord-308095-mehmk49a	41	13	,	,	,
cord-308095-mehmk49a	41	14	also	also	RB
cord-308095-mehmk49a	41	15	shed	shed	VBD
cord-308095-mehmk49a	41	16	light	light	NN
cord-308095-mehmk49a	41	17	on	on	IN
cord-308095-mehmk49a	41	18	its	-PRON-	PRP$
cord-308095-mehmk49a	41	19	fraudulent	fraudulent	JJ
cord-308095-mehmk49a	41	20	marketing	marketing	NN
cord-308095-mehmk49a	41	21	practices	practice	NNS
cord-308095-mehmk49a	41	22	(	(	-LRB-
cord-308095-mehmk49a	41	23	Emanuel	Emanuel	NNP
cord-308095-mehmk49a	41	24	and	and	CC
cord-308095-mehmk49a	41	25	Thomas	Thomas	NNP
cord-308095-mehmk49a	41	26	2019	2019	CD
cord-308095-mehmk49a	41	27	)	)	-RRB-
cord-308095-mehmk49a	41	28	.	.	.
cord-308095-mehmk49a	42	1	We	-PRON-	PRP
cord-308095-mehmk49a	42	2	know	know	VBP
cord-308095-mehmk49a	42	3	more	more	JJR
cord-308095-mehmk49a	42	4	about	about	IN
cord-308095-mehmk49a	42	5	the	the	DT
cord-308095-mehmk49a	42	6	"	"	``
cord-308095-mehmk49a	42	7	webs	webs	NNP
cord-308095-mehmk49a	42	8	of	of	IN
cord-308095-mehmk49a	42	9	influence	influence	NN
cord-308095-mehmk49a	42	10	"	"	''
cord-308095-mehmk49a	42	11	woven	weave	VBN
cord-308095-mehmk49a	42	12	by	by	IN
cord-308095-mehmk49a	42	13	these	these	DT
cord-308095-mehmk49a	42	14	companies	company	NNS
cord-308095-mehmk49a	42	15	than	than	IN
cord-308095-mehmk49a	42	16	about	about	IN
cord-308095-mehmk49a	42	17	the	the	DT
cord-308095-mehmk49a	42	18	strategies	strategy	NNS
cord-308095-mehmk49a	42	19	of	of	IN
cord-308095-mehmk49a	42	20	other	other	JJ
cord-308095-mehmk49a	42	21	companies	company	NNS
cord-308095-mehmk49a	42	22	that	that	WDT
cord-308095-mehmk49a	42	23	have	have	VBP
cord-308095-mehmk49a	42	24	been	be	VBN
cord-308095-mehmk49a	42	25	more	more	RBR
cord-308095-mehmk49a	42	26	successful	successful	JJ
cord-308095-mehmk49a	42	27	,	,	,
cord-308095-mehmk49a	42	28	thus	thus	RB
cord-308095-mehmk49a	42	29	far	far	RB
cord-308095-mehmk49a	42	30	,	,	,
cord-308095-mehmk49a	42	31	at	at	IN
cord-308095-mehmk49a	42	32	keeping	keep	VBG
cord-308095-mehmk49a	42	33	evidence	evidence	NN
cord-308095-mehmk49a	42	34	out	out	IN
cord-308095-mehmk49a	42	35	of	of	IN
cord-308095-mehmk49a	42	36	the	the	DT
cord-308095-mehmk49a	42	37	public	public	JJ
cord-308095-mehmk49a	42	38	domain	domain	NN
cord-308095-mehmk49a	42	39	-	-	:
cord-308095-mehmk49a	42	40	often	often	RB
cord-308095-mehmk49a	42	41	by	by	IN
cord-308095-mehmk49a	42	42	settling	settle	VBG
cord-308095-mehmk49a	42	43	cases	case	NNS
cord-308095-mehmk49a	42	44	before	before	IN
cord-308095-mehmk49a	42	45	they	-PRON-	PRP
cord-308095-mehmk49a	42	46	go	go	VBP
cord-308095-mehmk49a	42	47	to	to	IN
cord-308095-mehmk49a	42	48	trial	trial	NN
cord-308095-mehmk49a	42	49	.	.	.
cord-308095-mehmk49a	43	1	But	but	CC
cord-308095-mehmk49a	43	2	there	there	EX
cord-308095-mehmk49a	43	3	is	be	VBZ
cord-308095-mehmk49a	43	4	clear	clear	JJ
cord-308095-mehmk49a	43	5	evidence	evidence	NN
cord-308095-mehmk49a	43	6	that	that	IN
cord-308095-mehmk49a	43	7	aggressive	aggressive	JJ
cord-308095-mehmk49a	43	8	promotion	promotion	NN
cord-308095-mehmk49a	43	9	strategies	strategy	NNS
cord-308095-mehmk49a	43	10	were	be	VBD
cord-308095-mehmk49a	43	11	widespread	widespread	JJ
cord-308095-mehmk49a	43	12	,	,	,
cord-308095-mehmk49a	43	13	to	to	IN
cord-308095-mehmk49a	43	14	varying	vary	VBG
cord-308095-mehmk49a	43	15	degrees	degree	NNS
cord-308095-mehmk49a	43	16	,	,	,
cord-308095-mehmk49a	43	17	across	across	IN
cord-308095-mehmk49a	43	18	the	the	DT
cord-308095-mehmk49a	43	19	opioid	opioid	NN
cord-308095-mehmk49a	43	20	industry	industry	NN
cord-308095-mehmk49a	44	1	(	(	-LRB-
cord-308095-mehmk49a	44	2	Horwitz	Horwitz	NNP
cord-308095-mehmk49a	44	3	et	et	NNP
cord-308095-mehmk49a	44	4	al	al	NNP
cord-308095-mehmk49a	44	5	.	.	.
cord-308095-mehmk49a	44	6	2019	2019	CD
cord-308095-mehmk49a	44	7	)	)	-RRB-
cord-308095-mehmk49a	44	8	.	.	.
cord-308095-mehmk49a	45	1	Building	build	VBG
cord-308095-mehmk49a	45	2	on	on	IN
cord-308095-mehmk49a	45	3	other	other	JJ
cord-308095-mehmk49a	45	4	recent	recent	JJ
cord-308095-mehmk49a	45	5	work	work	NN
cord-308095-mehmk49a	45	6	(	(	-LRB-
cord-308095-mehmk49a	45	7	Marks	Marks	NNP
cord-308095-mehmk49a	45	8	2019a	2019a	CD
cord-308095-mehmk49a	45	9	(	(	-LRB-
cord-308095-mehmk49a	45	10	Marks	Marks	NNP
cord-308095-mehmk49a	45	11	,	,	,
cord-308095-mehmk49a	45	12	2019b	2019b	CD
cord-308095-mehmk49a	45	13	(	(	-LRB-
cord-308095-mehmk49a	45	14	Marks	Marks	NNP
cord-308095-mehmk49a	45	15	,	,	,
cord-308095-mehmk49a	45	16	2019c	2019c	CD
cord-308095-mehmk49a	45	17	,	,	,
cord-308095-mehmk49a	45	18	I	-PRON-	PRP
cord-308095-mehmk49a	45	19	will	will	MD
cord-308095-mehmk49a	45	20	1	1	CD
cord-308095-mehmk49a	46	1	The	the	DT
cord-308095-mehmk49a	46	2	Sackler	Sackler	NNP
cord-308095-mehmk49a	46	3	family	family	NN
cord-308095-mehmk49a	46	4	's	's	POS
cord-308095-mehmk49a	46	5	arts	art	NNS
cord-308095-mehmk49a	46	6	philanthropy	philanthropy	NN
cord-308095-mehmk49a	46	7	has	have	VBZ
cord-308095-mehmk49a	46	8	attracted	attract	VBN
cord-308095-mehmk49a	46	9	much	much	JJ
cord-308095-mehmk49a	46	10	attention	attention	NN
cord-308095-mehmk49a	46	11	.	.	.
cord-308095-mehmk49a	47	1	I	-PRON-	PRP
cord-308095-mehmk49a	47	2	focus	focus	VBP
cord-308095-mehmk49a	47	3	my	-PRON-	PRP$
cord-308095-mehmk49a	47	4	analysis	analysis	NN
cord-308095-mehmk49a	47	5	here	here	RB
cord-308095-mehmk49a	47	6	on	on	IN
cord-308095-mehmk49a	47	7	relationships	relationship	NNS
cord-308095-mehmk49a	47	8	with	with	IN
cord-308095-mehmk49a	47	9	entities	entity	NNS
cord-308095-mehmk49a	47	10	in	in	IN
cord-308095-mehmk49a	47	11	health	health	NN
cord-308095-mehmk49a	47	12	and	and	CC
cord-308095-mehmk49a	47	13	policy	policy	NN
cord-308095-mehmk49a	47	14	spheres	sphere	NNS
cord-308095-mehmk49a	47	15	because	because	IN
cord-308095-mehmk49a	47	16	they	-PRON-	PRP
cord-308095-mehmk49a	47	17	appear	appear	VBP
cord-308095-mehmk49a	47	18	to	to	TO
cord-308095-mehmk49a	47	19	have	have	VB
cord-308095-mehmk49a	47	20	most	most	RBS
cord-308095-mehmk49a	47	21	directly	directly	RB
cord-308095-mehmk49a	47	22	contributed	contribute	VBN
cord-308095-mehmk49a	47	23	to	to	IN
cord-308095-mehmk49a	47	24	the	the	DT
cord-308095-mehmk49a	47	25	opioid	opioid	JJ
cord-308095-mehmk49a	47	26	crisis	crisis	NN
cord-308095-mehmk49a	47	27	.	.	.
cord-308095-mehmk49a	48	1	But	but	CC
cord-308095-mehmk49a	48	2	I	-PRON-	PRP
cord-308095-mehmk49a	48	3	recognize	recognize	VBP
cord-308095-mehmk49a	48	4	that	that	IN
cord-308095-mehmk49a	48	5	arts	art	NNS
cord-308095-mehmk49a	48	6	philanthropy	philanthropy	NN
cord-308095-mehmk49a	48	7	also	also	RB
cord-308095-mehmk49a	48	8	merits	merit	VBZ
cord-308095-mehmk49a	48	9	ethical	ethical	JJ
cord-308095-mehmk49a	48	10	scrutiny	scrutiny	NN
cord-308095-mehmk49a	48	11	that	that	WDT
cord-308095-mehmk49a	48	12	I	-PRON-	PRP
cord-308095-mehmk49a	48	13	can	can	MD
cord-308095-mehmk49a	48	14	not	not	RB
cord-308095-mehmk49a	48	15	provide	provide	VB
cord-308095-mehmk49a	48	16	in	in	IN
cord-308095-mehmk49a	48	17	the	the	DT
cord-308095-mehmk49a	48	18	space	space	NN
cord-308095-mehmk49a	48	19	permitted	permit	VBD
cord-308095-mehmk49a	48	20	.	.	.
cord-308095-mehmk49a	49	1	tease	tease	VB
cord-308095-mehmk49a	49	2	apart	apart	RB
cord-308095-mehmk49a	49	3	some	some	DT
cord-308095-mehmk49a	49	4	strands	strand	NNS
cord-308095-mehmk49a	49	5	of	of	IN
cord-308095-mehmk49a	49	6	the	the	DT
cord-308095-mehmk49a	49	7	known	know	VBN
cord-308095-mehmk49a	49	8	webs	web	NNS
cord-308095-mehmk49a	49	9	of	of	IN
cord-308095-mehmk49a	49	10	influence	influence	NN
cord-308095-mehmk49a	49	11	of	of	IN
cord-308095-mehmk49a	49	12	the	the	DT
cord-308095-mehmk49a	49	13	opioid	opioid	JJ
cord-308095-mehmk49a	49	14	industry	industry	NN
cord-308095-mehmk49a	49	15	before	before	IN
cord-308095-mehmk49a	49	16	reviewing	review	VBG
cord-308095-mehmk49a	49	17	the	the	DT
cord-308095-mehmk49a	49	18	cumulative	cumulative	JJ
cord-308095-mehmk49a	49	19	effects	effect	NNS
cord-308095-mehmk49a	49	20	and	and	CC
cord-308095-mehmk49a	49	21	exploring	explore	VBG
cord-308095-mehmk49a	49	22	the	the	DT
cord-308095-mehmk49a	49	23	ethical	ethical	JJ
cord-308095-mehmk49a	49	24	and	and	CC
cord-308095-mehmk49a	49	25	policy	policy	NN
cord-308095-mehmk49a	49	26	implications	implication	NNS
cord-308095-mehmk49a	49	27	.	.	.
cord-308095-mehmk49a	50	1	Arthur	Arthur	NNP
cord-308095-mehmk49a	50	2	M.	M.	NNP
cord-308095-mehmk49a	50	3	Sackler	Sackler	NNP
cord-308095-mehmk49a	50	4	died	die	VBD
cord-308095-mehmk49a	50	5	in	in	IN
cord-308095-mehmk49a	50	6	1987	1987	CD
cord-308095-mehmk49a	50	7	,	,	,
cord-308095-mehmk49a	50	8	long	long	RB
cord-308095-mehmk49a	50	9	before	before	IN
cord-308095-mehmk49a	50	10	Purdue	Purdue	NNP
cord-308095-mehmk49a	50	11	Pharma	Pharma	NNP
cord-308095-mehmk49a	50	12	's	's	POS
cord-308095-mehmk49a	50	13	1996	1996	CD
cord-308095-mehmk49a	50	14	launch	launch	NN
cord-308095-mehmk49a	50	15	and	and	CC
cord-308095-mehmk49a	50	16	subsequent	subsequent	JJ
cord-308095-mehmk49a	50	17	aggressive	aggressive	JJ
cord-308095-mehmk49a	50	18	marketing	marketing	NN
cord-308095-mehmk49a	50	19	of	of	IN
cord-308095-mehmk49a	50	20	its	-PRON-	PRP$
cord-308095-mehmk49a	50	21	leading	lead	VBG
cord-308095-mehmk49a	50	22	opioid	opioid	JJ
cord-308095-mehmk49a	50	23	brand	brand	NN
cord-308095-mehmk49a	50	24	,	,	,
cord-308095-mehmk49a	50	25	OxyContin	OxyContin	NNP
cord-308095-mehmk49a	50	26	.	.	.
cord-308095-mehmk49a	51	1	But	but	CC
cord-308095-mehmk49a	51	2	the	the	DT
cord-308095-mehmk49a	51	3	roots	root	NNS
cord-308095-mehmk49a	51	4	of	of	IN
cord-308095-mehmk49a	51	5	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	51	6	marketing	marketing	NN
cord-308095-mehmk49a	51	7	to	to	IN
cord-308095-mehmk49a	51	8	physicians	physician	NNS
cord-308095-mehmk49a	51	9	go	go	VB
cord-308095-mehmk49a	51	10	back	back	RB
cord-308095-mehmk49a	51	11	seven	seven	CD
cord-308095-mehmk49a	51	12	decades	decade	NNS
cord-308095-mehmk49a	51	13	(	(	-LRB-
cord-308095-mehmk49a	51	14	Greene	Greene	NNP
cord-308095-mehmk49a	51	15	and	and	CC
cord-308095-mehmk49a	51	16	Podolsky	Podolsky	NNP
cord-308095-mehmk49a	51	17	2009	2009	CD
cord-308095-mehmk49a	51	18	)	)	-RRB-
cord-308095-mehmk49a	51	19	,	,	,
cord-308095-mehmk49a	51	20	and	and	CC
cord-308095-mehmk49a	51	21	Sackler	Sackler	NNP
cord-308095-mehmk49a	51	22	was	be	VBD
cord-308095-mehmk49a	51	23	a	a	DT
cord-308095-mehmk49a	51	24	vital	vital	JJ
cord-308095-mehmk49a	51	25	rhizome	rhizome	NN
cord-308095-mehmk49a	51	26	(	(	-LRB-
cord-308095-mehmk49a	51	27	Podolsky	Podolsky	NNP
cord-308095-mehmk49a	51	28	,	,	,
cord-308095-mehmk49a	51	29	Hertzberg	Hertzberg	NNP
cord-308095-mehmk49a	51	30	,	,	,
cord-308095-mehmk49a	51	31	and	and	CC
cord-308095-mehmk49a	51	32	Greene	Greene	NNP
cord-308095-mehmk49a	51	33	2019	2019	CD
cord-308095-mehmk49a	51	34	)	)	-RRB-
cord-308095-mehmk49a	51	35	.	.	.
cord-308095-mehmk49a	52	1	He	-PRON-	PRP
cord-308095-mehmk49a	52	2	may	may	MD
cord-308095-mehmk49a	52	3	not	not	RB
cord-308095-mehmk49a	52	4	have	have	VB
cord-308095-mehmk49a	52	5	invented	invent	VBN
cord-308095-mehmk49a	52	6	the	the	DT
cord-308095-mehmk49a	52	7	practice	practice	NN
cord-308095-mehmk49a	52	8	of	of	IN
cord-308095-mehmk49a	52	9	medical	medical	JJ
cord-308095-mehmk49a	52	10	marketing	marketing	NN
cord-308095-mehmk49a	52	11	but	but	CC
cord-308095-mehmk49a	52	12	,	,	,
cord-308095-mehmk49a	52	13	as	as	IN
cord-308095-mehmk49a	52	14	the	the	DT
cord-308095-mehmk49a	52	15	Medical	Medical	NNP
cord-308095-mehmk49a	52	16	Advertising	Advertising	NNP
cord-308095-mehmk49a	52	17	Hall	Hall	NNP
cord-308095-mehmk49a	52	18	of	of	IN
cord-308095-mehmk49a	52	19	Fame	Fame	NNP
cord-308095-mehmk49a	52	20	put	put	VBD
cord-308095-mehmk49a	52	21	it	-PRON-	PRP
cord-308095-mehmk49a	52	22	:	:	:
cord-308095-mehmk49a	53	1	"	"	``
cord-308095-mehmk49a	53	2	No	no	DT
cord-308095-mehmk49a	53	3	single	single	JJ
cord-308095-mehmk49a	53	4	individual	individual	NN
cord-308095-mehmk49a	53	5	did	do	VBD
cord-308095-mehmk49a	53	6	more	more	RBR
cord-308095-mehmk49a	53	7	to	to	TO
cord-308095-mehmk49a	53	8	shape	shape	VB
cord-308095-mehmk49a	53	9	the	the	DT
cord-308095-mehmk49a	53	10	character	character	NN
cord-308095-mehmk49a	53	11	of	of	IN
cord-308095-mehmk49a	53	12	medical	medical	JJ
cord-308095-mehmk49a	53	13	advertising	advertising	NN
cord-308095-mehmk49a	53	14	than	than	IN
cord-308095-mehmk49a	53	15	the	the	DT
cord-308095-mehmk49a	53	16	multi	multi	JJ
cord-308095-mehmk49a	53	17	-	-	JJ
cord-308095-mehmk49a	53	18	talented	talented	JJ
cord-308095-mehmk49a	53	19	Dr.	Dr.	NNP
cord-308095-mehmk49a	53	20	Arthur	Arthur	NNP
cord-308095-mehmk49a	53	21	Sackler	Sackler	NNP
cord-308095-mehmk49a	53	22	.	.	.
cord-308095-mehmk49a	54	1	His	-PRON-	PRP$
cord-308095-mehmk49a	54	2	seminal	seminal	JJ
cord-308095-mehmk49a	54	3	contribution	contribution	NN
cord-308095-mehmk49a	54	4	was	be	VBD
cord-308095-mehmk49a	54	5	bringing	bring	VBG
cord-308095-mehmk49a	54	6	the	the	DT
cord-308095-mehmk49a	54	7	full	full	JJ
cord-308095-mehmk49a	54	8	power	power	NN
cord-308095-mehmk49a	54	9	of	of	IN
cord-308095-mehmk49a	54	10	advertising	advertising	NN
cord-308095-mehmk49a	54	11	and	and	CC
cord-308095-mehmk49a	54	12	promotion	promotion	NN
cord-308095-mehmk49a	54	13	to	to	IN
cord-308095-mehmk49a	54	14	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	54	15	marketing	marketing	NN
cord-308095-mehmk49a	54	16	"	"	''
cord-308095-mehmk49a	54	17	(	(	-LRB-
cord-308095-mehmk49a	54	18	Podolsky	Podolsky	NNP
cord-308095-mehmk49a	54	19	2015	2015	CD
cord-308095-mehmk49a	54	20	,	,	,
cord-308095-mehmk49a	54	21	25	25	CD
cord-308095-mehmk49a	54	22	)	)	-RRB-
cord-308095-mehmk49a	54	23	.	.	.
cord-308095-mehmk49a	55	1	The	the	DT
cord-308095-mehmk49a	55	2	extent	extent	NN
cord-308095-mehmk49a	55	3	and	and	CC
cord-308095-mehmk49a	55	4	efficacy	efficacy	NN
cord-308095-mehmk49a	55	5	of	of	IN
cord-308095-mehmk49a	55	6	opioid	opioid	JJ
cord-308095-mehmk49a	55	7	marketing	marketing	NN
cord-308095-mehmk49a	55	8	in	in	IN
cord-308095-mehmk49a	55	9	recent	recent	JJ
cord-308095-mehmk49a	55	10	years	year	NNS
cord-308095-mehmk49a	55	11	has	have	VBZ
cord-308095-mehmk49a	55	12	arguably	arguably	RB
cord-308095-mehmk49a	55	13	gone	go	VBN
cord-308095-mehmk49a	55	14	far	far	RB
cord-308095-mehmk49a	55	15	beyond	beyond	IN
cord-308095-mehmk49a	55	16	Sackler	Sackler	NNP
cord-308095-mehmk49a	55	17	's	's	POS
cord-308095-mehmk49a	55	18	wildest	wild	JJS
cord-308095-mehmk49a	55	19	dreams	dream	NNS
cord-308095-mehmk49a	55	20	or	or	CC
cord-308095-mehmk49a	55	21	,	,	,
cord-308095-mehmk49a	55	22	more	more	RBR
cord-308095-mehmk49a	55	23	charitably	charitably	RB
cord-308095-mehmk49a	55	24	,	,	,
cord-308095-mehmk49a	55	25	his	-PRON-	PRP$
cord-308095-mehmk49a	55	26	worst	bad	JJS
cord-308095-mehmk49a	55	27	nightmares	nightmare	NNS
cord-308095-mehmk49a	55	28	.	.	.
cord-308095-mehmk49a	56	1	Between	between	IN
cord-308095-mehmk49a	56	2	2014	2014	CD
cord-308095-mehmk49a	56	3	and	and	CC
cord-308095-mehmk49a	56	4	2015	2015	CD
cord-308095-mehmk49a	56	5	,	,	,
cord-308095-mehmk49a	56	6	roughly	roughly	RB
cord-308095-mehmk49a	56	7	one	one	CD
cord-308095-mehmk49a	56	8	in	in	IN
cord-308095-mehmk49a	56	9	seven	seven	CD
cord-308095-mehmk49a	56	10	physicians	physician	NNS
cord-308095-mehmk49a	56	11	in	in	IN
cord-308095-mehmk49a	56	12	the	the	DT
cord-308095-mehmk49a	56	13	United	United	NNP
cord-308095-mehmk49a	56	14	States	States	NNP
cord-308095-mehmk49a	56	15	received	receive	VBD
cord-308095-mehmk49a	56	16	opioid	opioid	NN
cord-308095-mehmk49a	56	17	-	-	HYPH
cord-308095-mehmk49a	56	18	related	relate	VBN
cord-308095-mehmk49a	56	19	gifts	gift	NNS
cord-308095-mehmk49a	56	20	from	from	IN
cord-308095-mehmk49a	56	21	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	56	22	companies	company	NNS
cord-308095-mehmk49a	56	23	(	(	-LRB-
cord-308095-mehmk49a	56	24	Hollander	Hollander	NNP
cord-308095-mehmk49a	56	25	et	et	NNP
cord-308095-mehmk49a	56	26	al	al	NNP
cord-308095-mehmk49a	56	27	.	.	.
cord-308095-mehmk49a	56	28	2019	2019	CD
cord-308095-mehmk49a	56	29	)	)	-RRB-
cord-308095-mehmk49a	56	30	;	;	:
cord-308095-mehmk49a	56	31	another	another	DT
cord-308095-mehmk49a	56	32	analysis	analysis	NN
cord-308095-mehmk49a	56	33	of	of	IN
cord-308095-mehmk49a	56	34	a	a	DT
cord-308095-mehmk49a	56	35	similar	similar	JJ
cord-308095-mehmk49a	56	36	period	period	NN
cord-308095-mehmk49a	56	37	puts	put	VBZ
cord-308095-mehmk49a	56	38	the	the	DT
cord-308095-mehmk49a	56	39	figure	figure	NN
cord-308095-mehmk49a	56	40	for	for	IN
cord-308095-mehmk49a	56	41	family	family	NN
cord-308095-mehmk49a	56	42	physicians	physician	NNS
cord-308095-mehmk49a	56	43	even	even	RB
cord-308095-mehmk49a	56	44	higher	high	JJR
cord-308095-mehmk49a	56	45	at	at	IN
cord-308095-mehmk49a	56	46	one	one	CD
cord-308095-mehmk49a	56	47	in	in	IN
cord-308095-mehmk49a	56	48	five	five	CD
cord-308095-mehmk49a	56	49	(	(	-LRB-
cord-308095-mehmk49a	56	50	Hadland	Hadland	NNP
cord-308095-mehmk49a	56	51	,	,	,
cord-308095-mehmk49a	56	52	Krieger	Krieger	NNP
cord-308095-mehmk49a	56	53	,	,	,
cord-308095-mehmk49a	56	54	and	and	CC
cord-308095-mehmk49a	56	55	Marshall	Marshall	NNP
cord-308095-mehmk49a	56	56	2017	2017	CD
cord-308095-mehmk49a	56	57	)	)	-RRB-
cord-308095-mehmk49a	56	58	.	.	.
cord-308095-mehmk49a	57	1	During	during	IN
cord-308095-mehmk49a	57	2	this	this	DT
cord-308095-mehmk49a	57	3	time	time	NN
cord-308095-mehmk49a	57	4	,	,	,
cord-308095-mehmk49a	57	5	physicians	physician	NNS
cord-308095-mehmk49a	57	6	wrote	write	VBD
cord-308095-mehmk49a	57	7	more	more	JJR
cord-308095-mehmk49a	57	8	than	than	IN
cord-308095-mehmk49a	57	9	seventy	seventy	CD
cord-308095-mehmk49a	57	10	opioid	opioid	JJ
cord-308095-mehmk49a	57	11	prescriptions	prescription	NNS
cord-308095-mehmk49a	57	12	per	per	IN
cord-308095-mehmk49a	57	13	year	year	NN
cord-308095-mehmk49a	57	14	for	for	IN
cord-308095-mehmk49a	57	15	every	every	DT
cord-308095-mehmk49a	57	16	hundred	hundred	CD
cord-308095-mehmk49a	57	17	Americans	Americans	NNPS
cord-308095-mehmk49a	57	18	(	(	-LRB-
cord-308095-mehmk49a	57	19	CDC	CDC	NNP
cord-308095-mehmk49a	57	20	2019b	2019b	CD
cord-308095-mehmk49a	57	21	)	)	-RRB-
cord-308095-mehmk49a	57	22	.	.	.
cord-308095-mehmk49a	58	1	Unsurprisingly	unsurprisingly	RB
cord-308095-mehmk49a	58	2	,	,	,
cord-308095-mehmk49a	58	3	studies	study	NNS
cord-308095-mehmk49a	58	4	have	have	VBP
cord-308095-mehmk49a	58	5	found	find	VBN
cord-308095-mehmk49a	58	6	the	the	DT
cord-308095-mehmk49a	58	7	receipt	receipt	NN
cord-308095-mehmk49a	58	8	of	of	IN
cord-308095-mehmk49a	58	9	payments	payment	NNS
cord-308095-mehmk49a	58	10	from	from	IN
cord-308095-mehmk49a	58	11	opioid	opioid	JJ
cord-308095-mehmk49a	58	12	companies	company	NNS
cord-308095-mehmk49a	58	13	is	be	VBZ
cord-308095-mehmk49a	58	14	associated	associate	VBN
cord-308095-mehmk49a	58	15	with	with	IN
cord-308095-mehmk49a	58	16	increases	increase	NNS
cord-308095-mehmk49a	58	17	in	in	IN
cord-308095-mehmk49a	58	18	physicians	physician	NNS
cord-308095-mehmk49a	58	19	'	'	POS
cord-308095-mehmk49a	58	20	prescribing	prescribe	VBG
cord-308095-mehmk49a	58	21	rates	rate	NNS
cord-308095-mehmk49a	59	1	(	(	-LRB-
cord-308095-mehmk49a	59	2	Hadland	Hadland	NNP
cord-308095-mehmk49a	59	3	et	et	FW
cord-308095-mehmk49a	59	4	al	al	NNP
cord-308095-mehmk49a	59	5	.	.	.
cord-308095-mehmk49a	59	6	2018	2018	CD
cord-308095-mehmk49a	60	1	;	;	:
cord-308095-mehmk49a	60	2	Hollander	Hollander	NNP
cord-308095-mehmk49a	60	3	et	et	NNP
cord-308095-mehmk49a	60	4	al	al	NNP
cord-308095-mehmk49a	60	5	.	.	.
cord-308095-mehmk49a	60	6	2019	2019	CD
cord-308095-mehmk49a	60	7	)	)	-RRB-
cord-308095-mehmk49a	60	8	.	.	.
cord-308095-mehmk49a	61	1	That	that	RB
cord-308095-mehmk49a	61	2	is	is	RB
cord-308095-mehmk49a	61	3	,	,	,
cord-308095-mehmk49a	61	4	of	of	IN
cord-308095-mehmk49a	61	5	course	course	NN
cord-308095-mehmk49a	61	6	,	,	,
cord-308095-mehmk49a	61	7	the	the	DT
cord-308095-mehmk49a	61	8	reason	reason	NN
cord-308095-mehmk49a	61	9	drug	drug	NN
cord-308095-mehmk49a	61	10	companies	company	NNS
cord-308095-mehmk49a	61	11	engage	engage	VBP
cord-308095-mehmk49a	61	12	in	in	IN
cord-308095-mehmk49a	61	13	such	such	JJ
cord-308095-mehmk49a	61	14	practices	practice	NNS
cord-308095-mehmk49a	61	15	,	,	,
cord-308095-mehmk49a	61	16	and	and	CC
cord-308095-mehmk49a	61	17	similar	similar	JJ
cord-308095-mehmk49a	61	18	effects	effect	NNS
cord-308095-mehmk49a	61	19	have	have	VBP
cord-308095-mehmk49a	61	20	been	be	VBN
cord-308095-mehmk49a	61	21	found	find	VBN
cord-308095-mehmk49a	61	22	in	in	IN
cord-308095-mehmk49a	61	23	relation	relation	NN
cord-308095-mehmk49a	61	24	to	to	IN
cord-308095-mehmk49a	61	25	a	a	DT
cord-308095-mehmk49a	61	26	variety	variety	NN
cord-308095-mehmk49a	61	27	of	of	IN
cord-308095-mehmk49a	61	28	other	other	JJ
cord-308095-mehmk49a	61	29	prescription	prescription	NN
cord-308095-mehmk49a	61	30	drugs	drug	NNS
cord-308095-mehmk49a	61	31	.	.	.
cord-308095-mehmk49a	62	1	But	but	CC
cord-308095-mehmk49a	62	2	disturbing	disturb	VBG
cord-308095-mehmk49a	62	3	recent	recent	JJ
cord-308095-mehmk49a	62	4	research	research	NN
cord-308095-mehmk49a	62	5	reveals	reveal	VBZ
cord-308095-mehmk49a	62	6	why	why	WRB
cord-308095-mehmk49a	62	7	,	,	,
cord-308095-mehmk49a	62	8	in	in	IN
cord-308095-mehmk49a	62	9	the	the	DT
cord-308095-mehmk49a	62	10	case	case	NN
cord-308095-mehmk49a	62	11	of	of	IN
cord-308095-mehmk49a	62	12	opioids	opioid	NNS
cord-308095-mehmk49a	62	13	,	,	,
cord-308095-mehmk49a	62	14	the	the	DT
cord-308095-mehmk49a	62	15	resulting	result	VBG
cord-308095-mehmk49a	62	16	increase	increase	NN
cord-308095-mehmk49a	62	17	in	in	IN
cord-308095-mehmk49a	62	18	prescribing	prescribing	NN
cord-308095-mehmk49a	62	19	is	be	VBZ
cord-308095-mehmk49a	62	20	especially	especially	RB
cord-308095-mehmk49a	62	21	problematic	problematic	JJ
cord-308095-mehmk49a	62	22	.	.	.
cord-308095-mehmk49a	63	1	A	a	DT
cord-308095-mehmk49a	63	2	study	study	NN
cord-308095-mehmk49a	63	3	of	of	IN
cord-308095-mehmk49a	63	4	67,507	67,507	CD
cord-308095-mehmk49a	63	5	physicians	physician	NNS
cord-308095-mehmk49a	63	6	in	in	IN
cord-308095-mehmk49a	63	7	2,208	2,208	CD
cord-308095-mehmk49a	63	8	counties	county	NNS
cord-308095-mehmk49a	63	9	across	across	IN
cord-308095-mehmk49a	63	10	the	the	DT
cord-308095-mehmk49a	63	11	United	United	NNP
cord-308095-mehmk49a	63	12	States	States	NNP
cord-308095-mehmk49a	63	13	between	between	IN
cord-308095-mehmk49a	63	14	2013	2013	CD
cord-308095-mehmk49a	63	15	and	and	CC
cord-308095-mehmk49a	63	16	2015	2015	CD
cord-308095-mehmk49a	63	17	concluded	conclude	VBD
cord-308095-mehmk49a	63	18	that	that	IN
cord-308095-mehmk49a	63	19	drug	drug	NN
cord-308095-mehmk49a	63	20	companies	company	NNS
cord-308095-mehmk49a	63	21	'	'	POS
cord-308095-mehmk49a	63	22	marketing	marketing	NN
cord-308095-mehmk49a	63	23	of	of	IN
cord-308095-mehmk49a	63	24	opioids	opioid	NNS
cord-308095-mehmk49a	63	25	to	to	IN
cord-308095-mehmk49a	63	26	physicians	physician	NNS
cord-308095-mehmk49a	63	27	was	be	VBD
cord-308095-mehmk49a	63	28	associated	associate	VBN
cord-308095-mehmk49a	63	29	with	with	IN
cord-308095-mehmk49a	63	30	not	not	RB
cord-308095-mehmk49a	63	31	only	only	RB
cord-308095-mehmk49a	63	32	increased	increase	VBN
cord-308095-mehmk49a	63	33	opioid	opioid	NN
cord-308095-mehmk49a	63	34	prescribing	prescribing	NN
cord-308095-mehmk49a	63	35	but	but	CC
cord-308095-mehmk49a	63	36	also	also	RB
cord-308095-mehmk49a	63	37	elevated	elevated	JJ
cord-308095-mehmk49a	63	38	mortality	mortality	NN
cord-308095-mehmk49a	63	39	from	from	IN
cord-308095-mehmk49a	63	40	overdoses	overdose	NNS
cord-308095-mehmk49a	63	41	(	(	-LRB-
cord-308095-mehmk49a	63	42	Hadland	Hadland	NNP
cord-308095-mehmk49a	63	43	,	,	,
cord-308095-mehmk49a	63	44	Rivera	Rivera	NNP
cord-308095-mehmk49a	63	45	-	-	HYPH
cord-308095-mehmk49a	63	46	Aguirre	Aguirre	NNP
cord-308095-mehmk49a	63	47	,	,	,
cord-308095-mehmk49a	63	48	and	and	CC
cord-308095-mehmk49a	63	49	Marshall	Marshall	NNP
cord-308095-mehmk49a	63	50	2019	2019	CD
cord-308095-mehmk49a	63	51	)	)	-RRB-
cord-308095-mehmk49a	63	52	.	.	.
cord-308095-mehmk49a	64	1	More	more	RBR
cord-308095-mehmk49a	64	2	troubling	troubling	JJ
cord-308095-mehmk49a	64	3	still	still	RB
cord-308095-mehmk49a	64	4	,	,	,
cord-308095-mehmk49a	64	5	court	court	NN
cord-308095-mehmk49a	64	6	documents	document	NNS
cord-308095-mehmk49a	64	7	recently	recently	RB
cord-308095-mehmk49a	64	8	filed	file	VBN
cord-308095-mehmk49a	64	9	by	by	IN
cord-308095-mehmk49a	64	10	the	the	DT
cord-308095-mehmk49a	64	11	Attorney	Attorney	NNP
cord-308095-mehmk49a	64	12	-	-	HYPH
cord-308095-mehmk49a	64	13	General	General	NNP
cord-308095-mehmk49a	64	14	of	of	IN
cord-308095-mehmk49a	64	15	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	64	16	allege	allege	VBP
cord-308095-mehmk49a	64	17	that	that	IN
cord-308095-mehmk49a	64	18	doctors	doctor	NNS
cord-308095-mehmk49a	64	19	who	who	WP
cord-308095-mehmk49a	64	20	met	meet	VBD
cord-308095-mehmk49a	64	21	with	with	IN
cord-308095-mehmk49a	64	22	Purdue	Purdue	NNP
cord-308095-mehmk49a	64	23	Pharma	Pharma	NNP
cord-308095-mehmk49a	64	24	drug	drug	NN
cord-308095-mehmk49a	64	25	reps	rep	NNS
cord-308095-mehmk49a	64	26	were	be	VBD
cord-308095-mehmk49a	64	27	ten	ten	CD
cord-308095-mehmk49a	64	28	times	time	NNS
cord-308095-mehmk49a	64	29	more	more	RBR
cord-308095-mehmk49a	64	30	likely	likely	JJ
cord-308095-mehmk49a	64	31	to	to	TO
cord-308095-mehmk49a	64	32	have	have	VB
cord-308095-mehmk49a	64	33	prescribed	prescribe	VBN
cord-308095-mehmk49a	64	34	opioids	opioid	NNS
cord-308095-mehmk49a	64	35	to	to	IN
cord-308095-mehmk49a	64	36	patients	patient	NNS
cord-308095-mehmk49a	64	37	who	who	WP
cord-308095-mehmk49a	64	38	later	later	RB
cord-308095-mehmk49a	64	39	died	die	VBD
cord-308095-mehmk49a	64	40	of	of	IN
cord-308095-mehmk49a	64	41	an	an	DT
cord-308095-mehmk49a	64	42	overdose	overdose	NN
cord-308095-mehmk49a	64	43	than	than	IN
cord-308095-mehmk49a	64	44	physicians	physician	NNS
cord-308095-mehmk49a	64	45	who	who	WP
cord-308095-mehmk49a	64	46	prescribed	prescribe	VBD
cord-308095-mehmk49a	64	47	opioids	opioid	NNS
cord-308095-mehmk49a	64	48	without	without	IN
cord-308095-mehmk49a	64	49	having	have	VBG
cord-308095-mehmk49a	64	50	met	meet	VBN
cord-308095-mehmk49a	64	51	the	the	DT
cord-308095-mehmk49a	64	52	company	company	NN
cord-308095-mehmk49a	64	53	's	's	POS
cord-308095-mehmk49a	64	54	drug	drug	NN
cord-308095-mehmk49a	64	55	reps	rep	NNS
cord-308095-mehmk49a	64	56	(	(	-LRB-
cord-308095-mehmk49a	64	57	Attorney	Attorney	NNP
cord-308095-mehmk49a	64	58	-	-	HYPH
cord-308095-mehmk49a	64	59	General	General	NNP
cord-308095-mehmk49a	64	60	of	of	IN
cord-308095-mehmk49a	64	61	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	64	62	[	[	-LRB-
cord-308095-mehmk49a	64	63	A.G.	A.G.	NNP
cord-308095-mehmk49a	64	64	Mass.	Massachusetts	NNP
cord-308095-mehmk49a	64	65	]	]	-RRB-
cord-308095-mehmk49a	64	66	2019	2019	CD
cord-308095-mehmk49a	64	67	;	;	:
cord-308095-mehmk49a	64	68	Joseph	Joseph	NNP
cord-308095-mehmk49a	64	69	2019a	2019a	CD
cord-308095-mehmk49a	64	70	)	)	-RRB-
cord-308095-mehmk49a	64	71	.	.	.
cord-308095-mehmk49a	65	1	In	in	IN
cord-308095-mehmk49a	65	2	February	February	NNP
cord-308095-mehmk49a	65	3	2018	2018	CD
cord-308095-mehmk49a	65	4	,	,	,
cord-308095-mehmk49a	65	5	Purdue	Purdue	NNP
cord-308095-mehmk49a	65	6	Pharma	Pharma	NNP
cord-308095-mehmk49a	65	7	said	say	VBD
cord-308095-mehmk49a	65	8	it	-PRON-	PRP
cord-308095-mehmk49a	65	9	would	would	MD
cord-308095-mehmk49a	65	10	stop	stop	VB
cord-308095-mehmk49a	65	11	marketing	market	VBG
cord-308095-mehmk49a	65	12	opioids	opioid	NNS
cord-308095-mehmk49a	65	13	to	to	IN
cord-308095-mehmk49a	65	14	physicians	physician	NNS
cord-308095-mehmk49a	65	15	(	(	-LRB-
cord-308095-mehmk49a	65	16	Poston	Poston	NNP
cord-308095-mehmk49a	65	17	2018	2018	CD
cord-308095-mehmk49a	65	18	)	)	-RRB-
cord-308095-mehmk49a	65	19	.	.	.
cord-308095-mehmk49a	66	1	But	but	CC
cord-308095-mehmk49a	66	2	we	-PRON-	PRP
cord-308095-mehmk49a	66	3	should	should	MD
cord-308095-mehmk49a	66	4	not	not	RB
cord-308095-mehmk49a	66	5	derive	derive	VB
cord-308095-mehmk49a	66	6	any	any	DT
cord-308095-mehmk49a	66	7	comfort	comfort	NN
cord-308095-mehmk49a	66	8	from	from	IN
cord-308095-mehmk49a	66	9	these	these	DT
cord-308095-mehmk49a	66	10	kinds	kind	NNS
cord-308095-mehmk49a	66	11	of	of	IN
cord-308095-mehmk49a	66	12	voluntary	voluntary	JJ
cord-308095-mehmk49a	66	13	commitments	commitment	NNS
cord-308095-mehmk49a	66	14	.	.	.
cord-308095-mehmk49a	67	1	First	first	RB
cord-308095-mehmk49a	67	2	,	,	,
cord-308095-mehmk49a	67	3	the	the	DT
cord-308095-mehmk49a	67	4	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	67	5	court	court	NN
cord-308095-mehmk49a	67	6	documents	document	NNS
cord-308095-mehmk49a	67	7	make	make	VBP
cord-308095-mehmk49a	67	8	clear	clear	JJ
cord-308095-mehmk49a	67	9	that	that	IN
cord-308095-mehmk49a	67	10	the	the	DT
cord-308095-mehmk49a	67	11	company	company	NN
cord-308095-mehmk49a	67	12	continued	continue	VBD
cord-308095-mehmk49a	67	13	its	-PRON-	PRP$
cord-308095-mehmk49a	67	14	aggressive	aggressive	JJ
cord-308095-mehmk49a	67	15	marketing	marketing	NN
cord-308095-mehmk49a	67	16	strategy	strategy	NN
cord-308095-mehmk49a	67	17	for	for	IN
cord-308095-mehmk49a	67	18	at	at	IN
cord-308095-mehmk49a	67	19	least	least	JJS
cord-308095-mehmk49a	67	20	a	a	DT
cord-308095-mehmk49a	67	21	decade	decade	NN
cord-308095-mehmk49a	67	22	after	after	IN
cord-308095-mehmk49a	67	23	it	-PRON-	PRP
cord-308095-mehmk49a	67	24	pleaded	plead	VBD
cord-308095-mehmk49a	67	25	guilty	guilty	JJ
cord-308095-mehmk49a	67	26	in	in	IN
cord-308095-mehmk49a	67	27	2007	2007	CD
cord-308095-mehmk49a	67	28	to	to	IN
cord-308095-mehmk49a	67	29	misleading	misleading	JJ
cord-308095-mehmk49a	67	30	physicians	physician	NNS
cord-308095-mehmk49a	67	31	and	and	CC
cord-308095-mehmk49a	67	32	patients	patient	NNS
cord-308095-mehmk49a	67	33	by	by	IN
cord-308095-mehmk49a	67	34	downplaying	downplay	VBG
cord-308095-mehmk49a	67	35	the	the	DT
cord-308095-mehmk49a	67	36	risks	risk	NNS
cord-308095-mehmk49a	67	37	of	of	IN
cord-308095-mehmk49a	67	38	addiction	addiction	NN
cord-308095-mehmk49a	67	39	and	and	CC
cord-308095-mehmk49a	67	40	abuse	abuse	NN
cord-308095-mehmk49a	67	41	of	of	IN
cord-308095-mehmk49a	67	42	its	-PRON-	PRP$
cord-308095-mehmk49a	67	43	leading	lead	VBG
cord-308095-mehmk49a	67	44	brand	brand	NN
cord-308095-mehmk49a	67	45	,	,	,
cord-308095-mehmk49a	67	46	OxyContin	OxyContin	NNP
cord-308095-mehmk49a	67	47	(	(	-LRB-
cord-308095-mehmk49a	67	48	Meier	Meier	NNP
cord-308095-mehmk49a	67	49	2007	2007	CD
cord-308095-mehmk49a	67	50	)	)	-RRB-
cord-308095-mehmk49a	67	51	.	.	.
cord-308095-mehmk49a	68	1	That	that	DT
cord-308095-mehmk49a	68	2	strategy	strategy	NN
cord-308095-mehmk49a	68	3	was	be	VBD
cord-308095-mehmk49a	68	4	complemented	complement	VBN
cord-308095-mehmk49a	68	5	by	by	IN
cord-308095-mehmk49a	68	6	an	an	DT
cord-308095-mehmk49a	68	7	insidious	insidious	JJ
cord-308095-mehmk49a	68	8	kickback	kickback	NN
cord-308095-mehmk49a	68	9	scheme	scheme	NN
cord-308095-mehmk49a	68	10	:	:	:
cord-308095-mehmk49a	68	11	Purdue	Purdue	NNP
cord-308095-mehmk49a	68	12	Pharma	Pharma	NNP
cord-308095-mehmk49a	68	13	paid	pay	VBD
cord-308095-mehmk49a	68	14	a	a	DT
cord-308095-mehmk49a	68	15	technology	technology	NN
cord-308095-mehmk49a	68	16	company	company	NN
cord-308095-mehmk49a	68	17	to	to	TO
cord-308095-mehmk49a	68	18	generate	generate	VB
cord-308095-mehmk49a	68	19	prompts	prompt	NNS
cord-308095-mehmk49a	68	20	in	in	IN
cord-308095-mehmk49a	68	21	electronic	electronic	JJ
cord-308095-mehmk49a	68	22	health	health	NN
cord-308095-mehmk49a	68	23	records	record	NNS
cord-308095-mehmk49a	68	24	(	(	-LRB-
cord-308095-mehmk49a	68	25	EHR	EHR	NNP
cord-308095-mehmk49a	68	26	)	)	-RRB-
cord-308095-mehmk49a	68	27	software	software	NN
cord-308095-mehmk49a	68	28	encouraging	encourage	VBG
cord-308095-mehmk49a	68	29	physicians	physician	NNS
cord-308095-mehmk49a	68	30	to	to	TO
cord-308095-mehmk49a	68	31	prescribe	prescribe	VB
cord-308095-mehmk49a	68	32	more	more	JJR
cord-308095-mehmk49a	68	33	opioids	opioid	NNS
cord-308095-mehmk49a	68	34	(	(	-LRB-
cord-308095-mehmk49a	68	35	Farzan	Farzan	NNP
cord-308095-mehmk49a	68	36	2020	2020	CD
cord-308095-mehmk49a	68	37	)	)	-RRB-
cord-308095-mehmk49a	68	38	.	.	.
cord-308095-mehmk49a	69	1	Second	second	RB
cord-308095-mehmk49a	69	2	,	,	,
cord-308095-mehmk49a	69	3	a	a	DT
cord-308095-mehmk49a	69	4	consortium	consortium	NN
cord-308095-mehmk49a	69	5	of	of	IN
cord-308095-mehmk49a	69	6	companies	company	NNS
cord-308095-mehmk49a	69	7	known	know	VBN
cord-308095-mehmk49a	69	8	as	as	IN
cord-308095-mehmk49a	69	9	Mundipharma	Mundipharma	NNP
cord-308095-mehmk49a	69	10	,	,	,
cord-308095-mehmk49a	69	11	also	also	RB
cord-308095-mehmk49a	69	12	owned	own	VBN
cord-308095-mehmk49a	69	13	by	by	IN
cord-308095-mehmk49a	69	14	members	member	NNS
cord-308095-mehmk49a	69	15	of	of	IN
cord-308095-mehmk49a	69	16	the	the	DT
cord-308095-mehmk49a	69	17	Sackler	Sackler	NNP
cord-308095-mehmk49a	69	18	family	family	NN
cord-308095-mehmk49a	69	19	,	,	,
cord-308095-mehmk49a	69	20	has	have	VBZ
cord-308095-mehmk49a	69	21	been	be	VBN
cord-308095-mehmk49a	69	22	making	make	VBG
cord-308095-mehmk49a	69	23	efforts	effort	NNS
cord-308095-mehmk49a	69	24	to	to	TO
cord-308095-mehmk49a	69	25	expand	expand	VB
cord-308095-mehmk49a	69	26	opioid	opioid	JJ
cord-308095-mehmk49a	69	27	markets	market	NNS
cord-308095-mehmk49a	69	28	internationally	internationally	RB
cord-308095-mehmk49a	69	29	.	.	.
cord-308095-mehmk49a	70	1	While	while	IN
cord-308095-mehmk49a	70	2	some	some	DT
cord-308095-mehmk49a	70	3	of	of	IN
cord-308095-mehmk49a	70	4	Mundipharma	Mundipharma	NNP
cord-308095-mehmk49a	70	5	's	's	POS
cord-308095-mehmk49a	70	6	apparent	apparent	JJ
cord-308095-mehmk49a	70	7	practices	practice	NNS
cord-308095-mehmk49a	70	8	in	in	IN
cord-308095-mehmk49a	70	9	China	China	NNP
cord-308095-mehmk49a	70	10	go	go	VBP
cord-308095-mehmk49a	70	11	beyond	beyond	IN
cord-308095-mehmk49a	70	12	what	what	WP
cord-308095-mehmk49a	70	13	has	have	VBZ
cord-308095-mehmk49a	70	14	been	be	VBN
cord-308095-mehmk49a	70	15	alleged	allege	VBN
cord-308095-mehmk49a	70	16	in	in	IN
cord-308095-mehmk49a	70	17	the	the	DT
cord-308095-mehmk49a	70	18	United	United	NNP
cord-308095-mehmk49a	70	19	States	States	NNP
cord-308095-mehmk49a	70	20	,	,	,
cord-308095-mehmk49a	70	21	the	the	DT
cord-308095-mehmk49a	70	22	broad	broad	JJ
cord-308095-mehmk49a	70	23	strategy	strategy	NN
cord-308095-mehmk49a	70	24	of	of	IN
cord-308095-mehmk49a	70	25	downplaying	downplay	VBG
cord-308095-mehmk49a	70	26	the	the	DT
cord-308095-mehmk49a	70	27	risks	risk	NNS
cord-308095-mehmk49a	70	28	of	of	IN
cord-308095-mehmk49a	70	29	addiction	addiction	NN
cord-308095-mehmk49a	70	30	and	and	CC
cord-308095-mehmk49a	70	31	abuse	abuse	NN
cord-308095-mehmk49a	70	32	clearly	clearly	RB
cord-308095-mehmk49a	70	33	resembles	resemble	VBZ
cord-308095-mehmk49a	70	34	Purdue	Purdue	NNP
cord-308095-mehmk49a	70	35	Pharma	Pharma	NNP
cord-308095-mehmk49a	70	36	's	's	POS
cord-308095-mehmk49a	70	37	North	north	JJ
cord-308095-mehmk49a	70	38	American	american	JJ
cord-308095-mehmk49a	70	39	strategies	strategy	NNS
cord-308095-mehmk49a	70	40	(	(	-LRB-
cord-308095-mehmk49a	70	41	Kinetz	Kinetz	NNP
cord-308095-mehmk49a	70	42	2019	2019	CD
cord-308095-mehmk49a	70	43	)	)	-RRB-
cord-308095-mehmk49a	70	44	.	.	.
cord-308095-mehmk49a	71	1	As	as	IN
cord-308095-mehmk49a	71	2	former	former	JJ
cord-308095-mehmk49a	71	3	U.S.	U.S.	NNP
cord-308095-mehmk49a	71	4	Food	Food	NNP
cord-308095-mehmk49a	71	5	and	and	CC
cord-308095-mehmk49a	71	6	Drug	Drug	NNP
cord-308095-mehmk49a	71	7	Administration	Administration	NNP
cord-308095-mehmk49a	71	8	(	(	-LRB-
cord-308095-mehmk49a	71	9	FDA	FDA	NNP
cord-308095-mehmk49a	71	10	)	)	-RRB-
cord-308095-mehmk49a	71	11	commissioner	commissioner	NN
cord-308095-mehmk49a	71	12	David	David	NNP
cord-308095-mehmk49a	71	13	Kessler	Kessler	NNP
cord-308095-mehmk49a	71	14	observed	observe	VBD
cord-308095-mehmk49a	71	15	,	,	,
cord-308095-mehmk49a	71	16	"	"	``
cord-308095-mehmk49a	71	17	It	-PRON-	PRP
cord-308095-mehmk49a	71	18	's	be	VBZ
cord-308095-mehmk49a	71	19	right	right	RB
cord-308095-mehmk49a	71	20	out	out	IN
cord-308095-mehmk49a	71	21	of	of	IN
cord-308095-mehmk49a	71	22	the	the	DT
cord-308095-mehmk49a	71	23	playbook	playbook	NN
cord-308095-mehmk49a	71	24	of	of	IN
cord-308095-mehmk49a	71	25	Big	Big	NNP
cord-308095-mehmk49a	71	26	Tobacco	Tobacco	NNP
cord-308095-mehmk49a	71	27	.	.	.
cord-308095-mehmk49a	72	1	As	as	IN
cord-308095-mehmk49a	72	2	the	the	DT
cord-308095-mehmk49a	72	3	United	United	NNP
cord-308095-mehmk49a	72	4	States	States	NNP
cord-308095-mehmk49a	72	5	takes	take	VBZ
cord-308095-mehmk49a	72	6	steps	step	NNS
cord-308095-mehmk49a	72	7	to	to	TO
cord-308095-mehmk49a	72	8	limit	limit	VB
cord-308095-mehmk49a	72	9	sales	sale	NNS
cord-308095-mehmk49a	72	10	here	here	RB
cord-308095-mehmk49a	72	11	,	,	,
cord-308095-mehmk49a	72	12	the	the	DT
cord-308095-mehmk49a	72	13	company	company	NN
cord-308095-mehmk49a	72	14	goes	go	VBZ
cord-308095-mehmk49a	72	15	abroad	abroad	RB
cord-308095-mehmk49a	72	16	"	"	''
cord-308095-mehmk49a	73	1	(	(	-LRB-
cord-308095-mehmk49a	73	2	Ryan	Ryan	NNP
cord-308095-mehmk49a	73	3	,	,	,
cord-308095-mehmk49a	73	4	Girion	Girion	NNP
cord-308095-mehmk49a	73	5	,	,	,
cord-308095-mehmk49a	73	6	and	and	CC
cord-308095-mehmk49a	73	7	Glover	Glover	NNP
cord-308095-mehmk49a	73	8	2016	2016	CD
cord-308095-mehmk49a	73	9	,	,	,
cord-308095-mehmk49a	73	10	¶9	¶9	NNP
cord-308095-mehmk49a	73	11	)	)	-RRB-
cord-308095-mehmk49a	73	12	.	.	.
cord-308095-mehmk49a	74	1	Purdue	Purdue	NNP
cord-308095-mehmk49a	74	2	Pharma	Pharma	NNP
cord-308095-mehmk49a	74	3	is	be	VBZ
cord-308095-mehmk49a	74	4	just	just	RB
cord-308095-mehmk49a	74	5	one	one	CD
cord-308095-mehmk49a	74	6	of	of	IN
cord-308095-mehmk49a	74	7	several	several	JJ
cord-308095-mehmk49a	74	8	opioid	opioid	JJ
cord-308095-mehmk49a	74	9	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	74	10	that	that	WDT
cord-308095-mehmk49a	74	11	have	have	VBP
cord-308095-mehmk49a	74	12	been	be	VBN
cord-308095-mehmk49a	74	13	making	make	VBG
cord-308095-mehmk49a	74	14	payments	payment	NNS
cord-308095-mehmk49a	74	15	to	to	IN
cord-308095-mehmk49a	74	16	physicians	physician	NNS
cord-308095-mehmk49a	74	17	(	(	-LRB-
cord-308095-mehmk49a	74	18	see	see	VB
cord-308095-mehmk49a	74	19	,	,	,
cord-308095-mehmk49a	74	20	e.g.	e.g.	RB
cord-308095-mehmk49a	74	21	,	,	,
cord-308095-mehmk49a	74	22	Hollander	Hollander	NNP
cord-308095-mehmk49a	74	23	2019)-and	2019)-and	CD
cord-308095-mehmk49a	75	1	it	-PRON-	PRP
cord-308095-mehmk49a	75	2	is	be	VBZ
cord-308095-mehmk49a	75	3	not	not	RB
cord-308095-mehmk49a	75	4	the	the	DT
cord-308095-mehmk49a	75	5	only	only	JJ
cord-308095-mehmk49a	75	6	company	company	NN
cord-308095-mehmk49a	75	7	to	to	TO
cord-308095-mehmk49a	75	8	have	have	VB
cord-308095-mehmk49a	75	9	engaged	engage	VBN
cord-308095-mehmk49a	75	10	in	in	IN
cord-308095-mehmk49a	75	11	the	the	DT
cord-308095-mehmk49a	75	12	aggressive	aggressive	JJ
cord-308095-mehmk49a	75	13	marketing	marketing	NN
cord-308095-mehmk49a	75	14	of	of	IN
cord-308095-mehmk49a	75	15	opioids	opioid	NNS
cord-308095-mehmk49a	75	16	(	(	-LRB-
cord-308095-mehmk49a	75	17	Horwitz	Horwitz	NNP
cord-308095-mehmk49a	75	18	et	et	NNP
cord-308095-mehmk49a	75	19	al	al	NNP
cord-308095-mehmk49a	75	20	.	.	.
cord-308095-mehmk49a	75	21	2019	2019	CD
cord-308095-mehmk49a	75	22	)	)	-RRB-
cord-308095-mehmk49a	75	23	.	.	.
cord-308095-mehmk49a	76	1	A	a	DT
cord-308095-mehmk49a	76	2	U.S.	U.S.	NNP
cord-308095-mehmk49a	76	3	Senate	Senate	NNP
cord-308095-mehmk49a	76	4	report	report	NN
cord-308095-mehmk49a	76	5	describes	describe	VBZ
cord-308095-mehmk49a	76	6	in	in	IN
cord-308095-mehmk49a	76	7	some	some	DT
cord-308095-mehmk49a	76	8	detail	detail	NN
cord-308095-mehmk49a	76	9	how	how	WRB
cord-308095-mehmk49a	76	10	another	another	DT
cord-308095-mehmk49a	76	11	company	company	NN
cord-308095-mehmk49a	76	12	,	,	,
cord-308095-mehmk49a	76	13	Insys	Insys	NNP
cord-308095-mehmk49a	76	14	,	,	,
cord-308095-mehmk49a	76	15	engaged	engage	VBN
cord-308095-mehmk49a	76	16	in	in	IN
cord-308095-mehmk49a	76	17	similarly	similarly	RB
cord-308095-mehmk49a	76	18	aggressive	aggressive	JJ
cord-308095-mehmk49a	76	19	practices	practice	NNS
cord-308095-mehmk49a	76	20	(	(	-LRB-
cord-308095-mehmk49a	76	21	Homeland	Homeland	NNP
cord-308095-mehmk49a	76	22	Security	Security	NNP
cord-308095-mehmk49a	76	23	and	and	CC
cord-308095-mehmk49a	76	24	Government	Government	NNP
cord-308095-mehmk49a	76	25	Affairs	Affairs	NNPS
cord-308095-mehmk49a	76	26	Committee	Committee	NNP
cord-308095-mehmk49a	76	27	[	[	-LRB-
cord-308095-mehmk49a	76	28	HSGAC	HSGAC	NNP
cord-308095-mehmk49a	76	29	]	]	-RRB-
cord-308095-mehmk49a	76	30	2018b	2018b	CD
cord-308095-mehmk49a	76	31	)	)	-RRB-
cord-308095-mehmk49a	76	32	.	.	.
cord-308095-mehmk49a	77	1	The	the	DT
cord-308095-mehmk49a	77	2	report	report	NN
cord-308095-mehmk49a	77	3	revealed	reveal	VBD
cord-308095-mehmk49a	77	4	that	that	IN
cord-308095-mehmk49a	77	5	executives	executive	NNS
cord-308095-mehmk49a	77	6	emphasized	emphasize	VBD
cord-308095-mehmk49a	77	7	to	to	IN
cord-308095-mehmk49a	77	8	their	-PRON-	PRP$
cord-308095-mehmk49a	77	9	sales	sale	NNS
cord-308095-mehmk49a	77	10	reps	rep	NNS
cord-308095-mehmk49a	77	11	the	the	DT
cord-308095-mehmk49a	77	12	importance	importance	NN
cord-308095-mehmk49a	77	13	of	of	IN
cord-308095-mehmk49a	77	14	"	"	``
cord-308095-mehmk49a	77	15	owning	own	VBG
cord-308095-mehmk49a	77	16	"	"	''
cord-308095-mehmk49a	77	17	physicians	physician	NNS
cord-308095-mehmk49a	77	18	and	and	CC
cord-308095-mehmk49a	77	19	of	of	IN
cord-308095-mehmk49a	77	20	"	"	``
cord-308095-mehmk49a	77	21	holding	hold	VBG
cord-308095-mehmk49a	77	22	the	the	DT
cord-308095-mehmk49a	77	23	customer	customer	NN
cord-308095-mehmk49a	77	24	[	[	-LRB-
cord-308095-mehmk49a	77	25	that	that	RB
cord-308095-mehmk49a	77	26	is	is	RB
cord-308095-mehmk49a	77	27	,	,	,
cord-308095-mehmk49a	77	28	the	the	DT
cord-308095-mehmk49a	77	29	physician	physician	NN
cord-308095-mehmk49a	77	30	]	]	-RRB-
cord-308095-mehmk49a	77	31	accountable	accountable	JJ
cord-308095-mehmk49a	77	32	"	"	''
cord-308095-mehmk49a	77	33	when	when	WRB
cord-308095-mehmk49a	77	34	they	-PRON-	PRP
cord-308095-mehmk49a	77	35	failed	fail	VBD
cord-308095-mehmk49a	77	36	to	to	TO
cord-308095-mehmk49a	77	37	sustain	sustain	VB
cord-308095-mehmk49a	77	38	or	or	CC
cord-308095-mehmk49a	77	39	increase	increase	VB
cord-308095-mehmk49a	77	40	sales	sale	NNS
cord-308095-mehmk49a	77	41	of	of	IN
cord-308095-mehmk49a	77	42	Subsys	Subsys	NNP
cord-308095-mehmk49a	77	43	,	,	,
cord-308095-mehmk49a	77	44	a	a	DT
cord-308095-mehmk49a	77	45	fentanyl	fentanyl	NN
cord-308095-mehmk49a	77	46	brand	brand	NN
cord-308095-mehmk49a	77	47	.	.	.
cord-308095-mehmk49a	78	1	The	the	DT
cord-308095-mehmk49a	78	2	company	company	NN
cord-308095-mehmk49a	78	3	's	's	POS
cord-308095-mehmk49a	78	4	new	new	JJ
cord-308095-mehmk49a	78	5	CEO	CEO	NNP
cord-308095-mehmk49a	78	6	informed	inform	VBD
cord-308095-mehmk49a	78	7	the	the	DT
cord-308095-mehmk49a	78	8	Senate	Senate	NNP
cord-308095-mehmk49a	78	9	Committee	Committee	NNP
cord-308095-mehmk49a	78	10	that	that	IN
cord-308095-mehmk49a	78	11	the	the	DT
cord-308095-mehmk49a	78	12	company	company	NN
cord-308095-mehmk49a	78	13	had	have	VBD
cord-308095-mehmk49a	78	14	learned	learn	VBN
cord-308095-mehmk49a	78	15	from	from	IN
cord-308095-mehmk49a	78	16	past	past	JJ
cord-308095-mehmk49a	78	17	mistakes	mistake	NNS
cord-308095-mehmk49a	78	18	and	and	CC
cord-308095-mehmk49a	78	19	replaced	replace	VBD
cord-308095-mehmk49a	78	20	most	most	JJS
cord-308095-mehmk49a	78	21	of	of	IN
cord-308095-mehmk49a	78	22	its	-PRON-	PRP$
cord-308095-mehmk49a	78	23	sales	sale	NNS
cord-308095-mehmk49a	78	24	force	force	NN
cord-308095-mehmk49a	78	25	.	.	.
cord-308095-mehmk49a	79	1	But	but	CC
cord-308095-mehmk49a	79	2	in	in	IN
cord-308095-mehmk49a	79	3	the	the	DT
cord-308095-mehmk49a	79	4	wake	wake	NN
cord-308095-mehmk49a	79	5	of	of	IN
cord-308095-mehmk49a	79	6	multiple	multiple	JJ
cord-308095-mehmk49a	79	7	indictments	indictment	NNS
cord-308095-mehmk49a	79	8	,	,	,
cord-308095-mehmk49a	79	9	congressional	congressional	JJ
cord-308095-mehmk49a	79	10	investigations	investigation	NNS
cord-308095-mehmk49a	79	11	,	,	,
cord-308095-mehmk49a	79	12	civil	civil	JJ
cord-308095-mehmk49a	79	13	lawsuits	lawsuit	NNS
cord-308095-mehmk49a	79	14	,	,	,
cord-308095-mehmk49a	79	15	and	and	CC
cord-308095-mehmk49a	79	16	much	much	RB
cord-308095-mehmk49a	79	17	highly	highly	RB
cord-308095-mehmk49a	79	18	critical	critical	JJ
cord-308095-mehmk49a	79	19	media	medium	NNS
cord-308095-mehmk49a	79	20	attention	attention	NN
cord-308095-mehmk49a	79	21	(	(	-LRB-
cord-308095-mehmk49a	79	22	see	see	UH
cord-308095-mehmk49a	79	23	,	,	,
cord-308095-mehmk49a	79	24	e.g.	e.g.	RB
cord-308095-mehmk49a	79	25	,	,	,
cord-308095-mehmk49a	79	26	Woodson	Woodson	NNP
cord-308095-mehmk49a	79	27	2019	2019	CD
cord-308095-mehmk49a	79	28	)	)	-RRB-
cord-308095-mehmk49a	79	29	,	,	,
cord-308095-mehmk49a	79	30	this	this	DT
cord-308095-mehmk49a	79	31	is	be	VBZ
cord-308095-mehmk49a	79	32	too	too	RB
cord-308095-mehmk49a	79	33	little	little	JJ
cord-308095-mehmk49a	79	34	too	too	RB
cord-308095-mehmk49a	79	35	late	late	RB
cord-308095-mehmk49a	79	36	.	.	.
cord-308095-mehmk49a	80	1	It	-PRON-	PRP
cord-308095-mehmk49a	80	2	remains	remain	VBZ
cord-308095-mehmk49a	80	3	to	to	TO
cord-308095-mehmk49a	80	4	be	be	VB
cord-308095-mehmk49a	80	5	seen	see	VBN
cord-308095-mehmk49a	80	6	whether	whether	IN
cord-308095-mehmk49a	80	7	the	the	DT
cord-308095-mehmk49a	80	8	conviction	conviction	NN
cord-308095-mehmk49a	80	9	of	of	IN
cord-308095-mehmk49a	80	10	several	several	JJ
cord-308095-mehmk49a	80	11	former	former	JJ
cord-308095-mehmk49a	80	12	Insys	Insys	NNP
cord-308095-mehmk49a	80	13	executives	executive	NNS
cord-308095-mehmk49a	80	14	for	for	IN
cord-308095-mehmk49a	80	15	fraudand	fraudand	VB
cord-308095-mehmk49a	80	16	the	the	DT
cord-308095-mehmk49a	80	17	prospect	prospect	NN
cord-308095-mehmk49a	80	18	of	of	IN
cord-308095-mehmk49a	80	19	imprisonment	imprisonment	NN
cord-308095-mehmk49a	80	20	for	for	IN
cord-308095-mehmk49a	80	21	several	several	JJ
cord-308095-mehmk49a	80	22	yearswill	yearswill	NN
cord-308095-mehmk49a	80	23	change	change	VB
cord-308095-mehmk49a	80	24	corporate	corporate	JJ
cord-308095-mehmk49a	80	25	cost	cost	NN
cord-308095-mehmk49a	80	26	-	-	HYPH
cord-308095-mehmk49a	80	27	benefit	benefit	NN
cord-308095-mehmk49a	80	28	analyses	analysis	NNS
cord-308095-mehmk49a	80	29	in	in	IN
cord-308095-mehmk49a	80	30	ways	way	NNS
cord-308095-mehmk49a	80	31	that	that	WDT
cord-308095-mehmk49a	80	32	previous	previous	JJ
cord-308095-mehmk49a	80	33	fines	fine	NNS
cord-308095-mehmk49a	80	34	on	on	IN
cord-308095-mehmk49a	80	35	companies	company	NNS
cord-308095-mehmk49a	80	36	have	have	VBP
cord-308095-mehmk49a	80	37	not	not	RB
cord-308095-mehmk49a	80	38	(	(	-LRB-
cord-308095-mehmk49a	80	39	Emanual	Emanual	NNP
cord-308095-mehmk49a	80	40	and	and	CC
cord-308095-mehmk49a	80	41	Thomas	Thomas	NNP
cord-308095-mehmk49a	80	42	,	,	,
cord-308095-mehmk49a	80	43	2019	2019	CD
cord-308095-mehmk49a	80	44	;	;	:
cord-308095-mehmk49a	80	45	Raymond	Raymond	NNP
cord-308095-mehmk49a	80	46	2019	2019	CD
cord-308095-mehmk49a	80	47	;	;	:
cord-308095-mehmk49a	80	48	Thomas	Thomas	NNP
cord-308095-mehmk49a	80	49	2020	2020	CD
cord-308095-mehmk49a	80	50	)	)	-RRB-
cord-308095-mehmk49a	80	51	.	.	.
cord-308095-mehmk49a	81	1	Influencing	influence	VBG
cord-308095-mehmk49a	81	2	the	the	DT
cord-308095-mehmk49a	81	3	Academy	Academy	NNP
cord-308095-mehmk49a	81	4	:	:	:
cord-308095-mehmk49a	81	5	Universities	Universities	NNP
cord-308095-mehmk49a	81	6	and	and	CC
cord-308095-mehmk49a	81	7	Academic	Academic	NNP
cord-308095-mehmk49a	81	8	Medical	Medical	NNP
cord-308095-mehmk49a	81	9	Centres	Centres	NNPS
cord-308095-mehmk49a	81	10	Remarkably	remarkably	RB
cord-308095-mehmk49a	81	11	,	,	,
cord-308095-mehmk49a	81	12	academic	academic	JJ
cord-308095-mehmk49a	81	13	institutions	institution	NNS
cord-308095-mehmk49a	81	14	continued	continue	VBD
cord-308095-mehmk49a	81	15	to	to	TO
cord-308095-mehmk49a	81	16	accept	accept	VB
cord-308095-mehmk49a	81	17	donations	donation	NNS
cord-308095-mehmk49a	81	18	from	from	IN
cord-308095-mehmk49a	81	19	and	and	CC
cord-308095-mehmk49a	81	20	build	build	VB
cord-308095-mehmk49a	81	21	relationships	relationship	NNS
cord-308095-mehmk49a	81	22	with	with	IN
cord-308095-mehmk49a	81	23	Purdue	Purdue	NNP
cord-308095-mehmk49a	81	24	Pharma	Pharma	NNP
cord-308095-mehmk49a	81	25	after	after	IN
cord-308095-mehmk49a	81	26	the	the	DT
cord-308095-mehmk49a	81	27	company	company	NN
cord-308095-mehmk49a	81	28	and	and	CC
cord-308095-mehmk49a	81	29	several	several	JJ
cord-308095-mehmk49a	81	30	of	of	IN
cord-308095-mehmk49a	81	31	its	-PRON-	PRP$
cord-308095-mehmk49a	81	32	executives	executive	NNS
cord-308095-mehmk49a	81	33	had	have	VBD
cord-308095-mehmk49a	81	34	pleaded	plead	VBN
cord-308095-mehmk49a	81	35	guilty	guilty	JJ
cord-308095-mehmk49a	81	36	in	in	IN
cord-308095-mehmk49a	81	37	2007	2007	CD
cord-308095-mehmk49a	81	38	to	to	IN
cord-308095-mehmk49a	81	39	misleading	mislead	VBG
cord-308095-mehmk49a	81	40	doctors	doctor	NNS
cord-308095-mehmk49a	81	41	and	and	CC
cord-308095-mehmk49a	81	42	patients	patient	NNS
cord-308095-mehmk49a	81	43	about	about	IN
cord-308095-mehmk49a	81	44	the	the	DT
cord-308095-mehmk49a	81	45	addiction	addiction	NN
cord-308095-mehmk49a	81	46	risks	risk	NNS
cord-308095-mehmk49a	81	47	of	of	IN
cord-308095-mehmk49a	81	48	OxyContin	OxyContin	NNP
cord-308095-mehmk49a	81	49	(	(	-LRB-
cord-308095-mehmk49a	81	50	Meier	Meier	NNP
cord-308095-mehmk49a	81	51	2007	2007	CD
cord-308095-mehmk49a	81	52	)	)	-RRB-
cord-308095-mehmk49a	81	53	.	.	.
cord-308095-mehmk49a	82	1	A	a	DT
cord-308095-mehmk49a	82	2	recent	recent	JJ
cord-308095-mehmk49a	82	3	independent	independent	JJ
cord-308095-mehmk49a	82	4	review	review	NN
cord-308095-mehmk49a	82	5	(	(	-LRB-
cord-308095-mehmk49a	82	6	commissioned	commission	VBN
cord-308095-mehmk49a	82	7	by	by	IN
cord-308095-mehmk49a	82	8	Tufts	Tufts	NNP
cord-308095-mehmk49a	82	9	)	)	-RRB-
cord-308095-mehmk49a	82	10	found	find	VBD
cord-308095-mehmk49a	82	11	"	"	``
cord-308095-mehmk49a	82	12	no	no	DT
cord-308095-mehmk49a	82	13	evidence	evidence	NN
cord-308095-mehmk49a	82	14	of	of	IN
cord-308095-mehmk49a	82	15	any	any	DT
cord-308095-mehmk49a	82	16	meaningful	meaningful	JJ
cord-308095-mehmk49a	82	17	attempt	attempt	NN
cord-308095-mehmk49a	82	18	by	by	IN
cord-308095-mehmk49a	82	19	Tufts	Tufts	NNP
cord-308095-mehmk49a	82	20	to	to	TO
cord-308095-mehmk49a	82	21	reconsider	reconsider	VB
cord-308095-mehmk49a	82	22	its	-PRON-	PRP$
cord-308095-mehmk49a	82	23	relationship	relationship	NN
cord-308095-mehmk49a	82	24	with	with	IN
cord-308095-mehmk49a	82	25	,	,	,
cord-308095-mehmk49a	82	26	or	or	CC
cord-308095-mehmk49a	82	27	distance	distance	VB
cord-308095-mehmk49a	82	28	itself	-PRON-	PRP
cord-308095-mehmk49a	82	29	from	from	IN
cord-308095-mehmk49a	82	30	,	,	,
cord-308095-mehmk49a	82	31	the	the	DT
cord-308095-mehmk49a	82	32	Sacklers	Sacklers	NNPS
cord-308095-mehmk49a	82	33	or	or	CC
cord-308095-mehmk49a	82	34	Purdue	Purdue	NNP
cord-308095-mehmk49a	82	35	"	"	''
cord-308095-mehmk49a	82	36	in	in	IN
cord-308095-mehmk49a	82	37	the	the	DT
cord-308095-mehmk49a	82	38	wake	wake	NN
cord-308095-mehmk49a	82	39	of	of	IN
cord-308095-mehmk49a	82	40	the	the	DT
cord-308095-mehmk49a	82	41	guilty	guilty	JJ
cord-308095-mehmk49a	82	42	plea	plea	NN
cord-308095-mehmk49a	82	43	-	-	:
cord-308095-mehmk49a	82	44	or	or	CC
cord-308095-mehmk49a	82	45	at	at	IN
cord-308095-mehmk49a	82	46	any	any	DT
cord-308095-mehmk49a	82	47	time	time	NN
cord-308095-mehmk49a	82	48	prior	prior	RB
cord-308095-mehmk49a	82	49	to	to	IN
cord-308095-mehmk49a	82	50	the	the	DT
cord-308095-mehmk49a	82	51	publication	publication	NN
cord-308095-mehmk49a	82	52	in	in	IN
cord-308095-mehmk49a	82	53	autumn	autumn	NN
cord-308095-mehmk49a	82	54	2017	2017	CD
cord-308095-mehmk49a	82	55	of	of	IN
cord-308095-mehmk49a	82	56	highprofile	highprofile	NNP
cord-308095-mehmk49a	82	57	magazine	magazine	NN
cord-308095-mehmk49a	82	58	articles	article	NNS
cord-308095-mehmk49a	82	59	severely	severely	RB
cord-308095-mehmk49a	82	60	criticizing	criticize	VBG
cord-308095-mehmk49a	82	61	Purdue	Purdue	NNP
cord-308095-mehmk49a	82	62	and	and	CC
cord-308095-mehmk49a	82	63	members	member	NNS
cord-308095-mehmk49a	82	64	of	of	IN
cord-308095-mehmk49a	82	65	the	the	DT
cord-308095-mehmk49a	82	66	Sackler	Sackler	NNP
cord-308095-mehmk49a	82	67	family	family	NN
cord-308095-mehmk49a	82	68	(	(	-LRB-
cord-308095-mehmk49a	82	69	Yurko	Yurko	NNP
cord-308095-mehmk49a	82	70	and	and	CC
cord-308095-mehmk49a	82	71	Remz	Remz	NNP
cord-308095-mehmk49a	82	72	2019	2019	CD
cord-308095-mehmk49a	82	73	,	,	,
cord-308095-mehmk49a	82	74	10	10	CD
cord-308095-mehmk49a	82	75	;	;	:
cord-308095-mehmk49a	82	76	Keefe	Keefe	NNP
cord-308095-mehmk49a	82	77	2017	2017	CD
cord-308095-mehmk49a	82	78	)	)	-RRB-
cord-308095-mehmk49a	82	79	.	.	.
cord-308095-mehmk49a	83	1	Tufts	Tufts	NNP
cord-308095-mehmk49a	83	2	was	be	VBD
cord-308095-mehmk49a	83	3	not	not	RB
cord-308095-mehmk49a	83	4	the	the	DT
cord-308095-mehmk49a	83	5	only	only	JJ
cord-308095-mehmk49a	83	6	academic	academic	JJ
cord-308095-mehmk49a	83	7	institution	institution	NN
cord-308095-mehmk49a	83	8	to	to	TO
cord-308095-mehmk49a	83	9	accept	accept	VB
cord-308095-mehmk49a	83	10	gifts	gift	NNS
cord-308095-mehmk49a	83	11	from	from	IN
cord-308095-mehmk49a	83	12	Purdue	Purdue	NNP
cord-308095-mehmk49a	83	13	Pharma	Pharma	NNP
cord-308095-mehmk49a	83	14	after	after	IN
cord-308095-mehmk49a	83	15	the	the	DT
cord-308095-mehmk49a	83	16	2007	2007	CD
cord-308095-mehmk49a	83	17	guilty	guilty	JJ
cord-308095-mehmk49a	83	18	plea	plea	NN
cord-308095-mehmk49a	83	19	.	.	.
cord-308095-mehmk49a	84	1	In	in	IN
cord-308095-mehmk49a	84	2	2010	2010	CD
cord-308095-mehmk49a	84	3	-	-	SYM
cord-308095-mehmk49a	84	4	2011	2011	CD
cord-308095-mehmk49a	84	5	,	,	,
cord-308095-mehmk49a	84	6	MGH	MGH	NNP
cord-308095-mehmk49a	84	7	received	receive	VBD
cord-308095-mehmk49a	84	8	an	an	DT
cord-308095-mehmk49a	84	9	additional	additional	JJ
cord-308095-mehmk49a	84	10	$	$	$
cord-308095-mehmk49a	84	11	3	3	CD
cord-308095-mehmk49a	84	12	million	million	CD
cord-308095-mehmk49a	84	13	gift	gift	NN
cord-308095-mehmk49a	84	14	for	for	IN
cord-308095-mehmk49a	84	15	its	-PRON-	PRP$
cord-308095-mehmk49a	84	16	pain	pain	NN
cord-308095-mehmk49a	84	17	centre	centre	NN
cord-308095-mehmk49a	84	18	.	.	.
cord-308095-mehmk49a	85	1	Around	around	IN
cord-308095-mehmk49a	85	2	this	this	DT
cord-308095-mehmk49a	85	3	time	time	NN
cord-308095-mehmk49a	85	4	,	,	,
cord-308095-mehmk49a	85	5	the	the	DT
cord-308095-mehmk49a	85	6	company	company	NN
cord-308095-mehmk49a	85	7	also	also	RB
cord-308095-mehmk49a	85	8	made	make	VBD
cord-308095-mehmk49a	85	9	gifts	gift	NNS
cord-308095-mehmk49a	85	10	to	to	TO
cord-308095-mehmk49a	85	11	promote	promote	VB
cord-308095-mehmk49a	85	12	opioids	opioid	NNS
cord-308095-mehmk49a	85	13	in	in	IN
cord-308095-mehmk49a	85	14	programmes	programme	NNS
cord-308095-mehmk49a	85	15	at	at	IN
cord-308095-mehmk49a	85	16	a	a	DT
cord-308095-mehmk49a	85	17	dozen	dozen	NN
cord-308095-mehmk49a	85	18	institutions	institution	NNS
cord-308095-mehmk49a	85	19	in	in	IN
cord-308095-mehmk49a	85	20	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	85	21	alone	alone	JJ
cord-308095-mehmk49a	85	22	.	.	.
cord-308095-mehmk49a	86	1	These	these	DT
cord-308095-mehmk49a	86	2	gifts	gift	NNS
cord-308095-mehmk49a	86	3	included	include	VBD
cord-308095-mehmk49a	86	4	five	five	CD
cord-308095-mehmk49a	86	5	-	-	HYPH
cord-308095-mehmk49a	86	6	figure	figure	NN
cord-308095-mehmk49a	86	7	sums	sum	NNS
cord-308095-mehmk49a	86	8	to	to	IN
cord-308095-mehmk49a	86	9	Boston	Boston	NNP
cord-308095-mehmk49a	86	10	University	University	NNP
cord-308095-mehmk49a	86	11	,	,	,
cord-308095-mehmk49a	86	12	Northeastern	Northeastern	NNP
cord-308095-mehmk49a	86	13	University	University	NNP
cord-308095-mehmk49a	86	14	,	,	,
cord-308095-mehmk49a	86	15	and	and	CC
cord-308095-mehmk49a	86	16	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	86	17	College	College	NNP
cord-308095-mehmk49a	86	18	of	of	IN
cord-308095-mehmk49a	86	19	Pharmacy	Pharmacy	NNP
cord-308095-mehmk49a	87	1	(	(	-LRB-
cord-308095-mehmk49a	87	2	A.G.	A.G.	NNP
cord-308095-mehmk49a	87	3	Mass.	Massachusetts	NNP
cord-308095-mehmk49a	87	4	2019	2019	CD
cord-308095-mehmk49a	87	5	)	)	-RRB-
cord-308095-mehmk49a	87	6	.	.	.
cord-308095-mehmk49a	88	1	The	the	DT
cord-308095-mehmk49a	88	2	donations	donation	NNS
cord-308095-mehmk49a	88	3	made	make	VBD
cord-308095-mehmk49a	88	4	sense	sense	NN
cord-308095-mehmk49a	88	5	from	from	IN
cord-308095-mehmk49a	88	6	the	the	DT
cord-308095-mehmk49a	88	7	donor	donor	NN
cord-308095-mehmk49a	88	8	's	's	POS
cord-308095-mehmk49a	88	9	perspective	perspective	NN
cord-308095-mehmk49a	88	10	-	-	:
cord-308095-mehmk49a	88	11	at	at	IN
cord-308095-mehmk49a	88	12	a	a	DT
cord-308095-mehmk49a	88	13	time	time	NN
cord-308095-mehmk49a	88	14	when	when	WRB
cord-308095-mehmk49a	88	15	opioid	opioid	JJ
cord-308095-mehmk49a	88	16	companies	company	NNS
cord-308095-mehmk49a	88	17	were	be	VBD
cord-308095-mehmk49a	88	18	coming	come	VBG
cord-308095-mehmk49a	88	19	under	under	IN
cord-308095-mehmk49a	88	20	greater	great	JJR
cord-308095-mehmk49a	88	21	scrutiny	scrutiny	NN
cord-308095-mehmk49a	88	22	,	,	,
cord-308095-mehmk49a	88	23	these	these	DT
cord-308095-mehmk49a	88	24	relationships	relationship	NNS
cord-308095-mehmk49a	88	25	gave	give	VBD
cord-308095-mehmk49a	88	26	Purdue	Purdue	NNP
cord-308095-mehmk49a	88	27	Pharma	Pharma	NNP
cord-308095-mehmk49a	88	28	opportunities	opportunity	NNS
cord-308095-mehmk49a	88	29	not	not	RB
cord-308095-mehmk49a	88	30	only	only	RB
cord-308095-mehmk49a	88	31	to	to	TO
cord-308095-mehmk49a	88	32	influence	influence	VB
cord-308095-mehmk49a	88	33	students	student	NNS
cord-308095-mehmk49a	88	34	and	and	CC
cord-308095-mehmk49a	88	35	doctors	doctor	NNS
cord-308095-mehmk49a	88	36	but	but	CC
cord-308095-mehmk49a	88	37	also	also	RB
cord-308095-mehmk49a	88	38	to	to	TO
cord-308095-mehmk49a	88	39	burnish	burnish	VB
cord-308095-mehmk49a	88	40	the	the	DT
cord-308095-mehmk49a	88	41	company	company	NN
cord-308095-mehmk49a	88	42	's	's	POS
cord-308095-mehmk49a	88	43	reputation	reputation	NN
cord-308095-mehmk49a	88	44	.	.	.
cord-308095-mehmk49a	89	1	But	but	CC
cord-308095-mehmk49a	89	2	these	these	DT
cord-308095-mehmk49a	89	3	gifts	gift	NNS
cord-308095-mehmk49a	89	4	were	be	VBD
cord-308095-mehmk49a	89	5	extremely	extremely	RB
cord-308095-mehmk49a	89	6	perilous	perilous	JJ
cord-308095-mehmk49a	89	7	to	to	IN
cord-308095-mehmk49a	89	8	the	the	DT
cord-308095-mehmk49a	89	9	integrity	integrity	NN
cord-308095-mehmk49a	89	10	of	of	IN
cord-308095-mehmk49a	89	11	and	and	CC
cord-308095-mehmk49a	89	12	public	public	JJ
cord-308095-mehmk49a	89	13	trust	trust	NN
cord-308095-mehmk49a	89	14	in	in	IN
cord-308095-mehmk49a	89	15	the	the	DT
cord-308095-mehmk49a	89	16	recipients	recipient	NNS
cord-308095-mehmk49a	89	17	-	-	:
cord-308095-mehmk49a	89	18	as	as	RB
cord-308095-mehmk49a	89	19	well	well	RB
cord-308095-mehmk49a	89	20	as	as	IN
cord-308095-mehmk49a	89	21	patient	patient	JJ
cord-308095-mehmk49a	89	22	health	health	NN
cord-308095-mehmk49a	89	23	.	.	.
cord-308095-mehmk49a	90	1	Contemporaneous	contemporaneous	JJ
cord-308095-mehmk49a	90	2	documents	document	NNS
cord-308095-mehmk49a	90	3	make	make	VBP
cord-308095-mehmk49a	90	4	these	these	DT
cord-308095-mehmk49a	90	5	perils	peril	NNS
cord-308095-mehmk49a	90	6	strikingly	strikingly	RB
cord-308095-mehmk49a	90	7	clear	clear	JJ
cord-308095-mehmk49a	90	8	.	.	.
cord-308095-mehmk49a	91	1	In	in	IN
cord-308095-mehmk49a	91	2	2014	2014	CD
cord-308095-mehmk49a	91	3	,	,	,
cord-308095-mehmk49a	91	4	when	when	WRB
cord-308095-mehmk49a	91	5	Purdue	Purdue	NNP
cord-308095-mehmk49a	91	6	's	's	POS
cord-308095-mehmk49a	91	7	medical	medical	JJ
cord-308095-mehmk49a	91	8	liaison	liaison	NN
cord-308095-mehmk49a	91	9	staff	staff	NN
cord-308095-mehmk49a	91	10	succeeded	succeed	VBN
cord-308095-mehmk49a	91	11	in	in	IN
cord-308095-mehmk49a	91	12	getting	get	VBG
cord-308095-mehmk49a	91	13	two	two	CD
cord-308095-mehmk49a	91	14	"	"	``
cord-308095-mehmk49a	91	15	unbranded	unbranded	JJ
cord-308095-mehmk49a	91	16	curricula	curricula	NN
cord-308095-mehmk49a	91	17	"	"	''
cord-308095-mehmk49a	91	18	approved	approve	VBN
cord-308095-mehmk49a	91	19	for	for	IN
cord-308095-mehmk49a	91	20	teaching	teach	VBG
cord-308095-mehmk49a	91	21	Tufts	Tufts	NNP
cord-308095-mehmk49a	91	22	studentsdescribed	studentsdescribe	VBN
cord-308095-mehmk49a	91	23	by	by	IN
cord-308095-mehmk49a	91	24	the	the	DT
cord-308095-mehmk49a	91	25	university	university	NN
cord-308095-mehmk49a	91	26	as	as	IN
cord-308095-mehmk49a	91	27	"	"	``
cord-308095-mehmk49a	91	28	the	the	DT
cord-308095-mehmk49a	91	29	next	next	JJ
cord-308095-mehmk49a	91	30	generation	generation	NN
cord-308095-mehmk49a	91	31	of	of	IN
cord-308095-mehmk49a	91	32	leaders	leader	NNS
cord-308095-mehmk49a	91	33	in	in	IN
cord-308095-mehmk49a	91	34	the	the	DT
cord-308095-mehmk49a	91	35	field	field	NN
cord-308095-mehmk49a	91	36	of	of	IN
cord-308095-mehmk49a	91	37	pain"-the	pain"-the	DT
cord-308095-mehmk49a	91	38	accounts	account	NNS
cord-308095-mehmk49a	91	39	team	team	NN
cord-308095-mehmk49a	91	40	congratulated	congratulate	VBD
cord-308095-mehmk49a	91	41	their	-PRON-	PRP$
cord-308095-mehmk49a	91	42	colleagues	colleague	NNS
cord-308095-mehmk49a	91	43	for	for	IN
cord-308095-mehmk49a	91	44	"	"	``
cord-308095-mehmk49a	91	45	penetrating	penetrate	VBG
cord-308095-mehmk49a	91	46	this	this	DT
cord-308095-mehmk49a	91	47	account	account	NN
cord-308095-mehmk49a	91	48	"	"	''
cord-308095-mehmk49a	91	49	(	(	-LRB-
cord-308095-mehmk49a	91	50	A.G.	A.G.	NNP
cord-308095-mehmk49a	91	51	Mass	Mass	NNP
cord-308095-mehmk49a	91	52	2019	2019	CD
cord-308095-mehmk49a	91	53	,	,	,
cord-308095-mehmk49a	91	54	¶285	¶285	NNP
cord-308095-mehmk49a	91	55	)	)	-RRB-
cord-308095-mehmk49a	91	56	.	.	.
cord-308095-mehmk49a	92	1	In	in	IN
cord-308095-mehmk49a	92	2	2015	2015	CD
cord-308095-mehmk49a	92	3	-	-	SYM
cord-308095-mehmk49a	92	4	2016	2016	CD
cord-308095-mehmk49a	92	5	,	,	,
cord-308095-mehmk49a	92	6	the	the	DT
cord-308095-mehmk49a	92	7	Tufts	Tufts	NNP
cord-308095-mehmk49a	92	8	University	University	NNP
cord-308095-mehmk49a	92	9	School	School	NNP
cord-308095-mehmk49a	92	10	of	of	IN
cord-308095-mehmk49a	92	11	Medicine	Medicine	NNP
cord-308095-mehmk49a	92	12	decided	decide	VBD
cord-308095-mehmk49a	92	13	not	not	RB
cord-308095-mehmk49a	92	14	to	to	TO
cord-308095-mehmk49a	92	15	assign	assign	VB
cord-308095-mehmk49a	92	16	as	as	IN
cord-308095-mehmk49a	92	17	the	the	DT
cord-308095-mehmk49a	92	18	"	"	``
cord-308095-mehmk49a	92	19	Common	Common	NNP
cord-308095-mehmk49a	92	20	Book	Book	NNP
cord-308095-mehmk49a	92	21	"	"	''
cord-308095-mehmk49a	92	22	for	for	IN
cord-308095-mehmk49a	92	23	all	all	DT
cord-308095-mehmk49a	92	24	incoming	incoming	JJ
cord-308095-mehmk49a	92	25	medical	medical	JJ
cord-308095-mehmk49a	92	26	students	student	NNS
cord-308095-mehmk49a	92	27	,	,	,
cord-308095-mehmk49a	92	28	Sam	Sam	NNP
cord-308095-mehmk49a	92	29	Quinones	Quinones	NNP
cord-308095-mehmk49a	92	30	'	'	POS
cord-308095-mehmk49a	92	31	Dreamland	Dreamland	NNP
cord-308095-mehmk49a	92	32	(	(	-LRB-
cord-308095-mehmk49a	92	33	2006	2006	CD
cord-308095-mehmk49a	92	34	)	)	-RRB-
cord-308095-mehmk49a	92	35	,	,	,
cord-308095-mehmk49a	92	36	"	"	``
cord-308095-mehmk49a	92	37	in	in	IN
cord-308095-mehmk49a	92	38	significant	significant	JJ
cord-308095-mehmk49a	92	39	part	part	NN
cord-308095-mehmk49a	92	40	"	"	''
cord-308095-mehmk49a	92	41	because	because	IN
cord-308095-mehmk49a	92	42	the	the	DT
cord-308095-mehmk49a	92	43	book	book	NN
cord-308095-mehmk49a	92	44	criticized	criticize	VBD
cord-308095-mehmk49a	92	45	Purdue	Purdue	NNP
cord-308095-mehmk49a	92	46	Pharma	Pharma	NNP
cord-308095-mehmk49a	92	47	for	for	IN
cord-308095-mehmk49a	92	48	its	-PRON-	PRP$
cord-308095-mehmk49a	92	49	role	role	NN
cord-308095-mehmk49a	92	50	in	in	IN
cord-308095-mehmk49a	92	51	the	the	DT
cord-308095-mehmk49a	92	52	opioid	opioid	JJ
cord-308095-mehmk49a	92	53	crisis	crisis	NN
cord-308095-mehmk49a	92	54	and	and	CC
cord-308095-mehmk49a	92	55	there	there	EX
cord-308095-mehmk49a	92	56	was	be	VBD
cord-308095-mehmk49a	92	57	a	a	DT
cord-308095-mehmk49a	92	58	"	"	``
cord-308095-mehmk49a	92	59	desire	desire	NN
cord-308095-mehmk49a	92	60	to	to	TO
cord-308095-mehmk49a	92	61	avoid	avoid	VB
cord-308095-mehmk49a	92	62	controversy	controversy	NN
cord-308095-mehmk49a	92	63	"	"	''
cord-308095-mehmk49a	92	64	in	in	IN
cord-308095-mehmk49a	92	65	the	the	DT
cord-308095-mehmk49a	92	66	donor	donor	NN
cord-308095-mehmk49a	92	67	relationships	relationship	NNS
cord-308095-mehmk49a	92	68	with	with	IN
cord-308095-mehmk49a	92	69	Purdue	Purdue	NNP
cord-308095-mehmk49a	92	70	Pharma	Pharma	NNP
cord-308095-mehmk49a	92	71	and	and	CC
cord-308095-mehmk49a	92	72	the	the	DT
cord-308095-mehmk49a	92	73	Sackler	Sackler	NNP
cord-308095-mehmk49a	92	74	family	family	NN
cord-308095-mehmk49a	92	75	(	(	-LRB-
cord-308095-mehmk49a	92	76	Yurko	Yurko	NNP
cord-308095-mehmk49a	92	77	and	and	CC
cord-308095-mehmk49a	92	78	Remz	Remz	NNP
cord-308095-mehmk49a	92	79	2019	2019	CD
cord-308095-mehmk49a	92	80	,	,	,
cord-308095-mehmk49a	92	81	23	23	CD
cord-308095-mehmk49a	92	82	)	)	-RRB-
cord-308095-mehmk49a	92	83	.	.	.
cord-308095-mehmk49a	93	1	The	the	DT
cord-308095-mehmk49a	93	2	following	following	JJ
cord-308095-mehmk49a	93	3	year	year	NN
cord-308095-mehmk49a	93	4	some	some	DT
cord-308095-mehmk49a	93	5	students	student	NNS
cord-308095-mehmk49a	93	6	became	become	VBD
cord-308095-mehmk49a	93	7	upset	upset	JJ
cord-308095-mehmk49a	93	8	after	after	IN
cord-308095-mehmk49a	93	9	a	a	DT
cord-308095-mehmk49a	93	10	lecture	lecture	NN
cord-308095-mehmk49a	93	11	by	by	IN
cord-308095-mehmk49a	93	12	a	a	DT
cord-308095-mehmk49a	93	13	senior	senior	JJ
cord-308095-mehmk49a	93	14	employee	employee	NN
cord-308095-mehmk49a	93	15	of	of	IN
cord-308095-mehmk49a	93	16	Purdue	Purdue	NNP
cord-308095-mehmk49a	93	17	Pharma	Pharma	NNP
cord-308095-mehmk49a	93	18	with	with	IN
cord-308095-mehmk49a	93	19	an	an	DT
cord-308095-mehmk49a	93	20	adjunct	adjunct	JJ
cord-308095-mehmk49a	93	21	appointment	appointment	NN
cord-308095-mehmk49a	93	22	at	at	IN
cord-308095-mehmk49a	93	23	Tufts	Tufts	NNP
cord-308095-mehmk49a	93	24	(	(	-LRB-
cord-308095-mehmk49a	93	25	who	who	WP
cord-308095-mehmk49a	93	26	had	have	VBD
cord-308095-mehmk49a	93	27	been	be	VBN
cord-308095-mehmk49a	93	28	giving	give	VBG
cord-308095-mehmk49a	93	29	occasional	occasional	JJ
cord-308095-mehmk49a	93	30	lectures	lecture	NNS
cord-308095-mehmk49a	93	31	on	on	IN
cord-308095-mehmk49a	93	32	opioids	opioid	NNS
cord-308095-mehmk49a	93	33	for	for	IN
cord-308095-mehmk49a	93	34	a	a	DT
cord-308095-mehmk49a	93	35	decade	decade	NN
cord-308095-mehmk49a	93	36	)	)	-RRB-
cord-308095-mehmk49a	93	37	.	.	.
cord-308095-mehmk49a	94	1	They	-PRON-	PRP
cord-308095-mehmk49a	94	2	complained	complain	VBD
cord-308095-mehmk49a	94	3	that	that	IN
cord-308095-mehmk49a	94	4	he	-PRON-	PRP
cord-308095-mehmk49a	94	5	was	be	VBD
cord-308095-mehmk49a	94	6	"	"	``
cord-308095-mehmk49a	94	7	sweeping	sweep	VBG
cord-308095-mehmk49a	94	8	the	the	DT
cord-308095-mehmk49a	94	9	opioid	opioid	JJ
cord-308095-mehmk49a	94	10	crisis	crisis	NN
cord-308095-mehmk49a	94	11	under	under	IN
cord-308095-mehmk49a	94	12	the	the	DT
cord-308095-mehmk49a	94	13	rug	rug	NN
cord-308095-mehmk49a	94	14	"	"	''
cord-308095-mehmk49a	94	15	and	and	CC
cord-308095-mehmk49a	94	16	was	be	VBD
cord-308095-mehmk49a	94	17	"	"	``
cord-308095-mehmk49a	94	18	an	an	DT
cord-308095-mehmk49a	94	19	apologist	apologist	NN
cord-308095-mehmk49a	94	20	for	for	IN
cord-308095-mehmk49a	94	21	the	the	DT
cord-308095-mehmk49a	94	22	pharma	pharma	NNS
cord-308095-mehmk49a	94	23	industry	industry	NN
cord-308095-mehmk49a	94	24	"	"	''
cord-308095-mehmk49a	94	25	(	(	-LRB-
cord-308095-mehmk49a	94	26	Yurko	Yurko	NNP
cord-308095-mehmk49a	94	27	and	and	CC
cord-308095-mehmk49a	94	28	Remz	Remz	NNP
cord-308095-mehmk49a	94	29	2019	2019	CD
cord-308095-mehmk49a	94	30	,	,	,
cord-308095-mehmk49a	94	31	20	20	CD
cord-308095-mehmk49a	94	32	)	)	-RRB-
cord-308095-mehmk49a	94	33	.	.	.
cord-308095-mehmk49a	95	1	There	there	EX
cord-308095-mehmk49a	95	2	are	be	VBP
cord-308095-mehmk49a	95	3	also	also	RB
cord-308095-mehmk49a	95	4	thousands	thousand	NNS
cord-308095-mehmk49a	95	5	of	of	IN
cord-308095-mehmk49a	95	6	pages	page	NNS
cord-308095-mehmk49a	95	7	of	of	IN
cord-308095-mehmk49a	95	8	emails	email	NNS
cord-308095-mehmk49a	95	9	,	,	,
cord-308095-mehmk49a	95	10	memoranda	memorandum	NNS
cord-308095-mehmk49a	95	11	,	,	,
cord-308095-mehmk49a	95	12	and	and	CC
cord-308095-mehmk49a	95	13	other	other	JJ
cord-308095-mehmk49a	95	14	contemporaneous	contemporaneous	JJ
cord-308095-mehmk49a	95	15	documentssummarized	documentssummarize	VBN
cord-308095-mehmk49a	95	16	in	in	IN
cord-308095-mehmk49a	95	17	the	the	DT
cord-308095-mehmk49a	95	18	complaint	complaint	NN
cord-308095-mehmk49a	95	19	of	of	IN
cord-308095-mehmk49a	95	20	the	the	DT
cord-308095-mehmk49a	95	21	Attorney	Attorney	NNP
cord-308095-mehmk49a	95	22	-	-	HYPH
cord-308095-mehmk49a	95	23	General	General	NNP
cord-308095-mehmk49a	95	24	of	of	IN
cord-308095-mehmk49a	95	25	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	95	26	made	make	VBD
cord-308095-mehmk49a	95	27	public	public	JJ
cord-308095-mehmk49a	95	28	in	in	IN
cord-308095-mehmk49a	95	29	2019-that	2019-that	CD
cord-308095-mehmk49a	95	30	reveal	reveal	NN
cord-308095-mehmk49a	95	31	how	how	WRB
cord-308095-mehmk49a	95	32	Purdue	Purdue	NNP
cord-308095-mehmk49a	95	33	Pharma	Pharma	NNP
cord-308095-mehmk49a	95	34	's	's	POS
cord-308095-mehmk49a	95	35	relationships	relationship	NNS
cord-308095-mehmk49a	95	36	with	with	IN
cord-308095-mehmk49a	95	37	academic	academic	JJ
cord-308095-mehmk49a	95	38	institutions	institution	NNS
cord-308095-mehmk49a	95	39	provided	provide	VBD
cord-308095-mehmk49a	95	40	opportunities	opportunity	NNS
cord-308095-mehmk49a	95	41	to	to	TO
cord-308095-mehmk49a	95	42	influence	influence	VB
cord-308095-mehmk49a	95	43	research	research	NN
cord-308095-mehmk49a	95	44	,	,	,
cord-308095-mehmk49a	95	45	curricula	curricula	NN
cord-308095-mehmk49a	95	46	,	,	,
cord-308095-mehmk49a	95	47	speaker	speaker	NN
cord-308095-mehmk49a	95	48	series	series	NN
cord-308095-mehmk49a	95	49	,	,	,
cord-308095-mehmk49a	95	50	and	and	CC
cord-308095-mehmk49a	95	51	other	other	JJ
cord-308095-mehmk49a	95	52	events	event	NNS
cord-308095-mehmk49a	95	53	.	.	.
cord-308095-mehmk49a	96	1	These	these	DT
cord-308095-mehmk49a	96	2	opportunities	opportunity	NNS
cord-308095-mehmk49a	96	3	were	be	VBD
cord-308095-mehmk49a	96	4	enhanced	enhance	VBN
cord-308095-mehmk49a	96	5	by	by	IN
cord-308095-mehmk49a	96	6	the	the	DT
cord-308095-mehmk49a	96	7	appointment	appointment	NN
cord-308095-mehmk49a	96	8	of	of	IN
cord-308095-mehmk49a	96	9	Purdue	Purdue	NNP
cord-308095-mehmk49a	96	10	executives	executive	NNS
cord-308095-mehmk49a	96	11	and	and	CC
cord-308095-mehmk49a	96	12	employees	employee	NNS
cord-308095-mehmk49a	96	13	to	to	TO
cord-308095-mehmk49a	96	14	faculty	faculty	NN
cord-308095-mehmk49a	96	15	and	and	CC
cord-308095-mehmk49a	96	16	advisory	advisory	JJ
cord-308095-mehmk49a	96	17	boards	board	NNS
cord-308095-mehmk49a	96	18	,	,	,
cord-308095-mehmk49a	96	19	as	as	RB
cord-308095-mehmk49a	96	20	well	well	RB
cord-308095-mehmk49a	96	21	as	as	IN
cord-308095-mehmk49a	96	22	by	by	IN
cord-308095-mehmk49a	96	23	regular	regular	JJ
cord-308095-mehmk49a	96	24	contact	contact	NN
cord-308095-mehmk49a	96	25	with	with	IN
cord-308095-mehmk49a	96	26	these	these	DT
cord-308095-mehmk49a	96	27	individuals	individual	NNS
cord-308095-mehmk49a	96	28	(	(	-LRB-
cord-308095-mehmk49a	96	29	A.G.	A.G.	NNP
cord-308095-mehmk49a	96	30	Mass.	Massachusetts	NNP
cord-308095-mehmk49a	96	31	2019	2019	CD
cord-308095-mehmk49a	96	32	)	)	-RRB-
cord-308095-mehmk49a	96	33	.	.	.
cord-308095-mehmk49a	97	1	In	in	IN
cord-308095-mehmk49a	97	2	addition	addition	NN
cord-308095-mehmk49a	97	3	,	,	,
cord-308095-mehmk49a	97	4	one	one	CD
cord-308095-mehmk49a	97	5	recent	recent	JJ
cord-308095-mehmk49a	97	6	estimate	estimate	NN
cord-308095-mehmk49a	97	7	puts	put	VBZ
cord-308095-mehmk49a	97	8	the	the	DT
cord-308095-mehmk49a	97	9	total	total	JJ
cord-308095-mehmk49a	97	10	gifts	gift	NNS
cord-308095-mehmk49a	97	11	from	from	IN
cord-308095-mehmk49a	97	12	the	the	DT
cord-308095-mehmk49a	97	13	Sackler	Sackler	NNP
cord-308095-mehmk49a	97	14	family	family	NN
cord-308095-mehmk49a	97	15	and	and	CC
cord-308095-mehmk49a	97	16	its	-PRON-	PRP$
cord-308095-mehmk49a	97	17	foundations	foundation	NNS
cord-308095-mehmk49a	97	18	to	to	IN
cord-308095-mehmk49a	97	19	universities	university	NNS
cord-308095-mehmk49a	97	20	in	in	IN
cord-308095-mehmk49a	97	21	the	the	DT
cord-308095-mehmk49a	97	22	United	United	NNP
cord-308095-mehmk49a	97	23	States	States	NNP
cord-308095-mehmk49a	97	24	,	,	,
cord-308095-mehmk49a	97	25	the	the	DT
cord-308095-mehmk49a	97	26	United	United	NNP
cord-308095-mehmk49a	97	27	Kingdom	Kingdom	NNP
cord-308095-mehmk49a	97	28	,	,	,
cord-308095-mehmk49a	97	29	and	and	CC
cord-308095-mehmk49a	97	30	elsewhere	elsewhere	RB
cord-308095-mehmk49a	97	31	in	in	IN
cord-308095-mehmk49a	97	32	excess	excess	NN
cord-308095-mehmk49a	97	33	of	of	IN
cord-308095-mehmk49a	97	34	$	$	$
cord-308095-mehmk49a	97	35	60	60	CD
cord-308095-mehmk49a	97	36	million	million	CD
cord-308095-mehmk49a	97	37	during	during	IN
cord-308095-mehmk49a	97	38	the	the	DT
cord-308095-mehmk49a	97	39	last	last	JJ
cord-308095-mehmk49a	97	40	five	five	CD
cord-308095-mehmk49a	97	41	years	year	NNS
cord-308095-mehmk49a	97	42	(	(	-LRB-
cord-308095-mehmk49a	97	43	AP	AP	NNP
cord-308095-mehmk49a	97	44	2019	2019	CD
cord-308095-mehmk49a	97	45	)	)	-RRB-
cord-308095-mehmk49a	97	46	.	.	.
cord-308095-mehmk49a	98	1	2	2	LS
cord-308095-mehmk49a	99	1	In	in	IN
cord-308095-mehmk49a	99	2	public	public	JJ
cord-308095-mehmk49a	99	3	health	health	NN
cord-308095-mehmk49a	99	4	,	,	,
cord-308095-mehmk49a	99	5	corporate	corporate	JJ
cord-308095-mehmk49a	99	6	strategies	strategy	NNS
cord-308095-mehmk49a	99	7	of	of	IN
cord-308095-mehmk49a	99	8	influence	influence	NN
cord-308095-mehmk49a	99	9	tend	tend	VBP
cord-308095-mehmk49a	99	10	to	to	TO
cord-308095-mehmk49a	99	11	involve	involve	VB
cord-308095-mehmk49a	99	12	public	public	JJ
cord-308095-mehmk49a	99	13	health	health	NN
cord-308095-mehmk49a	99	14	NGOs	NGOs	NNPS
cord-308095-mehmk49a	99	15	,	,	,
cord-308095-mehmk49a	99	16	as	as	RB
cord-308095-mehmk49a	99	17	well	well	RB
cord-308095-mehmk49a	99	18	as	as	IN
cord-308095-mehmk49a	99	19	academic	academic	JJ
cord-308095-mehmk49a	99	20	institutions	institution	NNS
cord-308095-mehmk49a	99	21	.	.	.
cord-308095-mehmk49a	100	1	And	and	CC
cord-308095-mehmk49a	100	2	,	,	,
cord-308095-mehmk49a	100	3	perhaps	perhaps	RB
cord-308095-mehmk49a	100	4	unsurprisingly	unsurprisingly	RB
cord-308095-mehmk49a	100	5	,	,	,
cord-308095-mehmk49a	100	6	the	the	DT
cord-308095-mehmk49a	100	7	leadership	leadership	NN
cord-308095-mehmk49a	100	8	of	of	IN
cord-308095-mehmk49a	100	9	these	these	DT
cord-308095-mehmk49a	100	10	institutions	institution	NNS
cord-308095-mehmk49a	100	11	often	often	RB
cord-308095-mehmk49a	100	12	overlaps	overlap	VBZ
cord-308095-mehmk49a	100	13	.	.	.
cord-308095-mehmk49a	101	1	For	for	IN
cord-308095-mehmk49a	101	2	example	example	NN
cord-308095-mehmk49a	101	3	,	,	,
cord-308095-mehmk49a	101	4	one	one	CD
cord-308095-mehmk49a	101	5	of	of	IN
cord-308095-mehmk49a	101	6	the	the	DT
cord-308095-mehmk49a	101	7	founders	founder	NNS
cord-308095-mehmk49a	101	8	of	of	IN
cord-308095-mehmk49a	101	9	the	the	DT
cord-308095-mehmk49a	101	10	Tufts	Tufts	NNP
cord-308095-mehmk49a	101	11	pain	pain	NN
cord-308095-mehmk49a	101	12	initiative	initiative	NN
cord-308095-mehmk49a	101	13	also	also	RB
cord-308095-mehmk49a	101	14	served	serve	VBD
cord-308095-mehmk49a	101	15	as	as	IN
cord-308095-mehmk49a	101	16	president	president	NN
cord-308095-mehmk49a	101	17	of	of	IN
cord-308095-mehmk49a	101	18	the	the	DT
cord-308095-mehmk49a	101	19	American	American	NNP
cord-308095-mehmk49a	101	20	Academy	Academy	NNP
cord-308095-mehmk49a	101	21	of	of	IN
cord-308095-mehmk49a	101	22	Pain	Pain	NNP
cord-308095-mehmk49a	101	23	Medicine	Medicine	NNP
cord-308095-mehmk49a	101	24	(	(	-LRB-
cord-308095-mehmk49a	101	25	a	a	DT
cord-308095-mehmk49a	101	26	medical	medical	JJ
cord-308095-mehmk49a	101	27	professional	professional	JJ
cord-308095-mehmk49a	101	28	association	association	NN
cord-308095-mehmk49a	101	29	)	)	-RRB-
cord-308095-mehmk49a	101	30	and	and	CC
cord-308095-mehmk49a	101	31	on	on	IN
cord-308095-mehmk49a	101	32	the	the	DT
cord-308095-mehmk49a	101	33	board	board	NN
cord-308095-mehmk49a	101	34	of	of	IN
cord-308095-mehmk49a	101	35	the	the	DT
cord-308095-mehmk49a	101	36	American	American	NNP
cord-308095-mehmk49a	101	37	Chronic	Chronic	NNP
cord-308095-mehmk49a	101	38	Pain	Pain	NNP
cord-308095-mehmk49a	101	39	Association	Association	NNP
cord-308095-mehmk49a	101	40	(	(	-LRB-
cord-308095-mehmk49a	101	41	a	a	DT
cord-308095-mehmk49a	101	42	patient	patient	JJ
cord-308095-mehmk49a	101	43	advocacy	advocacy	NN
cord-308095-mehmk49a	101	44	organization	organization	NN
cord-308095-mehmk49a	101	45	)	)	-RRB-
cord-308095-mehmk49a	101	46	(	(	-LRB-
cord-308095-mehmk49a	101	47	Joseph	Joseph	NNP
cord-308095-mehmk49a	101	48	2019c	2019c	CD
cord-308095-mehmk49a	101	49	)	)	-RRB-
cord-308095-mehmk49a	101	50	.	.	.
cord-308095-mehmk49a	102	1	As	as	IN
cord-308095-mehmk49a	102	2	a	a	DT
cord-308095-mehmk49a	102	3	result	result	NN
cord-308095-mehmk49a	102	4	,	,	,
cord-308095-mehmk49a	102	5	pharmaceutical	pharmaceutical	NN
cord-308095-mehmk49a	102	6	companies	company	NNS
cord-308095-mehmk49a	102	7	could	could	MD
cord-308095-mehmk49a	102	8	influence	influence	VB
cord-308095-mehmk49a	102	9	professional	professional	JJ
cord-308095-mehmk49a	102	10	associations	association	NNS
cord-308095-mehmk49a	102	11	and	and	CC
cord-308095-mehmk49a	102	12	advocacy	advocacy	NN
cord-308095-mehmk49a	102	13	groups	group	NNS
cord-308095-mehmk49a	102	14	without	without	IN
cord-308095-mehmk49a	102	15	making	make	VBG
cord-308095-mehmk49a	102	16	additional	additional	JJ
cord-308095-mehmk49a	102	17	financial	financial	JJ
cord-308095-mehmk49a	102	18	contributions	contribution	NNS
cord-308095-mehmk49a	102	19	to	to	IN
cord-308095-mehmk49a	102	20	those	those	DT
cord-308095-mehmk49a	102	21	organizations	organization	NNS
cord-308095-mehmk49a	102	22	.	.	.
cord-308095-mehmk49a	103	1	Nevertheless	nevertheless	RB
cord-308095-mehmk49a	103	2	,	,	,
cord-308095-mehmk49a	103	3	opioid	opioid	JJ
cord-308095-mehmk49a	103	4	companies	company	NNS
cord-308095-mehmk49a	103	5	also	also	RB
cord-308095-mehmk49a	103	6	targeted	target	VBD
cord-308095-mehmk49a	103	7	civil	civil	JJ
cord-308095-mehmk49a	103	8	society	society	NN
cord-308095-mehmk49a	103	9	groups	group	NNS
cord-308095-mehmk49a	103	10	,	,	,
cord-308095-mehmk49a	103	11	and	and	CC
cord-308095-mehmk49a	103	12	gifts	gift	NNS
cord-308095-mehmk49a	103	13	to	to	IN
cord-308095-mehmk49a	103	14	these	these	DT
cord-308095-mehmk49a	103	15	entities	entity	NNS
cord-308095-mehmk49a	103	16	were	be	VBD
cord-308095-mehmk49a	103	17	a	a	DT
cord-308095-mehmk49a	103	18	central	central	JJ
cord-308095-mehmk49a	103	19	component	component	NN
cord-308095-mehmk49a	103	20	of	of	IN
cord-308095-mehmk49a	103	21	several	several	JJ
cord-308095-mehmk49a	103	22	opioid	opioid	JJ
cord-308095-mehmk49a	103	23	companies	company	NNS
cord-308095-mehmk49a	103	24	'	'	POS
cord-308095-mehmk49a	103	25	strategies	strategy	NNS
cord-308095-mehmk49a	103	26	of	of	IN
cord-308095-mehmk49a	103	27	influence	influence	NN
cord-308095-mehmk49a	103	28	.	.	.
cord-308095-mehmk49a	104	1	Industry	industry	NN
cord-308095-mehmk49a	104	2	funding	funding	NN
cord-308095-mehmk49a	104	3	of	of	IN
cord-308095-mehmk49a	104	4	patient	patient	JJ
cord-308095-mehmk49a	104	5	advocacy	advocacy	NN
cord-308095-mehmk49a	104	6	organizations	organization	NNS
cord-308095-mehmk49a	104	7	(	(	-LRB-
cord-308095-mehmk49a	104	8	PAOs	PAOs	NNP
cord-308095-mehmk49a	104	9	)	)	-RRB-
cord-308095-mehmk49a	104	10	,	,	,
cord-308095-mehmk49a	104	11	professional	professional	JJ
cord-308095-mehmk49a	104	12	societies	society	NNS
cord-308095-mehmk49a	104	13	,	,	,
cord-308095-mehmk49a	104	14	and	and	CC
cord-308095-mehmk49a	104	15	other	other	JJ
cord-308095-mehmk49a	104	16	health	health	NN
cord-308095-mehmk49a	104	17	-	-	HYPH
cord-308095-mehmk49a	104	18	related	relate	VBN
cord-308095-mehmk49a	104	19	NGOs	NGOs	NNPS
cord-308095-mehmk49a	104	20	more	more	RBR
cord-308095-mehmk49a	104	21	broadly	broadly	RB
cord-308095-mehmk49a	104	22	has	have	VBZ
cord-308095-mehmk49a	104	23	become	become	VBN
cord-308095-mehmk49a	104	24	widespread	widespread	JJ
cord-308095-mehmk49a	105	1	(	(	-LRB-
cord-308095-mehmk49a	105	2	McCoy	McCoy	NNP
cord-308095-mehmk49a	105	3	et	et	NNP
cord-308095-mehmk49a	105	4	al	al	NNP
cord-308095-mehmk49a	105	5	.	.	.
cord-308095-mehmk49a	105	6	2017	2017	CD
cord-308095-mehmk49a	106	1	;	;	:
cord-308095-mehmk49a	106	2	Rose	Rose	NNP
cord-308095-mehmk49a	106	3	et	et	FW
cord-308095-mehmk49a	106	4	al	al	NNP
cord-308095-mehmk49a	106	5	.	.	.
cord-308095-mehmk49a	106	6	2017	2017	CD
cord-308095-mehmk49a	106	7	;	;	.
cord-308095-mehmk49a	107	1	Aaron	Aaron	NNP
cord-308095-mehmk49a	107	2	and	and	CC
cord-308095-mehmk49a	107	3	Siegel	Siegel	NNP
cord-308095-mehmk49a	107	4	2017	2017	CD
cord-308095-mehmk49a	107	5	)	)	-RRB-
cord-308095-mehmk49a	107	6	.	.	.
cord-308095-mehmk49a	108	1	These	these	DT
cord-308095-mehmk49a	108	2	organizations	organization	NNS
cord-308095-mehmk49a	108	3	often	often	RB
cord-308095-mehmk49a	108	4	face	face	VBP
cord-308095-mehmk49a	108	5	tight	tight	JJ
cord-308095-mehmk49a	108	6	financial	financial	JJ
cord-308095-mehmk49a	108	7	constraints	constraint	NNS
cord-308095-mehmk49a	108	8	and	and	CC
cord-308095-mehmk49a	108	9	,	,	,
cord-308095-mehmk49a	108	10	not	not	RB
cord-308095-mehmk49a	108	11	surprisingly	surprisingly	RB
cord-308095-mehmk49a	108	12	,	,	,
cord-308095-mehmk49a	108	13	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	108	14	companies	company	NNS
cord-308095-mehmk49a	108	15	are	be	VBP
cord-308095-mehmk49a	108	16	more	more	JJR
cord-308095-mehmk49a	108	17	than	than	IN
cord-308095-mehmk49a	108	18	happy	happy	JJ
cord-308095-mehmk49a	108	19	to	to	TO
cord-308095-mehmk49a	108	20	"	"	``
cord-308095-mehmk49a	108	21	help	help	VB
cord-308095-mehmk49a	108	22	out	out	RP
cord-308095-mehmk49a	108	23	.	.	.
cord-308095-mehmk49a	108	24	"	"	''
cord-308095-mehmk49a	109	1	Although	although	IN
cord-308095-mehmk49a	109	2	a	a	DT
cord-308095-mehmk49a	109	3	corporate	corporate	JJ
cord-308095-mehmk49a	109	4	donation	donation	NN
cord-308095-mehmk49a	109	5	may	may	MD
cord-308095-mehmk49a	109	6	be	be	VB
cord-308095-mehmk49a	109	7	a	a	DT
cord-308095-mehmk49a	109	8	drop	drop	NN
cord-308095-mehmk49a	109	9	in	in	IN
cord-308095-mehmk49a	109	10	the	the	DT
cord-308095-mehmk49a	109	11	ocean	ocean	NN
cord-308095-mehmk49a	109	12	of	of	IN
cord-308095-mehmk49a	109	13	business	business	NN
cord-308095-mehmk49a	109	14	revenues	revenue	NNS
cord-308095-mehmk49a	109	15	and	and	CC
cord-308095-mehmk49a	109	16	profits	profit	NNS
cord-308095-mehmk49a	109	17	,	,	,
cord-308095-mehmk49a	109	18	the	the	DT
cord-308095-mehmk49a	109	19	gift	gift	NN
cord-308095-mehmk49a	109	20	can	can	MD
cord-308095-mehmk49a	109	21	be	be	VB
cord-308095-mehmk49a	109	22	the	the	DT
cord-308095-mehmk49a	109	23	main	main	JJ
cord-308095-mehmk49a	109	24	-	-	:
cord-308095-mehmk49a	109	25	or	or	CC
cord-308095-mehmk49a	109	26	onlything	onlything	NN
cord-308095-mehmk49a	109	27	keeping	keep	VBG
cord-308095-mehmk49a	109	28	the	the	DT
cord-308095-mehmk49a	109	29	recipient	recipient	NN
cord-308095-mehmk49a	109	30	afloat	afloat	RB
cord-308095-mehmk49a	109	31	(	(	-LRB-
cord-308095-mehmk49a	109	32	Marks	Marks	NNP
cord-308095-mehmk49a	109	33	2019a	2019a	CD
cord-308095-mehmk49a	109	34	)	)	-RRB-
cord-308095-mehmk49a	109	35	.	.	.
cord-308095-mehmk49a	110	1	The	the	DT
cord-308095-mehmk49a	110	2	contributions	contribution	NNS
cord-308095-mehmk49a	110	3	of	of	IN
cord-308095-mehmk49a	110	4	opioid	opioid	JJ
cord-308095-mehmk49a	110	5	companies	company	NNS
cord-308095-mehmk49a	110	6	to	to	IN
cord-308095-mehmk49a	110	7	PAOs	pao	NNS
cord-308095-mehmk49a	110	8	and	and	CC
cord-308095-mehmk49a	110	9	health	health	NN
cord-308095-mehmk49a	110	10	professional	professional	JJ
cord-308095-mehmk49a	110	11	associations	association	NNS
cord-308095-mehmk49a	110	12	have	have	VBP
cord-308095-mehmk49a	110	13	been	be	VBN
cord-308095-mehmk49a	110	14	consistent	consistent	JJ
cord-308095-mehmk49a	110	15	with	with	IN
cord-308095-mehmk49a	110	16	practices	practice	NNS
cord-308095-mehmk49a	110	17	in	in	IN
cord-308095-mehmk49a	110	18	the	the	DT
cord-308095-mehmk49a	110	19	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	110	20	sector	sector	NN
cord-308095-mehmk49a	110	21	more	more	RBR
cord-308095-mehmk49a	110	22	broadly	broadly	RB
cord-308095-mehmk49a	110	23	.	.	.
cord-308095-mehmk49a	111	1	A	a	DT
cord-308095-mehmk49a	111	2	U.S.	U.S.	NNP
cord-308095-mehmk49a	111	3	Senate	Senate	NNP
cord-308095-mehmk49a	111	4	report	report	NN
cord-308095-mehmk49a	111	5	revealed	reveal	VBD
cord-308095-mehmk49a	111	6	that	that	IN
cord-308095-mehmk49a	111	7	five	five	CD
cord-308095-mehmk49a	111	8	opioid	opioid	JJ
cord-308095-mehmk49a	111	9	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	111	10	gave	give	VBD
cord-308095-mehmk49a	111	11	$	$	$
cord-308095-mehmk49a	111	12	9	9	CD
cord-308095-mehmk49a	111	13	million	million	CD
cord-308095-mehmk49a	111	14	to	to	TO
cord-308095-mehmk49a	111	15	fourteen	fourteen	CD
cord-308095-mehmk49a	111	16	patient	patient	JJ
cord-308095-mehmk49a	111	17	advocacy	advocacy	NN
cord-308095-mehmk49a	111	18	organizations	organization	NNS
cord-308095-mehmk49a	111	19	and	and	CC
cord-308095-mehmk49a	111	20	health	health	NN
cord-308095-mehmk49a	111	21	professional	professional	JJ
cord-308095-mehmk49a	111	22	organizations	organization	NNS
cord-308095-mehmk49a	111	23	over	over	IN
cord-308095-mehmk49a	111	24	the	the	DT
cord-308095-mehmk49a	111	25	five	five	CD
cord-308095-mehmk49a	111	26	-	-	HYPH
cord-308095-mehmk49a	111	27	year	year	NN
cord-308095-mehmk49a	111	28	period	period	NN
cord-308095-mehmk49a	111	29	2012	2012	CD
cord-308095-mehmk49a	111	30	-	-	SYM
cord-308095-mehmk49a	111	31	2017	2017	CD
cord-308095-mehmk49a	111	32	(	(	-LRB-
cord-308095-mehmk49a	111	33	HSGAC	HSGAC	NNP
cord-308095-mehmk49a	111	34	2018a	2018a	CD
cord-308095-mehmk49a	111	35	)	)	-RRB-
cord-308095-mehmk49a	111	36	.	.	.
cord-308095-mehmk49a	112	1	Purdue	Purdue	NNP
cord-308095-mehmk49a	112	2	and	and	CC
cord-308095-mehmk49a	112	3	Insys	Insys	NNP
cord-308095-mehmk49a	112	4	were	be	VBD
cord-308095-mehmk49a	112	5	the	the	DT
cord-308095-mehmk49a	112	6	largest	large	JJS
cord-308095-mehmk49a	112	7	donors	donor	NNS
cord-308095-mehmk49a	112	8	by	by	IN
cord-308095-mehmk49a	112	9	far	far	RB
cord-308095-mehmk49a	112	10	,	,	,
cord-308095-mehmk49a	112	11	giving	give	VBG
cord-308095-mehmk49a	112	12	in	in	IN
cord-308095-mehmk49a	112	13	excess	excess	NN
cord-308095-mehmk49a	112	14	of	of	IN
cord-308095-mehmk49a	112	15	$	$	$
cord-308095-mehmk49a	112	16	4	4	CD
cord-308095-mehmk49a	112	17	million	million	CD
cord-308095-mehmk49a	112	18	and	and	CC
cord-308095-mehmk49a	112	19	$	$	$
cord-308095-mehmk49a	112	20	3	3	CD
cord-308095-mehmk49a	112	21	million	million	CD
cord-308095-mehmk49a	112	22	respectively	respectively	RB
cord-308095-mehmk49a	112	23	.	.	.
cord-308095-mehmk49a	113	1	While	while	IN
cord-308095-mehmk49a	113	2	the	the	DT
cord-308095-mehmk49a	113	3	U.S.	U.S.	NNP
cord-308095-mehmk49a	113	4	Pain	Pain	NNP
cord-308095-mehmk49a	113	5	Foundation	Foundation	NNP
cord-308095-mehmk49a	113	6	received	receive	VBD
cord-308095-mehmk49a	113	7	more	more	JJR
cord-308095-mehmk49a	113	8	than	than	IN
cord-308095-mehmk49a	113	9	any	any	DT
cord-308095-mehmk49a	113	10	other	other	JJ
cord-308095-mehmk49a	113	11	organization	organization	NN
cord-308095-mehmk49a	113	12	-	-	:
cord-308095-mehmk49a	113	13	in	in	IN
cord-308095-mehmk49a	113	14	excess	excess	NN
cord-308095-mehmk49a	113	15	of	of	IN
cord-308095-mehmk49a	113	16	$	$	$
cord-308095-mehmk49a	113	17	2.9	2.9	CD
cord-308095-mehmk49a	113	18	millionseveral	millionseveral	JJ
cord-308095-mehmk49a	113	19	other	other	JJ
cord-308095-mehmk49a	113	20	groups	group	NNS
cord-308095-mehmk49a	113	21	were	be	VBD
cord-308095-mehmk49a	113	22	also	also	RB
cord-308095-mehmk49a	113	23	dependent	dependent	JJ
cord-308095-mehmk49a	113	24	on	on	IN
cord-308095-mehmk49a	113	25	funding	funding	NN
cord-308095-mehmk49a	113	26	from	from	IN
cord-308095-mehmk49a	113	27	opioid	opioid	JJ
cord-308095-mehmk49a	113	28	companies	company	NNS
cord-308095-mehmk49a	113	29	.	.	.
cord-308095-mehmk49a	114	1	Notably	notably	RB
cord-308095-mehmk49a	114	2	,	,	,
cord-308095-mehmk49a	114	3	the	the	DT
cord-308095-mehmk49a	114	4	Academy	Academy	NNP
cord-308095-mehmk49a	114	5	of	of	IN
cord-308095-mehmk49a	114	6	Integrative	Integrative	NNP
cord-308095-mehmk49a	114	7	Pain	Pain	NNP
cord-308095-mehmk49a	114	8	Management	Management	NNP
cord-308095-mehmk49a	114	9	received	receive	VBD
cord-308095-mehmk49a	114	10	more	more	JJR
cord-308095-mehmk49a	114	11	than	than	IN
cord-308095-mehmk49a	114	12	$	$	$
cord-308095-mehmk49a	114	13	1	1	CD
cord-308095-mehmk49a	114	14	million	million	CD
cord-308095-mehmk49a	114	15	and	and	CC
cord-308095-mehmk49a	114	16	,	,	,
cord-308095-mehmk49a	114	17	when	when	WRB
cord-308095-mehmk49a	114	18	this	this	DT
cord-308095-mehmk49a	114	19	funding	funding	NN
cord-308095-mehmk49a	114	20	dried	dry	VBD
cord-308095-mehmk49a	114	21	up	up	RP
cord-308095-mehmk49a	114	22	in	in	IN
cord-308095-mehmk49a	114	23	the	the	DT
cord-308095-mehmk49a	114	24	wake	wake	NN
cord-308095-mehmk49a	114	25	of	of	IN
cord-308095-mehmk49a	114	26	the	the	DT
cord-308095-mehmk49a	114	27	U.S.	U.S.	NNP
cord-308095-mehmk49a	114	28	Senate	Senate	NNP
cord-308095-mehmk49a	114	29	report	report	NN
cord-308095-mehmk49a	114	30	,	,	,
cord-308095-mehmk49a	114	31	the	the	DT
cord-308095-mehmk49a	114	32	organization	organization	NN
cord-308095-mehmk49a	114	33	closed	close	VBD
cord-308095-mehmk49a	114	34	because	because	IN
cord-308095-mehmk49a	114	35	it	-PRON-	PRP
cord-308095-mehmk49a	114	36	lacked	lack	VBD
cord-308095-mehmk49a	114	37	sufficient	sufficient	JJ
cord-308095-mehmk49a	114	38	funds	fund	NNS
cord-308095-mehmk49a	114	39	to	to	TO
cord-308095-mehmk49a	114	40	maintain	maintain	VB
cord-308095-mehmk49a	114	41	operations	operation	NNS
cord-308095-mehmk49a	114	42	(	(	-LRB-
cord-308095-mehmk49a	114	43	Anson	Anson	NNP
cord-308095-mehmk49a	114	44	2019	2019	CD
cord-308095-mehmk49a	114	45	)	)	-RRB-
cord-308095-mehmk49a	114	46	.	.	.
cord-308095-mehmk49a	115	1	The	the	DT
cord-308095-mehmk49a	115	2	American	american	JJ
cord-308095-mehmk49a	115	3	Pain	Pain	NNP
cord-308095-mehmk49a	115	4	Society	Society	NNP
cord-308095-mehmk49a	115	5	received	receive	VBD
cord-308095-mehmk49a	115	6	almost	almost	RB
cord-308095-mehmk49a	115	7	$	$	$
cord-308095-mehmk49a	115	8	1	1	CD
cord-308095-mehmk49a	115	9	million	million	CD
cord-308095-mehmk49a	115	10	from	from	IN
cord-308095-mehmk49a	115	11	opioid	opioid	JJ
cord-308095-mehmk49a	115	12	companies	company	NNS
cord-308095-mehmk49a	115	13	,	,	,
cord-308095-mehmk49a	115	14	and	and	CC
cord-308095-mehmk49a	115	15	it	-PRON-	PRP
cord-308095-mehmk49a	115	16	also	also	RB
cord-308095-mehmk49a	115	17	dissolved	dissolve	VBD
cord-308095-mehmk49a	115	18	in	in	IN
cord-308095-mehmk49a	115	19	2019	2019	CD
cord-308095-mehmk49a	115	20	after	after	IN
cord-308095-mehmk49a	115	21	facing	face	VBG
cord-308095-mehmk49a	115	22	lawsuits	lawsuit	NNS
cord-308095-mehmk49a	115	23	for	for	IN
cord-308095-mehmk49a	115	24	its	-PRON-	PRP$
cord-308095-mehmk49a	115	25	role	role	NN
cord-308095-mehmk49a	115	26	in	in	IN
cord-308095-mehmk49a	115	27	exacerbating	exacerbate	VBG
cord-308095-mehmk49a	115	28	the	the	DT
cord-308095-mehmk49a	115	29	opioid	opioid	JJ
cord-308095-mehmk49a	115	30	crisis	crisis	NN
cord-308095-mehmk49a	115	31	(	(	-LRB-
cord-308095-mehmk49a	115	32	McGreal	McGreal	NNP
cord-308095-mehmk49a	115	33	2019	2019	CD
cord-308095-mehmk49a	115	34	)	)	-RRB-
cord-308095-mehmk49a	115	35	.	.	.
cord-308095-mehmk49a	116	1	It	-PRON-	PRP
cord-308095-mehmk49a	116	2	is	be	VBZ
cord-308095-mehmk49a	116	3	notable	notable	JJ
cord-308095-mehmk49a	116	4	that	that	IN
cord-308095-mehmk49a	116	5	the	the	DT
cord-308095-mehmk49a	116	6	organizations	organization	NNS
cord-308095-mehmk49a	116	7	discussed	discuss	VBN
cord-308095-mehmk49a	116	8	in	in	IN
cord-308095-mehmk49a	116	9	the	the	DT
cord-308095-mehmk49a	116	10	report	report	NN
cord-308095-mehmk49a	116	11	continued	continue	VBD
cord-308095-mehmk49a	116	12	to	to	TO
cord-308095-mehmk49a	116	13	accept	accept	VB
cord-308095-mehmk49a	116	14	opioid	opioid	JJ
cord-308095-mehmk49a	116	15	industry	industry	NN
cord-308095-mehmk49a	116	16	money	money	NN
cord-308095-mehmk49a	116	17	after	after	IN
cord-308095-mehmk49a	116	18	one	one	CD
cord-308095-mehmk49a	116	19	of	of	IN
cord-308095-mehmk49a	116	20	them	-PRON-	PRP
cord-308095-mehmk49a	116	21	,	,	,
cord-308095-mehmk49a	116	22	the	the	DT
cord-308095-mehmk49a	116	23	American	American	NNP
cord-308095-mehmk49a	116	24	Pain	Pain	NNP
cord-308095-mehmk49a	116	25	Foundation	Foundation	NNP
cord-308095-mehmk49a	116	26	,	,	,
cord-308095-mehmk49a	116	27	closed	close	VBD
cord-308095-mehmk49a	116	28	its	-PRON-	PRP$
cord-308095-mehmk49a	116	29	doors	door	NNS
cord-308095-mehmk49a	116	30	in	in	IN
cord-308095-mehmk49a	116	31	2012	2012	CD
cord-308095-mehmk49a	116	32	in	in	IN
cord-308095-mehmk49a	116	33	the	the	DT
cord-308095-mehmk49a	116	34	wake	wake	NN
cord-308095-mehmk49a	116	35	of	of	IN
cord-308095-mehmk49a	116	36	an	an	DT
cord-308095-mehmk49a	116	37	investigation	investigation	NN
cord-308095-mehmk49a	116	38	revealing	reveal	VBG
cord-308095-mehmk49a	116	39	its	-PRON-	PRP$
cord-308095-mehmk49a	116	40	dependence	dependence	NN
cord-308095-mehmk49a	116	41	on	on	IN
cord-308095-mehmk49a	116	42	opioid	opioid	JJ
cord-308095-mehmk49a	116	43	industry	industry	NN
cord-308095-mehmk49a	116	44	funding	funding	NN
cord-308095-mehmk49a	116	45	(	(	-LRB-
cord-308095-mehmk49a	116	46	Ornstein	Ornstein	NNP
cord-308095-mehmk49a	116	47	and	and	CC
cord-308095-mehmk49a	116	48	Weber	Weber	NNP
cord-308095-mehmk49a	116	49	2012	2012	CD
cord-308095-mehmk49a	116	50	)	)	-RRB-
cord-308095-mehmk49a	116	51	.	.	.
cord-308095-mehmk49a	117	1	Groups	group	NNS
cord-308095-mehmk49a	117	2	that	that	WDT
cord-308095-mehmk49a	117	3	received	receive	VBD
cord-308095-mehmk49a	117	4	money	money	NN
cord-308095-mehmk49a	117	5	from	from	IN
cord-308095-mehmk49a	117	6	the	the	DT
cord-308095-mehmk49a	117	7	opioid	opioid	JJ
cord-308095-mehmk49a	117	8	industry	industry	NN
cord-308095-mehmk49a	117	9	subsequently	subsequently	RB
cord-308095-mehmk49a	117	10	engaged	engage	VBD
cord-308095-mehmk49a	117	11	in	in	IN
cord-308095-mehmk49a	117	12	activities	activity	NNS
cord-308095-mehmk49a	117	13	-	-	,
cord-308095-mehmk49a	117	14	including	include	VBG
cord-308095-mehmk49a	117	15	participation	participation	NN
cord-308095-mehmk49a	117	16	in	in	IN
cord-308095-mehmk49a	117	17	policymaking	policymaking	NN
cord-308095-mehmk49a	117	18	processes	process	NNS
cord-308095-mehmk49a	117	19	-	-	:
cord-308095-mehmk49a	117	20	that	that	WDT
cord-308095-mehmk49a	117	21	protected	protect	VBD
cord-308095-mehmk49a	117	22	and	and	CC
cord-308095-mehmk49a	117	23	promoted	promote	VBD
cord-308095-mehmk49a	117	24	the	the	DT
cord-308095-mehmk49a	117	25	interests	interest	NNS
cord-308095-mehmk49a	117	26	of	of	IN
cord-308095-mehmk49a	117	27	their	-PRON-	PRP$
cord-308095-mehmk49a	117	28	donors	donor	NNS
cord-308095-mehmk49a	117	29	.	.	.
cord-308095-mehmk49a	118	1	As	as	IN
cord-308095-mehmk49a	118	2	a	a	DT
cord-308095-mehmk49a	118	3	result	result	NN
cord-308095-mehmk49a	118	4	,	,	,
cord-308095-mehmk49a	118	5	some	some	DT
cord-308095-mehmk49a	118	6	patient	patient	JJ
cord-308095-mehmk49a	118	7	advocacy	advocacy	NN
cord-308095-mehmk49a	118	8	groups	group	NNS
cord-308095-mehmk49a	118	9	and	and	CC
cord-308095-mehmk49a	118	10	health	health	NN
cord-308095-mehmk49a	118	11	professional	professional	JJ
cord-308095-mehmk49a	118	12	societies	society	NNS
cord-308095-mehmk49a	118	13	have	have	VBP
cord-308095-mehmk49a	118	14	been	be	VBN
cord-308095-mehmk49a	118	15	characterized	characterize	VBN
cord-308095-mehmk49a	118	16	as	as	IN
cord-308095-mehmk49a	118	17	"	"	``
cord-308095-mehmk49a	118	18	front	front	JJ
cord-308095-mehmk49a	118	19	groups	group	NNS
cord-308095-mehmk49a	118	20	"	"	''
cord-308095-mehmk49a	118	21	for	for	IN
cord-308095-mehmk49a	118	22	industry	industry	NN
cord-308095-mehmk49a	118	23	(	(	-LRB-
cord-308095-mehmk49a	118	24	e.g.	e.g.	RB
cord-308095-mehmk49a	118	25	,	,	,
cord-308095-mehmk49a	118	26	Michaels	Michaels	NNP
cord-308095-mehmk49a	118	27	2020	2020	CD
cord-308095-mehmk49a	118	28	)	)	-RRB-
cord-308095-mehmk49a	118	29	.	.	.
cord-308095-mehmk49a	119	1	But	but	CC
cord-308095-mehmk49a	119	2	even	even	RB
cord-308095-mehmk49a	119	3	when	when	WRB
cord-308095-mehmk49a	119	4	organizations	organization	NNS
cord-308095-mehmk49a	119	5	are	be	VBP
cord-308095-mehmk49a	119	6	genuinely	genuinely	RB
cord-308095-mehmk49a	119	7	created	create	VBN
cord-308095-mehmk49a	119	8	to	to	TO
cord-308095-mehmk49a	119	9	promote	promote	VB
cord-308095-mehmk49a	119	10	the	the	DT
cord-308095-mehmk49a	119	11	interests	interest	NNS
cord-308095-mehmk49a	119	12	of	of	IN
cord-308095-mehmk49a	119	13	patients	patient	NNS
cord-308095-mehmk49a	119	14	,	,	,
cord-308095-mehmk49a	119	15	they	-PRON-	PRP
cord-308095-mehmk49a	119	16	can	can	MD
cord-308095-mehmk49a	119	17	be	be	VB
cord-308095-mehmk49a	119	18	profoundly	profoundly	RB
cord-308095-mehmk49a	119	19	influenced	influence	VBN
cord-308095-mehmk49a	119	20	by	by	IN
cord-308095-mehmk49a	119	21	gifts	gift	NNS
cord-308095-mehmk49a	119	22	from	from	IN
cord-308095-mehmk49a	119	23	and	and	CC
cord-308095-mehmk49a	119	24	relationships	relationship	NNS
cord-308095-mehmk49a	119	25	with	with	IN
cord-308095-mehmk49a	119	26	corporate	corporate	JJ
cord-308095-mehmk49a	119	27	actors	actor	NNS
cord-308095-mehmk49a	119	28	-	-	:
cord-308095-mehmk49a	119	29	as	as	IN
cord-308095-mehmk49a	119	30	the	the	DT
cord-308095-mehmk49a	119	31	ethnographic	ethnographic	JJ
cord-308095-mehmk49a	119	32	and	and	CC
cord-308095-mehmk49a	119	33	behavioural	behavioural	JJ
cord-308095-mehmk49a	119	34	science	science	NN
cord-308095-mehmk49a	119	35	research	research	NN
cord-308095-mehmk49a	119	36	on	on	IN
cord-308095-mehmk49a	119	37	reciprocity	reciprocity	NN
cord-308095-mehmk49a	119	38	makes	make	VBZ
cord-308095-mehmk49a	119	39	clear	clear	JJ
cord-308095-mehmk49a	119	40	.	.	.
cord-308095-mehmk49a	120	1	Reciprocity	reciprocity	NN
cord-308095-mehmk49a	120	2	need	nee	MD
cord-308095-mehmk49a	120	3	not	not	RB
cord-308095-mehmk49a	120	4	involve	involve	VB
cord-308095-mehmk49a	120	5	an	an	DT
cord-308095-mehmk49a	120	6	explicit	explicit	JJ
cord-308095-mehmk49a	120	7	exchange	exchange	NN
cord-308095-mehmk49a	120	8	(	(	-LRB-
cord-308095-mehmk49a	120	9	often	often	RB
cord-308095-mehmk49a	120	10	called	call	VBN
cord-308095-mehmk49a	120	11	a	a	DT
cord-308095-mehmk49a	120	12	quid	quid	NN
cord-308095-mehmk49a	120	13	pro	pro	FW
cord-308095-mehmk49a	120	14	quo	quo	FW
cord-308095-mehmk49a	120	15	)	)	-RRB-
cord-308095-mehmk49a	120	16	;	;	:
cord-308095-mehmk49a	120	17	on	on	IN
cord-308095-mehmk49a	120	18	the	the	DT
cord-308095-mehmk49a	120	19	contrary	contrary	NN
cord-308095-mehmk49a	120	20	,	,	,
cord-308095-mehmk49a	120	21	gifts	gift	NNS
cord-308095-mehmk49a	120	22	can	can	MD
cord-308095-mehmk49a	120	23	give	give	VB
cord-308095-mehmk49a	120	24	rise	rise	NN
cord-308095-mehmk49a	120	25	to	to	IN
cord-308095-mehmk49a	120	26	subtle	subtle	JJ
cord-308095-mehmk49a	120	27	reciprocity	reciprocity	NN
cord-308095-mehmk49a	120	28	-	-	:
cord-308095-mehmk49a	120	29	which	which	WDT
cord-308095-mehmk49a	120	30	often	often	RB
cord-308095-mehmk49a	120	31	manifests	manifest	VBZ
cord-308095-mehmk49a	120	32	as	as	IN
cord-308095-mehmk49a	120	33	a	a	DT
cord-308095-mehmk49a	120	34	general	general	JJ
cord-308095-mehmk49a	120	35	disposition	disposition	NN
cord-308095-mehmk49a	120	36	toward	toward	IN
cord-308095-mehmk49a	120	37	helping	help	VBG
cord-308095-mehmk49a	120	38	another	another	DT
cord-308095-mehmk49a	120	39	(	(	-LRB-
cord-308095-mehmk49a	120	40	Marks	Marks	NNP
cord-308095-mehmk49a	120	41	2019a	2019a	CD
cord-308095-mehmk49a	120	42	)	)	-RRB-
cord-308095-mehmk49a	120	43	.	.	.
cord-308095-mehmk49a	121	1	Companies	company	NNS
cord-308095-mehmk49a	121	2	understand	understand	VBP
cord-308095-mehmk49a	121	3	and	and	CC
cord-308095-mehmk49a	121	4	commonly	commonly	RB
cord-308095-mehmk49a	121	5	exploit	exploit	VB
cord-308095-mehmk49a	121	6	this	this	DT
cord-308095-mehmk49a	121	7	to	to	TO
cord-308095-mehmk49a	121	8	promote	promote	VB
cord-308095-mehmk49a	121	9	policies	policy	NNS
cord-308095-mehmk49a	121	10	that	that	WDT
cord-308095-mehmk49a	121	11	protect	protect	VBP
cord-308095-mehmk49a	121	12	their	-PRON-	PRP$
cord-308095-mehmk49a	121	13	interests	interest	NNS
cord-308095-mehmk49a	121	14	.	.	.
cord-308095-mehmk49a	122	1	A	a	DT
cord-308095-mehmk49a	122	2	recent	recent	JJ
cord-308095-mehmk49a	122	3	study	study	NN
cord-308095-mehmk49a	122	4	concludes	conclude	VBZ
cord-308095-mehmk49a	122	5	that	that	IN
cord-308095-mehmk49a	122	6	corporations	corporation	NNS
cord-308095-mehmk49a	122	7	"	"	``
cord-308095-mehmk49a	122	8	strategically	strategically	RB
cord-308095-mehmk49a	122	9	deploy	deploy	VBP
cord-308095-mehmk49a	122	10	charitable	charitable	JJ
cord-308095-mehmk49a	122	11	grants	grant	NNS
cord-308095-mehmk49a	122	12	"	"	''
cord-308095-mehmk49a	122	13	to	to	IN
cord-308095-mehmk49a	122	14	non	non	JJ
cord-308095-mehmk49a	122	15	-	-	JJ
cord-308095-mehmk49a	122	16	profit	profit	JJ
cord-308095-mehmk49a	122	17	organizations	organization	NNS
cord-308095-mehmk49a	122	18	so	so	IN
cord-308095-mehmk49a	122	19	that	that	IN
cord-308095-mehmk49a	122	20	the	the	DT
cord-308095-mehmk49a	122	21	recipients	recipient	NNS
cord-308095-mehmk49a	122	22	will	will	MD
cord-308095-mehmk49a	122	23	comment	comment	VB
cord-308095-mehmk49a	122	24	favourably	favourably	RB
cord-308095-mehmk49a	122	25	in	in	IN
cord-308095-mehmk49a	122	26	regulatory	regulatory	JJ
cord-308095-mehmk49a	122	27	processes	process	NNS
cord-308095-mehmk49a	122	28	(	(	-LRB-
cord-308095-mehmk49a	122	29	Bertrand	Bertrand	NNP
cord-308095-mehmk49a	122	30	et	et	NNP
cord-308095-mehmk49a	122	31	al	al	NNP
cord-308095-mehmk49a	122	32	.	.	.
cord-308095-mehmk49a	122	33	2018	2018	CD
cord-308095-mehmk49a	122	34	,	,	,
cord-308095-mehmk49a	122	35	1	1	CD
cord-308095-mehmk49a	122	36	)	)	-RRB-
cord-308095-mehmk49a	122	37	.	.	.
cord-308095-mehmk49a	123	1	The	the	DT
cord-308095-mehmk49a	123	2	authors	author	NNS
cord-308095-mehmk49a	123	3	also	also	RB
cord-308095-mehmk49a	123	4	found	find	VBD
cord-308095-mehmk49a	123	5	that	that	IN
cord-308095-mehmk49a	123	6	this	this	DT
cord-308095-mehmk49a	123	7	strategy	strategy	NN
cord-308095-mehmk49a	123	8	is	be	VBZ
cord-308095-mehmk49a	123	9	effective	effective	JJ
cord-308095-mehmk49a	123	10	at	at	IN
cord-308095-mehmk49a	123	11	promoting	promote	VBG
cord-308095-mehmk49a	123	12	regulatory	regulatory	JJ
cord-308095-mehmk49a	123	13	discussions	discussion	NNS
cord-308095-mehmk49a	123	14	more	more	RBR
cord-308095-mehmk49a	123	15	closely	closely	RB
cord-308095-mehmk49a	123	16	aligned	align	VBN
cord-308095-mehmk49a	123	17	with	with	IN
cord-308095-mehmk49a	123	18	the	the	DT
cord-308095-mehmk49a	123	19	companies	company	NNS
cord-308095-mehmk49a	123	20	'	'	POS
cord-308095-mehmk49a	123	21	perspectives	perspective	NNS
cord-308095-mehmk49a	123	22	and	and	CC
cord-308095-mehmk49a	123	23	commercial	commercial	JJ
cord-308095-mehmk49a	123	24	interests	interest	NNS
cord-308095-mehmk49a	123	25	.	.	.
cord-308095-mehmk49a	124	1	When	when	WRB
cord-308095-mehmk49a	124	2	the	the	DT
cord-308095-mehmk49a	124	3	Centers	Centers	NNPS
cord-308095-mehmk49a	124	4	for	for	IN
cord-308095-mehmk49a	124	5	Disease	Disease	NNP
cord-308095-mehmk49a	124	6	Control	Control	NNP
cord-308095-mehmk49a	124	7	and	and	CC
cord-308095-mehmk49a	124	8	Prevention	Prevention	NNP
cord-308095-mehmk49a	124	9	(	(	-LRB-
cord-308095-mehmk49a	124	10	the	the	DT
cord-308095-mehmk49a	124	11	CDC	CDC	NNP
cord-308095-mehmk49a	124	12	)	)	-RRB-
cord-308095-mehmk49a	124	13	issued	issue	VBD
cord-308095-mehmk49a	124	14	draft	draft	NN
cord-308095-mehmk49a	124	15	guidelines	guideline	NNS
cord-308095-mehmk49a	124	16	in	in	IN
cord-308095-mehmk49a	124	17	2016	2016	CD
cord-308095-mehmk49a	124	18	recommending	recommend	VBG
cord-308095-mehmk49a	124	19	greater	great	JJR
cord-308095-mehmk49a	124	20	restraint	restraint	NN
cord-308095-mehmk49a	124	21	in	in	IN
cord-308095-mehmk49a	124	22	opioid	opioid	JJ
cord-308095-mehmk49a	124	23	prescribing	prescribing	NN
cord-308095-mehmk49a	124	24	,	,	,
cord-308095-mehmk49a	124	25	opposition	opposition	NN
cord-308095-mehmk49a	124	26	was	be	VBD
cord-308095-mehmk49a	124	27	significantly	significantly	RB
cord-308095-mehmk49a	124	28	higher	high	JJR
cord-308095-mehmk49a	124	29	among	among	IN
cord-308095-mehmk49a	124	30	organizations	organization	NNS
cord-308095-mehmk49a	124	31	that	that	WDT
cord-308095-mehmk49a	124	32	had	have	VBD
cord-308095-mehmk49a	124	33	received	receive	VBN
cord-308095-mehmk49a	124	34	funding	funding	NN
cord-308095-mehmk49a	124	35	from	from	IN
cord-308095-mehmk49a	124	36	the	the	DT
cord-308095-mehmk49a	124	37	opioid	opioid	NN
cord-308095-mehmk49a	124	38	industry	industry	NN
cord-308095-mehmk49a	125	1	(	(	-LRB-
cord-308095-mehmk49a	125	2	Lin	Lin	NNP
cord-308095-mehmk49a	125	3	et	et	NNP
cord-308095-mehmk49a	125	4	al	al	NNP
cord-308095-mehmk49a	125	5	.	.	.
cord-308095-mehmk49a	125	6	2017	2017	CD
cord-308095-mehmk49a	125	7	)	)	-RRB-
cord-308095-mehmk49a	125	8	.	.	.
cord-308095-mehmk49a	126	1	In	in	IN
cord-308095-mehmk49a	126	2	addition	addition	NN
cord-308095-mehmk49a	126	3	,	,	,
cord-308095-mehmk49a	126	4	a	a	DT
cord-308095-mehmk49a	126	5	number	number	NN
cord-308095-mehmk49a	126	6	of	of	IN
cord-308095-mehmk49a	126	7	groups	group	NNS
cord-308095-mehmk49a	126	8	that	that	WDT
cord-308095-mehmk49a	126	9	received	receive	VBD
cord-308095-mehmk49a	126	10	opioid	opioid	JJ
cord-308095-mehmk49a	126	11	industry	industry	NN
cord-308095-mehmk49a	126	12	funding	funding	NN
cord-308095-mehmk49a	126	13	lobbied	lobby	VBD
cord-308095-mehmk49a	126	14	against	against	IN
cord-308095-mehmk49a	126	15	legislation	legislation	NN
cord-308095-mehmk49a	126	16	restricting	restrict	VBG
cord-308095-mehmk49a	126	17	opioid	opioid	JJ
cord-308095-mehmk49a	126	18	prescribing	prescribing	NN
cord-308095-mehmk49a	126	19	and	and	CC
cord-308095-mehmk49a	126	20	produced	produce	VBD
cord-308095-mehmk49a	126	21	their	-PRON-	PRP$
cord-308095-mehmk49a	126	22	own	own	JJ
cord-308095-mehmk49a	126	23	guidelines	guideline	NNS
cord-308095-mehmk49a	126	24	downplaying	downplay	VBG
cord-308095-mehmk49a	126	25	the	the	DT
cord-308095-mehmk49a	126	26	addiction	addiction	NN
cord-308095-mehmk49a	126	27	risks	risk	NNS
cord-308095-mehmk49a	126	28	(	(	-LRB-
cord-308095-mehmk49a	126	29	HSGAC	HSGAC	NNP
cord-308095-mehmk49a	126	30	2018a	2018a	CD
cord-308095-mehmk49a	126	31	)	)	-RRB-
cord-308095-mehmk49a	126	32	.	.	.
cord-308095-mehmk49a	127	1	Recently	recently	RB
cord-308095-mehmk49a	127	2	released	release	VBN
cord-308095-mehmk49a	127	3	internal	internal	JJ
cord-308095-mehmk49a	127	4	documents	document	NNS
cord-308095-mehmk49a	127	5	reveal	reveal	VBP
cord-308095-mehmk49a	127	6	that	that	IN
cord-308095-mehmk49a	127	7	Purdue	Purdue	NNP
cord-308095-mehmk49a	127	8	Pharma	Pharma	NNP
cord-308095-mehmk49a	127	9	considered	consider	VBD
cord-308095-mehmk49a	127	10	these	these	DT
cord-308095-mehmk49a	127	11	kinds	kind	NNS
cord-308095-mehmk49a	127	12	of	of	IN
cord-308095-mehmk49a	127	13	guidelines	guideline	NNS
cord-308095-mehmk49a	127	14	to	to	TO
cord-308095-mehmk49a	127	15	be	be	VB
cord-308095-mehmk49a	127	16	"	"	``
cord-308095-mehmk49a	127	17	an	an	DT
cord-308095-mehmk49a	127	18	effective	effective	JJ
cord-308095-mehmk49a	127	19	tool	tool	NN
cord-308095-mehmk49a	127	20	for	for	IN
cord-308095-mehmk49a	127	21	selling	sell	VBG
cord-308095-mehmk49a	127	22	our	-PRON-	PRP$
cord-308095-mehmk49a	127	23	products	product	NNS
cord-308095-mehmk49a	127	24	"	"	''
cord-308095-mehmk49a	128	1	(	(	-LRB-
cord-308095-mehmk49a	128	2	Ross	Ross	NNP
cord-308095-mehmk49a	128	3	2019	2019	CD
cord-308095-mehmk49a	128	4	,	,	,
cord-308095-mehmk49a	128	5	¶19	¶19	NNP
cord-308095-mehmk49a	128	6	)	)	-RRB-
cord-308095-mehmk49a	128	7	.	.	.
cord-308095-mehmk49a	129	1	Influence	influence	NN
cord-308095-mehmk49a	129	2	on	on	IN
cord-308095-mehmk49a	129	3	health	health	NN
cord-308095-mehmk49a	129	4	-	-	HYPH
cord-308095-mehmk49a	129	5	related	relate	VBN
cord-308095-mehmk49a	129	6	NGOs	NGOs	NNPS
cord-308095-mehmk49a	129	7	is	be	VBZ
cord-308095-mehmk49a	129	8	especially	especially	RB
cord-308095-mehmk49a	129	9	important	important	JJ
cord-308095-mehmk49a	129	10	because	because	IN
cord-308095-mehmk49a	129	11	of	of	IN
cord-308095-mehmk49a	129	12	the	the	DT
cord-308095-mehmk49a	129	13	ways	way	NNS
cord-308095-mehmk49a	129	14	in	in	IN
cord-308095-mehmk49a	129	15	which	which	WDT
cord-308095-mehmk49a	129	16	these	these	DT
cord-308095-mehmk49a	129	17	bodies	body	NNS
cord-308095-mehmk49a	129	18	may	may	MD
cord-308095-mehmk49a	129	19	,	,	,
cord-308095-mehmk49a	129	20	in	in	IN
cord-308095-mehmk49a	129	21	turn	turn	NN
cord-308095-mehmk49a	129	22	,	,	,
cord-308095-mehmk49a	129	23	influence	influence	NN
cord-308095-mehmk49a	129	24	policymakers	policymaker	NNS
cord-308095-mehmk49a	129	25	,	,	,
cord-308095-mehmk49a	129	26	policymaking	policymaking	NN
cord-308095-mehmk49a	129	27	,	,	,
cord-308095-mehmk49a	129	28	and	and	CC
cord-308095-mehmk49a	129	29	the	the	DT
cord-308095-mehmk49a	129	30	resulting	result	VBG
cord-308095-mehmk49a	129	31	policies	policy	NNS
cord-308095-mehmk49a	129	32	.	.	.
cord-308095-mehmk49a	130	1	A	a	DT
cord-308095-mehmk49a	130	2	recent	recent	JJ
cord-308095-mehmk49a	130	3	article	article	NN
cord-308095-mehmk49a	130	4	in	in	IN
cord-308095-mehmk49a	130	5	the	the	DT
cord-308095-mehmk49a	130	6	BMJ	BMJ	NNP
cord-308095-mehmk49a	130	7	expressed	express	VBD
cord-308095-mehmk49a	130	8	concern	concern	NN
cord-308095-mehmk49a	130	9	that	that	IN
cord-308095-mehmk49a	130	10	the	the	DT
cord-308095-mehmk49a	130	11	National	National	NNP
cord-308095-mehmk49a	130	12	Academies	Academies	NNPS
cord-308095-mehmk49a	130	13	of	of	IN
cord-308095-mehmk49a	130	14	Science	Science	NNP
cord-308095-mehmk49a	130	15	,	,	,
cord-308095-mehmk49a	130	16	Engineering	Engineering	NNP
cord-308095-mehmk49a	130	17	,	,	,
cord-308095-mehmk49a	130	18	and	and	CC
cord-308095-mehmk49a	130	19	Medicine	Medicine	NNP
cord-308095-mehmk49a	130	20	(	(	-LRB-
cord-308095-mehmk49a	130	21	NASEM)-an	NASEM)-an	NNP
cord-308095-mehmk49a	130	22	NGO	NGO	NNP
cord-308095-mehmk49a	130	23	established	establish	VBN
cord-308095-mehmk49a	130	24	by	by	IN
cord-308095-mehmk49a	130	25	federal	federal	JJ
cord-308095-mehmk49a	130	26	statute	statute	NN
cord-308095-mehmk49a	130	27	with	with	IN
cord-308095-mehmk49a	130	28	the	the	DT
cord-308095-mehmk49a	130	29	express	express	JJ
cord-308095-mehmk49a	130	30	purpose	purpose	NN
cord-308095-mehmk49a	130	31	of	of	IN
cord-308095-mehmk49a	130	32	providing	provide	VBG
cord-308095-mehmk49a	130	33	independent	independent	JJ
cord-308095-mehmk49a	130	34	advice	advice	NN
cord-308095-mehmk49a	130	35	to	to	IN
cord-308095-mehmk49a	130	36	the	the	DT
cord-308095-mehmk49a	130	37	federal	federal	JJ
cord-308095-mehmk49a	130	38	government	government	NN
cord-308095-mehmk49a	130	39	in	in	IN
cord-308095-mehmk49a	130	40	the	the	DT
cord-308095-mehmk49a	130	41	United	United	NNP
cord-308095-mehmk49a	130	42	States	States	NNP
cord-308095-mehmk49a	130	43	-	-	:
cord-308095-mehmk49a	130	44	had	have	VBD
cord-308095-mehmk49a	130	45	received	receive	VBN
cord-308095-mehmk49a	130	46	millions	million	NNS
cord-308095-mehmk49a	130	47	of	of	IN
cord-308095-mehmk49a	130	48	dollars	dollar	NNS
cord-308095-mehmk49a	130	49	from	from	IN
cord-308095-mehmk49a	130	50	several	several	JJ
cord-308095-mehmk49a	130	51	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	130	52	companies	company	NNS
cord-308095-mehmk49a	130	53	(	(	-LRB-
cord-308095-mehmk49a	130	54	including	include	VBG
cord-308095-mehmk49a	130	55	opioid	opioid	JJ
cord-308095-mehmk49a	130	56	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	130	57	)	)	-RRB-
cord-308095-mehmk49a	130	58	,	,	,
cord-308095-mehmk49a	130	59	as	as	RB
cord-308095-mehmk49a	130	60	well	well	RB
cord-308095-mehmk49a	130	61	as	as	IN
cord-308095-mehmk49a	130	62	gifts	gift	NNS
cord-308095-mehmk49a	130	63	from	from	IN
cord-308095-mehmk49a	130	64	members	member	NNS
cord-308095-mehmk49a	130	65	of	of	IN
cord-308095-mehmk49a	130	66	the	the	DT
cord-308095-mehmk49a	130	67	Sackler	Sackler	NNP
cord-308095-mehmk49a	130	68	family	family	NN
cord-308095-mehmk49a	130	69	(	(	-LRB-
cord-308095-mehmk49a	130	70	Schwab	Schwab	NNP
cord-308095-mehmk49a	130	71	2019	2019	CD
cord-308095-mehmk49a	130	72	)	)	-RRB-
cord-308095-mehmk49a	130	73	.	.	.
cord-308095-mehmk49a	131	1	The	the	DT
cord-308095-mehmk49a	131	2	article	article	NN
cord-308095-mehmk49a	131	3	also	also	RB
cord-308095-mehmk49a	131	4	expressed	express	VBD
cord-308095-mehmk49a	131	5	concern	concern	NN
cord-308095-mehmk49a	131	6	that	that	IN
cord-308095-mehmk49a	131	7	members	member	NNS
cord-308095-mehmk49a	131	8	of	of	IN
cord-308095-mehmk49a	131	9	NASEM	NASEM	NNP
cord-308095-mehmk49a	131	10	panels	panel	NNS
cord-308095-mehmk49a	131	11	,	,	,
cord-308095-mehmk49a	131	12	including	include	VBG
cord-308095-mehmk49a	131	13	one	one	CD
cord-308095-mehmk49a	131	14	commissioned	commission	VBN
cord-308095-mehmk49a	131	15	to	to	TO
cord-308095-mehmk49a	131	16	advise	advise	VB
cord-308095-mehmk49a	131	17	policymakers	policymaker	NNS
cord-308095-mehmk49a	131	18	on	on	IN
cord-308095-mehmk49a	131	19	clinical	clinical	JJ
cord-308095-mehmk49a	131	20	practice	practice	NN
cord-308095-mehmk49a	131	21	guidelines	guideline	NNS
cord-308095-mehmk49a	131	22	for	for	IN
cord-308095-mehmk49a	131	23	prescribing	prescribe	VBG
cord-308095-mehmk49a	131	24	opioids	opioid	NNS
cord-308095-mehmk49a	131	25	,	,	,
cord-308095-mehmk49a	131	26	had	have	VBD
cord-308095-mehmk49a	131	27	received	receive	VBN
cord-308095-mehmk49a	131	28	payments	payment	NNS
cord-308095-mehmk49a	131	29	from	from	IN
cord-308095-mehmk49a	131	30	opioid	opioid	JJ
cord-308095-mehmk49a	131	31	companies	company	NNS
cord-308095-mehmk49a	131	32	(	(	-LRB-
cord-308095-mehmk49a	131	33	in	in	IN
cord-308095-mehmk49a	131	34	the	the	DT
cord-308095-mehmk49a	131	35	form	form	NN
cord-308095-mehmk49a	131	36	of	of	IN
cord-308095-mehmk49a	131	37	research	research	NN
cord-308095-mehmk49a	131	38	funding	funding	NN
cord-308095-mehmk49a	131	39	,	,	,
cord-308095-mehmk49a	131	40	consultancy	consultancy	NN
cord-308095-mehmk49a	131	41	fees	fee	NNS
cord-308095-mehmk49a	131	42	,	,	,
cord-308095-mehmk49a	131	43	and	and	CC
cord-308095-mehmk49a	131	44	advisory	advisory	JJ
cord-308095-mehmk49a	131	45	board	board	NN
cord-308095-mehmk49a	131	46	retainers	retainer	NNS
cord-308095-mehmk49a	131	47	)	)	-RRB-
cord-308095-mehmk49a	131	48	.	.	.
cord-308095-mehmk49a	132	1	Representations	representation	NNS
cord-308095-mehmk49a	132	2	from	from	IN
cord-308095-mehmk49a	132	3	bodies	body	NNS
cord-308095-mehmk49a	132	4	that	that	WDT
cord-308095-mehmk49a	132	5	appear	appear	VBP
cord-308095-mehmk49a	132	6	to	to	TO
cord-308095-mehmk49a	132	7	be	be	VB
cord-308095-mehmk49a	132	8	independent	independent	JJ
cord-308095-mehmk49a	132	9	or	or	CC
cord-308095-mehmk49a	132	10	-	-	:
cord-308095-mehmk49a	132	11	at	at	IN
cord-308095-mehmk49a	132	12	the	the	DT
cord-308095-mehmk49a	132	13	very	very	RB
cord-308095-mehmk49a	132	14	least	least	JJS
cord-308095-mehmk49a	132	15	,	,	,
cord-308095-mehmk49a	132	16	that	that	WDT
cord-308095-mehmk49a	132	17	appear	appear	VBP
cord-308095-mehmk49a	132	18	to	to	TO
cord-308095-mehmk49a	132	19	be	be	VB
cord-308095-mehmk49a	132	20	promoting	promote	VBG
cord-308095-mehmk49a	132	21	the	the	DT
cord-308095-mehmk49a	132	22	interests	interest	NNS
cord-308095-mehmk49a	132	23	of	of	IN
cord-308095-mehmk49a	132	24	patients	patient	NNS
cord-308095-mehmk49a	132	25	-	-	:
cord-308095-mehmk49a	132	26	may	may	MD
cord-308095-mehmk49a	132	27	be	be	VB
cord-308095-mehmk49a	132	28	viewed	view	VBN
cord-308095-mehmk49a	132	29	with	with	IN
cord-308095-mehmk49a	132	30	much	much	RB
cord-308095-mehmk49a	132	31	less	less	JJR
cord-308095-mehmk49a	132	32	scepticism	scepticism	NN
cord-308095-mehmk49a	132	33	by	by	IN
cord-308095-mehmk49a	132	34	public	public	JJ
cord-308095-mehmk49a	132	35	officials	official	NNS
cord-308095-mehmk49a	132	36	than	than	IN
cord-308095-mehmk49a	132	37	representations	representation	NNS
cord-308095-mehmk49a	132	38	coming	come	VBG
cord-308095-mehmk49a	132	39	directly	directly	RB
cord-308095-mehmk49a	132	40	from	from	IN
cord-308095-mehmk49a	132	41	companies	company	NNS
cord-308095-mehmk49a	132	42	.	.	.
cord-308095-mehmk49a	133	1	But	but	CC
cord-308095-mehmk49a	133	2	,	,	,
cord-308095-mehmk49a	133	3	once	once	RB
cord-308095-mehmk49a	133	4	again	again	RB
cord-308095-mehmk49a	133	5	,	,	,
cord-308095-mehmk49a	133	6	opioid	opioid	JJ
cord-308095-mehmk49a	133	7	companies	company	NNS
cord-308095-mehmk49a	133	8	left	leave	VBD
cord-308095-mehmk49a	133	9	nothing	nothing	NN
cord-308095-mehmk49a	133	10	to	to	TO
cord-308095-mehmk49a	133	11	chance	chance	VB
cord-308095-mehmk49a	133	12	.	.	.
cord-308095-mehmk49a	134	1	Just	just	RB
cord-308095-mehmk49a	134	2	as	as	IN
cord-308095-mehmk49a	134	3	they	-PRON-	PRP
cord-308095-mehmk49a	134	4	made	make	VBD
cord-308095-mehmk49a	134	5	direct	direct	JJ
cord-308095-mehmk49a	134	6	payments	payment	NNS
cord-308095-mehmk49a	134	7	to	to	IN
cord-308095-mehmk49a	134	8	PAOs	pao	NNS
cord-308095-mehmk49a	134	9	and	and	CC
cord-308095-mehmk49a	134	10	health	health	NN
cord-308095-mehmk49a	134	11	professional	professional	JJ
cord-308095-mehmk49a	134	12	associations	association	NNS
cord-308095-mehmk49a	134	13	to	to	TO
cord-308095-mehmk49a	134	14	bolster	bolster	VB
cord-308095-mehmk49a	134	15	indirect	indirect	JJ
cord-308095-mehmk49a	134	16	influence	influence	NN
cord-308095-mehmk49a	134	17	arising	arise	VBG
cord-308095-mehmk49a	134	18	from	from	IN
cord-308095-mehmk49a	134	19	relationships	relationship	NNS
cord-308095-mehmk49a	134	20	with	with	IN
cord-308095-mehmk49a	134	21	leading	lead	VBG
cord-308095-mehmk49a	134	22	health	health	NN
cord-308095-mehmk49a	134	23	professionals	professional	NNS
cord-308095-mehmk49a	134	24	,	,	,
cord-308095-mehmk49a	134	25	companies	company	NNS
cord-308095-mehmk49a	134	26	also	also	RB
cord-308095-mehmk49a	134	27	reinforced	reinforce	VBD
cord-308095-mehmk49a	134	28	indirect	indirect	JJ
cord-308095-mehmk49a	134	29	influence	influence	NN
cord-308095-mehmk49a	134	30	of	of	IN
cord-308095-mehmk49a	134	31	public	public	JJ
cord-308095-mehmk49a	134	32	officials	official	NNS
cord-308095-mehmk49a	134	33	,	,	,
cord-308095-mehmk49a	134	34	legislators	legislator	NNS
cord-308095-mehmk49a	134	35	,	,	,
cord-308095-mehmk49a	134	36	and	and	CC
cord-308095-mehmk49a	134	37	policymakers	policymaker	NNS
cord-308095-mehmk49a	134	38	by	by	IN
cord-308095-mehmk49a	134	39	making	make	VBG
cord-308095-mehmk49a	134	40	contributions	contribution	NNS
cord-308095-mehmk49a	134	41	to	to	IN
cord-308095-mehmk49a	134	42	political	political	JJ
cord-308095-mehmk49a	134	43	campaigns	campaign	NNS
cord-308095-mehmk49a	134	44	and	and	CC
cord-308095-mehmk49a	134	45	public	public	JJ
cord-308095-mehmk49a	134	46	health	health	NN
cord-308095-mehmk49a	134	47	initiatives	initiative	NNS
cord-308095-mehmk49a	134	48	.	.	.
cord-308095-mehmk49a	135	1	According	accord	VBG
cord-308095-mehmk49a	135	2	to	to	IN
cord-308095-mehmk49a	135	3	the	the	DT
cord-308095-mehmk49a	135	4	Center	Center	NNP
cord-308095-mehmk49a	135	5	for	for	IN
cord-308095-mehmk49a	135	6	Public	Public	NNP
cord-308095-mehmk49a	135	7	Integrity	Integrity	NNP
cord-308095-mehmk49a	135	8	(	(	-LRB-
cord-308095-mehmk49a	135	9	CPI	CPI	NNP
cord-308095-mehmk49a	135	10	)	)	-RRB-
cord-308095-mehmk49a	135	11	and	and	CC
cord-308095-mehmk49a	135	12	the	the	DT
cord-308095-mehmk49a	135	13	Associated	Associated	NNP
cord-308095-mehmk49a	135	14	Press	Press	NNP
cord-308095-mehmk49a	135	15	,	,	,
cord-308095-mehmk49a	135	16	between	between	IN
cord-308095-mehmk49a	135	17	2006	2006	CD
cord-308095-mehmk49a	135	18	and	and	CC
cord-308095-mehmk49a	135	19	2015	2015	CD
cord-308095-mehmk49a	135	20	,	,	,
cord-308095-mehmk49a	135	21	opioid	opioid	JJ
cord-308095-mehmk49a	135	22	companies	company	NNS
cord-308095-mehmk49a	135	23	spent	spend	VBD
cord-308095-mehmk49a	135	24	$	$	$
cord-308095-mehmk49a	135	25	880	880	CD
cord-308095-mehmk49a	135	26	million	million	CD
cord-308095-mehmk49a	135	27	on	on	IN
cord-308095-mehmk49a	135	28	lobbying	lobbying	NN
cord-308095-mehmk49a	135	29	and	and	CC
cord-308095-mehmk49a	135	30	campaign	campaign	NN
cord-308095-mehmk49a	135	31	contributions	contribution	NNS
cord-308095-mehmk49a	135	32	-	-	:
cord-308095-mehmk49a	135	33	dwarfing	dwarf	VBG
cord-308095-mehmk49a	135	34	the	the	DT
cord-308095-mehmk49a	135	35	$	$	$
cord-308095-mehmk49a	135	36	4	4	CD
cord-308095-mehmk49a	135	37	million	million	CD
cord-308095-mehmk49a	135	38	spent	spend	VBN
cord-308095-mehmk49a	135	39	by	by	IN
cord-308095-mehmk49a	135	40	groups	group	NNS
cord-308095-mehmk49a	135	41	advocating	advocate	VBG
cord-308095-mehmk49a	135	42	limits	limit	NNS
cord-308095-mehmk49a	135	43	on	on	IN
cord-308095-mehmk49a	135	44	opioid	opioid	JJ
cord-308095-mehmk49a	135	45	prescribing	prescribing	NN
cord-308095-mehmk49a	135	46	,	,	,
cord-308095-mehmk49a	135	47	and	and	CC
cord-308095-mehmk49a	135	48	(	(	-LRB-
cord-308095-mehmk49a	135	49	more	more	RBR
cord-308095-mehmk49a	135	50	surprisingly	surprisingly	RB
cord-308095-mehmk49a	135	51	)	)	-RRB-
cord-308095-mehmk49a	135	52	exceeding	exceed	VBG
cord-308095-mehmk49a	135	53	by	by	IN
cord-308095-mehmk49a	135	54	a	a	DT
cord-308095-mehmk49a	135	55	factor	factor	NN
cord-308095-mehmk49a	135	56	of	of	IN
cord-308095-mehmk49a	135	57	eight	eight	CD
cord-308095-mehmk49a	135	58	the	the	DT
cord-308095-mehmk49a	135	59	gun	gun	NN
cord-308095-mehmk49a	135	60	lobby	lobby	NN
cord-308095-mehmk49a	135	61	's	's	POS
cord-308095-mehmk49a	135	62	political	political	JJ
cord-308095-mehmk49a	135	63	spending	spending	NN
cord-308095-mehmk49a	135	64	(	(	-LRB-
cord-308095-mehmk49a	135	65	CPI	CPI	NNP
cord-308095-mehmk49a	135	66	2016a	2016a	CD
cord-308095-mehmk49a	135	67	(	(	-LRB-
cord-308095-mehmk49a	135	68	CPI	CPI	NNP
cord-308095-mehmk49a	135	69	,	,	,
cord-308095-mehmk49a	135	70	2016b	2016b	NNS
cord-308095-mehmk49a	135	71	.	.	.
cord-308095-mehmk49a	136	1	The	the	DT
cord-308095-mehmk49a	136	2	CPI	CPI	NNP
cord-308095-mehmk49a	136	3	found	find	VBD
cord-308095-mehmk49a	136	4	that	that	IN
cord-308095-mehmk49a	136	5	the	the	DT
cord-308095-mehmk49a	136	6	industry	industry	NN
cord-308095-mehmk49a	136	7	and	and	CC
cord-308095-mehmk49a	136	8	its	-PRON-	PRP$
cord-308095-mehmk49a	136	9	allies	ally	NNS
cord-308095-mehmk49a	136	10	contributed	contribute	VBD
cord-308095-mehmk49a	136	11	to	to	IN
cord-308095-mehmk49a	136	12	roughly	roughly	RB
cord-308095-mehmk49a	136	13	7,100	7,100	CD
cord-308095-mehmk49a	136	14	candidates	candidate	NNS
cord-308095-mehmk49a	136	15	for	for	IN
cord-308095-mehmk49a	136	16	state	state	NN
cord-308095-mehmk49a	136	17	-	-	HYPH
cord-308095-mehmk49a	136	18	level	level	NN
cord-308095-mehmk49a	136	19	offices	office	NNS
cord-308095-mehmk49a	136	20	,	,	,
cord-308095-mehmk49a	136	21	employing	employ	VBG
cord-308095-mehmk49a	136	22	on	on	IN
cord-308095-mehmk49a	136	23	average	average	JJ
cord-308095-mehmk49a	136	24	1,350	1,350	CD
cord-308095-mehmk49a	136	25	lobbyists	lobbyist	NNS
cord-308095-mehmk49a	136	26	a	a	DT
cord-308095-mehmk49a	136	27	year	year	NN
cord-308095-mehmk49a	136	28	,	,	,
cord-308095-mehmk49a	136	29	covering	cover	VBG
cord-308095-mehmk49a	136	30	all	all	DT
cord-308095-mehmk49a	136	31	state	state	NN
cord-308095-mehmk49a	136	32	capitals	capital	NNS
cord-308095-mehmk49a	136	33	.	.	.
cord-308095-mehmk49a	137	1	Another	another	DT
cord-308095-mehmk49a	137	2	study	study	NN
cord-308095-mehmk49a	137	3	examined	examine	VBD
cord-308095-mehmk49a	137	4	campaign	campaign	NN
cord-308095-mehmk49a	137	5	contributions	contribution	NNS
cord-308095-mehmk49a	137	6	to	to	IN
cord-308095-mehmk49a	137	7	members	member	NNS
cord-308095-mehmk49a	137	8	of	of	IN
cord-308095-mehmk49a	137	9	the	the	DT
cord-308095-mehmk49a	137	10	U.S.	U.S.	NNP
cord-308095-mehmk49a	137	11	House	House	NNP
cord-308095-mehmk49a	137	12	and	and	CC
cord-308095-mehmk49a	137	13	Senate	Senate	NNP
cord-308095-mehmk49a	137	14	committees	committee	NNS
cord-308095-mehmk49a	137	15	charged	charge	VBN
cord-308095-mehmk49a	137	16	with	with	IN
cord-308095-mehmk49a	137	17	responsibility	responsibility	NN
cord-308095-mehmk49a	137	18	for	for	IN
cord-308095-mehmk49a	137	19	leading	lead	VBG
cord-308095-mehmk49a	137	20	the	the	DT
cord-308095-mehmk49a	137	21	legislative	legislative	JJ
cord-308095-mehmk49a	137	22	branch	branch	NN
cord-308095-mehmk49a	137	23	's	's	POS
cord-308095-mehmk49a	137	24	response	response	NN
cord-308095-mehmk49a	137	25	to	to	IN
cord-308095-mehmk49a	137	26	the	the	DT
cord-308095-mehmk49a	137	27	opioid	opioid	JJ
cord-308095-mehmk49a	137	28	crisis	crisis	NN
cord-308095-mehmk49a	137	29	.	.	.
cord-308095-mehmk49a	138	1	It	-PRON-	PRP
cord-308095-mehmk49a	138	2	found	find	VBD
cord-308095-mehmk49a	138	3	that	that	IN
cord-308095-mehmk49a	138	4	,	,	,
cord-308095-mehmk49a	138	5	during	during	IN
cord-308095-mehmk49a	138	6	the	the	DT
cord-308095-mehmk49a	138	7	two	two	CD
cord-308095-mehmk49a	138	8	-	-	HYPH
cord-308095-mehmk49a	138	9	year	year	NN
cord-308095-mehmk49a	138	10	election	election	NN
cord-308095-mehmk49a	138	11	cycle	cycle	NN
cord-308095-mehmk49a	138	12	ending	end	VBG
cord-308095-mehmk49a	138	13	in	in	IN
cord-308095-mehmk49a	138	14	November	November	NNP
cord-308095-mehmk49a	138	15	2016	2016	CD
cord-308095-mehmk49a	138	16	,	,	,
cord-308095-mehmk49a	138	17	almost	almost	RB
cord-308095-mehmk49a	138	18	90	90	CD
cord-308095-mehmk49a	138	19	per	per	IN
cord-308095-mehmk49a	138	20	cent	cent	NN
cord-308095-mehmk49a	138	21	of	of	IN
cord-308095-mehmk49a	138	22	the	the	DT
cord-308095-mehmk49a	138	23	members	member	NNS
cord-308095-mehmk49a	138	24	of	of	IN
cord-308095-mehmk49a	138	25	the	the	DT
cord-308095-mehmk49a	138	26	House	House	NNP
cord-308095-mehmk49a	138	27	committee	committee	NN
cord-308095-mehmk49a	138	28	(	(	-LRB-
cord-308095-mehmk49a	138	29	forty	forty	CD
cord-308095-mehmk49a	138	30	-	-	HYPH
cord-308095-mehmk49a	138	31	nine	nine	CD
cord-308095-mehmk49a	138	32	of	of	IN
cord-308095-mehmk49a	138	33	fifty	fifty	CD
cord-308095-mehmk49a	138	34	-	-	HYPH
cord-308095-mehmk49a	138	35	five	five	CD
cord-308095-mehmk49a	138	36	)	)	-RRB-
cord-308095-mehmk49a	138	37	,	,	,
cord-308095-mehmk49a	138	38	and	and	CC
cord-308095-mehmk49a	138	39	close	close	VB
cord-308095-mehmk49a	138	40	to	to	TO
cord-308095-mehmk49a	138	41	two	two	CD
cord-308095-mehmk49a	138	42	-	-	HYPH
cord-308095-mehmk49a	138	43	thirds	third	NNS
cord-308095-mehmk49a	138	44	of	of	IN
cord-308095-mehmk49a	138	45	the	the	DT
cord-308095-mehmk49a	138	46	members	member	NNS
cord-308095-mehmk49a	138	47	of	of	IN
cord-308095-mehmk49a	138	48	the	the	DT
cord-308095-mehmk49a	138	49	Senate	Senate	NNP
cord-308095-mehmk49a	138	50	committee	committee	NN
cord-308095-mehmk49a	138	51	(	(	-LRB-
cord-308095-mehmk49a	138	52	fifteen	fifteen	CD
cord-308095-mehmk49a	138	53	of	of	IN
cord-308095-mehmk49a	138	54	twenty	twenty	CD
cord-308095-mehmk49a	138	55	-	-	HYPH
cord-308095-mehmk49a	138	56	three	three	CD
cord-308095-mehmk49a	138	57	)	)	-RRB-
cord-308095-mehmk49a	138	58	had	have	VBD
cord-308095-mehmk49a	138	59	received	receive	VBN
cord-308095-mehmk49a	138	60	money	money	NN
cord-308095-mehmk49a	138	61	from	from	IN
cord-308095-mehmk49a	138	62	political	political	JJ
cord-308095-mehmk49a	138	63	action	action	NN
cord-308095-mehmk49a	138	64	committees	committee	NNS
cord-308095-mehmk49a	138	65	(	(	-LRB-
cord-308095-mehmk49a	138	66	PACs	PACs	NNPS
cord-308095-mehmk49a	138	67	)	)	-RRB-
cord-308095-mehmk49a	138	68	that	that	WDT
cord-308095-mehmk49a	138	69	were	be	VBD
cord-308095-mehmk49a	138	70	associated	associate	VBN
cord-308095-mehmk49a	138	71	with	with	IN
cord-308095-mehmk49a	138	72	firms	firm	NNS
cord-308095-mehmk49a	138	73	under	under	IN
cord-308095-mehmk49a	138	74	investigation	investigation	NN
cord-308095-mehmk49a	138	75	by	by	IN
cord-308095-mehmk49a	138	76	state	state	NN
cord-308095-mehmk49a	138	77	and	and	CC
cord-308095-mehmk49a	138	78	federal	federal	JJ
cord-308095-mehmk49a	138	79	officials	official	NNS
cord-308095-mehmk49a	138	80	for	for	IN
cord-308095-mehmk49a	138	81	exacerbating	exacerbate	VBG
cord-308095-mehmk49a	138	82	the	the	DT
cord-308095-mehmk49a	138	83	opioid	opioid	JJ
cord-308095-mehmk49a	138	84	crisis	crisis	NN
cord-308095-mehmk49a	138	85	(	(	-LRB-
cord-308095-mehmk49a	138	86	McCoy	McCoy	NNP
cord-308095-mehmk49a	138	87	and	and	CC
cord-308095-mehmk49a	138	88	Kanter	Kanter	NNP
cord-308095-mehmk49a	138	89	2018	2018	CD
cord-308095-mehmk49a	138	90	)	)	-RRB-
cord-308095-mehmk49a	138	91	.	.	.
cord-308095-mehmk49a	139	1	Once	once	RB
cord-308095-mehmk49a	139	2	again	again	RB
cord-308095-mehmk49a	139	3	,	,	,
cord-308095-mehmk49a	139	4	while	while	IN
cord-308095-mehmk49a	139	5	shocking	shocking	JJ
cord-308095-mehmk49a	139	6	,	,	,
cord-308095-mehmk49a	139	7	this	this	DT
cord-308095-mehmk49a	139	8	was	be	VBD
cord-308095-mehmk49a	139	9	reasonably	reasonably	RB
cord-308095-mehmk49a	139	10	predictable	predictable	JJ
cord-308095-mehmk49a	139	11	.	.	.
cord-308095-mehmk49a	140	1	We	-PRON-	PRP
cord-308095-mehmk49a	140	2	should	should	MD
cord-308095-mehmk49a	140	3	anticipate	anticipate	VB
cord-308095-mehmk49a	140	4	that	that	IN
cord-308095-mehmk49a	140	5	opioid	opioid	JJ
cord-308095-mehmk49a	140	6	companies	company	NNS
cord-308095-mehmk49a	140	7	would	would	MD
cord-308095-mehmk49a	140	8	try	try	VB
cord-308095-mehmk49a	140	9	to	to	TO
cord-308095-mehmk49a	140	10	influence	influence	VB
cord-308095-mehmk49a	140	11	legislators	legislator	NNS
cord-308095-mehmk49a	140	12	to	to	IN
cord-308095-mehmk49a	140	13	the	the	DT
cord-308095-mehmk49a	140	14	full	full	JJ
cord-308095-mehmk49a	140	15	extent	extent	NN
cord-308095-mehmk49a	140	16	that	that	IN
cord-308095-mehmk49a	140	17	the	the	DT
cord-308095-mehmk49a	140	18	law	law	NN
cord-308095-mehmk49a	140	19	allows	allow	VBZ
cord-308095-mehmk49a	140	20	in	in	IN
cord-308095-mehmk49a	140	21	their	-PRON-	PRP$
cord-308095-mehmk49a	140	22	efforts	effort	NNS
cord-308095-mehmk49a	140	23	to	to	TO
cord-308095-mehmk49a	140	24	prevent	prevent	VB
cord-308095-mehmk49a	140	25	legislators	legislator	NNS
cord-308095-mehmk49a	140	26	from	from	IN
cord-308095-mehmk49a	140	27	undermining	undermine	VBG
cord-308095-mehmk49a	140	28	their	-PRON-	PRP$
cord-308095-mehmk49a	140	29	commercial	commercial	JJ
cord-308095-mehmk49a	140	30	interests	interest	NNS
cord-308095-mehmk49a	140	31	when	when	WRB
cord-308095-mehmk49a	140	32	responding	respond	VBG
cord-308095-mehmk49a	140	33	to	to	IN
cord-308095-mehmk49a	140	34	the	the	DT
cord-308095-mehmk49a	140	35	opioid	opioid	JJ
cord-308095-mehmk49a	140	36	crisis	crisis	NN
cord-308095-mehmk49a	140	37	.	.	.
cord-308095-mehmk49a	141	1	And	and	CC
cord-308095-mehmk49a	141	2	we	-PRON-	PRP
cord-308095-mehmk49a	141	3	should	should	MD
cord-308095-mehmk49a	141	4	also	also	RB
cord-308095-mehmk49a	141	5	expect	expect	VB
cord-308095-mehmk49a	141	6	that	that	IN
cord-308095-mehmk49a	141	7	these	these	DT
cord-308095-mehmk49a	141	8	companies	company	NNS
cord-308095-mehmk49a	141	9	'	'	POS
cord-308095-mehmk49a	141	10	strategies	strategy	NNS
cord-308095-mehmk49a	141	11	of	of	IN
cord-308095-mehmk49a	141	12	political	political	JJ
cord-308095-mehmk49a	141	13	influence	influence	NN
cord-308095-mehmk49a	141	14	would	would	MD
cord-308095-mehmk49a	141	15	not	not	RB
cord-308095-mehmk49a	141	16	be	be	VB
cord-308095-mehmk49a	141	17	confined	confine	VBN
cord-308095-mehmk49a	141	18	to	to	IN
cord-308095-mehmk49a	141	19	lobbying	lobbying	NN
cord-308095-mehmk49a	141	20	and	and	CC
cord-308095-mehmk49a	141	21	campaign	campaign	NN
cord-308095-mehmk49a	141	22	contributions	contribution	NNS
cord-308095-mehmk49a	141	23	.	.	.
cord-308095-mehmk49a	142	1	Another	another	DT
cord-308095-mehmk49a	142	2	key	key	JJ
cord-308095-mehmk49a	142	3	element	element	NN
cord-308095-mehmk49a	142	4	in	in	IN
cord-308095-mehmk49a	142	5	the	the	DT
cord-308095-mehmk49a	142	6	opioid	opioid	JJ
cord-308095-mehmk49a	142	7	companies	company	NNS
cord-308095-mehmk49a	142	8	'	'	POS
cord-308095-mehmk49a	142	9	strategies	strategy	NNS
cord-308095-mehmk49a	142	10	-	-	,
cord-308095-mehmk49a	142	11	consistent	consistent	JJ
cord-308095-mehmk49a	142	12	with	with	IN
cord-308095-mehmk49a	142	13	corporate	corporate	JJ
cord-308095-mehmk49a	142	14	strategies	strategy	NNS
cord-308095-mehmk49a	142	15	in	in	IN
cord-308095-mehmk49a	142	16	other	other	JJ
cord-308095-mehmk49a	142	17	sectors	sector	NNS
cord-308095-mehmk49a	142	18	such	such	JJ
cord-308095-mehmk49a	142	19	as	as	IN
cord-308095-mehmk49a	142	20	food	food	NN
cord-308095-mehmk49a	142	21	and	and	CC
cord-308095-mehmk49a	142	22	soda	soda	NN
cord-308095-mehmk49a	142	23	-	-	:
cord-308095-mehmk49a	142	24	is	be	VBZ
cord-308095-mehmk49a	142	25	to	to	TO
cord-308095-mehmk49a	142	26	engage	engage	VB
cord-308095-mehmk49a	142	27	in	in	IN
cord-308095-mehmk49a	142	28	partnerships	partnership	NNS
cord-308095-mehmk49a	142	29	with	with	IN
cord-308095-mehmk49a	142	30	government	government	NN
cord-308095-mehmk49a	142	31	agencies	agency	NNS
cord-308095-mehmk49a	142	32	.	.	.
cord-308095-mehmk49a	143	1	These	these	DT
cord-308095-mehmk49a	143	2	are	be	VBP
cord-308095-mehmk49a	143	3	often	often	RB
cord-308095-mehmk49a	143	4	termed	term	VBN
cord-308095-mehmk49a	143	5	"	"	``
cord-308095-mehmk49a	143	6	public	public	JJ
cord-308095-mehmk49a	143	7	-	-	HYPH
cord-308095-mehmk49a	143	8	private	private	JJ
cord-308095-mehmk49a	143	9	partnerships	partnership	NNS
cord-308095-mehmk49a	143	10	"	"	''
cord-308095-mehmk49a	143	11	or	or	CC
cord-308095-mehmk49a	143	12	,	,	,
cord-308095-mehmk49a	143	13	when	when	WRB
cord-308095-mehmk49a	143	14	academic	academic	JJ
cord-308095-mehmk49a	143	15	institutions	institution	NNS
cord-308095-mehmk49a	143	16	and	and	CC
cord-308095-mehmk49a	143	17	public	public	JJ
cord-308095-mehmk49a	143	18	health	health	NN
cord-308095-mehmk49a	143	19	NGOs	NGOs	NNPS
cord-308095-mehmk49a	143	20	participate	participate	VBP
cord-308095-mehmk49a	143	21	too	too	RB
cord-308095-mehmk49a	143	22	,	,	,
cord-308095-mehmk49a	143	23	"	"	''
cord-308095-mehmk49a	143	24	multistakeholder	multistakeholder	NN
cord-308095-mehmk49a	143	25	initiatives	initiative	NNS
cord-308095-mehmk49a	143	26	"	"	''
cord-308095-mehmk49a	143	27	(	(	-LRB-
cord-308095-mehmk49a	143	28	Marks	Marks	NNP
cord-308095-mehmk49a	143	29	2019a	2019a	CD
cord-308095-mehmk49a	143	30	)	)	-RRB-
cord-308095-mehmk49a	143	31	.	.	.
cord-308095-mehmk49a	144	1	Sometimes	sometimes	RB
cord-308095-mehmk49a	144	2	,	,	,
cord-308095-mehmk49a	144	3	it	-PRON-	PRP
cord-308095-mehmk49a	144	4	is	be	VBZ
cord-308095-mehmk49a	144	5	the	the	DT
cord-308095-mehmk49a	144	6	corporate	corporate	JJ
cord-308095-mehmk49a	144	7	actors	actor	NNS
cord-308095-mehmk49a	144	8	that	that	WDT
cord-308095-mehmk49a	144	9	initiate	initiate	VBP
cord-308095-mehmk49a	144	10	these	these	DT
cord-308095-mehmk49a	144	11	relationships	relationship	NNS
cord-308095-mehmk49a	144	12	;	;	:
cord-308095-mehmk49a	144	13	at	at	IN
cord-308095-mehmk49a	144	14	other	other	JJ
cord-308095-mehmk49a	144	15	times	time	NNS
cord-308095-mehmk49a	144	16	,	,	,
cord-308095-mehmk49a	144	17	the	the	DT
cord-308095-mehmk49a	144	18	public	public	JJ
cord-308095-mehmk49a	144	19	bodies	body	NNS
cord-308095-mehmk49a	144	20	do	do	VBP
cord-308095-mehmk49a	144	21	so	so	RB
cord-308095-mehmk49a	144	22	.	.	.
cord-308095-mehmk49a	145	1	In	in	IN
cord-308095-mehmk49a	145	2	2017	2017	CD
cord-308095-mehmk49a	145	3	,	,	,
cord-308095-mehmk49a	145	4	the	the	DT
cord-308095-mehmk49a	145	5	National	National	NNP
cord-308095-mehmk49a	145	6	Institutes	Institutes	NNPS
cord-308095-mehmk49a	145	7	of	of	IN
cord-308095-mehmk49a	145	8	Health	Health	NNP
cord-308095-mehmk49a	145	9	(	(	-LRB-
cord-308095-mehmk49a	145	10	NIH	NIH	NNP
cord-308095-mehmk49a	145	11	)	)	-RRB-
cord-308095-mehmk49a	145	12	launched	launch	VBD
cord-308095-mehmk49a	145	13	a	a	DT
cord-308095-mehmk49a	145	14	"	"	``
cord-308095-mehmk49a	145	15	public	public	JJ
cord-308095-mehmk49a	145	16	-	-	HYPH
cord-308095-mehmk49a	145	17	private	private	JJ
cord-308095-mehmk49a	145	18	initiative	initiative	NN
cord-308095-mehmk49a	145	19	"	"	''
cord-308095-mehmk49a	145	20	to	to	TO
cord-308095-mehmk49a	145	21	address	address	VB
cord-308095-mehmk49a	145	22	the	the	DT
cord-308095-mehmk49a	145	23	opioid	opioid	JJ
cord-308095-mehmk49a	145	24	crisis	crisis	NN
cord-308095-mehmk49a	145	25	.	.	.
cord-308095-mehmk49a	146	1	More	More	JJR
cord-308095-mehmk49a	146	2	than	than	IN
cord-308095-mehmk49a	146	3	one	one	CD
cord-308095-mehmk49a	146	4	-	-	HYPH
cord-308095-mehmk49a	146	5	third	third	NN
cord-308095-mehmk49a	146	6	of	of	IN
cord-308095-mehmk49a	146	7	the	the	DT
cord-308095-mehmk49a	146	8	participants	participant	NNS
cord-308095-mehmk49a	146	9	at	at	IN
cord-308095-mehmk49a	146	10	its	-PRON-	PRP$
cord-308095-mehmk49a	146	11	first	first	JJ
cord-308095-mehmk49a	146	12	two	two	CD
cord-308095-mehmk49a	146	13	meetings	meeting	NNS
cord-308095-mehmk49a	146	14	in	in	IN
cord-308095-mehmk49a	146	15	June	June	NNP
cord-308095-mehmk49a	146	16	2017	2017	CD
cord-308095-mehmk49a	146	17	were	be	VBD
cord-308095-mehmk49a	146	18	executives	executive	NNS
cord-308095-mehmk49a	146	19	of	of	IN
cord-308095-mehmk49a	146	20	drug	drug	NN
cord-308095-mehmk49a	146	21	companies	company	NNS
cord-308095-mehmk49a	146	22	,	,	,
cord-308095-mehmk49a	146	23	device	device	NN
cord-308095-mehmk49a	146	24	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	146	25	,	,	,
cord-308095-mehmk49a	146	26	or	or	CC
cord-308095-mehmk49a	146	27	other	other	JJ
cord-308095-mehmk49a	146	28	industry	industry	NN
cord-308095-mehmk49a	146	29	actors	actor	NNS
cord-308095-mehmk49a	146	30	(	(	-LRB-
cord-308095-mehmk49a	146	31	NIH	NIH	NNP
cord-308095-mehmk49a	146	32	2019	2019	CD
cord-308095-mehmk49a	146	33	)	)	-RRB-
cord-308095-mehmk49a	146	34	.	.	.
cord-308095-mehmk49a	147	1	They	-PRON-	PRP
cord-308095-mehmk49a	147	2	included	include	VBD
cord-308095-mehmk49a	147	3	representatives	representative	NNS
cord-308095-mehmk49a	147	4	of	of	IN
cord-308095-mehmk49a	147	5	Purdue	Purdue	NNP
cord-308095-mehmk49a	147	6	Pharma	Pharma	NNP
cord-308095-mehmk49a	147	7	and	and	CC
cord-308095-mehmk49a	147	8	Johnson	Johnson	NNP
cord-308095-mehmk49a	147	9	&	&	CC
cord-308095-mehmk49a	147	10	Johnson	Johnson	NNP
cord-308095-mehmk49a	147	11	-	-	:
cord-308095-mehmk49a	147	12	which	which	WDT
cord-308095-mehmk49a	147	13	,	,	,
cord-308095-mehmk49a	147	14	along	along	IN
cord-308095-mehmk49a	147	15	with	with	IN
cord-308095-mehmk49a	147	16	its	-PRON-	PRP$
cord-308095-mehmk49a	147	17	subsidiary	subsidiary	NN
cord-308095-mehmk49a	147	18	,	,	,
cord-308095-mehmk49a	147	19	Janssen	Janssen	NNP
cord-308095-mehmk49a	147	20	Pharmaceuticals	Pharmaceuticals	NNP
cord-308095-mehmk49a	147	21	,	,	,
cord-308095-mehmk49a	147	22	was	be	VBD
cord-308095-mehmk49a	147	23	also	also	RB
cord-308095-mehmk49a	147	24	a	a	DT
cord-308095-mehmk49a	147	25	defendant	defendant	NN
cord-308095-mehmk49a	147	26	in	in	IN
cord-308095-mehmk49a	147	27	opioid	opioid	JJ
cord-308095-mehmk49a	147	28	litigation	litigation	NN
cord-308095-mehmk49a	147	29	.	.	.
cord-308095-mehmk49a	148	1	Notably	notably	RB
cord-308095-mehmk49a	148	2	,	,	,
cord-308095-mehmk49a	148	3	when	when	WRB
cord-308095-mehmk49a	148	4	the	the	DT
cord-308095-mehmk49a	148	5	NIH	NIH	NNP
cord-308095-mehmk49a	148	6	launched	launch	VBD
cord-308095-mehmk49a	148	7	the	the	DT
cord-308095-mehmk49a	148	8	partnership	partnership	NN
cord-308095-mehmk49a	148	9	initiative	initiative	NN
cord-308095-mehmk49a	148	10	,	,	,
cord-308095-mehmk49a	148	11	it	-PRON-	PRP
cord-308095-mehmk49a	148	12	made	make	VBD
cord-308095-mehmk49a	148	13	no	no	DT
cord-308095-mehmk49a	148	14	mention	mention	NN
cord-308095-mehmk49a	148	15	of	of	IN
cord-308095-mehmk49a	148	16	the	the	DT
cord-308095-mehmk49a	148	17	role	role	NN
cord-308095-mehmk49a	148	18	that	that	WDT
cord-308095-mehmk49a	148	19	its	-PRON-	PRP$
cord-308095-mehmk49a	148	20	"	"	``
cord-308095-mehmk49a	148	21	private	private	JJ
cord-308095-mehmk49a	148	22	partners	partner	NNS
cord-308095-mehmk49a	148	23	"	"	''
cord-308095-mehmk49a	148	24	played	play	VBN
cord-308095-mehmk49a	148	25	in	in	IN
cord-308095-mehmk49a	148	26	creating	create	VBG
cord-308095-mehmk49a	148	27	or	or	CC
cord-308095-mehmk49a	148	28	exacerbating	exacerbate	VBG
cord-308095-mehmk49a	148	29	the	the	DT
cord-308095-mehmk49a	148	30	opioid	opioid	JJ
cord-308095-mehmk49a	148	31	crisis	crisis	NN
cord-308095-mehmk49a	148	32	in	in	IN
cord-308095-mehmk49a	148	33	the	the	DT
cord-308095-mehmk49a	148	34	"	"	``
cord-308095-mehmk49a	148	35	special	special	JJ
cord-308095-mehmk49a	148	36	report	report	NN
cord-308095-mehmk49a	148	37	"	"	''
cord-308095-mehmk49a	148	38	written	write	VBN
cord-308095-mehmk49a	148	39	by	by	IN
cord-308095-mehmk49a	148	40	the	the	DT
cord-308095-mehmk49a	148	41	directors	director	NNS
cord-308095-mehmk49a	148	42	of	of	IN
cord-308095-mehmk49a	148	43	the	the	DT
cord-308095-mehmk49a	148	44	NIH	NIH	NNP
cord-308095-mehmk49a	148	45	and	and	CC
cord-308095-mehmk49a	148	46	the	the	DT
cord-308095-mehmk49a	148	47	National	National	NNP
cord-308095-mehmk49a	148	48	Institute	Institute	NNP
cord-308095-mehmk49a	148	49	of	of	IN
cord-308095-mehmk49a	148	50	Mental	Mental	NNP
cord-308095-mehmk49a	148	51	Health	Health	NNP
cord-308095-mehmk49a	148	52	(	(	-LRB-
cord-308095-mehmk49a	148	53	NIMH	NIMH	NNP
cord-308095-mehmk49a	148	54	)	)	-RRB-
cord-308095-mehmk49a	148	55	and	and	CC
cord-308095-mehmk49a	148	56	published	publish	VBN
cord-308095-mehmk49a	148	57	in	in	IN
cord-308095-mehmk49a	148	58	the	the	DT
cord-308095-mehmk49a	148	59	New	New	NNP
cord-308095-mehmk49a	148	60	England	England	NNP
cord-308095-mehmk49a	148	61	Journal	Journal	NNP
cord-308095-mehmk49a	148	62	of	of	IN
cord-308095-mehmk49a	148	63	Medicine	Medicine	NNP
cord-308095-mehmk49a	148	64	(	(	-LRB-
cord-308095-mehmk49a	148	65	Volkow	Volkow	NNP
cord-308095-mehmk49a	148	66	and	and	CC
cord-308095-mehmk49a	148	67	Collins	Collins	NNP
cord-308095-mehmk49a	148	68	2017	2017	CD
cord-308095-mehmk49a	148	69	)	)	-RRB-
cord-308095-mehmk49a	148	70	.	.	.
cord-308095-mehmk49a	149	1	On	on	IN
cord-308095-mehmk49a	149	2	its	-PRON-	PRP$
cord-308095-mehmk49a	149	3	website	website	NN
cord-308095-mehmk49a	149	4	,	,	,
cord-308095-mehmk49a	149	5	the	the	DT
cord-308095-mehmk49a	149	6	NIH	NIH	NNP
cord-308095-mehmk49a	149	7	director	director	NN
cord-308095-mehmk49a	149	8	used	use	VBD
cord-308095-mehmk49a	149	9	the	the	DT
cord-308095-mehmk49a	149	10	passive	passive	JJ
cord-308095-mehmk49a	149	11	voice	voice	NN
cord-308095-mehmk49a	149	12	to	to	TO
cord-308095-mehmk49a	149	13	avoid	avoid	VB
cord-308095-mehmk49a	149	14	pointing	point	VBG
cord-308095-mehmk49a	149	15	the	the	DT
cord-308095-mehmk49a	149	16	finger	finger	NN
cord-308095-mehmk49a	149	17	at	at	IN
cord-308095-mehmk49a	149	18	drug	drug	NN
cord-308095-mehmk49a	149	19	companies	company	NNS
cord-308095-mehmk49a	149	20	:	:	:
cord-308095-mehmk49a	149	21	"	"	``
cord-308095-mehmk49a	149	22	The	the	DT
cord-308095-mehmk49a	149	23	belief	belief	NN
cord-308095-mehmk49a	149	24	that	that	IN
cord-308095-mehmk49a	149	25	people	people	NNS
cord-308095-mehmk49a	149	26	with	with	IN
cord-308095-mehmk49a	149	27	pain	pain	NN
cord-308095-mehmk49a	149	28	would	would	MD
cord-308095-mehmk49a	149	29	not	not	RB
cord-308095-mehmk49a	149	30	become	become	VB
cord-308095-mehmk49a	149	31	addicted	addicted	JJ
cord-308095-mehmk49a	149	32	to	to	IN
cord-308095-mehmk49a	149	33	opioids	opioid	NNS
cord-308095-mehmk49a	149	34	was	be	VBD
cord-308095-mehmk49a	149	35	promoted	promote	VBN
cord-308095-mehmk49a	149	36	20	20	CD
cord-308095-mehmk49a	149	37	years	year	NNS
cord-308095-mehmk49a	149	38	ago	ago	RB
cord-308095-mehmk49a	149	39	in	in	IN
cord-308095-mehmk49a	149	40	the	the	DT
cord-308095-mehmk49a	149	41	medical	medical	JJ
cord-308095-mehmk49a	149	42	community	community	NN
cord-308095-mehmk49a	149	43	"	"	''
cord-308095-mehmk49a	149	44	(	(	-LRB-
cord-308095-mehmk49a	149	45	Collins	Collins	NNP
cord-308095-mehmk49a	149	46	2017	2017	CD
cord-308095-mehmk49a	149	47	,	,	,
cord-308095-mehmk49a	149	48	¶2	¶2	NNP
cord-308095-mehmk49a	149	49	)	)	-RRB-
cord-308095-mehmk49a	149	50	.	.	.
cord-308095-mehmk49a	150	1	This	this	DT
cord-308095-mehmk49a	150	2	statement	statement	NN
cord-308095-mehmk49a	150	3	begs	beg	VBZ
cord-308095-mehmk49a	150	4	the	the	DT
cord-308095-mehmk49a	150	5	question	question	NN
cord-308095-mehmk49a	150	6	:	:	:
cord-308095-mehmk49a	150	7	promoted	promote	VBN
cord-308095-mehmk49a	150	8	by	by	IN
cord-308095-mehmk49a	150	9	whom	whom	WP
cord-308095-mehmk49a	150	10	?	?	.
cord-308095-mehmk49a	151	1	It	-PRON-	PRP
cord-308095-mehmk49a	151	2	is	be	VBZ
cord-308095-mehmk49a	151	3	not	not	RB
cord-308095-mehmk49a	151	4	hard	hard	JJ
cord-308095-mehmk49a	151	5	to	to	TO
cord-308095-mehmk49a	151	6	see	see	VB
cord-308095-mehmk49a	151	7	why	why	WRB
cord-308095-mehmk49a	151	8	Collins	Collins	NNP
cord-308095-mehmk49a	151	9	avoided	avoid	VBD
cord-308095-mehmk49a	151	10	that	that	DT
cord-308095-mehmk49a	151	11	question	question	NN
cord-308095-mehmk49a	151	12	.	.	.
cord-308095-mehmk49a	152	1	Self	self	NN
cord-308095-mehmk49a	152	2	-	-	HYPH
cord-308095-mehmk49a	152	3	censorship	censorship	NN
cord-308095-mehmk49a	152	4	is	be	VBZ
cord-308095-mehmk49a	152	5	common	common	JJ
cord-308095-mehmk49a	152	6	among	among	IN
cord-308095-mehmk49a	152	7	the	the	DT
cord-308095-mehmk49a	152	8	recipients	recipient	NNS
cord-308095-mehmk49a	152	9	of	of	IN
cord-308095-mehmk49a	152	10	gifts	gift	NNS
cord-308095-mehmk49a	152	11	and	and	CC
cord-308095-mehmk49a	152	12	among	among	IN
cord-308095-mehmk49a	152	13	public	public	JJ
cord-308095-mehmk49a	152	14	bodies	body	NNS
cord-308095-mehmk49a	152	15	participating	participate	VBG
cord-308095-mehmk49a	152	16	in	in	IN
cord-308095-mehmk49a	152	17	partnerships	partnership	NNS
cord-308095-mehmk49a	152	18	(	(	-LRB-
cord-308095-mehmk49a	152	19	Marks	Marks	NNP
cord-308095-mehmk49a	152	20	2019a	2019a	CD
cord-308095-mehmk49a	152	21	)	)	-RRB-
cord-308095-mehmk49a	152	22	.	.	.
cord-308095-mehmk49a	153	1	The	the	DT
cord-308095-mehmk49a	153	2	NIH	NIH	NNP
cord-308095-mehmk49a	153	3	clearly	clearly	RB
cord-308095-mehmk49a	153	4	did	do	VBD
cord-308095-mehmk49a	153	5	not	not	RB
cord-308095-mehmk49a	153	6	want	want	VB
cord-308095-mehmk49a	153	7	to	to	TO
cord-308095-mehmk49a	153	8	alienate	alienate	VB
cord-308095-mehmk49a	153	9	the	the	DT
cord-308095-mehmk49a	153	10	drug	drug	NN
cord-308095-mehmk49a	153	11	companies	company	NNS
cord-308095-mehmk49a	153	12	with	with	IN
cord-308095-mehmk49a	153	13	which	which	WDT
cord-308095-mehmk49a	153	14	it	-PRON-	PRP
cord-308095-mehmk49a	153	15	wished	wish	VBD
cord-308095-mehmk49a	153	16	to	to	IN
cord-308095-mehmk49a	153	17	partner	partner	NN
cord-308095-mehmk49a	153	18	.	.	.
cord-308095-mehmk49a	154	1	While	while	IN
cord-308095-mehmk49a	154	2	the	the	DT
cord-308095-mehmk49a	154	3	NIH	NIH	NNP
cord-308095-mehmk49a	154	4	considered	consider	VBD
cord-308095-mehmk49a	154	5	Purdue	Purdue	NNP
cord-308095-mehmk49a	154	6	Pharma	Pharma	NNP
cord-308095-mehmk49a	154	7	a	a	DT
cord-308095-mehmk49a	154	8	"	"	``
cord-308095-mehmk49a	154	9	partner	partner	NN
cord-308095-mehmk49a	154	10	,	,	,
cord-308095-mehmk49a	154	11	"	"	''
cord-308095-mehmk49a	154	12	the	the	DT
cord-308095-mehmk49a	154	13	company	company	NN
cord-308095-mehmk49a	154	14	wanted	want	VBD
cord-308095-mehmk49a	154	15	to	to	TO
cord-308095-mehmk49a	154	16	make	make	VB
cord-308095-mehmk49a	154	17	sure	sure	JJ
cord-308095-mehmk49a	154	18	that	that	IN
cord-308095-mehmk49a	154	19	the	the	DT
cord-308095-mehmk49a	154	20	broader	broad	JJR
cord-308095-mehmk49a	154	21	public	public	NN
cord-308095-mehmk49a	154	22	did	do	VBD
cord-308095-mehmk49a	154	23	so	so	RB
cord-308095-mehmk49a	154	24	too	too	RB
cord-308095-mehmk49a	154	25	.	.	.
cord-308095-mehmk49a	155	1	It	-PRON-	PRP
cord-308095-mehmk49a	155	2	ran	run	VBD
cord-308095-mehmk49a	155	3	full	full	JJ
cord-308095-mehmk49a	155	4	-	-	HYPH
cord-308095-mehmk49a	155	5	page	page	NN
cord-308095-mehmk49a	155	6	advertisements	advertisement	NNS
cord-308095-mehmk49a	155	7	in	in	IN
cord-308095-mehmk49a	155	8	the	the	DT
cord-308095-mehmk49a	155	9	New	New	NNP
cord-308095-mehmk49a	155	10	York	York	NNP
cord-308095-mehmk49a	155	11	Times	Times	NNP
cord-308095-mehmk49a	155	12	(	(	-LRB-
cord-308095-mehmk49a	155	13	among	among	IN
cord-308095-mehmk49a	155	14	others	other	NNS
cord-308095-mehmk49a	155	15	)	)	-RRB-
cord-308095-mehmk49a	155	16	that	that	WDT
cord-308095-mehmk49a	155	17	concluded	conclude	VBD
cord-308095-mehmk49a	155	18	with	with	IN
cord-308095-mehmk49a	155	19	these	these	DT
cord-308095-mehmk49a	155	20	words	word	NNS
cord-308095-mehmk49a	155	21	:	:	:
cord-308095-mehmk49a	155	22	"	"	``
cord-308095-mehmk49a	155	23	We	-PRON-	PRP
cord-308095-mehmk49a	155	24	want	want	VBP
cord-308095-mehmk49a	155	25	everyone	everyone	NN
cord-308095-mehmk49a	155	26	engaged	engage	VBN
cord-308095-mehmk49a	155	27	to	to	TO
cord-308095-mehmk49a	155	28	know	know	VB
cord-308095-mehmk49a	155	29	that	that	IN
cord-308095-mehmk49a	155	30	you	-PRON-	PRP
cord-308095-mehmk49a	155	31	have	have	VBP
cord-308095-mehmk49a	155	32	a	a	DT
cord-308095-mehmk49a	155	33	partner	partner	NN
cord-308095-mehmk49a	155	34	in	in	IN
cord-308095-mehmk49a	155	35	Purdue	Purdue	NNP
cord-308095-mehmk49a	155	36	Pharma	Pharma	NNP
cord-308095-mehmk49a	155	37	.	.	.
cord-308095-mehmk49a	156	1	This	this	DT
cord-308095-mehmk49a	156	2	is	be	VBZ
cord-308095-mehmk49a	156	3	our	-PRON-	PRP$
cord-308095-mehmk49a	156	4	fight	fight	NN
cord-308095-mehmk49a	156	5	too	too	RB
cord-308095-mehmk49a	156	6	"	"	''
cord-308095-mehmk49a	156	7	(	(	-LRB-
cord-308095-mehmk49a	156	8	Purdue	Purdue	NNP
cord-308095-mehmk49a	156	9	Pharma	Pharma	NNP
cord-308095-mehmk49a	156	10	2018	2018	CD
cord-308095-mehmk49a	156	11	,	,	,
cord-308095-mehmk49a	156	12	¶5	¶5	NNP
cord-308095-mehmk49a	156	13	)	)	-RRB-
cord-308095-mehmk49a	156	14	.	.	.
cord-308095-mehmk49a	157	1	At	at	IN
cord-308095-mehmk49a	157	2	the	the	DT
cord-308095-mehmk49a	157	3	same	same	JJ
cord-308095-mehmk49a	157	4	time	time	NN
cord-308095-mehmk49a	157	5	,	,	,
cord-308095-mehmk49a	157	6	the	the	DT
cord-308095-mehmk49a	157	7	company	company	NN
cord-308095-mehmk49a	157	8	appears	appear	VBZ
cord-308095-mehmk49a	157	9	to	to	TO
cord-308095-mehmk49a	157	10	have	have	VB
cord-308095-mehmk49a	157	11	been	be	VBN
cord-308095-mehmk49a	157	12	engaged	engage	VBN
cord-308095-mehmk49a	157	13	in	in	IN
cord-308095-mehmk49a	157	14	a	a	DT
cord-308095-mehmk49a	157	15	very	very	RB
cord-308095-mehmk49a	157	16	different	different	JJ
cord-308095-mehmk49a	157	17	kind	kind	NN
cord-308095-mehmk49a	157	18	of	of	IN
cord-308095-mehmk49a	157	19	battle	battle	NN
cord-308095-mehmk49a	157	20	-	-	:
cord-308095-mehmk49a	157	21	an	an	DT
cord-308095-mehmk49a	157	22	internal	internal	JJ
cord-308095-mehmk49a	157	23	debate	debate	NN
cord-308095-mehmk49a	157	24	about	about	IN
cord-308095-mehmk49a	157	25	whether	whether	IN
cord-308095-mehmk49a	157	26	or	or	CC
cord-308095-mehmk49a	157	27	not	not	RB
cord-308095-mehmk49a	157	28	to	to	TO
cord-308095-mehmk49a	157	29	continue	continue	VB
cord-308095-mehmk49a	157	30	disputing	dispute	VBG
cord-308095-mehmk49a	157	31	the	the	DT
cord-308095-mehmk49a	157	32	claim	claim	NN
cord-308095-mehmk49a	157	33	that	that	IN
cord-308095-mehmk49a	157	34	OxyContin	OxyContin	NNP
cord-308095-mehmk49a	157	35	can	can	MD
cord-308095-mehmk49a	157	36	be	be	VB
cord-308095-mehmk49a	157	37	addictive	addictive	JJ
cord-308095-mehmk49a	157	38	even	even	RB
cord-308095-mehmk49a	157	39	when	when	WRB
cord-308095-mehmk49a	157	40	taken	take	VBN
cord-308095-mehmk49a	157	41	as	as	IN
cord-308095-mehmk49a	157	42	directed	direct	VBN
cord-308095-mehmk49a	157	43	.	.	.
cord-308095-mehmk49a	158	1	On	on	IN
cord-308095-mehmk49a	158	2	July	July	NNP
cord-308095-mehmk49a	158	3	19	19	CD
cord-308095-mehmk49a	158	4	,	,	,
cord-308095-mehmk49a	158	5	2018	2018	CD
cord-308095-mehmk49a	158	6	,	,	,
cord-308095-mehmk49a	158	7	Purdue	Purdue	NNP
cord-308095-mehmk49a	158	8	ran	run	VBD
cord-308095-mehmk49a	158	9	another	another	DT
cord-308095-mehmk49a	158	10	full	full	JJ
cord-308095-mehmk49a	158	11	-	-	HYPH
cord-308095-mehmk49a	158	12	page	page	NN
cord-308095-mehmk49a	158	13	"	"	''
cord-308095-mehmk49a	158	14	advocacy	advocacy	NN
cord-308095-mehmk49a	158	15	ad	ad	NN
cord-308095-mehmk49a	158	16	"	"	''
cord-308095-mehmk49a	158	17	in	in	IN
cord-308095-mehmk49a	158	18	the	the	DT
cord-308095-mehmk49a	158	19	Washington	Washington	NNP
cord-308095-mehmk49a	158	20	Post	Post	NNP
cord-308095-mehmk49a	158	21	stating	state	VBG
cord-308095-mehmk49a	158	22	that	that	IN
cord-308095-mehmk49a	158	23	the	the	DT
cord-308095-mehmk49a	158	24	company	company	NN
cord-308095-mehmk49a	158	25	was	be	VBD
cord-308095-mehmk49a	158	26	"	"	``
cord-308095-mehmk49a	158	27	acutely	acutely	RB
cord-308095-mehmk49a	158	28	aware	aware	JJ
cord-308095-mehmk49a	158	29	of	of	IN
cord-308095-mehmk49a	158	30	the	the	DT
cord-308095-mehmk49a	158	31	public	public	JJ
cord-308095-mehmk49a	158	32	health	health	NN
cord-308095-mehmk49a	158	33	risks	risk	VBZ
cord-308095-mehmk49a	158	34	opioid	opioid	JJ
cord-308095-mehmk49a	158	35	analgesics	analgesic	NNS
cord-308095-mehmk49a	158	36	can	can	MD
cord-308095-mehmk49a	158	37	create	create	VB
cord-308095-mehmk49a	158	38	,	,	,
cord-308095-mehmk49a	158	39	even	even	RB
cord-308095-mehmk49a	158	40	when	when	WRB
cord-308095-mehmk49a	158	41	taken	take	VBN
cord-308095-mehmk49a	158	42	as	as	IN
cord-308095-mehmk49a	158	43	prescribed	prescribe	VBN
cord-308095-mehmk49a	158	44	"	"	''
cord-308095-mehmk49a	158	45	(	(	-LRB-
cord-308095-mehmk49a	158	46	Schulte	Schulte	NNP
cord-308095-mehmk49a	158	47	2018	2018	CD
cord-308095-mehmk49a	158	48	,	,	,
cord-308095-mehmk49a	158	49	¶2	¶2	NNP
cord-308095-mehmk49a	158	50	,	,	,
cord-308095-mehmk49a	158	51	emphasis	emphasis	NN
cord-308095-mehmk49a	158	52	added	add	VBD
cord-308095-mehmk49a	158	53	)	)	-RRB-
cord-308095-mehmk49a	158	54	.	.	.
cord-308095-mehmk49a	159	1	But	but	CC
cord-308095-mehmk49a	159	2	less	less	JJR
cord-308095-mehmk49a	159	3	than	than	IN
cord-308095-mehmk49a	159	4	a	a	DT
cord-308095-mehmk49a	159	5	week	week	NN
cord-308095-mehmk49a	159	6	later	later	RB
cord-308095-mehmk49a	159	7	,	,	,
cord-308095-mehmk49a	159	8	when	when	WRB
cord-308095-mehmk49a	159	9	the	the	DT
cord-308095-mehmk49a	159	10	company	company	NN
cord-308095-mehmk49a	159	11	reran	rerun	VBD
cord-308095-mehmk49a	159	12	the	the	DT
cord-308095-mehmk49a	159	13	advertisement	advertisement	NN
cord-308095-mehmk49a	159	14	,	,	,
cord-308095-mehmk49a	159	15	it	-PRON-	PRP
cord-308095-mehmk49a	159	16	deleted	delete	VBD
cord-308095-mehmk49a	159	17	the	the	DT
cord-308095-mehmk49a	159	18	words	word	NNS
cord-308095-mehmk49a	159	19	"	"	``
cord-308095-mehmk49a	159	20	even	even	RB
cord-308095-mehmk49a	159	21	when	when	WRB
cord-308095-mehmk49a	159	22	taken	take	VBN
cord-308095-mehmk49a	159	23	as	as	IN
cord-308095-mehmk49a	159	24	prescribed	prescribe	VBN
cord-308095-mehmk49a	159	25	.	.	.
cord-308095-mehmk49a	159	26	"	"	''
cord-308095-mehmk49a	160	1	In	in	IN
cord-308095-mehmk49a	160	2	addition	addition	NN
cord-308095-mehmk49a	160	3	,	,	,
cord-308095-mehmk49a	160	4	while	while	IN
cord-308095-mehmk49a	160	5	the	the	DT
cord-308095-mehmk49a	160	6	company	company	NN
cord-308095-mehmk49a	160	7	was	be	VBD
cord-308095-mehmk49a	160	8	being	be	VBG
cord-308095-mehmk49a	160	9	described	describe	VBN
cord-308095-mehmk49a	160	10	by	by	IN
cord-308095-mehmk49a	160	11	the	the	DT
cord-308095-mehmk49a	160	12	NIH	NIH	NNP
cord-308095-mehmk49a	160	13	as	as	IN
cord-308095-mehmk49a	160	14	a	a	DT
cord-308095-mehmk49a	160	15	"	"	``
cord-308095-mehmk49a	160	16	partner"-and	partner"-and	NN
cord-308095-mehmk49a	160	17	while	while	IN
cord-308095-mehmk49a	160	18	it	-PRON-	PRP
cord-308095-mehmk49a	160	19	was	be	VBD
cord-308095-mehmk49a	160	20	positioning	position	VBG
cord-308095-mehmk49a	160	21	itself	-PRON-	PRP
cord-308095-mehmk49a	160	22	as	as	IN
cord-308095-mehmk49a	160	23	a	a	DT
cord-308095-mehmk49a	160	24	partner	partner	NN
cord-308095-mehmk49a	160	25	-	-	:
cord-308095-mehmk49a	160	26	Purdue	Purdue	NNP
cord-308095-mehmk49a	160	27	Pharma	Pharma	NNP
cord-308095-mehmk49a	160	28	was	be	VBD
cord-308095-mehmk49a	160	29	also	also	RB
cord-308095-mehmk49a	160	30	working	work	VBG
cord-308095-mehmk49a	160	31	on	on	IN
cord-308095-mehmk49a	160	32	plans	plan	NNS
cord-308095-mehmk49a	160	33	to	to	TO
cord-308095-mehmk49a	160	34	expand	expand	VB
cord-308095-mehmk49a	160	35	the	the	DT
cord-308095-mehmk49a	160	36	opioid	opioid	JJ
cord-308095-mehmk49a	160	37	market	market	NN
cord-308095-mehmk49a	160	38	,	,	,
cord-308095-mehmk49a	160	39	including	include	VBG
cord-308095-mehmk49a	160	40	the	the	DT
cord-308095-mehmk49a	160	41	market	market	NN
cord-308095-mehmk49a	160	42	for	for	IN
cord-308095-mehmk49a	160	43	therapies	therapy	NNS
cord-308095-mehmk49a	160	44	to	to	TO
cord-308095-mehmk49a	160	45	treat	treat	VB
cord-308095-mehmk49a	160	46	opioid	opioid	JJ
cord-308095-mehmk49a	160	47	addiction	addiction	NN
cord-308095-mehmk49a	160	48	resulting	result	VBG
cord-308095-mehmk49a	160	49	from	from	IN
cord-308095-mehmk49a	160	50	the	the	DT
cord-308095-mehmk49a	160	51	company	company	NN
cord-308095-mehmk49a	160	52	's	's	POS
cord-308095-mehmk49a	160	53	own	own	JJ
cord-308095-mehmk49a	160	54	aggressive	aggressive	JJ
cord-308095-mehmk49a	160	55	opioid	opioid	JJ
cord-308095-mehmk49a	160	56	marketing	marketing	NN
cord-308095-mehmk49a	160	57	strategies	strategy	NNS
cord-308095-mehmk49a	160	58	(	(	-LRB-
cord-308095-mehmk49a	160	59	A.G.	A.G.	NNP
cord-308095-mehmk49a	160	60	Mass.	Massachusetts	NNP
cord-308095-mehmk49a	160	61	2019	2019	CD
cord-308095-mehmk49a	160	62	)	)	-RRB-
cord-308095-mehmk49a	160	63	.	.	.
cord-308095-mehmk49a	161	1	To	to	TO
cord-308095-mehmk49a	161	2	be	be	VB
cord-308095-mehmk49a	161	3	clear	clear	JJ
cord-308095-mehmk49a	161	4	,	,	,
cord-308095-mehmk49a	161	5	the	the	DT
cord-308095-mehmk49a	161	6	efforts	effort	NNS
cord-308095-mehmk49a	161	7	of	of	IN
cord-308095-mehmk49a	161	8	the	the	DT
cord-308095-mehmk49a	161	9	opioid	opioid	JJ
cord-308095-mehmk49a	161	10	industry	industry	NN
cord-308095-mehmk49a	161	11	to	to	TO
cord-308095-mehmk49a	161	12	influence	influence	VB
cord-308095-mehmk49a	161	13	policymakers	policymaker	NNS
cord-308095-mehmk49a	161	14	and	and	CC
cord-308095-mehmk49a	161	15	prescribers	prescriber	NNS
cord-308095-mehmk49a	161	16	were	be	VBD
cord-308095-mehmk49a	161	17	not	not	RB
cord-308095-mehmk49a	161	18	limited	limit	VBN
cord-308095-mehmk49a	161	19	to	to	IN
cord-308095-mehmk49a	161	20	the	the	DT
cord-308095-mehmk49a	161	21	United	United	NNP
cord-308095-mehmk49a	161	22	States	States	NNP
cord-308095-mehmk49a	161	23	.	.	.
cord-308095-mehmk49a	162	1	Investigative	investigative	JJ
cord-308095-mehmk49a	162	2	journalists	journalist	NNS
cord-308095-mehmk49a	162	3	have	have	VBP
cord-308095-mehmk49a	162	4	uncovered	uncover	VBN
cord-308095-mehmk49a	162	5	similar	similar	JJ
cord-308095-mehmk49a	162	6	efforts	effort	NNS
cord-308095-mehmk49a	162	7	to	to	TO
cord-308095-mehmk49a	162	8	exploit	exploit	VB
cord-308095-mehmk49a	162	9	international	international	JJ
cord-308095-mehmk49a	162	10	markets	market	NNS
cord-308095-mehmk49a	162	11	(	(	-LRB-
cord-308095-mehmk49a	162	12	Ryan	Ryan	NNP
cord-308095-mehmk49a	162	13	,	,	,
cord-308095-mehmk49a	162	14	Girion	Girion	NNP
cord-308095-mehmk49a	162	15	,	,	,
cord-308095-mehmk49a	162	16	and	and	CC
cord-308095-mehmk49a	162	17	Glover	Glover	NNP
cord-308095-mehmk49a	162	18	2016	2016	CD
cord-308095-mehmk49a	162	19	;	;	:
cord-308095-mehmk49a	162	20	Kinetz	Kinetz	NNP
cord-308095-mehmk49a	162	21	2019	2019	CD
cord-308095-mehmk49a	162	22	)	)	-RRB-
cord-308095-mehmk49a	162	23	.	.	.
cord-308095-mehmk49a	163	1	And	and	CC
cord-308095-mehmk49a	163	2	these	these	DT
cord-308095-mehmk49a	163	3	efforts	effort	NNS
cord-308095-mehmk49a	163	4	appear	appear	VBP
cord-308095-mehmk49a	163	5	to	to	TO
cord-308095-mehmk49a	163	6	have	have	VB
cord-308095-mehmk49a	163	7	increased	increase	VBN
cord-308095-mehmk49a	163	8	as	as	IN
cord-308095-mehmk49a	163	9	opioid	opioid	JJ
cord-308095-mehmk49a	163	10	prescribing	prescribing	NN
cord-308095-mehmk49a	163	11	came	come	VBD
cord-308095-mehmk49a	163	12	under	under	IN
cord-308095-mehmk49a	163	13	increasing	increase	VBG
cord-308095-mehmk49a	163	14	scrutiny	scrutiny	NN
cord-308095-mehmk49a	163	15	in	in	IN
cord-308095-mehmk49a	163	16	the	the	DT
cord-308095-mehmk49a	163	17	United	United	NNP
cord-308095-mehmk49a	163	18	States	States	NNP
cord-308095-mehmk49a	163	19	.	.	.
cord-308095-mehmk49a	164	1	Global	global	JJ
cord-308095-mehmk49a	164	2	promotion	promotion	NN
cord-308095-mehmk49a	164	3	has	have	VBZ
cord-308095-mehmk49a	164	4	been	be	VBN
cord-308095-mehmk49a	164	5	spearheaded	spearhead	VBN
cord-308095-mehmk49a	164	6	by	by	IN
cord-308095-mehmk49a	164	7	Mundipharma	Mundipharma	NNP
cord-308095-mehmk49a	164	8	,	,	,
cord-308095-mehmk49a	164	9	a	a	DT
cord-308095-mehmk49a	164	10	consortium	consortium	NN
cord-308095-mehmk49a	164	11	of	of	IN
cord-308095-mehmk49a	164	12	companies	company	NNS
cord-308095-mehmk49a	164	13	with	with	IN
cord-308095-mehmk49a	164	14	offices	office	NNS
cord-308095-mehmk49a	164	15	in	in	IN
cord-308095-mehmk49a	164	16	more	more	JJR
cord-308095-mehmk49a	164	17	than	than	IN
cord-308095-mehmk49a	164	18	120	120	CD
cord-308095-mehmk49a	164	19	countries	country	NNS
cord-308095-mehmk49a	164	20	.	.	.
cord-308095-mehmk49a	165	1	A	a	DT
cord-308095-mehmk49a	165	2	recent	recent	JJ
cord-308095-mehmk49a	165	3	congressional	congressional	JJ
cord-308095-mehmk49a	165	4	report	report	NN
cord-308095-mehmk49a	165	5	produced	produce	VBN
cord-308095-mehmk49a	165	6	by	by	IN
cord-308095-mehmk49a	165	7	the	the	DT
cord-308095-mehmk49a	165	8	offices	office	NNS
cord-308095-mehmk49a	165	9	of	of	IN
cord-308095-mehmk49a	165	10	two	two	CD
cord-308095-mehmk49a	165	11	U.S.	U.S.	NNP
cord-308095-mehmk49a	165	12	representatives	representative	NNS
cord-308095-mehmk49a	165	13	outlined	outline	VBD
cord-308095-mehmk49a	165	14	the	the	DT
cord-308095-mehmk49a	165	15	ways	way	NNS
cord-308095-mehmk49a	165	16	in	in	IN
cord-308095-mehmk49a	165	17	which	which	WDT
cord-308095-mehmk49a	165	18	this	this	DT
cord-308095-mehmk49a	165	19	consortium	consortium	NN
cord-308095-mehmk49a	165	20	appears	appear	VBZ
cord-308095-mehmk49a	165	21	to	to	TO
cord-308095-mehmk49a	165	22	have	have	VB
cord-308095-mehmk49a	165	23	successfully	successfully	RB
cord-308095-mehmk49a	165	24	influenced	influence	VBN
cord-308095-mehmk49a	165	25	at	at	IN
cord-308095-mehmk49a	165	26	least	least	JJS
cord-308095-mehmk49a	165	27	two	two	CD
cord-308095-mehmk49a	165	28	WHO	who	WP
cord-308095-mehmk49a	165	29	policy	policy	NN
cord-308095-mehmk49a	165	30	documents	document	NNS
cord-308095-mehmk49a	165	31	related	relate	VBN
cord-308095-mehmk49a	165	32	to	to	IN
cord-308095-mehmk49a	165	33	opioid	opioid	JJ
cord-308095-mehmk49a	165	34	prescribing	prescribing	NN
cord-308095-mehmk49a	165	35	-	-	:
cord-308095-mehmk49a	165	36	including	include	VBG
cord-308095-mehmk49a	165	37	2012	2012	CD
cord-308095-mehmk49a	165	38	guidelines	guideline	NNS
cord-308095-mehmk49a	165	39	that	that	WDT
cord-308095-mehmk49a	165	40	address	address	VBP
cord-308095-mehmk49a	165	41	pain	pain	NN
cord-308095-mehmk49a	165	42	management	management	NN
cord-308095-mehmk49a	165	43	in	in	IN
cord-308095-mehmk49a	165	44	children	child	NNS
cord-308095-mehmk49a	165	45	(	(	-LRB-
cord-308095-mehmk49a	165	46	Clark	Clark	NNP
cord-308095-mehmk49a	165	47	and	and	CC
cord-308095-mehmk49a	165	48	Rogers	Rogers	NNP
cord-308095-mehmk49a	165	49	2019	2019	CD
cord-308095-mehmk49a	165	50	;	;	:
cord-308095-mehmk49a	165	51	WHO	who	WP
cord-308095-mehmk49a	165	52	2011	2011	CD
cord-308095-mehmk49a	165	53	WHO	WHO	NNP
cord-308095-mehmk49a	165	54	,	,	,
cord-308095-mehmk49a	165	55	2012	2012	CD
cord-308095-mehmk49a	165	56	.	.	.
cord-308095-mehmk49a	166	1	In	in	IN
cord-308095-mehmk49a	166	2	several	several	JJ
cord-308095-mehmk49a	166	3	ways	way	NNS
cord-308095-mehmk49a	166	4	,	,	,
cord-308095-mehmk49a	166	5	these	these	DT
cord-308095-mehmk49a	166	6	guidelines	guideline	NNS
cord-308095-mehmk49a	166	7	(	(	-LRB-
cord-308095-mehmk49a	166	8	which	which	WDT
cord-308095-mehmk49a	166	9	were	be	VBD
cord-308095-mehmk49a	166	10	discontinued	discontinue	VBN
cord-308095-mehmk49a	166	11	by	by	IN
cord-308095-mehmk49a	166	12	the	the	DT
cord-308095-mehmk49a	166	13	WHO	WHO	NNP
cord-308095-mehmk49a	166	14	in	in	IN
cord-308095-mehmk49a	166	15	2019	2019	CD
cord-308095-mehmk49a	166	16	in	in	IN
cord-308095-mehmk49a	166	17	the	the	DT
cord-308095-mehmk49a	166	18	wake	wake	NN
cord-308095-mehmk49a	166	19	of	of	IN
cord-308095-mehmk49a	166	20	the	the	DT
cord-308095-mehmk49a	166	21	congressional	congressional	JJ
cord-308095-mehmk49a	166	22	report	report	NN
cord-308095-mehmk49a	166	23	)	)	-RRB-
cord-308095-mehmk49a	166	24	were	be	VBD
cord-308095-mehmk49a	166	25	remarkably	remarkably	RB
cord-308095-mehmk49a	166	26	consistent	consistent	JJ
cord-308095-mehmk49a	166	27	with	with	IN
cord-308095-mehmk49a	166	28	Purdue	Purdue	NNP
cord-308095-mehmk49a	166	29	's	's	POS
cord-308095-mehmk49a	166	30	marketing	marketing	NN
cord-308095-mehmk49a	166	31	strategies	strategy	NNS
cord-308095-mehmk49a	166	32	.	.	.
cord-308095-mehmk49a	167	1	For	for	IN
cord-308095-mehmk49a	167	2	example	example	NN
cord-308095-mehmk49a	167	3	,	,	,
cord-308095-mehmk49a	167	4	they	-PRON-	PRP
cord-308095-mehmk49a	167	5	embraced	embrace	VBD
cord-308095-mehmk49a	167	6	Purdue	Purdue	NNP
cord-308095-mehmk49a	167	7	's	's	POS
cord-308095-mehmk49a	167	8	characterization	characterization	NN
cord-308095-mehmk49a	167	9	of	of	IN
cord-308095-mehmk49a	167	10	doctors	doctor	NNS
cord-308095-mehmk49a	167	11	'	'	POS
cord-308095-mehmk49a	167	12	concerns	concern	NNS
cord-308095-mehmk49a	167	13	about	about	IN
cord-308095-mehmk49a	167	14	prescribing	prescribe	VBG
cord-308095-mehmk49a	167	15	opioids	opioid	NNS
cord-308095-mehmk49a	167	16	as	as	IN
cord-308095-mehmk49a	167	17	"	"	``
cord-308095-mehmk49a	167	18	opiophobia	opiophobia	NNP
cord-308095-mehmk49a	167	19	.	.	.
cord-308095-mehmk49a	168	1	"	"	''
cord-308095-mehmk49a	169	1	The	the	DT
cord-308095-mehmk49a	169	2	guidelines	guideline	NNS
cord-308095-mehmk49a	169	3	also	also	RB
cord-308095-mehmk49a	169	4	stated	state	VBD
cord-308095-mehmk49a	169	5	that	that	IN
cord-308095-mehmk49a	169	6	there	there	EX
cord-308095-mehmk49a	169	7	is	be	VBZ
cord-308095-mehmk49a	169	8	no	no	DT
cord-308095-mehmk49a	169	9	maximum	maximum	JJ
cord-308095-mehmk49a	169	10	dose	dose	NN
cord-308095-mehmk49a	169	11	for	for	IN
cord-308095-mehmk49a	169	12	opioidseven	opioidseven	NNP
cord-308095-mehmk49a	169	13	in	in	IN
cord-308095-mehmk49a	169	14	the	the	DT
cord-308095-mehmk49a	169	15	case	case	NN
cord-308095-mehmk49a	169	16	of	of	IN
cord-308095-mehmk49a	169	17	children	child	NNS
cord-308095-mehmk49a	169	18	.	.	.
cord-308095-mehmk49a	170	1	(	(	-LRB-
cord-308095-mehmk49a	170	2	Purdue	Purdue	NNP
cord-308095-mehmk49a	170	3	Pharma	Pharma	NNP
cord-308095-mehmk49a	170	4	and	and	CC
cord-308095-mehmk49a	170	5	other	other	JJ
cord-308095-mehmk49a	170	6	opioid	opioid	JJ
cord-308095-mehmk49a	170	7	companies	company	NNS
cord-308095-mehmk49a	170	8	pushed	push	VBD
cord-308095-mehmk49a	170	9	broadly	broadly	RB
cord-308095-mehmk49a	170	10	for	for	IN
cord-308095-mehmk49a	170	11	higher	high	JJR
cord-308095-mehmk49a	170	12	doses	dose	NNS
cord-308095-mehmk49a	170	13	,	,	,
cord-308095-mehmk49a	170	14	as	as	IN
cord-308095-mehmk49a	170	15	they	-PRON-	PRP
cord-308095-mehmk49a	170	16	are	be	VBP
cord-308095-mehmk49a	170	17	significantly	significantly	RB
cord-308095-mehmk49a	170	18	more	more	RBR
cord-308095-mehmk49a	170	19	lucrative	lucrative	JJ
cord-308095-mehmk49a	170	20	than	than	IN
cord-308095-mehmk49a	170	21	lower	low	JJR
cord-308095-mehmk49a	170	22	doses	dose	NNS
cord-308095-mehmk49a	170	23	.	.	.
cord-308095-mehmk49a	170	24	)	)	-RRB-
cord-308095-mehmk49a	171	1	The	the	DT
cord-308095-mehmk49a	171	2	congressional	congressional	JJ
cord-308095-mehmk49a	171	3	report	report	NN
cord-308095-mehmk49a	171	4	also	also	RB
cord-308095-mehmk49a	171	5	highlighted	highlight	VBD
cord-308095-mehmk49a	171	6	the	the	DT
cord-308095-mehmk49a	171	7	role	role	NN
cord-308095-mehmk49a	171	8	of	of	IN
cord-308095-mehmk49a	171	9	patient	patient	JJ
cord-308095-mehmk49a	171	10	advocacy	advocacy	NN
cord-308095-mehmk49a	171	11	organizations	organization	NNS
cord-308095-mehmk49a	171	12	,	,	,
cord-308095-mehmk49a	171	13	professional	professional	JJ
cord-308095-mehmk49a	171	14	associations	association	NNS
cord-308095-mehmk49a	171	15	,	,	,
cord-308095-mehmk49a	171	16	and	and	CC
cord-308095-mehmk49a	171	17	industry	industry	NN
cord-308095-mehmk49a	171	18	-	-	HYPH
cord-308095-mehmk49a	171	19	favourable	favourable	JJ
cord-308095-mehmk49a	171	20	articles	article	NNS
cord-308095-mehmk49a	171	21	published	publish	VBN
cord-308095-mehmk49a	171	22	in	in	IN
cord-308095-mehmk49a	171	23	their	-PRON-	PRP$
cord-308095-mehmk49a	171	24	journals	journal	NNS
cord-308095-mehmk49a	171	25	as	as	IN
cord-308095-mehmk49a	171	26	avenues	avenue	NNS
cord-308095-mehmk49a	171	27	for	for	IN
cord-308095-mehmk49a	171	28	indirect	indirect	JJ
cord-308095-mehmk49a	171	29	influence	influence	NN
cord-308095-mehmk49a	171	30	on	on	IN
cord-308095-mehmk49a	171	31	the	the	DT
cord-308095-mehmk49a	171	32	WHO	WHO	NNP
cord-308095-mehmk49a	171	33	(	(	-LRB-
cord-308095-mehmk49a	171	34	Clark	Clark	NNP
cord-308095-mehmk49a	171	35	and	and	CC
cord-308095-mehmk49a	171	36	Rogers	Rogers	NNP
cord-308095-mehmk49a	171	37	2019	2019	CD
cord-308095-mehmk49a	171	38	)	)	-RRB-
cord-308095-mehmk49a	171	39	.	.	.
cord-308095-mehmk49a	172	1	Although	although	IN
cord-308095-mehmk49a	172	2	Purdue	Purdue	NNP
cord-308095-mehmk49a	172	3	Pharma	Pharma	NNP
cord-308095-mehmk49a	172	4	has	have	VBZ
cord-308095-mehmk49a	172	5	received	receive	VBN
cord-308095-mehmk49a	172	6	considerable	considerable	JJ
cord-308095-mehmk49a	172	7	media	medium	NNS
cord-308095-mehmk49a	172	8	attention	attention	NN
cord-308095-mehmk49a	172	9	in	in	IN
cord-308095-mehmk49a	172	10	recent	recent	JJ
cord-308095-mehmk49a	172	11	months	month	NNS
cord-308095-mehmk49a	172	12	for	for	IN
cord-308095-mehmk49a	172	13	the	the	DT
cord-308095-mehmk49a	172	14	aggressive	aggressive	JJ
cord-308095-mehmk49a	172	15	marketing	marketing	NN
cord-308095-mehmk49a	172	16	of	of	IN
cord-308095-mehmk49a	172	17	opioids	opioid	NNS
cord-308095-mehmk49a	172	18	,	,	,
cord-308095-mehmk49a	172	19	it	-PRON-	PRP
cord-308095-mehmk49a	172	20	is	be	VBZ
cord-308095-mehmk49a	172	21	important	important	JJ
cord-308095-mehmk49a	172	22	to	to	TO
cord-308095-mehmk49a	172	23	keep	keep	VB
cord-308095-mehmk49a	172	24	in	in	IN
cord-308095-mehmk49a	172	25	mind	mind	NN
cord-308095-mehmk49a	172	26	that	that	IN
cord-308095-mehmk49a	172	27	several	several	JJ
cord-308095-mehmk49a	172	28	companies	company	NNS
cord-308095-mehmk49a	172	29	are	be	VBP
cord-308095-mehmk49a	172	30	alleged	allege	VBN
cord-308095-mehmk49a	172	31	to	to	TO
cord-308095-mehmk49a	172	32	have	have	VB
cord-308095-mehmk49a	172	33	engaged	engage	VBN
cord-308095-mehmk49a	172	34	in	in	IN
cord-308095-mehmk49a	172	35	such	such	JJ
cord-308095-mehmk49a	172	36	practices	practice	NNS
cord-308095-mehmk49a	172	37	.	.	.
cord-308095-mehmk49a	173	1	The	the	DT
cord-308095-mehmk49a	173	2	picture	picture	NN
cord-308095-mehmk49a	173	3	that	that	WDT
cord-308095-mehmk49a	173	4	emerges	emerge	VBZ
cord-308095-mehmk49a	173	5	is	be	VBZ
cord-308095-mehmk49a	173	6	one	one	CD
cord-308095-mehmk49a	173	7	of	of	IN
cord-308095-mehmk49a	173	8	multiple	multiple	JJ
cord-308095-mehmk49a	173	9	corporations	corporation	NNS
cord-308095-mehmk49a	173	10	making	make	VBG
cord-308095-mehmk49a	173	11	gifts	gift	NNS
cord-308095-mehmk49a	173	12	to	to	IN
cord-308095-mehmk49a	173	13	and	and	CC
cord-308095-mehmk49a	173	14	partnering	partner	VBG
cord-308095-mehmk49a	173	15	with	with	IN
cord-308095-mehmk49a	173	16	a	a	DT
cord-308095-mehmk49a	173	17	variety	variety	NN
cord-308095-mehmk49a	173	18	of	of	IN
cord-308095-mehmk49a	173	19	public	public	JJ
cord-308095-mehmk49a	173	20	health	health	NN
cord-308095-mehmk49a	173	21	agencies	agency	NNS
cord-308095-mehmk49a	173	22	,	,	,
cord-308095-mehmk49a	173	23	academic	academic	JJ
cord-308095-mehmk49a	173	24	institutions	institution	NNS
cord-308095-mehmk49a	173	25	,	,	,
cord-308095-mehmk49a	173	26	and	and	CC
cord-308095-mehmk49a	173	27	health	health	NN
cord-308095-mehmk49a	173	28	-	-	HYPH
cord-308095-mehmk49a	173	29	related	relate	VBN
cord-308095-mehmk49a	173	30	NGOs	NGOs	NNPS
cord-308095-mehmk49a	173	31	.	.	.
cord-308095-mehmk49a	174	1	These	these	DT
cord-308095-mehmk49a	174	2	gifts	gift	NNS
cord-308095-mehmk49a	174	3	and	and	CC
cord-308095-mehmk49a	174	4	relationships	relationship	NNS
cord-308095-mehmk49a	174	5	were	be	VBD
cord-308095-mehmk49a	174	6	part	part	NN
cord-308095-mehmk49a	174	7	of	of	IN
cord-308095-mehmk49a	174	8	larger	large	JJR
cord-308095-mehmk49a	174	9	strategies	strategy	NNS
cord-308095-mehmk49a	174	10	that	that	WDT
cord-308095-mehmk49a	174	11	were	be	VBD
cord-308095-mehmk49a	174	12	intended	intend	VBN
cord-308095-mehmk49a	174	13	to	to	TO
cord-308095-mehmk49a	174	14	have	have	VB
cord-308095-mehmk49a	174	15	,	,	,
cord-308095-mehmk49a	174	16	and	and	CC
cord-308095-mehmk49a	174	17	did	do	VBD
cord-308095-mehmk49a	174	18	have	have	VB
cord-308095-mehmk49a	174	19	,	,	,
cord-308095-mehmk49a	174	20	a	a	DT
cord-308095-mehmk49a	174	21	number	number	NN
cord-308095-mehmk49a	174	22	of	of	IN
cord-308095-mehmk49a	174	23	interrelated	interrelated	JJ
cord-308095-mehmk49a	174	24	effects	effect	NNS
cord-308095-mehmk49a	174	25	-	-	,
cord-308095-mehmk49a	174	26	all	all	DT
cord-308095-mehmk49a	174	27	of	of	IN
cord-308095-mehmk49a	174	28	which	which	WDT
cord-308095-mehmk49a	174	29	served	serve	VBD
cord-308095-mehmk49a	174	30	to	to	TO
cord-308095-mehmk49a	174	31	increase	increase	VB
cord-308095-mehmk49a	174	32	the	the	DT
cord-308095-mehmk49a	174	33	revenues	revenue	NNS
cord-308095-mehmk49a	174	34	and	and	CC
cord-308095-mehmk49a	174	35	profits	profit	NNS
cord-308095-mehmk49a	174	36	of	of	IN
cord-308095-mehmk49a	174	37	the	the	DT
cord-308095-mehmk49a	174	38	opioid	opioid	JJ
cord-308095-mehmk49a	174	39	companies	company	NNS
cord-308095-mehmk49a	174	40	.	.	.
cord-308095-mehmk49a	175	1	The	the	DT
cord-308095-mehmk49a	175	2	strategies	strategy	NNS
cord-308095-mehmk49a	175	3	were	be	VBD
cord-308095-mehmk49a	175	4	designed	design	VBN
cord-308095-mehmk49a	175	5	to	to	TO
cord-308095-mehmk49a	175	6	expand	expand	VB
cord-308095-mehmk49a	175	7	the	the	DT
cord-308095-mehmk49a	175	8	base	base	NN
cord-308095-mehmk49a	175	9	of	of	IN
cord-308095-mehmk49a	175	10	patients	patient	NNS
cord-308095-mehmk49a	175	11	who	who	WP
cord-308095-mehmk49a	175	12	would	would	MD
cord-308095-mehmk49a	175	13	be	be	VB
cord-308095-mehmk49a	175	14	prescribed	prescribe	VBN
cord-308095-mehmk49a	175	15	opioids	opioid	NNS
cord-308095-mehmk49a	175	16	from	from	IN
cord-308095-mehmk49a	175	17	(	(	-LRB-
cord-308095-mehmk49a	175	18	often	often	RB
cord-308095-mehmk49a	175	19	terminal	terminal	JJ
cord-308095-mehmk49a	175	20	)	)	-RRB-
cord-308095-mehmk49a	175	21	cancer	cancer	NN
cord-308095-mehmk49a	175	22	patients	patient	NNS
cord-308095-mehmk49a	175	23	to	to	IN
cord-308095-mehmk49a	175	24	non	non	JJ
cord-308095-mehmk49a	175	25	-	-	JJ
cord-308095-mehmk49a	175	26	cancer	cancer	JJ
cord-308095-mehmk49a	175	27	patients	patient	NNS
cord-308095-mehmk49a	175	28	experiencing	experience	VBG
cord-308095-mehmk49a	175	29	either	either	CC
cord-308095-mehmk49a	175	30	acute	acute	JJ
cord-308095-mehmk49a	175	31	or	or	CC
cord-308095-mehmk49a	175	32	chronic	chronic	JJ
cord-308095-mehmk49a	175	33	pain	pain	NN
cord-308095-mehmk49a	175	34	;	;	:
cord-308095-mehmk49a	175	35	to	to	TO
cord-308095-mehmk49a	175	36	promote	promote	VB
cord-308095-mehmk49a	175	37	the	the	DT
cord-308095-mehmk49a	175	38	acceptance	acceptance	NN
cord-308095-mehmk49a	175	39	of	of	IN
cord-308095-mehmk49a	175	40	opioids	opioid	NNS
cord-308095-mehmk49a	175	41	as	as	IN
cord-308095-mehmk49a	175	42	the	the	DT
cord-308095-mehmk49a	175	43	drug	drug	NN
cord-308095-mehmk49a	175	44	of	of	IN
cord-308095-mehmk49a	175	45	choice	choice	NN
cord-308095-mehmk49a	175	46	in	in	IN
cord-308095-mehmk49a	175	47	such	such	JJ
cord-308095-mehmk49a	175	48	cases	case	NNS
cord-308095-mehmk49a	175	49	,	,	,
cord-308095-mehmk49a	175	50	despite	despite	IN
cord-308095-mehmk49a	175	51	the	the	DT
cord-308095-mehmk49a	175	52	lack	lack	NN
cord-308095-mehmk49a	175	53	of	of	IN
cord-308095-mehmk49a	175	54	evidence	evidence	NN
cord-308095-mehmk49a	175	55	as	as	IN
cord-308095-mehmk49a	175	56	to	to	IN
cord-308095-mehmk49a	175	57	their	-PRON-	PRP$
cord-308095-mehmk49a	175	58	efficacy	efficacy	NN
cord-308095-mehmk49a	175	59	(	(	-LRB-
cord-308095-mehmk49a	175	60	especially	especially	RB
cord-308095-mehmk49a	175	61	for	for	IN
cord-308095-mehmk49a	175	62	chronic	chronic	JJ
cord-308095-mehmk49a	175	63	pain	pain	NN
cord-308095-mehmk49a	175	64	)	)	-RRB-
cord-308095-mehmk49a	175	65	;	;	:
cord-308095-mehmk49a	175	66	to	to	TO
cord-308095-mehmk49a	175	67	expedite	expedite	VB
cord-308095-mehmk49a	175	68	the	the	DT
cord-308095-mehmk49a	175	69	prescribing	prescribing	NN
cord-308095-mehmk49a	175	70	of	of	IN
cord-308095-mehmk49a	175	71	opioids	opioid	NNS
cord-308095-mehmk49a	175	72	in	in	IN
cord-308095-mehmk49a	175	73	place	place	NN
cord-308095-mehmk49a	175	74	of	of	IN
cord-308095-mehmk49a	175	75	other	other	JJ
cord-308095-mehmk49a	175	76	analgesics	analgesic	NNS
cord-308095-mehmk49a	175	77	and	and	CC
cord-308095-mehmk49a	175	78	pain	pain	NN
cord-308095-mehmk49a	175	79	therapies	therapy	NNS
cord-308095-mehmk49a	175	80	;	;	:
cord-308095-mehmk49a	175	81	to	to	TO
cord-308095-mehmk49a	175	82	downplay	downplay	VB
cord-308095-mehmk49a	175	83	the	the	DT
cord-308095-mehmk49a	175	84	risks	risk	NNS
cord-308095-mehmk49a	175	85	of	of	IN
cord-308095-mehmk49a	175	86	addiction	addiction	NN
cord-308095-mehmk49a	175	87	and	and	CC
cord-308095-mehmk49a	175	88	abuse	abuse	NN
cord-308095-mehmk49a	175	89	;	;	:
cord-308095-mehmk49a	175	90	to	to	TO
cord-308095-mehmk49a	175	91	characterize	characterize	VB
cord-308095-mehmk49a	175	92	doctors	doctor	NNS
cord-308095-mehmk49a	175	93	'	'	POS
cord-308095-mehmk49a	175	94	concerns	concern	NNS
cord-308095-mehmk49a	175	95	about	about	IN
cord-308095-mehmk49a	175	96	addiction	addiction	NN
cord-308095-mehmk49a	175	97	and	and	CC
cord-308095-mehmk49a	175	98	abuse	abuse	NN
cord-308095-mehmk49a	175	99	as	as	IN
cord-308095-mehmk49a	175	100	"	"	``
cord-308095-mehmk49a	175	101	opiophobia	opiophobia	NN
cord-308095-mehmk49a	175	102	"	"	''
cord-308095-mehmk49a	175	103	;	;	:
cord-308095-mehmk49a	175	104	to	to	TO
cord-308095-mehmk49a	175	105	promote	promote	VB
cord-308095-mehmk49a	175	106	the	the	DT
cord-308095-mehmk49a	175	107	view	view	NN
cord-308095-mehmk49a	175	108	that	that	IN
cord-308095-mehmk49a	175	109	opioids	opioid	NNS
cord-308095-mehmk49a	175	110	are	be	VBP
cord-308095-mehmk49a	175	111	not	not	RB
cord-308095-mehmk49a	175	112	addictive	addictive	JJ
cord-308095-mehmk49a	175	113	when	when	WRB
cord-308095-mehmk49a	175	114	taken	take	VBN
cord-308095-mehmk49a	175	115	as	as	IN
cord-308095-mehmk49a	175	116	directed	direct	VBN
cord-308095-mehmk49a	175	117	;	;	:
cord-308095-mehmk49a	175	118	and	and	CC
cord-308095-mehmk49a	175	119	to	to	TO
cord-308095-mehmk49a	175	120	blame	blame	VB
cord-308095-mehmk49a	175	121	patients	patient	NNS
cord-308095-mehmk49a	175	122	when	when	WRB
cord-308095-mehmk49a	175	123	they	-PRON-	PRP
cord-308095-mehmk49a	175	124	became	become	VBD
cord-308095-mehmk49a	175	125	addicted	addicted	JJ
cord-308095-mehmk49a	175	126	.	.	.
cord-308095-mehmk49a	176	1	The	the	DT
cord-308095-mehmk49a	176	2	success	success	NN
cord-308095-mehmk49a	176	3	of	of	IN
cord-308095-mehmk49a	176	4	the	the	DT
cord-308095-mehmk49a	176	5	opioid	opioid	JJ
cord-308095-mehmk49a	176	6	companies	company	NNS
cord-308095-mehmk49a	176	7	in	in	IN
cord-308095-mehmk49a	176	8	these	these	DT
cord-308095-mehmk49a	176	9	respects	respect	NNS
cord-308095-mehmk49a	176	10	was	be	VBD
cord-308095-mehmk49a	176	11	the	the	DT
cord-308095-mehmk49a	176	12	result	result	NN
cord-308095-mehmk49a	176	13	of	of	IN
cord-308095-mehmk49a	176	14	both	both	CC
cord-308095-mehmk49a	176	15	independent	independent	JJ
cord-308095-mehmk49a	176	16	and	and	CC
cord-308095-mehmk49a	176	17	coordinated	coordinated	JJ
cord-308095-mehmk49a	176	18	action	action	NN
cord-308095-mehmk49a	176	19	.	.	.
cord-308095-mehmk49a	177	1	Corporations	corporation	NNS
cord-308095-mehmk49a	177	2	may	may	MD
cord-308095-mehmk49a	177	3	influence	influence	VB
cord-308095-mehmk49a	177	4	policymakers	policymaker	NNS
cord-308095-mehmk49a	177	5	through	through	IN
cord-308095-mehmk49a	177	6	both	both	DT
cord-308095-mehmk49a	177	7	kinds	kind	NNS
cord-308095-mehmk49a	177	8	of	of	IN
cord-308095-mehmk49a	177	9	activity	activity	NN
cord-308095-mehmk49a	177	10	,	,	,
cord-308095-mehmk49a	177	11	and	and	CC
cord-308095-mehmk49a	177	12	trade	trade	NN
cord-308095-mehmk49a	177	13	associations	association	NNS
cord-308095-mehmk49a	177	14	often	often	RB
cord-308095-mehmk49a	177	15	play	play	VBP
cord-308095-mehmk49a	177	16	a	a	DT
cord-308095-mehmk49a	177	17	major	major	JJ
cord-308095-mehmk49a	177	18	role	role	NN
cord-308095-mehmk49a	177	19	in	in	IN
cord-308095-mehmk49a	177	20	coordinating	coordinate	VBG
cord-308095-mehmk49a	177	21	action	action	NN
cord-308095-mehmk49a	177	22	to	to	TO
cord-308095-mehmk49a	177	23	influence	influence	VB
cord-308095-mehmk49a	177	24	policy	policy	NN
cord-308095-mehmk49a	177	25	in	in	IN
cord-308095-mehmk49a	177	26	the	the	DT
cord-308095-mehmk49a	177	27	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	177	28	sector	sector	NN
cord-308095-mehmk49a	177	29	.	.	.
cord-308095-mehmk49a	178	1	PhRMA	phrma	JJ
cord-308095-mehmk49a	179	1	(	(	-LRB-
cord-308095-mehmk49a	179	2	Pharmaceutical	Pharmaceutical	NNP
cord-308095-mehmk49a	179	3	Research	Research	NNP
cord-308095-mehmk49a	179	4	and	and	CC
cord-308095-mehmk49a	179	5	Manufacturers	Manufacturers	NNPS
cord-308095-mehmk49a	179	6	of	of	IN
cord-308095-mehmk49a	179	7	America	America	NNP
cord-308095-mehmk49a	179	8	)	)	-RRB-
cord-308095-mehmk49a	179	9	,	,	,
cord-308095-mehmk49a	179	10	the	the	DT
cord-308095-mehmk49a	179	11	main	main	JJ
cord-308095-mehmk49a	179	12	trade	trade	NN
cord-308095-mehmk49a	179	13	association	association	NN
cord-308095-mehmk49a	179	14	representing	represent	VBG
cord-308095-mehmk49a	179	15	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	179	16	companies	company	NNS
cord-308095-mehmk49a	179	17	in	in	IN
cord-308095-mehmk49a	179	18	North	North	NNP
cord-308095-mehmk49a	179	19	America	America	NNP
cord-308095-mehmk49a	179	20	,	,	,
cord-308095-mehmk49a	179	21	has	have	VBZ
cord-308095-mehmk49a	179	22	coordinated	coordinate	VBN
cord-308095-mehmk49a	179	23	an	an	DT
cord-308095-mehmk49a	179	24	industry	industry	NN
cord-308095-mehmk49a	179	25	response	response	NN
cord-308095-mehmk49a	179	26	to	to	IN
cord-308095-mehmk49a	179	27	the	the	DT
cord-308095-mehmk49a	179	28	opioid	opioid	JJ
cord-308095-mehmk49a	179	29	crisis	crisis	NN
cord-308095-mehmk49a	179	30	.	.	.
cord-308095-mehmk49a	180	1	As	as	IN
cord-308095-mehmk49a	180	2	two	two	CD
cord-308095-mehmk49a	180	3	New	New	NNP
cord-308095-mehmk49a	180	4	York	York	NNP
cord-308095-mehmk49a	180	5	Times	Times	NNP
cord-308095-mehmk49a	180	6	journalists	journalist	NNS
cord-308095-mehmk49a	180	7	recently	recently	RB
cord-308095-mehmk49a	180	8	put	put	VBD
cord-308095-mehmk49a	180	9	it	-PRON-	PRP
cord-308095-mehmk49a	180	10	,	,	,
cord-308095-mehmk49a	180	11	"	"	``
cord-308095-mehmk49a	180	12	PhRMA	phrma	JJ
cord-308095-mehmk49a	180	13	is	be	VBZ
cord-308095-mehmk49a	180	14	trying	try	VBG
cord-308095-mehmk49a	180	15	to	to	TO
cord-308095-mehmk49a	180	16	position	position	VB
cord-308095-mehmk49a	180	17	the	the	DT
cord-308095-mehmk49a	180	18	industry	industry	NN
cord-308095-mehmk49a	180	19	on	on	IN
cord-308095-mehmk49a	180	20	the	the	DT
cord-308095-mehmk49a	180	21	right	right	JJ
cord-308095-mehmk49a	180	22	side	side	NN
cord-308095-mehmk49a	180	23	of	of	IN
cord-308095-mehmk49a	180	24	a	a	DT
cord-308095-mehmk49a	180	25	health	health	NN
cord-308095-mehmk49a	180	26	crisis	crisis	NN
cord-308095-mehmk49a	180	27	that	that	WDT
cord-308095-mehmk49a	180	28	many	many	JJ
cord-308095-mehmk49a	180	29	blame	blame	VBP
cord-308095-mehmk49a	180	30	it	-PRON-	PRP
cord-308095-mehmk49a	180	31	for	for	IN
cord-308095-mehmk49a	180	32	creating	create	VBG
cord-308095-mehmk49a	180	33	"	"	''
cord-308095-mehmk49a	180	34	(	(	-LRB-
cord-308095-mehmk49a	180	35	Corkery	Corkery	NNP
cord-308095-mehmk49a	180	36	and	and	CC
cord-308095-mehmk49a	180	37	Thomas	Thomas	NNP
cord-308095-mehmk49a	180	38	2018	2018	CD
cord-308095-mehmk49a	180	39	,	,	,
cord-308095-mehmk49a	180	40	¶10	¶10	NNP
cord-308095-mehmk49a	180	41	)	)	-RRB-
cord-308095-mehmk49a	180	42	.	.	.
cord-308095-mehmk49a	181	1	The	the	DT
cord-308095-mehmk49a	181	2	article	article	NN
cord-308095-mehmk49a	181	3	in	in	IN
cord-308095-mehmk49a	181	4	which	which	WDT
cord-308095-mehmk49a	181	5	that	that	DT
cord-308095-mehmk49a	181	6	observation	observation	NN
cord-308095-mehmk49a	181	7	was	be	VBD
cord-308095-mehmk49a	181	8	made	make	VBN
cord-308095-mehmk49a	181	9	raised	raise	VBN
cord-308095-mehmk49a	181	10	legitimate	legitimate	JJ
cord-308095-mehmk49a	181	11	concerns	concern	NNS
cord-308095-mehmk49a	181	12	about	about	IN
cord-308095-mehmk49a	181	13	PhRMA	phrma	JJ
cord-308095-mehmk49a	181	14	providing	provide	VBG
cord-308095-mehmk49a	181	15	funding	funding	NN
cord-308095-mehmk49a	181	16	to	to	IN
cord-308095-mehmk49a	181	17	the	the	DT
cord-308095-mehmk49a	181	18	patient	patient	JJ
cord-308095-mehmk49a	181	19	advocacy	advocacy	NN
cord-308095-mehmk49a	181	20	organization	organization	NN
cord-308095-mehmk49a	181	21	,	,	,
cord-308095-mehmk49a	181	22	Addiction	Addiction	NNP
cord-308095-mehmk49a	181	23	Policy	Policy	NNP
cord-308095-mehmk49a	181	24	Forum	Forum	NNP
cord-308095-mehmk49a	181	25	.	.	.
cord-308095-mehmk49a	182	1	Of	of	RB
cord-308095-mehmk49a	182	2	course	course	RB
cord-308095-mehmk49a	182	3	,	,	,
cord-308095-mehmk49a	182	4	the	the	DT
cord-308095-mehmk49a	182	5	trade	trade	NN
cord-308095-mehmk49a	182	6	association	association	NN
cord-308095-mehmk49a	182	7	's	's	POS
cord-308095-mehmk49a	182	8	support	support	NN
cord-308095-mehmk49a	182	9	of	of	IN
cord-308095-mehmk49a	182	10	this	this	DT
cord-308095-mehmk49a	182	11	advocacy	advocacy	NN
cord-308095-mehmk49a	182	12	group	group	NN
cord-308095-mehmk49a	182	13	is	be	VBZ
cord-308095-mehmk49a	182	14	not	not	RB
cord-308095-mehmk49a	182	15	an	an	DT
cord-308095-mehmk49a	182	16	isolated	isolated	JJ
cord-308095-mehmk49a	182	17	relationship	relationship	NN
cord-308095-mehmk49a	182	18	;	;	:
cord-308095-mehmk49a	182	19	it	-PRON-	PRP
cord-308095-mehmk49a	182	20	is	be	VBZ
cord-308095-mehmk49a	182	21	part	part	NN
cord-308095-mehmk49a	182	22	of	of	IN
cord-308095-mehmk49a	182	23	the	the	DT
cord-308095-mehmk49a	182	24	concerted	concerted	JJ
cord-308095-mehmk49a	182	25	strategy	strategy	NN
cord-308095-mehmk49a	182	26	intended	intend	VBN
cord-308095-mehmk49a	182	27	to	to	TO
cord-308095-mehmk49a	182	28	influence	influence	VB
cord-308095-mehmk49a	182	29	the	the	DT
cord-308095-mehmk49a	182	30	perceptions	perception	NNS
cord-308095-mehmk49a	182	31	of	of	IN
cord-308095-mehmk49a	182	32	policymakers	policymaker	NNS
cord-308095-mehmk49a	182	33	,	,	,
cord-308095-mehmk49a	182	34	physicians	physician	NNS
cord-308095-mehmk49a	182	35	,	,	,
cord-308095-mehmk49a	182	36	and	and	CC
cord-308095-mehmk49a	182	37	patients	patient	NNS
cord-308095-mehmk49a	182	38	(	(	-LRB-
cord-308095-mehmk49a	182	39	among	among	IN
cord-308095-mehmk49a	182	40	others	other	NNS
cord-308095-mehmk49a	182	41	)	)	-RRB-
cord-308095-mehmk49a	182	42	.	.	.
cord-308095-mehmk49a	183	1	Drug	drug	NN
cord-308095-mehmk49a	183	2	companies	company	NNS
cord-308095-mehmk49a	183	3	want	want	VBP
cord-308095-mehmk49a	183	4	us	-PRON-	PRP
cord-308095-mehmk49a	183	5	to	to	TO
cord-308095-mehmk49a	183	6	see	see	VB
cord-308095-mehmk49a	183	7	them	-PRON-	PRP
cord-308095-mehmk49a	183	8	as	as	IN
cord-308095-mehmk49a	183	9	partners	partner	NNS
cord-308095-mehmk49a	183	10	in	in	IN
cord-308095-mehmk49a	183	11	developing	develop	VBG
cord-308095-mehmk49a	183	12	solutions	solution	NNS
cord-308095-mehmk49a	183	13	to	to	IN
cord-308095-mehmk49a	183	14	the	the	DT
cord-308095-mehmk49a	183	15	opioid	opioid	JJ
cord-308095-mehmk49a	183	16	crisis	crisis	NN
cord-308095-mehmk49a	183	17	,	,	,
cord-308095-mehmk49a	183	18	rather	rather	RB
cord-308095-mehmk49a	183	19	than	than	IN
cord-308095-mehmk49a	183	20	actors	actor	NNS
cord-308095-mehmk49a	183	21	responsible	responsible	JJ
cord-308095-mehmk49a	183	22	for	for	IN
cord-308095-mehmk49a	183	23	creating	create	VBG
cord-308095-mehmk49a	183	24	or	or	CC
cord-308095-mehmk49a	183	25	exacerbating	exacerbate	VBG
cord-308095-mehmk49a	183	26	the	the	DT
cord-308095-mehmk49a	183	27	crisis	crisis	NN
cord-308095-mehmk49a	183	28	.	.	.
cord-308095-mehmk49a	184	1	Mirroring	mirror	VBG
cord-308095-mehmk49a	184	2	statements	statement	NNS
cord-308095-mehmk49a	184	3	made	make	VBN
cord-308095-mehmk49a	184	4	by	by	IN
cord-308095-mehmk49a	184	5	the	the	DT
cord-308095-mehmk49a	184	6	NIH	NIH	NNP
cord-308095-mehmk49a	184	7	and	and	CC
cord-308095-mehmk49a	184	8	the	the	DT
cord-308095-mehmk49a	184	9	National	National	NNP
cord-308095-mehmk49a	184	10	Institute	Institute	NNP
cord-308095-mehmk49a	184	11	on	on	IN
cord-308095-mehmk49a	184	12	Drug	Drug	NNP
cord-308095-mehmk49a	184	13	Abuse	Abuse	NNP
cord-308095-mehmk49a	184	14	(	(	-LRB-
cord-308095-mehmk49a	184	15	NIDA	NIDA	NNP
cord-308095-mehmk49a	184	16	)	)	-RRB-
cord-308095-mehmk49a	184	17	,	,	,
cord-308095-mehmk49a	184	18	PhRMA	PhRMA	NNP
cord-308095-mehmk49a	184	19	issued	issue	VBD
cord-308095-mehmk49a	184	20	its	-PRON-	PRP$
cord-308095-mehmk49a	184	21	own	own	JJ
cord-308095-mehmk49a	184	22	press	press	NN
cord-308095-mehmk49a	184	23	release	release	NN
cord-308095-mehmk49a	184	24	announcing	announce	VBG
cord-308095-mehmk49a	184	25	that	that	IN
cord-308095-mehmk49a	184	26	it	-PRON-	PRP
cord-308095-mehmk49a	184	27	was	be	VBD
cord-308095-mehmk49a	184	28	"	"	``
cord-308095-mehmk49a	184	29	working	work	VBG
cord-308095-mehmk49a	184	30	to	to	TO
cord-308095-mehmk49a	184	31	establish	establish	VB
cord-308095-mehmk49a	184	32	a	a	DT
cord-308095-mehmk49a	184	33	public	public	JJ
cord-308095-mehmk49a	184	34	-	-	HYPH
cord-308095-mehmk49a	184	35	private	private	JJ
cord-308095-mehmk49a	184	36	partnership	partnership	NN
cord-308095-mehmk49a	184	37	"	"	''
cord-308095-mehmk49a	184	38	designed	design	VBN
cord-308095-mehmk49a	184	39	to	to	TO
cord-308095-mehmk49a	184	40	"	"	``
cord-308095-mehmk49a	184	41	accelerate	accelerate	VB
cord-308095-mehmk49a	184	42	the	the	DT
cord-308095-mehmk49a	184	43	development	development	NN
cord-308095-mehmk49a	184	44	of	of	IN
cord-308095-mehmk49a	184	45	innovative	innovative	JJ
cord-308095-mehmk49a	184	46	new	new	JJ
cord-308095-mehmk49a	184	47	treatments	treatment	NNS
cord-308095-mehmk49a	184	48	and	and	CC
cord-308095-mehmk49a	184	49	therapies	therapy	NNS
cord-308095-mehmk49a	184	50	"	"	''
cord-308095-mehmk49a	184	51	(	(	-LRB-
cord-308095-mehmk49a	184	52	PhRMA	PhRMA	NNP
cord-308095-mehmk49a	184	53	2017	2017	CD
cord-308095-mehmk49a	184	54	)	)	-RRB-
cord-308095-mehmk49a	184	55	.	.	.
cord-308095-mehmk49a	185	1	These	these	DT
cord-308095-mehmk49a	185	2	are	be	VBP
cord-308095-mehmk49a	185	3	examples	example	NNS
cord-308095-mehmk49a	185	4	of	of	IN
cord-308095-mehmk49a	185	5	what	what	WP
cord-308095-mehmk49a	185	6	might	may	MD
cord-308095-mehmk49a	185	7	be	be	VB
cord-308095-mehmk49a	185	8	considered	consider	VBN
cord-308095-mehmk49a	185	9	corporate	corporate	JJ
cord-308095-mehmk49a	185	10	coordination	coordination	NN
cord-308095-mehmk49a	185	11	-	-	HYPH
cord-308095-mehmk49a	185	12	collaborative	collaborative	NN
cord-308095-mehmk49a	185	13	efforts	effort	NNS
cord-308095-mehmk49a	185	14	to	to	TO
cord-308095-mehmk49a	185	15	influence	influence	VB
cord-308095-mehmk49a	185	16	policy	policy	NN
cord-308095-mehmk49a	185	17	and	and	CC
cord-308095-mehmk49a	185	18	practice	practice	NN
cord-308095-mehmk49a	185	19	often	often	RB
cord-308095-mehmk49a	185	20	mediated	mediate	VBN
cord-308095-mehmk49a	185	21	by	by	IN
cord-308095-mehmk49a	185	22	a	a	DT
cord-308095-mehmk49a	185	23	trade	trade	NN
cord-308095-mehmk49a	185	24	association	association	NN
cord-308095-mehmk49a	185	25	.	.	.
cord-308095-mehmk49a	186	1	However	however	RB
cord-308095-mehmk49a	186	2	,	,	,
cord-308095-mehmk49a	186	3	it	-PRON-	PRP
cord-308095-mehmk49a	186	4	is	be	VBZ
cord-308095-mehmk49a	186	5	important	important	JJ
cord-308095-mehmk49a	186	6	to	to	TO
cord-308095-mehmk49a	186	7	recognize	recognize	VB
cord-308095-mehmk49a	186	8	that	that	IN
cord-308095-mehmk49a	186	9	the	the	DT
cord-308095-mehmk49a	186	10	independent	independent	JJ
cord-308095-mehmk49a	186	11	actions	action	NNS
cord-308095-mehmk49a	186	12	of	of	IN
cord-308095-mehmk49a	186	13	companies	company	NNS
cord-308095-mehmk49a	186	14	may	may	MD
cord-308095-mehmk49a	186	15	also	also	RB
cord-308095-mehmk49a	186	16	be	be	VB
cord-308095-mehmk49a	186	17	highly	highly	RB
cord-308095-mehmk49a	186	18	influential	influential	JJ
cord-308095-mehmk49a	186	19	,	,	,
cord-308095-mehmk49a	186	20	even	even	RB
cord-308095-mehmk49a	186	21	when	when	WRB
cord-308095-mehmk49a	186	22	competitive	competitive	JJ
cord-308095-mehmk49a	186	23	.	.	.
cord-308095-mehmk49a	187	1	We	-PRON-	PRP
cord-308095-mehmk49a	187	2	saw	see	VBD
cord-308095-mehmk49a	187	3	above	above	IN
cord-308095-mehmk49a	187	4	how	how	WRB
cord-308095-mehmk49a	187	5	five	five	CD
cord-308095-mehmk49a	187	6	different	different	JJ
cord-308095-mehmk49a	187	7	opioid	opioid	NN
cord-308095-mehmk49a	187	8	companies	company	NNS
cord-308095-mehmk49a	187	9	all	all	DT
cord-308095-mehmk49a	187	10	made	make	VBD
cord-308095-mehmk49a	187	11	financial	financial	JJ
cord-308095-mehmk49a	187	12	contributions	contribution	NNS
cord-308095-mehmk49a	187	13	to	to	IN
cord-308095-mehmk49a	187	14	patient	patient	JJ
cord-308095-mehmk49a	187	15	advocacy	advocacy	NN
cord-308095-mehmk49a	187	16	organizations	organization	NNS
cord-308095-mehmk49a	187	17	and	and	CC
cord-308095-mehmk49a	187	18	health	health	NN
cord-308095-mehmk49a	187	19	professional	professional	JJ
cord-308095-mehmk49a	187	20	associations	association	NNS
cord-308095-mehmk49a	187	21	related	relate	VBN
cord-308095-mehmk49a	187	22	to	to	IN
cord-308095-mehmk49a	187	23	pain	pain	NN
cord-308095-mehmk49a	187	24	management	management	NN
cord-308095-mehmk49a	187	25	.	.	.
cord-308095-mehmk49a	188	1	To	to	IN
cord-308095-mehmk49a	188	2	some	some	DT
cord-308095-mehmk49a	188	3	extent	extent	NN
cord-308095-mehmk49a	188	4	,	,	,
cord-308095-mehmk49a	188	5	these	these	DT
cord-308095-mehmk49a	188	6	activities	activity	NNS
cord-308095-mehmk49a	188	7	might	may	MD
cord-308095-mehmk49a	188	8	be	be	VB
cord-308095-mehmk49a	188	9	regarded	regard	VBN
cord-308095-mehmk49a	188	10	as	as	IN
cord-308095-mehmk49a	188	11	concurrent	concurrent	JJ
cord-308095-mehmk49a	188	12	-	-	:
cord-308095-mehmk49a	188	13	each	each	DT
cord-308095-mehmk49a	188	14	company	company	NN
cord-308095-mehmk49a	188	15	giving	give	VBG
cord-308095-mehmk49a	188	16	money	money	NN
cord-308095-mehmk49a	188	17	with	with	IN
cord-308095-mehmk49a	188	18	the	the	DT
cord-308095-mehmk49a	188	19	intention	intention	NN
cord-308095-mehmk49a	188	20	of	of	IN
cord-308095-mehmk49a	188	21	fostering	foster	VBG
cord-308095-mehmk49a	188	22	an	an	DT
cord-308095-mehmk49a	188	23	even	even	RB
cord-308095-mehmk49a	188	24	more	more	RBR
cord-308095-mehmk49a	188	25	permissive	permissive	JJ
cord-308095-mehmk49a	188	26	attitude	attitude	NN
cord-308095-mehmk49a	188	27	toward	toward	IN
cord-308095-mehmk49a	188	28	the	the	DT
cord-308095-mehmk49a	188	29	use	use	NN
cord-308095-mehmk49a	188	30	of	of	IN
cord-308095-mehmk49a	188	31	opioids	opioid	NNS
cord-308095-mehmk49a	188	32	that	that	WDT
cord-308095-mehmk49a	188	33	would	would	MD
cord-308095-mehmk49a	188	34	be	be	VB
cord-308095-mehmk49a	188	35	reflected	reflect	VBN
cord-308095-mehmk49a	188	36	in	in	IN
cord-308095-mehmk49a	188	37	the	the	DT
cord-308095-mehmk49a	188	38	recipients	recipient	NNS
cord-308095-mehmk49a	188	39	'	'	POS
cord-308095-mehmk49a	188	40	representations	representation	NNS
cord-308095-mehmk49a	188	41	to	to	IN
cord-308095-mehmk49a	188	42	policymakers	policymaker	NNS
cord-308095-mehmk49a	188	43	.	.	.
cord-308095-mehmk49a	189	1	But	but	CC
cord-308095-mehmk49a	189	2	some	some	DT
cord-308095-mehmk49a	189	3	of	of	IN
cord-308095-mehmk49a	189	4	these	these	DT
cord-308095-mehmk49a	189	5	activities	activity	NNS
cord-308095-mehmk49a	189	6	might	may	MD
cord-308095-mehmk49a	189	7	be	be	VB
cord-308095-mehmk49a	189	8	considered	consider	VBN
cord-308095-mehmk49a	189	9	competitive	competitive	JJ
cord-308095-mehmk49a	189	10	to	to	IN
cord-308095-mehmk49a	189	11	the	the	DT
cord-308095-mehmk49a	189	12	extent	extent	NN
cord-308095-mehmk49a	189	13	that	that	IN
cord-308095-mehmk49a	189	14	the	the	DT
cord-308095-mehmk49a	189	15	company	company	NN
cord-308095-mehmk49a	189	16	making	make	VBG
cord-308095-mehmk49a	189	17	the	the	DT
cord-308095-mehmk49a	189	18	donation	donation	NN
cord-308095-mehmk49a	189	19	intended	intend	VBN
cord-308095-mehmk49a	189	20	to	to	TO
cord-308095-mehmk49a	189	21	generate	generate	VB
cord-308095-mehmk49a	189	22	more	more	JJR
cord-308095-mehmk49a	189	23	prescriptions	prescription	NNS
cord-308095-mehmk49a	189	24	for	for	IN
cord-308095-mehmk49a	189	25	its	-PRON-	PRP$
cord-308095-mehmk49a	189	26	opioids	opioid	NNS
cord-308095-mehmk49a	189	27	by	by	IN
cord-308095-mehmk49a	189	28	"	"	``
cord-308095-mehmk49a	189	29	stealing	steal	VBG
cord-308095-mehmk49a	189	30	"	"	''
cord-308095-mehmk49a	189	31	potential	potential	JJ
cord-308095-mehmk49a	189	32	patients	patient	NNS
cord-308095-mehmk49a	189	33	from	from	IN
cord-308095-mehmk49a	189	34	its	-PRON-	PRP$
cord-308095-mehmk49a	189	35	competitors	competitor	NNS
cord-308095-mehmk49a	189	36	.	.	.
cord-308095-mehmk49a	190	1	Recent	recent	JJ
cord-308095-mehmk49a	190	2	court	court	NN
cord-308095-mehmk49a	190	3	filings	filing	NNS
cord-308095-mehmk49a	190	4	in	in	IN
cord-308095-mehmk49a	190	5	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	190	6	,	,	,
cord-308095-mehmk49a	190	7	for	for	IN
cord-308095-mehmk49a	190	8	example	example	NN
cord-308095-mehmk49a	190	9	,	,	,
cord-308095-mehmk49a	190	10	provide	provide	VB
cord-308095-mehmk49a	190	11	evidence	evidence	NN
cord-308095-mehmk49a	190	12	of	of	IN
cord-308095-mehmk49a	190	13	the	the	DT
cord-308095-mehmk49a	190	14	competitive	competitive	JJ
cord-308095-mehmk49a	190	15	strategies	strategy	NNS
cord-308095-mehmk49a	190	16	of	of	IN
cord-308095-mehmk49a	190	17	Purdue	Purdue	NNP
cord-308095-mehmk49a	190	18	Pharma	Pharma	NNP
cord-308095-mehmk49a	190	19	(	(	-LRB-
cord-308095-mehmk49a	190	20	see	see	VB
cord-308095-mehmk49a	190	21	A.G.	A.G.	NNP
cord-308095-mehmk49a	190	22	Mass.	Massachusetts	NNP
cord-308095-mehmk49a	190	23	2019	2019	CD
cord-308095-mehmk49a	190	24	)	)	-RRB-
cord-308095-mehmk49a	190	25	.	.	.
cord-308095-mehmk49a	191	1	But	but	CC
cord-308095-mehmk49a	191	2	whether	whether	IN
cord-308095-mehmk49a	191	3	concurrent	concurrent	JJ
cord-308095-mehmk49a	191	4	or	or	CC
cord-308095-mehmk49a	191	5	competitive	competitive	JJ
cord-308095-mehmk49a	191	6	,	,	,
cord-308095-mehmk49a	191	7	the	the	DT
cord-308095-mehmk49a	191	8	effect	effect	NN
cord-308095-mehmk49a	191	9	of	of	IN
cord-308095-mehmk49a	191	10	these	these	DT
cord-308095-mehmk49a	191	11	contributions	contribution	NNS
cord-308095-mehmk49a	191	12	was	be	VBD
cord-308095-mehmk49a	191	13	the	the	DT
cord-308095-mehmk49a	191	14	same	same	JJ
cord-308095-mehmk49a	191	15	:	:	:
cord-308095-mehmk49a	191	16	to	to	TO
cord-308095-mehmk49a	191	17	influence	influence	VB
cord-308095-mehmk49a	191	18	the	the	DT
cord-308095-mehmk49a	191	19	public	public	JJ
cord-308095-mehmk49a	191	20	statements	statement	NNS
cord-308095-mehmk49a	191	21	and	and	CC
cord-308095-mehmk49a	191	22	representations	representation	NNS
cord-308095-mehmk49a	191	23	of	of	IN
cord-308095-mehmk49a	191	24	civil	civil	JJ
cord-308095-mehmk49a	191	25	society	society	NN
cord-308095-mehmk49a	191	26	groups	group	NNS
cord-308095-mehmk49a	191	27	so	so	IN
cord-308095-mehmk49a	191	28	that	that	IN
cord-308095-mehmk49a	191	29	they	-PRON-	PRP
cord-308095-mehmk49a	191	30	too	too	RB
cord-308095-mehmk49a	191	31	favoured	favour	VBD
cord-308095-mehmk49a	191	32	the	the	DT
cord-308095-mehmk49a	191	33	relaxation	relaxation	NN
cord-308095-mehmk49a	191	34	of	of	IN
cord-308095-mehmk49a	191	35	prescribing	prescribe	VBG
cord-308095-mehmk49a	191	36	guidelines	guideline	NNS
cord-308095-mehmk49a	191	37	and	and	CC
cord-308095-mehmk49a	191	38	downplayed	downplay	VBD
cord-308095-mehmk49a	191	39	the	the	DT
cord-308095-mehmk49a	191	40	addiction	addiction	NN
cord-308095-mehmk49a	191	41	and	and	CC
cord-308095-mehmk49a	191	42	abuse	abuse	NN
cord-308095-mehmk49a	191	43	risks	risk	NNS
cord-308095-mehmk49a	191	44	.	.	.
cord-308095-mehmk49a	192	1	Competitive	competitive	JJ
cord-308095-mehmk49a	192	2	and	and	CC
cord-308095-mehmk49a	192	3	coordinated	coordinated	JJ
cord-308095-mehmk49a	192	4	corporate	corporate	JJ
cord-308095-mehmk49a	192	5	strategies	strategy	NNS
cord-308095-mehmk49a	192	6	of	of	IN
cord-308095-mehmk49a	192	7	influence	influence	NN
cord-308095-mehmk49a	192	8	may	may	MD
cord-308095-mehmk49a	192	9	occur	occur	VB
cord-308095-mehmk49a	192	10	simultaneously	simultaneously	RB
cord-308095-mehmk49a	192	11	as	as	RB
cord-308095-mehmk49a	192	12	well	well	RB
cord-308095-mehmk49a	192	13	as	as	IN
cord-308095-mehmk49a	192	14	sequentially	sequentially	RB
cord-308095-mehmk49a	192	15	.	.	.
cord-308095-mehmk49a	193	1	As	as	IN
cord-308095-mehmk49a	193	2	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	193	3	of	of	IN
cord-308095-mehmk49a	193	4	opioids	opioid	NNS
cord-308095-mehmk49a	193	5	and	and	CC
cord-308095-mehmk49a	193	6	suppliers	supplier	NNS
cord-308095-mehmk49a	193	7	of	of	IN
cord-308095-mehmk49a	193	8	active	active	JJ
cord-308095-mehmk49a	193	9	ingredients	ingredient	NNS
cord-308095-mehmk49a	193	10	to	to	IN
cord-308095-mehmk49a	193	11	other	other	JJ
cord-308095-mehmk49a	193	12	opioid	opioid	JJ
cord-308095-mehmk49a	193	13	companies	company	NNS
cord-308095-mehmk49a	193	14	(	(	-LRB-
cord-308095-mehmk49a	193	15	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	193	16	2019a	2019a	CD
cord-308095-mehmk49a	193	17	)	)	-RRB-
cord-308095-mehmk49a	193	18	,	,	,
cord-308095-mehmk49a	193	19	the	the	DT
cord-308095-mehmk49a	193	20	Johnson	Johnson	NNP
cord-308095-mehmk49a	193	21	&	&	CC
cord-308095-mehmk49a	193	22	Johnson	Johnson	NNP
cord-308095-mehmk49a	193	23	family	family	NN
cord-308095-mehmk49a	193	24	of	of	IN
cord-308095-mehmk49a	193	25	companies	company	NNS
cord-308095-mehmk49a	193	26	(	(	-LRB-
cord-308095-mehmk49a	193	27	which	which	WDT
cord-308095-mehmk49a	193	28	includes	include	VBZ
cord-308095-mehmk49a	193	29	Janssen	Janssen	NNP
cord-308095-mehmk49a	193	30	Pharmaceuticals	Pharmaceuticals	NNP
cord-308095-mehmk49a	193	31	)	)	-RRB-
cord-308095-mehmk49a	193	32	had	have	VBD
cord-308095-mehmk49a	193	33	an	an	DT
cord-308095-mehmk49a	193	34	additional	additional	JJ
cord-308095-mehmk49a	193	35	incentive	incentive	NN
cord-308095-mehmk49a	193	36	to	to	TO
cord-308095-mehmk49a	193	37	engage	engage	VB
cord-308095-mehmk49a	193	38	in	in	IN
cord-308095-mehmk49a	193	39	both	both	DT
cord-308095-mehmk49a	193	40	strategies	strategy	NNS
cord-308095-mehmk49a	193	41	.	.	.
cord-308095-mehmk49a	194	1	So	so	RB
cord-308095-mehmk49a	194	2	,	,	,
cord-308095-mehmk49a	194	3	any	any	DT
cord-308095-mehmk49a	194	4	counterstrategy	counterstrategy	NN
cord-308095-mehmk49a	194	5	intended	intend	VBD
cord-308095-mehmk49a	194	6	to	to	TO
cord-308095-mehmk49a	194	7	insulate	insulate	VB
cord-308095-mehmk49a	194	8	governments	government	NNS
cord-308095-mehmk49a	194	9	,	,	,
cord-308095-mehmk49a	194	10	universities	university	NNS
cord-308095-mehmk49a	194	11	,	,	,
cord-308095-mehmk49a	194	12	and	and	CC
cord-308095-mehmk49a	194	13	public	public	JJ
cord-308095-mehmk49a	194	14	health	health	NN
cord-308095-mehmk49a	194	15	NGOs	NGOs	NNPS
cord-308095-mehmk49a	194	16	from	from	IN
cord-308095-mehmk49a	194	17	corporate	corporate	JJ
cord-308095-mehmk49a	194	18	influence	influence	NN
cord-308095-mehmk49a	194	19	should	should	MD
cord-308095-mehmk49a	194	20	also	also	RB
cord-308095-mehmk49a	194	21	address	address	VB
cord-308095-mehmk49a	194	22	both	both	DT
cord-308095-mehmk49a	194	23	strategies	strategy	NNS
cord-308095-mehmk49a	194	24	.	.	.
cord-308095-mehmk49a	195	1	The	the	DT
cord-308095-mehmk49a	195	2	significance	significance	NN
cord-308095-mehmk49a	195	3	of	of	IN
cord-308095-mehmk49a	195	4	these	these	DT
cord-308095-mehmk49a	195	5	forms	form	NNS
cord-308095-mehmk49a	195	6	of	of	IN
cord-308095-mehmk49a	195	7	influence	influence	NN
cord-308095-mehmk49a	195	8	becomes	become	VBZ
cord-308095-mehmk49a	195	9	especially	especially	RB
cord-308095-mehmk49a	195	10	important	important	JJ
cord-308095-mehmk49a	195	11	when	when	WRB
cord-308095-mehmk49a	195	12	we	-PRON-	PRP
cord-308095-mehmk49a	195	13	consider	consider	VBP
cord-308095-mehmk49a	195	14	the	the	DT
cord-308095-mehmk49a	195	15	ethical	ethical	JJ
cord-308095-mehmk49a	195	16	challenges	challenge	NNS
cord-308095-mehmk49a	195	17	presented	present	VBN
cord-308095-mehmk49a	195	18	by	by	IN
cord-308095-mehmk49a	195	19	public	public	JJ
cord-308095-mehmk49a	195	20	-	-	HYPH
cord-308095-mehmk49a	195	21	private	private	JJ
cord-308095-mehmk49a	195	22	partnerships	partnership	NNS
cord-308095-mehmk49a	195	23	,	,	,
cord-308095-mehmk49a	195	24	which	which	WDT
cord-308095-mehmk49a	195	25	have	have	VBP
cord-308095-mehmk49a	195	26	become	become	VBN
cord-308095-mehmk49a	195	27	the	the	DT
cord-308095-mehmk49a	195	28	dominant	dominant	JJ
cord-308095-mehmk49a	195	29	paradigm	paradigm	NN
cord-308095-mehmk49a	195	30	in	in	IN
cord-308095-mehmk49a	195	31	public	public	JJ
cord-308095-mehmk49a	195	32	health	health	NN
cord-308095-mehmk49a	195	33	.	.	.
cord-308095-mehmk49a	196	1	As	as	IN
cord-308095-mehmk49a	196	2	I	-PRON-	PRP
cord-308095-mehmk49a	196	3	noted	note	VBD
cord-308095-mehmk49a	196	4	above	above	RB
cord-308095-mehmk49a	196	5	,	,	,
cord-308095-mehmk49a	196	6	the	the	DT
cord-308095-mehmk49a	196	7	NIH	NIH	NNP
cord-308095-mehmk49a	196	8	launched	launch	VBD
cord-308095-mehmk49a	196	9	a	a	DT
cord-308095-mehmk49a	196	10	"	"	``
cord-308095-mehmk49a	196	11	public	public	JJ
cord-308095-mehmk49a	196	12	-	-	HYPH
cord-308095-mehmk49a	196	13	private	private	JJ
cord-308095-mehmk49a	196	14	initiative	initiative	NN
cord-308095-mehmk49a	196	15	"	"	''
cord-308095-mehmk49a	196	16	in	in	IN
cord-308095-mehmk49a	196	17	response	response	NN
cord-308095-mehmk49a	196	18	to	to	IN
cord-308095-mehmk49a	196	19	the	the	DT
cord-308095-mehmk49a	196	20	opioid	opioid	JJ
cord-308095-mehmk49a	196	21	crisis	crisis	NN
cord-308095-mehmk49a	196	22	,	,	,
cord-308095-mehmk49a	196	23	bringing	bring	VBG
cord-308095-mehmk49a	196	24	together	together	RB
cord-308095-mehmk49a	196	25	representatives	representative	NNS
cord-308095-mehmk49a	196	26	of	of	IN
cord-308095-mehmk49a	196	27	dozens	dozen	NNS
cord-308095-mehmk49a	196	28	of	of	IN
cord-308095-mehmk49a	196	29	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	196	30	companies	company	NNS
cord-308095-mehmk49a	196	31	.	.	.
cord-308095-mehmk49a	197	1	Policymakers	policymaker	NNS
cord-308095-mehmk49a	197	2	often	often	RB
cord-308095-mehmk49a	197	3	justify	justify	VBP
cord-308095-mehmk49a	197	4	the	the	DT
cord-308095-mehmk49a	197	5	practice	practice	NN
cord-308095-mehmk49a	197	6	of	of	IN
cord-308095-mehmk49a	197	7	"	"	``
cord-308095-mehmk49a	197	8	engaging	engage	VBG
cord-308095-mehmk49a	197	9	"	"	''
cord-308095-mehmk49a	197	10	with	with	IN
cord-308095-mehmk49a	197	11	multiple	multiple	JJ
cord-308095-mehmk49a	197	12	competing	compete	VBG
cord-308095-mehmk49a	197	13	corporations	corporation	NNS
cord-308095-mehmk49a	197	14	in	in	IN
cord-308095-mehmk49a	197	15	a	a	DT
cord-308095-mehmk49a	197	16	partnership	partnership	NN
cord-308095-mehmk49a	197	17	initiative	initiative	NN
cord-308095-mehmk49a	197	18	on	on	IN
cord-308095-mehmk49a	197	19	the	the	DT
cord-308095-mehmk49a	197	20	grounds	ground	NNS
cord-308095-mehmk49a	197	21	that	that	IN
cord-308095-mehmk49a	197	22	this	this	DT
cord-308095-mehmk49a	197	23	ensures	ensure	VBZ
cord-308095-mehmk49a	197	24	no	no	DT
cord-308095-mehmk49a	197	25	single	single	JJ
cord-308095-mehmk49a	197	26	corporation	corporation	NN
cord-308095-mehmk49a	197	27	receives	receive	VBZ
cord-308095-mehmk49a	197	28	preferential	preferential	JJ
cord-308095-mehmk49a	197	29	treatment	treatment	NN
cord-308095-mehmk49a	197	30	.	.	.
cord-308095-mehmk49a	198	1	However	however	RB
cord-308095-mehmk49a	198	2	,	,	,
cord-308095-mehmk49a	198	3	it	-PRON-	PRP
cord-308095-mehmk49a	198	4	is	be	VBZ
cord-308095-mehmk49a	198	5	important	important	JJ
cord-308095-mehmk49a	198	6	to	to	TO
cord-308095-mehmk49a	198	7	recognize	recognize	VB
cord-308095-mehmk49a	198	8	the	the	DT
cord-308095-mehmk49a	198	9	ways	way	NNS
cord-308095-mehmk49a	198	10	in	in	IN
cord-308095-mehmk49a	198	11	which	which	WDT
cord-308095-mehmk49a	198	12	incorporating	incorporate	VBG
cord-308095-mehmk49a	198	13	multiple	multiple	JJ
cord-308095-mehmk49a	198	14	powerful	powerful	JJ
cord-308095-mehmk49a	198	15	corporate	corporate	JJ
cord-308095-mehmk49a	198	16	actors	actor	NNS
cord-308095-mehmk49a	198	17	from	from	IN
cord-308095-mehmk49a	198	18	the	the	DT
cord-308095-mehmk49a	198	19	same	same	JJ
cord-308095-mehmk49a	198	20	sector	sector	NN
cord-308095-mehmk49a	198	21	in	in	IN
cord-308095-mehmk49a	198	22	a	a	DT
cord-308095-mehmk49a	198	23	partnership	partnership	NN
cord-308095-mehmk49a	198	24	can	can	MD
cord-308095-mehmk49a	198	25	be	be	VB
cord-308095-mehmk49a	198	26	ethically	ethically	RB
cord-308095-mehmk49a	198	27	problematic	problematic	JJ
cord-308095-mehmk49a	198	28	.	.	.
cord-308095-mehmk49a	199	1	Bringing	bring	VBG
cord-308095-mehmk49a	199	2	together	together	RB
cord-308095-mehmk49a	199	3	multiple	multiple	JJ
cord-308095-mehmk49a	199	4	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	199	5	companies	company	NNS
cord-308095-mehmk49a	199	6	can	can	MD
cord-308095-mehmk49a	199	7	transform	transform	VB
cord-308095-mehmk49a	199	8	their	-PRON-	PRP$
cord-308095-mehmk49a	199	9	concurrent	concurrent	JJ
cord-308095-mehmk49a	199	10	actions	action	NNS
cord-308095-mehmk49a	199	11	into	into	IN
cord-308095-mehmk49a	199	12	coordinated	coordinated	JJ
cord-308095-mehmk49a	199	13	action	action	NN
cord-308095-mehmk49a	199	14	-	-	:
cord-308095-mehmk49a	199	15	thereby	thereby	RB
cord-308095-mehmk49a	199	16	magnifying	magnify	VBG
cord-308095-mehmk49a	199	17	the	the	DT
cord-308095-mehmk49a	199	18	companies	company	NNS
cord-308095-mehmk49a	199	19	'	'	POS
cord-308095-mehmk49a	199	20	influence	influence	NN
cord-308095-mehmk49a	199	21	.	.	.
cord-308095-mehmk49a	200	1	It	-PRON-	PRP
cord-308095-mehmk49a	200	2	is	be	VBZ
cord-308095-mehmk49a	200	3	in	in	IN
cord-308095-mehmk49a	200	4	the	the	DT
cord-308095-mehmk49a	200	5	interests	interest	NNS
cord-308095-mehmk49a	200	6	of	of	IN
cord-308095-mehmk49a	200	7	all	all	DT
cord-308095-mehmk49a	200	8	opioid	opioid	JJ
cord-308095-mehmk49a	200	9	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	200	10	,	,	,
cord-308095-mehmk49a	200	11	for	for	IN
cord-308095-mehmk49a	200	12	example	example	NN
cord-308095-mehmk49a	200	13	,	,	,
cord-308095-mehmk49a	200	14	that	that	IN
cord-308095-mehmk49a	200	15	the	the	DT
cord-308095-mehmk49a	200	16	marketing	marketing	NN
cord-308095-mehmk49a	200	17	and	and	CC
cord-308095-mehmk49a	200	18	sale	sale	NN
cord-308095-mehmk49a	200	19	of	of	IN
cord-308095-mehmk49a	200	20	opioids	opioid	NNS
cord-308095-mehmk49a	200	21	should	should	MD
cord-308095-mehmk49a	200	22	not	not	RB
cord-308095-mehmk49a	200	23	be	be	VB
cord-308095-mehmk49a	200	24	regulated	regulate	VBN
cord-308095-mehmk49a	200	25	more	more	RBR
cord-308095-mehmk49a	200	26	rigorously	rigorously	RB
cord-308095-mehmk49a	200	27	or	or	CC
cord-308095-mehmk49a	200	28	extensively	extensively	RB
cord-308095-mehmk49a	200	29	.	.	.
cord-308095-mehmk49a	201	1	It	-PRON-	PRP
cord-308095-mehmk49a	201	2	is	be	VBZ
cord-308095-mehmk49a	201	3	also	also	RB
cord-308095-mehmk49a	201	4	in	in	IN
cord-308095-mehmk49a	201	5	the	the	DT
cord-308095-mehmk49a	201	6	interests	interest	NNS
cord-308095-mehmk49a	201	7	of	of	IN
cord-308095-mehmk49a	201	8	all	all	DT
cord-308095-mehmk49a	201	9	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	201	10	companies	company	NNS
cord-308095-mehmk49a	201	11	,	,	,
cord-308095-mehmk49a	201	12	whether	whether	IN
cord-308095-mehmk49a	201	13	or	or	CC
cord-308095-mehmk49a	201	14	not	not	RB
cord-308095-mehmk49a	201	15	they	-PRON-	PRP
cord-308095-mehmk49a	201	16	are	be	VBP
cord-308095-mehmk49a	201	17	currently	currently	RB
cord-308095-mehmk49a	201	18	manufacturing	manufacture	VBG
cord-308095-mehmk49a	201	19	or	or	CC
cord-308095-mehmk49a	201	20	selling	sell	VBG
cord-308095-mehmk49a	201	21	opioids	opioid	NNS
cord-308095-mehmk49a	201	22	,	,	,
cord-308095-mehmk49a	201	23	for	for	IN
cord-308095-mehmk49a	201	24	public	public	JJ
cord-308095-mehmk49a	201	25	health	health	NN
cord-308095-mehmk49a	201	26	agencies	agency	NNS
cord-308095-mehmk49a	201	27	to	to	TO
cord-308095-mehmk49a	201	28	focus	focus	VB
cord-308095-mehmk49a	201	29	on	on	IN
cord-308095-mehmk49a	201	30	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	201	31	responses	response	NNS
cord-308095-mehmk49a	201	32	to	to	IN
cord-308095-mehmk49a	201	33	pain	pain	NN
cord-308095-mehmk49a	201	34	management	management	NN
cord-308095-mehmk49a	201	35	and	and	CC
cord-308095-mehmk49a	201	36	opioid	opioid	JJ
cord-308095-mehmk49a	201	37	addiction	addiction	NN
cord-308095-mehmk49a	201	38	.	.	.
cord-308095-mehmk49a	202	1	The	the	DT
cord-308095-mehmk49a	202	2	traditional	traditional	JJ
cord-308095-mehmk49a	202	3	lens	lens	NN
cord-308095-mehmk49a	202	4	for	for	IN
cord-308095-mehmk49a	202	5	understanding	understanding	NN
cord-308095-mehmk49a	202	6	and	and	CC
cord-308095-mehmk49a	202	7	addressing	address	VBG
cord-308095-mehmk49a	202	8	corporate	corporate	JJ
cord-308095-mehmk49a	202	9	influence	influence	NN
cord-308095-mehmk49a	202	10	in	in	IN
cord-308095-mehmk49a	202	11	medicine	medicine	NN
cord-308095-mehmk49a	202	12	and	and	CC
cord-308095-mehmk49a	202	13	public	public	JJ
cord-308095-mehmk49a	202	14	health	health	NN
cord-308095-mehmk49a	202	15	has	have	VBZ
cord-308095-mehmk49a	202	16	been	be	VBN
cord-308095-mehmk49a	202	17	conflicts	conflict	NNS
cord-308095-mehmk49a	202	18	of	of	IN
cord-308095-mehmk49a	202	19	interest	interest	NN
cord-308095-mehmk49a	202	20	.	.	.
cord-308095-mehmk49a	203	1	The	the	DT
cord-308095-mehmk49a	203	2	definition	definition	NN
cord-308095-mehmk49a	203	3	of	of	IN
cord-308095-mehmk49a	203	4	conflict	conflict	NN
cord-308095-mehmk49a	203	5	of	of	IN
cord-308095-mehmk49a	203	6	interest	interest	NN
cord-308095-mehmk49a	203	7	most	most	RBS
cord-308095-mehmk49a	203	8	frequently	frequently	RB
cord-308095-mehmk49a	203	9	employed	employ	VBN
cord-308095-mehmk49a	203	10	in	in	IN
cord-308095-mehmk49a	203	11	this	this	DT
cord-308095-mehmk49a	203	12	context	context	NN
cord-308095-mehmk49a	203	13	is	be	VBZ
cord-308095-mehmk49a	203	14	the	the	DT
cord-308095-mehmk49a	203	15	one	one	NN
cord-308095-mehmk49a	203	16	adopted	adopt	VBN
cord-308095-mehmk49a	203	17	by	by	IN
cord-308095-mehmk49a	203	18	the	the	DT
cord-308095-mehmk49a	203	19	Institute	Institute	NNP
cord-308095-mehmk49a	203	20	of	of	IN
cord-308095-mehmk49a	203	21	Medicine	Medicine	NNP
cord-308095-mehmk49a	203	22	(	(	-LRB-
cord-308095-mehmk49a	203	23	now	now	RB
cord-308095-mehmk49a	203	24	the	the	DT
cord-308095-mehmk49a	203	25	National	National	NNP
cord-308095-mehmk49a	203	26	Academy	Academy	NNP
cord-308095-mehmk49a	203	27	of	of	IN
cord-308095-mehmk49a	203	28	Medicine	Medicine	NNP
cord-308095-mehmk49a	203	29	)	)	-RRB-
cord-308095-mehmk49a	203	30	in	in	IN
cord-308095-mehmk49a	203	31	the	the	DT
cord-308095-mehmk49a	203	32	U.S.	U.S.	NNP
cord-308095-mehmk49a	203	33	:	:	:
cord-308095-mehmk49a	203	34	"	"	``
cord-308095-mehmk49a	203	35	a	a	DT
cord-308095-mehmk49a	203	36	set	set	NN
cord-308095-mehmk49a	203	37	of	of	IN
cord-308095-mehmk49a	203	38	circumstances	circumstance	NNS
cord-308095-mehmk49a	203	39	that	that	WDT
cord-308095-mehmk49a	203	40	creates	create	VBZ
cord-308095-mehmk49a	203	41	a	a	DT
cord-308095-mehmk49a	203	42	risk	risk	NN
cord-308095-mehmk49a	203	43	that	that	IN
cord-308095-mehmk49a	203	44	professional	professional	JJ
cord-308095-mehmk49a	203	45	judgment	judgment	NN
cord-308095-mehmk49a	203	46	or	or	CC
cord-308095-mehmk49a	203	47	actions	action	NNS
cord-308095-mehmk49a	203	48	regarding	regard	VBG
cord-308095-mehmk49a	203	49	a	a	DT
cord-308095-mehmk49a	203	50	primary	primary	JJ
cord-308095-mehmk49a	203	51	interest	interest	NN
cord-308095-mehmk49a	203	52	will	will	MD
cord-308095-mehmk49a	203	53	be	be	VB
cord-308095-mehmk49a	203	54	unduly	unduly	RB
cord-308095-mehmk49a	203	55	influenced	influence	VBN
cord-308095-mehmk49a	203	56	by	by	IN
cord-308095-mehmk49a	203	57	a	a	DT
cord-308095-mehmk49a	203	58	secondary	secondary	JJ
cord-308095-mehmk49a	203	59	interest	interest	NN
cord-308095-mehmk49a	203	60	"	"	''
cord-308095-mehmk49a	203	61	(	(	-LRB-
cord-308095-mehmk49a	203	62	Lo	Lo	NNP
cord-308095-mehmk49a	203	63	and	and	CC
cord-308095-mehmk49a	203	64	Field	Field	NNP
cord-308095-mehmk49a	203	65	2009	2009	CD
cord-308095-mehmk49a	203	66	,	,	,
cord-308095-mehmk49a	203	67	46	46	CD
cord-308095-mehmk49a	203	68	)	)	-RRB-
cord-308095-mehmk49a	203	69	.	.	.
cord-308095-mehmk49a	204	1	3	3	LS
cord-308095-mehmk49a	205	1	But	but	CC
cord-308095-mehmk49a	205	2	framing	frame	VBG
cord-308095-mehmk49a	205	3	the	the	DT
cord-308095-mehmk49a	205	4	problem	problem	NN
cord-308095-mehmk49a	205	5	of	of	IN
cord-308095-mehmk49a	205	6	corporate	corporate	JJ
cord-308095-mehmk49a	205	7	influence	influence	NN
cord-308095-mehmk49a	205	8	as	as	IN
cord-308095-mehmk49a	205	9	financial	financial	JJ
cord-308095-mehmk49a	205	10	conflicts	conflict	NNS
cord-308095-mehmk49a	205	11	of	of	IN
cord-308095-mehmk49a	205	12	interest	interest	NN
cord-308095-mehmk49a	205	13	tends	tend	VBZ
cord-308095-mehmk49a	205	14	to	to	TO
cord-308095-mehmk49a	205	15	have	have	VB
cord-308095-mehmk49a	205	16	two	two	CD
cord-308095-mehmk49a	205	17	consequences	consequence	NNS
cord-308095-mehmk49a	205	18	.	.	.
cord-308095-mehmk49a	206	1	First	first	RB
cord-308095-mehmk49a	206	2	,	,	,
cord-308095-mehmk49a	206	3	while	while	IN
cord-308095-mehmk49a	206	4	conflicts	conflict	NNS
cord-308095-mehmk49a	206	5	of	of	IN
cord-308095-mehmk49a	206	6	interest	interest	NN
cord-308095-mehmk49a	206	7	can	can	MD
cord-308095-mehmk49a	206	8	be	be	VB
cord-308095-mehmk49a	206	9	defined	define	VBN
cord-308095-mehmk49a	206	10	broadly	broadly	RB
cord-308095-mehmk49a	206	11	to	to	TO
cord-308095-mehmk49a	206	12	include	include	VB
cord-308095-mehmk49a	206	13	institutional	institutional	JJ
cord-308095-mehmk49a	206	14	conflicts	conflict	NNS
cord-308095-mehmk49a	206	15	,	,	,
cord-308095-mehmk49a	206	16	attention	attention	NN
cord-308095-mehmk49a	206	17	is	be	VBZ
cord-308095-mehmk49a	206	18	usually	usually	RB
cord-308095-mehmk49a	206	19	focused	focus	VBN
cord-308095-mehmk49a	206	20	on	on	IN
cord-308095-mehmk49a	206	21	individuals	individual	NNS
cord-308095-mehmk49a	206	22	rather	rather	RB
cord-308095-mehmk49a	206	23	than	than	IN
cord-308095-mehmk49a	206	24	institutions	institution	NNS
cord-308095-mehmk49a	206	25	-	-	:
cord-308095-mehmk49a	206	26	for	for	IN
cord-308095-mehmk49a	206	27	example	example	NN
cord-308095-mehmk49a	206	28	,	,	,
cord-308095-mehmk49a	206	29	physicians	physician	NNS
cord-308095-mehmk49a	206	30	who	who	WP
cord-308095-mehmk49a	206	31	receive	receive	VBP
cord-308095-mehmk49a	206	32	payments	payment	NNS
cord-308095-mehmk49a	206	33	from	from	IN
cord-308095-mehmk49a	206	34	drug	drug	NN
cord-308095-mehmk49a	206	35	companies	company	NNS
cord-308095-mehmk49a	206	36	,	,	,
cord-308095-mehmk49a	206	37	rather	rather	RB
cord-308095-mehmk49a	206	38	than	than	IN
cord-308095-mehmk49a	206	39	academic	academic	JJ
cord-308095-mehmk49a	206	40	medical	medical	JJ
cord-308095-mehmk49a	206	41	centres	centre	NNS
cord-308095-mehmk49a	206	42	or	or	CC
cord-308095-mehmk49a	206	43	universities	university	NNS
cord-308095-mehmk49a	206	44	that	that	WDT
cord-308095-mehmk49a	206	45	might	may	MD
cord-308095-mehmk49a	206	46	have	have	VB
cord-308095-mehmk49a	206	47	equally	equally	RB
cord-308095-mehmk49a	206	48	problematic	problematic	JJ
cord-308095-mehmk49a	206	49	relationships	relationship	NNS
cord-308095-mehmk49a	206	50	with	with	IN
cord-308095-mehmk49a	206	51	drug	drug	NN
cord-308095-mehmk49a	206	52	companies	company	NNS
cord-308095-mehmk49a	206	53	.	.	.
cord-308095-mehmk49a	207	1	Notably	notably	RB
cord-308095-mehmk49a	207	2	,	,	,
cord-308095-mehmk49a	207	3	a	a	DT
cord-308095-mehmk49a	207	4	recent	recent	JJ
cord-308095-mehmk49a	207	5	independent	independent	JJ
cord-308095-mehmk49a	207	6	review	review	NN
cord-308095-mehmk49a	207	7	commissioned	commission	VBN
cord-308095-mehmk49a	207	8	by	by	IN
cord-308095-mehmk49a	207	9	Tufts	Tufts	NNP
cord-308095-mehmk49a	207	10	to	to	TO
cord-308095-mehmk49a	207	11	explore	explore	VB
cord-308095-mehmk49a	207	12	the	the	DT
cord-308095-mehmk49a	207	13	university	university	NN
cord-308095-mehmk49a	207	14	's	's	POS
cord-308095-mehmk49a	207	15	relationships	relationship	NNS
cord-308095-mehmk49a	207	16	with	with	IN
cord-308095-mehmk49a	207	17	Purdue	Purdue	NNP
cord-308095-mehmk49a	207	18	Pharma	Pharma	NNP
cord-308095-mehmk49a	207	19	and	and	CC
cord-308095-mehmk49a	207	20	the	the	DT
cord-308095-mehmk49a	207	21	Sackler	Sackler	NNP
cord-308095-mehmk49a	207	22	family	family	NN
cord-308095-mehmk49a	207	23	found	find	VBD
cord-308095-mehmk49a	207	24	that	that	IN
cord-308095-mehmk49a	207	25	,	,	,
cord-308095-mehmk49a	207	26	while	while	IN
cord-308095-mehmk49a	207	27	there	there	EX
cord-308095-mehmk49a	207	28	were	be	VBD
cord-308095-mehmk49a	207	29	policies	policy	NNS
cord-308095-mehmk49a	207	30	addressing	address	VBG
cord-308095-mehmk49a	207	31	individual	individual	JJ
cord-308095-mehmk49a	207	32	conflicts	conflict	NNS
cord-308095-mehmk49a	207	33	of	of	IN
cord-308095-mehmk49a	207	34	interest	interest	NN
cord-308095-mehmk49a	207	35	,	,	,
cord-308095-mehmk49a	207	36	the	the	DT
cord-308095-mehmk49a	207	37	university	university	NN
cord-308095-mehmk49a	207	38	did	do	VBD
cord-308095-mehmk49a	207	39	not	not	RB
cord-308095-mehmk49a	207	40	have	have	VB
cord-308095-mehmk49a	207	41	-	-	:
cord-308095-mehmk49a	207	42	and	and	CC
cord-308095-mehmk49a	207	43	needs	need	VBZ
cord-308095-mehmk49a	207	44	to	to	TO
cord-308095-mehmk49a	207	45	establish	establish	VB
cord-308095-mehmk49a	207	46	-	-	:
cord-308095-mehmk49a	207	47	a	a	DT
cord-308095-mehmk49a	207	48	comprehensive	comprehensive	JJ
cord-308095-mehmk49a	207	49	institutional	institutional	JJ
cord-308095-mehmk49a	207	50	conflicts	conflict	NNS
cord-308095-mehmk49a	207	51	of	of	IN
cord-308095-mehmk49a	207	52	interest	interest	NN
cord-308095-mehmk49a	207	53	policy	policy	NN
cord-308095-mehmk49a	207	54	(	(	-LRB-
cord-308095-mehmk49a	207	55	Yurko	Yurko	NNP
cord-308095-mehmk49a	207	56	and	and	CC
cord-308095-mehmk49a	207	57	Remz	Remz	NNP
cord-308095-mehmk49a	207	58	2019	2019	CD
cord-308095-mehmk49a	207	59	)	)	-RRB-
cord-308095-mehmk49a	207	60	.	.	.
cord-308095-mehmk49a	208	1	Investigative	investigative	JJ
cord-308095-mehmk49a	208	2	journalism	journalism	NN
cord-308095-mehmk49a	208	3	also	also	RB
cord-308095-mehmk49a	208	4	tends	tend	VBZ
cord-308095-mehmk49a	208	5	to	to	TO
cord-308095-mehmk49a	208	6	highlight	highlight	VB
cord-308095-mehmk49a	208	7	individual	individual	JJ
cord-308095-mehmk49a	208	8	physicians	physician	NNS
cord-308095-mehmk49a	208	9	who	who	WP
cord-308095-mehmk49a	208	10	have	have	VBP
cord-308095-mehmk49a	208	11	failed	fail	VBN
cord-308095-mehmk49a	208	12	to	to	TO
cord-308095-mehmk49a	208	13	disclose	disclose	VB
cord-308095-mehmk49a	208	14	financial	financial	JJ
cord-308095-mehmk49a	208	15	conflicts	conflict	NNS
cord-308095-mehmk49a	208	16	of	of	IN
cord-308095-mehmk49a	208	17	interest	interest	NN
cord-308095-mehmk49a	208	18	arising	arise	VBG
cord-308095-mehmk49a	208	19	from	from	IN
cord-308095-mehmk49a	208	20	their	-PRON-	PRP$
cord-308095-mehmk49a	208	21	relationships	relationship	NNS
cord-308095-mehmk49a	208	22	with	with	IN
cord-308095-mehmk49a	208	23	corporate	corporate	JJ
cord-308095-mehmk49a	208	24	actors	actor	NNS
cord-308095-mehmk49a	208	25	(	(	-LRB-
cord-308095-mehmk49a	208	26	e.g.	e.g.	RB
cord-308095-mehmk49a	208	27	,	,	,
cord-308095-mehmk49a	208	28	Ornstein	Ornstein	NNP
cord-308095-mehmk49a	208	29	and	and	CC
cord-308095-mehmk49a	208	30	Thomas	Thomas	NNP
cord-308095-mehmk49a	208	31	2018	2018	CD
cord-308095-mehmk49a	208	32	)	)	-RRB-
cord-308095-mehmk49a	208	33	;	;	:
cord-308095-mehmk49a	208	34	less	less	JJR
cord-308095-mehmk49a	208	35	attention	attention	NN
cord-308095-mehmk49a	208	36	has	have	VBZ
cord-308095-mehmk49a	208	37	been	be	VBN
cord-308095-mehmk49a	208	38	paid	pay	VBN
cord-308095-mehmk49a	208	39	to	to	IN
cord-308095-mehmk49a	208	40	institutional	institutional	JJ
cord-308095-mehmk49a	208	41	practices	practice	NNS
cord-308095-mehmk49a	208	42	and	and	CC
cord-308095-mehmk49a	208	43	cultures	culture	NNS
cord-308095-mehmk49a	208	44	that	that	WDT
cord-308095-mehmk49a	208	45	might	may	MD
cord-308095-mehmk49a	208	46	promote	promote	VB
cord-308095-mehmk49a	208	47	such	such	JJ
cord-308095-mehmk49a	208	48	behaviours	behaviour	NNS
cord-308095-mehmk49a	208	49	.	.	.
cord-308095-mehmk49a	209	1	Conflicts	conflict	NNS
cord-308095-mehmk49a	209	2	of	of	IN
cord-308095-mehmk49a	209	3	interest	interest	NN
cord-308095-mehmk49a	209	4	at	at	IN
cord-308095-mehmk49a	209	5	the	the	DT
cord-308095-mehmk49a	209	6	institutional	institutional	JJ
cord-308095-mehmk49a	209	7	level	level	NN
cord-308095-mehmk49a	209	8	tend	tend	VBP
cord-308095-mehmk49a	209	9	to	to	TO
cord-308095-mehmk49a	209	10	be	be	VB
cord-308095-mehmk49a	209	11	poorly	poorly	RB
cord-308095-mehmk49a	209	12	managed	manage	VBN
cord-308095-mehmk49a	209	13	,	,	,
cord-308095-mehmk49a	209	14	if	if	IN
cord-308095-mehmk49a	209	15	they	-PRON-	PRP
cord-308095-mehmk49a	209	16	are	be	VBP
cord-308095-mehmk49a	209	17	managed	manage	VBN
cord-308095-mehmk49a	209	18	at	at	RB
cord-308095-mehmk49a	209	19	all	all	RB
cord-308095-mehmk49a	209	20	,	,	,
cord-308095-mehmk49a	209	21	and	and	CC
cord-308095-mehmk49a	209	22	rarely	rarely	RB
cord-308095-mehmk49a	209	23	are	be	VBP
cord-308095-mehmk49a	209	24	they	-PRON-	PRP
cord-308095-mehmk49a	209	25	eliminated	eliminate	VBN
cord-308095-mehmk49a	209	26	(	(	-LRB-
cord-308095-mehmk49a	209	27	Marks	Marks	NNP
cord-308095-mehmk49a	209	28	2019a	2019a	CD
cord-308095-mehmk49a	209	29	)	)	-RRB-
cord-308095-mehmk49a	209	30	.	.	.
cord-308095-mehmk49a	210	1	Once	once	IN
cord-308095-mehmk49a	210	2	conflicts	conflict	NNS
cord-308095-mehmk49a	210	3	of	of	IN
cord-308095-mehmk49a	210	4	interest	interest	NN
cord-308095-mehmk49a	210	5	have	have	VBP
cord-308095-mehmk49a	210	6	been	be	VBN
cord-308095-mehmk49a	210	7	recognized	recognize	VBN
cord-308095-mehmk49a	210	8	as	as	IN
cord-308095-mehmk49a	210	9	a	a	DT
cord-308095-mehmk49a	210	10	problem	problem	NN
cord-308095-mehmk49a	210	11	,	,	,
cord-308095-mehmk49a	210	12	the	the	DT
cord-308095-mehmk49a	210	13	most	most	RBS
cord-308095-mehmk49a	210	14	commonly	commonly	RB
cord-308095-mehmk49a	210	15	touted	tout	VBN
cord-308095-mehmk49a	210	16	policy	policy	NN
cord-308095-mehmk49a	210	17	solution	solution	NN
cord-308095-mehmk49a	210	18	is	be	VBZ
cord-308095-mehmk49a	210	19	disclosure	disclosure	NN
cord-308095-mehmk49a	210	20	of	of	IN
cord-308095-mehmk49a	210	21	the	the	DT
cord-308095-mehmk49a	210	22	conflict	conflict	NN
cord-308095-mehmk49a	210	23	.	.	.
cord-308095-mehmk49a	211	1	The	the	DT
cord-308095-mehmk49a	211	2	Physician	Physician	NNP
cord-308095-mehmk49a	211	3	Payments	Payments	NNP
cord-308095-mehmk49a	211	4	Sunshine	Sunshine	NNP
cord-308095-mehmk49a	211	5	Act	Act	NNP
cord-308095-mehmk49a	211	6	(	(	-LRB-
cord-308095-mehmk49a	211	7	PPSA)-part	PPSA)-part	NNP
cord-308095-mehmk49a	211	8	of	of	IN
cord-308095-mehmk49a	211	9	the	the	DT
cord-308095-mehmk49a	211	10	Affordable	Affordable	NNP
cord-308095-mehmk49a	211	11	Care	Care	NNP
cord-308095-mehmk49a	211	12	Actplaces	Actplaces	NNP
cord-308095-mehmk49a	211	13	the	the	DT
cord-308095-mehmk49a	211	14	responsibility	responsibility	NN
cord-308095-mehmk49a	211	15	on	on	IN
cord-308095-mehmk49a	211	16	drug	drug	NN
cord-308095-mehmk49a	211	17	and	and	CC
cord-308095-mehmk49a	211	18	device	device	NN
cord-308095-mehmk49a	211	19	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	211	20	to	to	TO
cord-308095-mehmk49a	211	21	disclose	disclose	VB
cord-308095-mehmk49a	211	22	their	-PRON-	PRP$
cord-308095-mehmk49a	211	23	payments	payment	NNS
cord-308095-mehmk49a	211	24	to	to	IN
cord-308095-mehmk49a	211	25	physicians	physician	NNS
cord-308095-mehmk49a	211	26	and	and	CC
cord-308095-mehmk49a	211	27	teaching	teaching	NN
cord-308095-mehmk49a	211	28	hospitals	hospital	NNS
cord-308095-mehmk49a	211	29	(	(	-LRB-
cord-308095-mehmk49a	211	30	Richardson	Richardson	NNP
cord-308095-mehmk49a	211	31	2014	2014	CD
cord-308095-mehmk49a	211	32	)	)	-RRB-
cord-308095-mehmk49a	211	33	.	.	.
cord-308095-mehmk49a	212	1	Section	section	NN
cord-308095-mehmk49a	212	2	6111	6111	CD
cord-308095-mehmk49a	212	3	of	of	IN
cord-308095-mehmk49a	212	4	the	the	DT
cord-308095-mehmk49a	212	5	Substance	Substance	NNP
cord-308095-mehmk49a	212	6	Use	Use	NNP
cord-308095-mehmk49a	212	7	-	-	HYPH
cord-308095-mehmk49a	212	8	Disorder	Disorder	NNP
cord-308095-mehmk49a	212	9	Prevention	Prevention	NNP
cord-308095-mehmk49a	212	10	that	that	WDT
cord-308095-mehmk49a	212	11	Promotes	promote	VBZ
cord-308095-mehmk49a	212	12	Opioid	Opioid	NNP
cord-308095-mehmk49a	212	13	Recovery	Recovery	NNP
cord-308095-mehmk49a	212	14	and	and	CC
cord-308095-mehmk49a	212	15	Treatment	Treatment	NNP
cord-308095-mehmk49a	212	16	for	for	IN
cord-308095-mehmk49a	212	17	Patients	Patients	NNPS
cord-308095-mehmk49a	212	18	and	and	CC
cord-308095-mehmk49a	212	19	Communities	Communities	NNPS
cord-308095-mehmk49a	213	1	(	(	-LRB-
cord-308095-mehmk49a	213	2	SUPPORT	SUPPORT	NNP
cord-308095-mehmk49a	213	3	)	)	-RRB-
cord-308095-mehmk49a	213	4	Act	Act	NNP
cord-308095-mehmk49a	213	5	of	of	IN
cord-308095-mehmk49a	213	6	2018-entitled	2018-entitled	CD
cord-308095-mehmk49a	213	7	"	"	``
cord-308095-mehmk49a	213	8	Fighting	fight	VBG
cord-308095-mehmk49a	213	9	the	the	DT
cord-308095-mehmk49a	213	10	Opioid	Opioid	NNP
cord-308095-mehmk49a	213	11	Crisis	Crisis	NNP
cord-308095-mehmk49a	213	12	with	with	IN
cord-308095-mehmk49a	213	13	Sunshine"-expands	sunshine"-expand	NNS
cord-308095-mehmk49a	213	14	the	the	DT
cord-308095-mehmk49a	213	15	scope	scope	NN
cord-308095-mehmk49a	213	16	of	of	IN
cord-308095-mehmk49a	213	17	transactions	transaction	NNS
cord-308095-mehmk49a	213	18	covered	cover	VBN
cord-308095-mehmk49a	213	19	by	by	IN
cord-308095-mehmk49a	213	20	the	the	DT
cord-308095-mehmk49a	213	21	PPSA	PPSA	NNP
cord-308095-mehmk49a	213	22	to	to	TO
cord-308095-mehmk49a	213	23	include	include	VB
cord-308095-mehmk49a	213	24	payments	payment	NNS
cord-308095-mehmk49a	213	25	to	to	IN
cord-308095-mehmk49a	213	26	physician	physician	NN
cord-308095-mehmk49a	213	27	assistants	assistant	NNS
cord-308095-mehmk49a	213	28	,	,	,
cord-308095-mehmk49a	213	29	nurse	nurse	NN
cord-308095-mehmk49a	213	30	practitioners	practitioner	NNS
cord-308095-mehmk49a	213	31	,	,	,
cord-308095-mehmk49a	213	32	clinical	clinical	JJ
cord-308095-mehmk49a	213	33	nurse	nurse	NN
cord-308095-mehmk49a	213	34	specialists	specialist	NNS
cord-308095-mehmk49a	213	35	,	,	,
cord-308095-mehmk49a	213	36	certified	certify	VBN
cord-308095-mehmk49a	213	37	registered	registered	JJ
cord-308095-mehmk49a	213	38	nurse	nurse	NN
cord-308095-mehmk49a	213	39	anaesthetists	anaesthetist	NNS
cord-308095-mehmk49a	213	40	,	,	,
cord-308095-mehmk49a	213	41	and	and	CC
cord-308095-mehmk49a	213	42	certified	certify	VBN
cord-308095-mehmk49a	213	43	nurse	nurse	NN
cord-308095-mehmk49a	213	44	-	-	HYPH
cord-308095-mehmk49a	213	45	midwives	midwife	NNS
cord-308095-mehmk49a	213	46	-	-	HYPH
cord-308095-mehmk49a	213	47	commencing	commence	VBG
cord-308095-mehmk49a	213	48	in	in	IN
cord-308095-mehmk49a	213	49	2022	2022	CD
cord-308095-mehmk49a	213	50	.	.	.
cord-308095-mehmk49a	214	1	Several	several	JJ
cord-308095-mehmk49a	214	2	scholars	scholar	NNS
cord-308095-mehmk49a	214	3	have	have	VBP
cord-308095-mehmk49a	214	4	also	also	RB
cord-308095-mehmk49a	214	5	explored	explore	VBN
cord-308095-mehmk49a	214	6	whether	whether	IN
cord-308095-mehmk49a	214	7	this	this	DT
cord-308095-mehmk49a	214	8	requirement	requirement	NN
cord-308095-mehmk49a	214	9	should	should	MD
cord-308095-mehmk49a	214	10	be	be	VB
cord-308095-mehmk49a	214	11	further	further	RB
cord-308095-mehmk49a	214	12	extended	extend	VBN
cord-308095-mehmk49a	214	13	to	to	TO
cord-308095-mehmk49a	214	14	include	include	VB
cord-308095-mehmk49a	214	15	payments	payment	NNS
cord-308095-mehmk49a	214	16	made	make	VBN
cord-308095-mehmk49a	214	17	to	to	IN
cord-308095-mehmk49a	214	18	patient	patient	JJ
cord-308095-mehmk49a	214	19	advocacy	advocacy	NN
cord-308095-mehmk49a	214	20	organizations	organization	NNS
cord-308095-mehmk49a	214	21	(	(	-LRB-
cord-308095-mehmk49a	214	22	e.g.	e.g.	RB
cord-308095-mehmk49a	214	23	,	,	,
cord-308095-mehmk49a	214	24	McCoy	McCoy	NNP
cord-308095-mehmk49a	214	25	2018	2018	CD
cord-308095-mehmk49a	214	26	;	;	:
cord-308095-mehmk49a	214	27	Kanter	Kanter	NNP
cord-308095-mehmk49a	214	28	2018	2018	CD
cord-308095-mehmk49a	214	29	)	)	-RRB-
cord-308095-mehmk49a	214	30	,	,	,
cord-308095-mehmk49a	214	31	and	and	CC
cord-308095-mehmk49a	214	32	in	in	IN
cord-308095-mehmk49a	214	33	October	October	NNP
cord-308095-mehmk49a	214	34	2018	2018	CD
cord-308095-mehmk49a	214	35	,	,	,
cord-308095-mehmk49a	214	36	Senator	Senator	NNP
cord-308095-mehmk49a	214	37	McCaskill	McCaskill	NNP
cord-308095-mehmk49a	214	38	introduced	introduce	VBD
cord-308095-mehmk49a	214	39	a	a	DT
cord-308095-mehmk49a	214	40	bill	bill	NN
cord-308095-mehmk49a	214	41	to	to	IN
cord-308095-mehmk49a	214	42	this	this	DT
cord-308095-mehmk49a	214	43	effect	effect	NN
cord-308095-mehmk49a	214	44	shortly	shortly	RB
cord-308095-mehmk49a	214	45	before	before	IN
cord-308095-mehmk49a	214	46	she	-PRON-	PRP
cord-308095-mehmk49a	214	47	lost	lose	VBD
cord-308095-mehmk49a	214	48	her	-PRON-	PRP$
cord-308095-mehmk49a	214	49	seat	seat	NN
cord-308095-mehmk49a	214	50	in	in	IN
cord-308095-mehmk49a	214	51	the	the	DT
cord-308095-mehmk49a	214	52	U.S.	U.S.	NNP
cord-308095-mehmk49a	214	53	Senate	Senate	NNP
cord-308095-mehmk49a	214	54	.	.	.
cord-308095-mehmk49a	215	1	Disclosure	disclosure	NN
cord-308095-mehmk49a	215	2	of	of	IN
cord-308095-mehmk49a	215	3	financial	financial	JJ
cord-308095-mehmk49a	215	4	conflicts	conflict	NNS
cord-308095-mehmk49a	215	5	of	of	IN
cord-308095-mehmk49a	215	6	interest	interest	NN
cord-308095-mehmk49a	215	7	with	with	IN
cord-308095-mehmk49a	215	8	corporate	corporate	JJ
cord-308095-mehmk49a	215	9	actors	actor	NNS
cord-308095-mehmk49a	215	10	is	be	VBZ
cord-308095-mehmk49a	215	11	necessary	necessary	JJ
cord-308095-mehmk49a	215	12	but	but	CC
cord-308095-mehmk49a	215	13	not	not	RB
cord-308095-mehmk49a	215	14	sufficient	sufficient	JJ
cord-308095-mehmk49a	215	15	to	to	TO
cord-308095-mehmk49a	215	16	address	address	VB
cord-308095-mehmk49a	215	17	the	the	DT
cord-308095-mehmk49a	215	18	systemic	systemic	JJ
cord-308095-mehmk49a	215	19	problem	problem	NN
cord-308095-mehmk49a	215	20	of	of	IN
cord-308095-mehmk49a	215	21	corporate	corporate	JJ
cord-308095-mehmk49a	215	22	influence	influence	NN
cord-308095-mehmk49a	215	23	.	.	.
cord-308095-mehmk49a	216	1	It	-PRON-	PRP
cord-308095-mehmk49a	216	2	is	be	VBZ
cord-308095-mehmk49a	216	3	the	the	DT
cord-308095-mehmk49a	216	4	"	"	``
cord-308095-mehmk49a	216	5	ethical	ethical	JJ
cord-308095-mehmk49a	216	6	floor	floor	NN
cord-308095-mehmk49a	216	7	"	"	''
cord-308095-mehmk49a	216	8	as	as	IN
cord-308095-mehmk49a	216	9	Bachynski	Bachynski	NNP
cord-308095-mehmk49a	216	10	and	and	CC
cord-308095-mehmk49a	216	11	Goldberg	Goldberg	NNP
cord-308095-mehmk49a	216	12	(	(	-LRB-
cord-308095-mehmk49a	216	13	2018	2018	CD
cord-308095-mehmk49a	216	14	,	,	,
cord-308095-mehmk49a	216	15	182	182	CD
cord-308095-mehmk49a	216	16	)	)	-RRB-
cord-308095-mehmk49a	216	17	put	put	VBD
cord-308095-mehmk49a	216	18	it	-PRON-	PRP
cord-308095-mehmk49a	216	19	-	-	:
cord-308095-mehmk49a	216	20	the	the	DT
cord-308095-mehmk49a	216	21	minimum	minimum	NN
cord-308095-mehmk49a	216	22	,	,	,
cord-308095-mehmk49a	216	23	but	but	CC
cord-308095-mehmk49a	216	24	far	far	RB
cord-308095-mehmk49a	216	25	from	from	IN
cord-308095-mehmk49a	216	26	all	all	DT
cord-308095-mehmk49a	216	27	,	,	,
cord-308095-mehmk49a	216	28	that	that	WDT
cord-308095-mehmk49a	216	29	is	be	VBZ
cord-308095-mehmk49a	216	30	required	require	VBN
cord-308095-mehmk49a	216	31	.	.	.
cord-308095-mehmk49a	217	1	Disclosure	disclosure	NN
cord-308095-mehmk49a	217	2	and	and	CC
cord-308095-mehmk49a	217	3	other	other	JJ
cord-308095-mehmk49a	217	4	measures	measure	NNS
cord-308095-mehmk49a	217	5	to	to	TO
cord-308095-mehmk49a	217	6	promote	promote	VB
cord-308095-mehmk49a	217	7	transparency	transparency	NN
cord-308095-mehmk49a	217	8	help	help	MD
cord-308095-mehmk49a	217	9	reveal	reveal	VB
cord-308095-mehmk49a	217	10	the	the	DT
cord-308095-mehmk49a	217	11	extent	extent	NN
cord-308095-mehmk49a	217	12	of	of	IN
cord-308095-mehmk49a	217	13	the	the	DT
cord-308095-mehmk49a	217	14	problem	problem	NN
cord-308095-mehmk49a	217	15	of	of	IN
cord-308095-mehmk49a	217	16	corporate	corporate	JJ
cord-308095-mehmk49a	217	17	influence	influence	NN
cord-308095-mehmk49a	217	18	.	.	.
cord-308095-mehmk49a	218	1	But	but	CC
cord-308095-mehmk49a	218	2	we	-PRON-	PRP
cord-308095-mehmk49a	218	3	can	can	MD
cord-308095-mehmk49a	218	4	not	not	RB
cord-308095-mehmk49a	218	5	and	and	CC
cord-308095-mehmk49a	218	6	should	should	MD
cord-308095-mehmk49a	218	7	not	not	RB
cord-308095-mehmk49a	218	8	rely	rely	VB
cord-308095-mehmk49a	218	9	on	on	IN
cord-308095-mehmk49a	218	10	such	such	JJ
cord-308095-mehmk49a	218	11	approaches	approach	NNS
cord-308095-mehmk49a	218	12	to	to	TO
cord-308095-mehmk49a	218	13	neutralize	neutralize	VB
cord-308095-mehmk49a	218	14	corporate	corporate	JJ
cord-308095-mehmk49a	218	15	influence	influence	NN
cord-308095-mehmk49a	218	16	.	.	.
cord-308095-mehmk49a	219	1	When	when	WRB
cord-308095-mehmk49a	219	2	policies	policy	NNS
cord-308095-mehmk49a	219	3	primarily	primarily	RB
cord-308095-mehmk49a	219	4	promote	promote	VBP
cord-308095-mehmk49a	219	5	disclosure	disclosure	NN
cord-308095-mehmk49a	219	6	of	of	IN
cord-308095-mehmk49a	219	7	conflicts	conflict	NNS
cord-308095-mehmk49a	219	8	instead	instead	RB
cord-308095-mehmk49a	219	9	of	of	IN
cord-308095-mehmk49a	219	10	their	-PRON-	PRP$
cord-308095-mehmk49a	219	11	elimination	elimination	NN
cord-308095-mehmk49a	219	12	,	,	,
cord-308095-mehmk49a	219	13	there	there	EX
cord-308095-mehmk49a	219	14	is	be	VBZ
cord-308095-mehmk49a	219	15	a	a	DT
cord-308095-mehmk49a	219	16	danger	danger	NN
cord-308095-mehmk49a	219	17	that	that	IN
cord-308095-mehmk49a	219	18	they	-PRON-	PRP
cord-308095-mehmk49a	219	19	may	may	MD
cord-308095-mehmk49a	219	20	exacerbate	exacerbate	VB
cord-308095-mehmk49a	219	21	the	the	DT
cord-308095-mehmk49a	219	22	problem	problem	NN
cord-308095-mehmk49a	219	23	of	of	IN
cord-308095-mehmk49a	219	24	corporate	corporate	JJ
cord-308095-mehmk49a	219	25	influence	influence	NN
cord-308095-mehmk49a	219	26	-	-	:
cord-308095-mehmk49a	219	27	particularly	particularly	RB
cord-308095-mehmk49a	219	28	when	when	WRB
cord-308095-mehmk49a	219	29	they	-PRON-	PRP
cord-308095-mehmk49a	219	30	lead	lead	VBP
cord-308095-mehmk49a	219	31	policymakers	policymaker	NNS
cord-308095-mehmk49a	219	32	and	and	CC
cord-308095-mehmk49a	219	33	the	the	DT
cord-308095-mehmk49a	219	34	relevant	relevant	JJ
cord-308095-mehmk49a	219	35	publics	public	NNS
cord-308095-mehmk49a	219	36	to	to	TO
cord-308095-mehmk49a	219	37	believe	believe	VB
cord-308095-mehmk49a	219	38	(	(	-LRB-
cord-308095-mehmk49a	219	39	mistakenly	mistakenly	RB
cord-308095-mehmk49a	219	40	)	)	-RRB-
cord-308095-mehmk49a	219	41	that	that	IN
cord-308095-mehmk49a	219	42	problematic	problematic	JJ
cord-308095-mehmk49a	219	43	influence	influence	NN
cord-308095-mehmk49a	219	44	has	have	VBZ
cord-308095-mehmk49a	219	45	been	be	VBN
cord-308095-mehmk49a	219	46	addressed	address	VBN
cord-308095-mehmk49a	219	47	.	.	.
cord-308095-mehmk49a	220	1	Several	several	JJ
cord-308095-mehmk49a	220	2	scholars	scholar	NNS
cord-308095-mehmk49a	220	3	have	have	VBP
cord-308095-mehmk49a	220	4	rightly	rightly	RB
cord-308095-mehmk49a	220	5	expressed	express	VBN
cord-308095-mehmk49a	220	6	concern	concern	NN
cord-308095-mehmk49a	220	7	that	that	IN
cord-308095-mehmk49a	220	8	disclosure	disclosure	NN
cord-308095-mehmk49a	220	9	,	,	,
cord-308095-mehmk49a	220	10	while	while	IN
cord-308095-mehmk49a	220	11	necessary	necessary	JJ
cord-308095-mehmk49a	220	12	,	,	,
cord-308095-mehmk49a	220	13	might	may	MD
cord-308095-mehmk49a	220	14	"	"	``
cord-308095-mehmk49a	220	15	crowd	crowd	VB
cord-308095-mehmk49a	220	16	out	out	RP
cord-308095-mehmk49a	220	17	"	"	``
cord-308095-mehmk49a	220	18	more	more	RBR
cord-308095-mehmk49a	220	19	effective	effective	JJ
cord-308095-mehmk49a	220	20	measures	measure	NNS
cord-308095-mehmk49a	220	21	to	to	TO
cord-308095-mehmk49a	220	22	address	address	VB
cord-308095-mehmk49a	220	23	corporate	corporate	JJ
cord-308095-mehmk49a	220	24	influence	influence	NN
cord-308095-mehmk49a	220	25	,	,	,
cord-308095-mehmk49a	220	26	including	include	VBG
cord-308095-mehmk49a	220	27	the	the	DT
cord-308095-mehmk49a	220	28	elimination	elimination	NN
cord-308095-mehmk49a	220	29	of	of	IN
cord-308095-mehmk49a	220	30	relationships	relationship	NNS
cord-308095-mehmk49a	220	31	giving	give	VBG
cord-308095-mehmk49a	220	32	rise	rise	NN
cord-308095-mehmk49a	220	33	to	to	IN
cord-308095-mehmk49a	220	34	financial	financial	JJ
cord-308095-mehmk49a	220	35	conflicts	conflict	NNS
cord-308095-mehmk49a	220	36	of	of	IN
cord-308095-mehmk49a	220	37	interest	interest	NN
cord-308095-mehmk49a	220	38	(	(	-LRB-
cord-308095-mehmk49a	220	39	e.g.	e.g.	RB
cord-308095-mehmk49a	220	40	,	,	,
cord-308095-mehmk49a	220	41	Cain	Cain	NNP
cord-308095-mehmk49a	220	42	,	,	,
cord-308095-mehmk49a	220	43	Loewenstein	Loewenstein	NNP
cord-308095-mehmk49a	220	44	,	,	,
cord-308095-mehmk49a	220	45	and	and	CC
cord-308095-mehmk49a	220	46	Moore	Moore	NNP
cord-308095-mehmk49a	220	47	2005	2005	CD
cord-308095-mehmk49a	220	48	;	;	:
cord-308095-mehmk49a	220	49	Loewenstein	Loewenstein	NNP
cord-308095-mehmk49a	220	50	,	,	,
cord-308095-mehmk49a	220	51	Cain	Cain	NNP
cord-308095-mehmk49a	220	52	,	,	,
cord-308095-mehmk49a	220	53	and	and	CC
cord-308095-mehmk49a	220	54	Sah	Sah	NNP
cord-308095-mehmk49a	220	55	2012	2012	CD
cord-308095-mehmk49a	220	56	;	;	:
cord-308095-mehmk49a	220	57	Chambers	chamber	NNS
cord-308095-mehmk49a	220	58	2017	2017	CD
cord-308095-mehmk49a	220	59	;	;	:
cord-308095-mehmk49a	220	60	Sah	Sah	NNP
cord-308095-mehmk49a	220	61	2019	2019	CD
cord-308095-mehmk49a	220	62	;	;	:
cord-308095-mehmk49a	220	63	Marks	Marks	NNP
cord-308095-mehmk49a	220	64	2019a	2019a	CD
cord-308095-mehmk49a	220	65	;	;	:
cord-308095-mehmk49a	220	66	Kanter	Kanter	NNP
cord-308095-mehmk49a	220	67	and	and	CC
cord-308095-mehmk49a	220	68	Loewenstein	Loewenstein	NNP
cord-308095-mehmk49a	220	69	2019	2019	CD
cord-308095-mehmk49a	220	70	;	;	:
cord-308095-mehmk49a	220	71	Goldberg	Goldberg	NNP
cord-308095-mehmk49a	220	72	2019	2019	CD
cord-308095-mehmk49a	220	73	;	;	:
cord-308095-mehmk49a	220	74	Marks	Marks	NNP
cord-308095-mehmk49a	220	75	2020	2020	CD
cord-308095-mehmk49a	220	76	)	)	-RRB-
cord-308095-mehmk49a	220	77	.	.	.
cord-308095-mehmk49a	221	1	This	this	DT
cord-308095-mehmk49a	221	2	concern	concern	NN
cord-308095-mehmk49a	221	3	is	be	VBZ
cord-308095-mehmk49a	221	4	especially	especially	RB
cord-308095-mehmk49a	221	5	acute	acute	JJ
cord-308095-mehmk49a	221	6	in	in	IN
cord-308095-mehmk49a	221	7	the	the	DT
cord-308095-mehmk49a	221	8	case	case	NN
cord-308095-mehmk49a	221	9	of	of	IN
cord-308095-mehmk49a	221	10	the	the	DT
cord-308095-mehmk49a	221	11	opioid	opioid	JJ
cord-308095-mehmk49a	221	12	crisis	crisis	NN
cord-308095-mehmk49a	221	13	-	-	HYPH
cord-308095-mehmk49a	221	14	fighting	fight	VBG
cord-308095-mehmk49a	221	15	the	the	DT
cord-308095-mehmk49a	221	16	crisis	crisis	NN
cord-308095-mehmk49a	221	17	will	will	MD
cord-308095-mehmk49a	221	18	require	require	VB
cord-308095-mehmk49a	221	19	more	more	JJR
cord-308095-mehmk49a	221	20	than	than	IN
cord-308095-mehmk49a	221	21	simply	simply	RB
cord-308095-mehmk49a	221	22	expanding	expand	VBG
cord-308095-mehmk49a	221	23	the	the	DT
cord-308095-mehmk49a	221	24	categories	category	NNS
cord-308095-mehmk49a	221	25	of	of	IN
cord-308095-mehmk49a	221	26	recipient	recipient	NN
cord-308095-mehmk49a	221	27	whose	whose	WP$
cord-308095-mehmk49a	221	28	payments	payment	NNS
cord-308095-mehmk49a	221	29	from	from	IN
cord-308095-mehmk49a	221	30	opioid	opioid	JJ
cord-308095-mehmk49a	221	31	and	and	CC
cord-308095-mehmk49a	221	32	other	other	JJ
cord-308095-mehmk49a	221	33	drug	drug	NN
cord-308095-mehmk49a	221	34	companies	company	NNS
cord-308095-mehmk49a	221	35	are	be	VBP
cord-308095-mehmk49a	221	36	subject	subject	JJ
cord-308095-mehmk49a	221	37	to	to	IN
cord-308095-mehmk49a	221	38	mandatory	mandatory	JJ
cord-308095-mehmk49a	221	39	disclosure	disclosure	NN
cord-308095-mehmk49a	221	40	.	.	.
cord-308095-mehmk49a	222	1	Given	give	VBN
cord-308095-mehmk49a	222	2	the	the	DT
cord-308095-mehmk49a	222	3	evidence	evidence	NN
cord-308095-mehmk49a	222	4	of	of	IN
cord-308095-mehmk49a	222	5	the	the	DT
cord-308095-mehmk49a	222	6	impact	impact	NN
cord-308095-mehmk49a	222	7	of	of	IN
cord-308095-mehmk49a	222	8	interactions	interaction	NNS
cord-308095-mehmk49a	222	9	with	with	IN
cord-308095-mehmk49a	222	10	drug	drug	NN
cord-308095-mehmk49a	222	11	reps	rep	NNS
cord-308095-mehmk49a	222	12	on	on	IN
cord-308095-mehmk49a	222	13	physicians	physician	NNS
cord-308095-mehmk49a	222	14	'	'	POS
cord-308095-mehmk49a	222	15	opioid	opioid	NN
cord-308095-mehmk49a	222	16	prescribing	prescribing	NN
cord-308095-mehmk49a	222	17	and	and	CC
cord-308095-mehmk49a	222	18	on	on	IN
cord-308095-mehmk49a	222	19	opioid	opioid	NN
cord-308095-mehmk49a	222	20	-	-	HYPH
cord-308095-mehmk49a	222	21	related	relate	VBN
cord-308095-mehmk49a	222	22	deaths	death	NNS
cord-308095-mehmk49a	222	23	,	,	,
cord-308095-mehmk49a	222	24	there	there	EX
cord-308095-mehmk49a	222	25	is	be	VBZ
cord-308095-mehmk49a	222	26	a	a	DT
cord-308095-mehmk49a	222	27	compelling	compelling	JJ
cord-308095-mehmk49a	222	28	case	case	NN
cord-308095-mehmk49a	222	29	that	that	IN
cord-308095-mehmk49a	222	30	the	the	DT
cord-308095-mehmk49a	222	31	best	good	JJS
cord-308095-mehmk49a	222	32	way	way	NN
cord-308095-mehmk49a	222	33	to	to	TO
cord-308095-mehmk49a	222	34	protect	protect	VB
cord-308095-mehmk49a	222	35	patients	patient	NNS
cord-308095-mehmk49a	222	36	and	and	CC
cord-308095-mehmk49a	222	37	insulate	insulate	VB
cord-308095-mehmk49a	222	38	physicians	physician	NNS
cord-308095-mehmk49a	222	39	from	from	IN
cord-308095-mehmk49a	222	40	such	such	JJ
cord-308095-mehmk49a	222	41	influence	influence	NN
cord-308095-mehmk49a	222	42	is	be	VBZ
cord-308095-mehmk49a	222	43	to	to	TO
cord-308095-mehmk49a	222	44	prohibit	prohibit	VB
cord-308095-mehmk49a	222	45	these	these	DT
cord-308095-mehmk49a	222	46	interactions	interaction	NNS
cord-308095-mehmk49a	222	47	.	.	.
cord-308095-mehmk49a	223	1	Disclosure	disclosure	NN
cord-308095-mehmk49a	223	2	rather	rather	RB
cord-308095-mehmk49a	223	3	than	than	IN
cord-308095-mehmk49a	223	4	elimination	elimination	NN
cord-308095-mehmk49a	223	5	of	of	IN
cord-308095-mehmk49a	223	6	these	these	DT
cord-308095-mehmk49a	223	7	relationships	relationship	NNS
cord-308095-mehmk49a	223	8	places	place	VBZ
cord-308095-mehmk49a	223	9	the	the	DT
cord-308095-mehmk49a	223	10	burden	burden	NN
cord-308095-mehmk49a	223	11	of	of	IN
cord-308095-mehmk49a	223	12	addressing	address	VBG
cord-308095-mehmk49a	223	13	this	this	DT
cord-308095-mehmk49a	223	14	systemic	systemic	JJ
cord-308095-mehmk49a	223	15	problem	problem	NN
cord-308095-mehmk49a	223	16	on	on	IN
cord-308095-mehmk49a	223	17	patientsindividuals	patientsindividual	NNS
cord-308095-mehmk49a	223	18	who	who	WP
cord-308095-mehmk49a	223	19	are	be	VBP
cord-308095-mehmk49a	223	20	least	least	RBS
cord-308095-mehmk49a	223	21	equipped	equipped	JJ
cord-308095-mehmk49a	223	22	to	to	TO
cord-308095-mehmk49a	223	23	tackle	tackle	VB
cord-308095-mehmk49a	223	24	it	-PRON-	PRP
cord-308095-mehmk49a	223	25	and	and	CC
cord-308095-mehmk49a	223	26	,	,	,
cord-308095-mehmk49a	223	27	worse	worse	RBR
cord-308095-mehmk49a	223	28	still	still	RB
cord-308095-mehmk49a	223	29	,	,	,
cord-308095-mehmk49a	223	30	are	be	VBP
cord-308095-mehmk49a	223	31	being	be	VBG
cord-308095-mehmk49a	223	32	harmed	harm	VBN
cord-308095-mehmk49a	223	33	by	by	IN
cord-308095-mehmk49a	223	34	it	-PRON-	PRP
cord-308095-mehmk49a	223	35	(	(	-LRB-
cord-308095-mehmk49a	223	36	see	see	VB
cord-308095-mehmk49a	223	37	also	also	RB
cord-308095-mehmk49a	223	38	Kanter	Kanter	NNP
cord-308095-mehmk49a	223	39	and	and	CC
cord-308095-mehmk49a	223	40	Loewenstein	Loewenstein	NNP
cord-308095-mehmk49a	223	41	2019	2019	CD
cord-308095-mehmk49a	223	42	)	)	-RRB-
cord-308095-mehmk49a	223	43	.	.	.
cord-308095-mehmk49a	224	1	Notably	notably	RB
cord-308095-mehmk49a	224	2	,	,	,
cord-308095-mehmk49a	224	3	the	the	DT
cord-308095-mehmk49a	224	4	vast	vast	JJ
cord-308095-mehmk49a	224	5	majority	majority	NN
cord-308095-mehmk49a	224	6	of	of	IN
cord-308095-mehmk49a	224	7	patients	patient	NNS
cord-308095-mehmk49a	224	8	have	have	VBP
cord-308095-mehmk49a	224	9	not	not	RB
cord-308095-mehmk49a	224	10	even	even	RB
cord-308095-mehmk49a	224	11	begun	begin	VBN
cord-308095-mehmk49a	224	12	to	to	TO
cord-308095-mehmk49a	224	13	discharge	discharge	VB
cord-308095-mehmk49a	224	14	that	that	DT
cord-308095-mehmk49a	224	15	burden	burden	NN
cord-308095-mehmk49a	224	16	-	-	:
cord-308095-mehmk49a	224	17	they	-PRON-	PRP
cord-308095-mehmk49a	224	18	remain	remain	VBP
cord-308095-mehmk49a	224	19	unaware	unaware	JJ
cord-308095-mehmk49a	224	20	of	of	IN
cord-308095-mehmk49a	224	21	whether	whether	IN
cord-308095-mehmk49a	224	22	their	-PRON-	PRP$
cord-308095-mehmk49a	224	23	doctors	doctor	NNS
cord-308095-mehmk49a	224	24	have	have	VBP
cord-308095-mehmk49a	224	25	received	receive	VBN
cord-308095-mehmk49a	224	26	payments	payment	NNS
cord-308095-mehmk49a	224	27	from	from	IN
cord-308095-mehmk49a	224	28	drug	drug	NN
cord-308095-mehmk49a	224	29	companies	company	NNS
cord-308095-mehmk49a	224	30	,	,	,
cord-308095-mehmk49a	224	31	even	even	RB
cord-308095-mehmk49a	224	32	though	though	IN
cord-308095-mehmk49a	224	33	this	this	DT
cord-308095-mehmk49a	224	34	information	information	NN
cord-308095-mehmk49a	224	35	has	have	VBZ
cord-308095-mehmk49a	224	36	been	be	VBN
cord-308095-mehmk49a	224	37	publicly	publicly	RB
cord-308095-mehmk49a	224	38	available	available	JJ
cord-308095-mehmk49a	224	39	on	on	IN
cord-308095-mehmk49a	224	40	the	the	DT
cord-308095-mehmk49a	224	41	internet	internet	NN
cord-308095-mehmk49a	224	42	for	for	IN
cord-308095-mehmk49a	224	43	several	several	JJ
cord-308095-mehmk49a	224	44	years	year	NNS
cord-308095-mehmk49a	224	45	.	.	.
cord-308095-mehmk49a	225	1	But	but	CC
cord-308095-mehmk49a	225	2	even	even	RB
cord-308095-mehmk49a	225	3	if	if	IN
cord-308095-mehmk49a	225	4	patients	patient	NNS
cord-308095-mehmk49a	225	5	access	access	VBP
cord-308095-mehmk49a	225	6	this	this	DT
cord-308095-mehmk49a	225	7	information	information	NN
cord-308095-mehmk49a	225	8	-	-	:
cord-308095-mehmk49a	225	9	or	or	CC
cord-308095-mehmk49a	225	10	if	if	IN
cord-308095-mehmk49a	225	11	it	-PRON-	PRP
cord-308095-mehmk49a	225	12	is	be	VBZ
cord-308095-mehmk49a	225	13	provided	provide	VBN
cord-308095-mehmk49a	225	14	directly	directly	RB
cord-308095-mehmk49a	225	15	to	to	IN
cord-308095-mehmk49a	225	16	them	-PRON-	PRP
cord-308095-mehmk49a	225	17	by	by	IN
cord-308095-mehmk49a	225	18	their	-PRON-	PRP$
cord-308095-mehmk49a	225	19	physician	physician	NN
cord-308095-mehmk49a	225	20	or	or	CC
cord-308095-mehmk49a	225	21	the	the	DT
cord-308095-mehmk49a	225	22	physician	physician	NN
cord-308095-mehmk49a	225	23	's	's	POS
cord-308095-mehmk49a	225	24	office	office	NN
cord-308095-mehmk49a	226	1	(	(	-LRB-
cord-308095-mehmk49a	226	2	Rose	Rose	NNP
cord-308095-mehmk49a	226	3	et	et	FW
cord-308095-mehmk49a	226	4	al	al	NNP
cord-308095-mehmk49a	226	5	.	.	.
cord-308095-mehmk49a	227	1	2019	2019	CD
cord-308095-mehmk49a	227	2	)	)	-RRB-
cord-308095-mehmk49a	228	1	-we	-we	:
cord-308095-mehmk49a	228	2	can	can	MD
cord-308095-mehmk49a	228	3	not	not	RB
cord-308095-mehmk49a	228	4	assume	assume	VB
cord-308095-mehmk49a	228	5	they	-PRON-	PRP
cord-308095-mehmk49a	228	6	will	will	MD
cord-308095-mehmk49a	228	7	understand	understand	VB
cord-308095-mehmk49a	228	8	why	why	WRB
cord-308095-mehmk49a	228	9	it	-PRON-	PRP
cord-308095-mehmk49a	228	10	matters	matter	VBZ
cord-308095-mehmk49a	228	11	.	.	.
cord-308095-mehmk49a	229	1	We	-PRON-	PRP
cord-308095-mehmk49a	229	2	should	should	MD
cord-308095-mehmk49a	229	3	certainly	certainly	RB
cord-308095-mehmk49a	229	4	not	not	RB
cord-308095-mehmk49a	229	5	expect	expect	VB
cord-308095-mehmk49a	229	6	them	-PRON-	PRP
cord-308095-mehmk49a	229	7	to	to	IN
cord-308095-mehmk49a	229	8	3	3	CD
cord-308095-mehmk49a	229	9	For	for	IN
cord-308095-mehmk49a	229	10	a	a	DT
cord-308095-mehmk49a	229	11	thoughtful	thoughtful	JJ
cord-308095-mehmk49a	229	12	critique	critique	NN
cord-308095-mehmk49a	229	13	of	of	IN
cord-308095-mehmk49a	229	14	this	this	DT
cord-308095-mehmk49a	229	15	definition	definition	NN
cord-308095-mehmk49a	229	16	,	,	,
cord-308095-mehmk49a	229	17	see	see	VB
cord-308095-mehmk49a	229	18	Rodwin	Rodwin	NNP
cord-308095-mehmk49a	229	19	2018	2018	CD
cord-308095-mehmk49a	229	20	.	.	.
cord-308095-mehmk49a	230	1	Rodwin	Rodwin	NNP
cord-308095-mehmk49a	230	2	argues	argue	VBZ
cord-308095-mehmk49a	230	3	that	that	IN
cord-308095-mehmk49a	230	4	the	the	DT
cord-308095-mehmk49a	230	5	Institute	Institute	NNP
cord-308095-mehmk49a	230	6	of	of	IN
cord-308095-mehmk49a	230	7	Medicine	Medicine	NNP
cord-308095-mehmk49a	230	8	's	's	POS
cord-308095-mehmk49a	230	9	2009	2009	CD
cord-308095-mehmk49a	230	10	definition	definition	NN
cord-308095-mehmk49a	230	11	of	of	IN
cord-308095-mehmk49a	230	12	conflicts	conflict	NNS
cord-308095-mehmk49a	230	13	of	of	IN
cord-308095-mehmk49a	230	14	interest	interest	NN
cord-308095-mehmk49a	230	15	"	"	''
cord-308095-mehmk49a	230	16	neglects	neglect	VBZ
cord-308095-mehmk49a	230	17	the	the	DT
cord-308095-mehmk49a	230	18	actor	actor	NN
cord-308095-mehmk49a	230	19	's	's	POS
cord-308095-mehmk49a	230	20	compromised	compromised	JJ
cord-308095-mehmk49a	230	21	loyalty	loyalty	NN
cord-308095-mehmk49a	230	22	to	to	IN
cord-308095-mehmk49a	230	23	the	the	DT
cord-308095-mehmk49a	230	24	party	party	NN
cord-308095-mehmk49a	230	25	or	or	CC
cord-308095-mehmk49a	230	26	mission	mission	NN
cord-308095-mehmk49a	230	27	she	-PRON-	PRP
cord-308095-mehmk49a	230	28	is	be	VBZ
cord-308095-mehmk49a	230	29	supposed	suppose	VBN
cord-308095-mehmk49a	230	30	to	to	TO
cord-308095-mehmk49a	230	31	serve	serve	VB
cord-308095-mehmk49a	230	32	"	"	''
cord-308095-mehmk49a	230	33	(	(	-LRB-
cord-308095-mehmk49a	230	34	70	70	CD
cord-308095-mehmk49a	230	35	)	)	-RRB-
cord-308095-mehmk49a	230	36	and	and	CC
cord-308095-mehmk49a	230	37	that	that	IN
cord-308095-mehmk49a	230	38	,	,	,
cord-308095-mehmk49a	230	39	by	by	IN
cord-308095-mehmk49a	230	40	referring	refer	VBG
cord-308095-mehmk49a	230	41	to	to	IN
cord-308095-mehmk49a	230	42	conflicts	conflict	NNS
cord-308095-mehmk49a	230	43	between	between	IN
cord-308095-mehmk49a	230	44	primary	primary	JJ
cord-308095-mehmk49a	230	45	and	and	CC
cord-308095-mehmk49a	230	46	secondary	secondary	JJ
cord-308095-mehmk49a	230	47	interests	interest	NNS
cord-308095-mehmk49a	230	48	rather	rather	RB
cord-308095-mehmk49a	230	49	than	than	IN
cord-308095-mehmk49a	230	50	conflicts	conflict	NNS
cord-308095-mehmk49a	230	51	between	between	IN
cord-308095-mehmk49a	230	52	obligations	obligation	NNS
cord-308095-mehmk49a	230	53	and	and	CC
cord-308095-mehmk49a	230	54	interests	interest	NNS
cord-308095-mehmk49a	230	55	,	,	,
cord-308095-mehmk49a	230	56	this	this	DT
cord-308095-mehmk49a	230	57	definition	definition	NN
cord-308095-mehmk49a	230	58	"	"	``
cord-308095-mehmk49a	230	59	diminishes	diminish	VBZ
cord-308095-mehmk49a	230	60	the	the	DT
cord-308095-mehmk49a	230	61	conflict	conflict	NN
cord-308095-mehmk49a	230	62	's	's	POS
cord-308095-mehmk49a	230	63	significance	significance	NN
cord-308095-mehmk49a	230	64	"	"	''
cord-308095-mehmk49a	230	65	(	(	-LRB-
cord-308095-mehmk49a	230	66	70	70	CD
cord-308095-mehmk49a	230	67	)	)	-RRB-
cord-308095-mehmk49a	230	68	.	.	.
cord-308095-mehmk49a	231	1	Rodwin	Rodwin	NNP
cord-308095-mehmk49a	231	2	also	also	RB
cord-308095-mehmk49a	231	3	expresses	express	VBZ
cord-308095-mehmk49a	231	4	concern	concern	NN
cord-308095-mehmk49a	231	5	that	that	IN
cord-308095-mehmk49a	231	6	"	"	``
cord-308095-mehmk49a	231	7	[	[	-LRB-
cord-308095-mehmk49a	231	8	e]fforts	e]ffort	NNS
cord-308095-mehmk49a	231	9	to	to	TO
cord-308095-mehmk49a	231	10	include	include	VB
cord-308095-mehmk49a	231	11	so	so	RB
cord-308095-mehmk49a	231	12	-	-	HYPH
cord-308095-mehmk49a	231	13	called	call	VBN
cord-308095-mehmk49a	231	14	intellectual	intellectual	JJ
cord-308095-mehmk49a	231	15	or	or	CC
cord-308095-mehmk49a	231	16	nonfinancial	nonfinancial	JJ
cord-308095-mehmk49a	231	17	conflicts	conflict	NNS
cord-308095-mehmk49a	231	18	as	as	IN
cord-308095-mehmk49a	231	19	conflicts	conflict	NNS
cord-308095-mehmk49a	231	20	of	of	IN
cord-308095-mehmk49a	231	21	interest	interest	NN
cord-308095-mehmk49a	231	22	blur	blur	VBP
cord-308095-mehmk49a	231	23	the	the	DT
cord-308095-mehmk49a	231	24	concept	concept	NN
cord-308095-mehmk49a	231	25	"	"	''
cord-308095-mehmk49a	231	26	(	(	-LRB-
cord-308095-mehmk49a	231	27	75	75	CD
cord-308095-mehmk49a	231	28	)	)	-RRB-
cord-308095-mehmk49a	231	29	.	.	.
cord-308095-mehmk49a	232	1	be	be	VB
cord-308095-mehmk49a	232	2	familiar	familiar	JJ
cord-308095-mehmk49a	232	3	with	with	IN
cord-308095-mehmk49a	232	4	the	the	DT
cord-308095-mehmk49a	232	5	relevant	relevant	JJ
cord-308095-mehmk49a	232	6	social	social	JJ
cord-308095-mehmk49a	232	7	science	science	NN
cord-308095-mehmk49a	232	8	-	-	HYPH
cord-308095-mehmk49a	232	9	including	include	VBG
cord-308095-mehmk49a	232	10	scholarship	scholarship	NN
cord-308095-mehmk49a	232	11	exploring	explore	VBG
cord-308095-mehmk49a	232	12	the	the	DT
cord-308095-mehmk49a	232	13	limitations	limitation	NNS
cord-308095-mehmk49a	232	14	and	and	CC
cord-308095-mehmk49a	232	15	potential	potential	JJ
cord-308095-mehmk49a	232	16	adverse	adverse	JJ
cord-308095-mehmk49a	232	17	effects	effect	NNS
cord-308095-mehmk49a	232	18	of	of	IN
cord-308095-mehmk49a	232	19	disclosure	disclosure	NN
cord-308095-mehmk49a	232	20	(	(	-LRB-
cord-308095-mehmk49a	232	21	e.g.	e.g.	RB
cord-308095-mehmk49a	232	22	,	,	,
cord-308095-mehmk49a	232	23	Cain	Cain	NNP
cord-308095-mehmk49a	232	24	,	,	,
cord-308095-mehmk49a	232	25	Loewenstein	Loewenstein	NNP
cord-308095-mehmk49a	232	26	,	,	,
cord-308095-mehmk49a	232	27	and	and	CC
cord-308095-mehmk49a	232	28	Moore	Moore	NNP
cord-308095-mehmk49a	232	29	2005	2005	CD
cord-308095-mehmk49a	232	30	;	;	:
cord-308095-mehmk49a	232	31	Lowenstein	Lowenstein	NNP
cord-308095-mehmk49a	232	32	,	,	,
cord-308095-mehmk49a	232	33	Sah	Sah	NNP
cord-308095-mehmk49a	232	34	,	,	,
cord-308095-mehmk49a	232	35	and	and	CC
cord-308095-mehmk49a	232	36	Cain	Cain	NNP
cord-308095-mehmk49a	232	37	2012	2012	CD
cord-308095-mehmk49a	232	38	;	;	:
cord-308095-mehmk49a	232	39	Sah	Sah	NNP
cord-308095-mehmk49a	232	40	2019	2019	CD
cord-308095-mehmk49a	232	41	)	)	-RRB-
cord-308095-mehmk49a	232	42	.	.	.
cord-308095-mehmk49a	233	1	Yet	yet	RB
cord-308095-mehmk49a	233	2	another	another	DT
cord-308095-mehmk49a	233	3	burden	burden	NN
cord-308095-mehmk49a	233	4	on	on	IN
cord-308095-mehmk49a	233	5	patients	patient	NNS
cord-308095-mehmk49a	233	6	resulting	result	VBG
cord-308095-mehmk49a	233	7	from	from	IN
cord-308095-mehmk49a	233	8	disclosure	disclosure	NN
cord-308095-mehmk49a	233	9	is	be	VBZ
cord-308095-mehmk49a	233	10	what	what	WP
cord-308095-mehmk49a	233	11	some	some	DT
cord-308095-mehmk49a	233	12	scholars	scholar	NNS
cord-308095-mehmk49a	233	13	call	call	VBP
cord-308095-mehmk49a	233	14	"	"	''
cord-308095-mehmk49a	233	15	insinuation	insinuation	NN
cord-308095-mehmk49a	233	16	anxiety"-although	anxiety"-although	NN
cord-308095-mehmk49a	233	17	patients	patient	NNS
cord-308095-mehmk49a	233	18	may	may	MD
cord-308095-mehmk49a	233	19	want	want	VB
cord-308095-mehmk49a	233	20	to	to	TO
cord-308095-mehmk49a	233	21	act	act	VB
cord-308095-mehmk49a	233	22	on	on	IN
cord-308095-mehmk49a	233	23	the	the	DT
cord-308095-mehmk49a	233	24	disclosure	disclosure	NN
cord-308095-mehmk49a	233	25	,	,	,
cord-308095-mehmk49a	233	26	they	-PRON-	PRP
cord-308095-mehmk49a	233	27	may	may	MD
cord-308095-mehmk49a	233	28	be	be	VB
cord-308095-mehmk49a	233	29	afraid	afraid	JJ
cord-308095-mehmk49a	233	30	to	to	TO
cord-308095-mehmk49a	233	31	signal	signal	VB
cord-308095-mehmk49a	233	32	distrust	distrust	NN
cord-308095-mehmk49a	233	33	to	to	IN
cord-308095-mehmk49a	233	34	their	-PRON-	PRP$
cord-308095-mehmk49a	233	35	physician	physician	NN
cord-308095-mehmk49a	233	36	(	(	-LRB-
cord-308095-mehmk49a	233	37	Loewenstein	Loewenstein	NNP
cord-308095-mehmk49a	233	38	,	,	,
cord-308095-mehmk49a	233	39	Cain	Cain	NNP
cord-308095-mehmk49a	233	40	,	,	,
cord-308095-mehmk49a	233	41	and	and	CC
cord-308095-mehmk49a	233	42	Sah	Sah	NNP
cord-308095-mehmk49a	233	43	2011	2011	CD
cord-308095-mehmk49a	233	44	;	;	:
cord-308095-mehmk49a	233	45	Sah	Sah	NNP
cord-308095-mehmk49a	233	46	2016	2016	CD
cord-308095-mehmk49a	233	47	;	;	:
cord-308095-mehmk49a	233	48	Sah	Sah	NNP
cord-308095-mehmk49a	233	49	,	,	,
cord-308095-mehmk49a	233	50	Loewenstein	Loewenstein	NNP
cord-308095-mehmk49a	233	51	,	,	,
cord-308095-mehmk49a	233	52	and	and	CC
cord-308095-mehmk49a	233	53	Cain	Cain	NNP
cord-308095-mehmk49a	233	54	2019	2019	CD
cord-308095-mehmk49a	233	55	)	)	-RRB-
cord-308095-mehmk49a	233	56	.	.	.
cord-308095-mehmk49a	234	1	And	and	CC
cord-308095-mehmk49a	234	2	,	,	,
cord-308095-mehmk49a	234	3	even	even	RB
cord-308095-mehmk49a	234	4	if	if	IN
cord-308095-mehmk49a	234	5	patients	patient	NNS
cord-308095-mehmk49a	234	6	are	be	VBP
cord-308095-mehmk49a	234	7	willing	willing	JJ
cord-308095-mehmk49a	234	8	to	to	TO
cord-308095-mehmk49a	234	9	act	act	VB
cord-308095-mehmk49a	234	10	,	,	,
cord-308095-mehmk49a	234	11	they	-PRON-	PRP
cord-308095-mehmk49a	234	12	may	may	MD
cord-308095-mehmk49a	234	13	not	not	RB
cord-308095-mehmk49a	234	14	have	have	VB
cord-308095-mehmk49a	234	15	the	the	DT
cord-308095-mehmk49a	234	16	time	time	NN
cord-308095-mehmk49a	234	17	or	or	CC
cord-308095-mehmk49a	234	18	resources	resource	NNS
cord-308095-mehmk49a	234	19	to	to	TO
cord-308095-mehmk49a	234	20	find	find	VB
cord-308095-mehmk49a	234	21	another	another	DT
cord-308095-mehmk49a	234	22	physician	physician	NN
cord-308095-mehmk49a	234	23	they	-PRON-	PRP
cord-308095-mehmk49a	234	24	trust	trust	VBP
cord-308095-mehmk49a	234	25	.	.	.
cord-308095-mehmk49a	235	1	This	this	DT
cord-308095-mehmk49a	235	2	is	be	VBZ
cord-308095-mehmk49a	235	3	a	a	DT
cord-308095-mehmk49a	235	4	great	great	JJ
cord-308095-mehmk49a	235	5	deal	deal	NN
cord-308095-mehmk49a	235	6	to	to	TO
cord-308095-mehmk49a	235	7	ask	ask	VB
cord-308095-mehmk49a	235	8	of	of	IN
cord-308095-mehmk49a	235	9	any	any	DT
cord-308095-mehmk49a	235	10	patient	patient	NN
cord-308095-mehmk49a	235	11	,	,	,
cord-308095-mehmk49a	235	12	let	let	VB
cord-308095-mehmk49a	235	13	alone	alone	RB
cord-308095-mehmk49a	235	14	one	one	CD
cord-308095-mehmk49a	235	15	in	in	IN
cord-308095-mehmk49a	235	16	severe	severe	JJ
cord-308095-mehmk49a	235	17	pain	pain	NN
cord-308095-mehmk49a	235	18	.	.	.
cord-308095-mehmk49a	236	1	Disclosure	disclosure	NN
cord-308095-mehmk49a	236	2	of	of	IN
cord-308095-mehmk49a	236	3	the	the	DT
cord-308095-mehmk49a	236	4	opioid	opioid	JJ
cord-308095-mehmk49a	236	5	industry	industry	NN
cord-308095-mehmk49a	236	6	's	's	POS
cord-308095-mehmk49a	236	7	relationships	relationship	NNS
cord-308095-mehmk49a	236	8	with	with	IN
cord-308095-mehmk49a	236	9	universities	university	NNS
cord-308095-mehmk49a	236	10	,	,	,
cord-308095-mehmk49a	236	11	academic	academic	JJ
cord-308095-mehmk49a	236	12	medical	medical	JJ
cord-308095-mehmk49a	236	13	centres	centre	NNS
cord-308095-mehmk49a	236	14	,	,	,
cord-308095-mehmk49a	236	15	and	and	CC
cord-308095-mehmk49a	236	16	teaching	teach	VBG
cord-308095-mehmk49a	236	17	hospitals	hospital	NNS
cord-308095-mehmk49a	236	18	,	,	,
cord-308095-mehmk49a	236	19	as	as	RB
cord-308095-mehmk49a	236	20	well	well	RB
cord-308095-mehmk49a	236	21	as	as	IN
cord-308095-mehmk49a	236	22	individual	individual	JJ
cord-308095-mehmk49a	236	23	researchers	researcher	NNS
cord-308095-mehmk49a	236	24	is	be	VBZ
cord-308095-mehmk49a	236	25	also	also	RB
cord-308095-mehmk49a	236	26	necessary	necessary	JJ
cord-308095-mehmk49a	236	27	,	,	,
cord-308095-mehmk49a	236	28	but	but	CC
cord-308095-mehmk49a	236	29	not	not	RB
cord-308095-mehmk49a	236	30	sufficient	sufficient	JJ
cord-308095-mehmk49a	236	31	,	,	,
cord-308095-mehmk49a	236	32	if	if	IN
cord-308095-mehmk49a	236	33	we	-PRON-	PRP
cord-308095-mehmk49a	236	34	are	be	VBP
cord-308095-mehmk49a	236	35	to	to	TO
cord-308095-mehmk49a	236	36	address	address	VB
cord-308095-mehmk49a	236	37	the	the	DT
cord-308095-mehmk49a	236	38	influence	influence	NN
cord-308095-mehmk49a	236	39	of	of	IN
cord-308095-mehmk49a	236	40	the	the	DT
cord-308095-mehmk49a	236	41	opioid	opioid	JJ
cord-308095-mehmk49a	236	42	industry	industry	NN
cord-308095-mehmk49a	236	43	on	on	IN
cord-308095-mehmk49a	236	44	medical	medical	JJ
cord-308095-mehmk49a	236	45	research	research	NN
cord-308095-mehmk49a	236	46	and	and	CC
cord-308095-mehmk49a	236	47	education	education	NN
cord-308095-mehmk49a	236	48	.	.	.
cord-308095-mehmk49a	237	1	We	-PRON-	PRP
cord-308095-mehmk49a	237	2	should	should	MD
cord-308095-mehmk49a	237	3	bear	bear	VB
cord-308095-mehmk49a	237	4	in	in	IN
cord-308095-mehmk49a	237	5	mind	mind	NN
cord-308095-mehmk49a	237	6	that	that	IN
cord-308095-mehmk49a	237	7	many	many	JJ
cord-308095-mehmk49a	237	8	of	of	IN
cord-308095-mehmk49a	237	9	the	the	DT
cord-308095-mehmk49a	237	10	relationships	relationship	NNS
cord-308095-mehmk49a	237	11	were	be	VBD
cord-308095-mehmk49a	237	12	not	not	RB
cord-308095-mehmk49a	237	13	a	a	DT
cord-308095-mehmk49a	237	14	secret	secret	NN
cord-308095-mehmk49a	237	15	-	-	HYPH
cord-308095-mehmk49a	237	16	for	for	RP
cord-308095-mehmk49a	237	17	example	example	NN
cord-308095-mehmk49a	237	18	,	,	,
cord-308095-mehmk49a	237	19	when	when	WRB
cord-308095-mehmk49a	237	20	Purdue	Purdue	NNP
cord-308095-mehmk49a	237	21	Pharma	Pharma	NNP
cord-308095-mehmk49a	237	22	gave	give	VBD
cord-308095-mehmk49a	237	23	a	a	DT
cord-308095-mehmk49a	237	24	$	$	$
cord-308095-mehmk49a	237	25	3	3	CD
cord-308095-mehmk49a	237	26	million	million	CD
cord-308095-mehmk49a	237	27	gift	gift	NN
cord-308095-mehmk49a	237	28	to	to	IN
cord-308095-mehmk49a	237	29	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	237	30	General	General	NNP
cord-308095-mehmk49a	237	31	Hospital	Hospital	NNP
cord-308095-mehmk49a	237	32	(	(	-LRB-
cord-308095-mehmk49a	237	33	MGH	MGH	NNP
cord-308095-mehmk49a	237	34	)	)	-RRB-
cord-308095-mehmk49a	237	35	in	in	IN
cord-308095-mehmk49a	237	36	2002	2002	CD
cord-308095-mehmk49a	237	37	,	,	,
cord-308095-mehmk49a	237	38	its	-PRON-	PRP$
cord-308095-mehmk49a	237	39	centre	centre	NN
cord-308095-mehmk49a	237	40	was	be	VBD
cord-308095-mehmk49a	237	41	named	name	VBN
cord-308095-mehmk49a	237	42	the	the	DT
cord-308095-mehmk49a	237	43	"	"	``
cord-308095-mehmk49a	237	44	MGH	MGH	NNP
cord-308095-mehmk49a	237	45	Purdue	Purdue	NNP
cord-308095-mehmk49a	237	46	Pharma	Pharma	NNP
cord-308095-mehmk49a	237	47	Pain	Pain	NNP
cord-308095-mehmk49a	237	48	Center	Center	NNP
cord-308095-mehmk49a	237	49	.	.	.
cord-308095-mehmk49a	238	1	"	"	``
cord-308095-mehmk49a	238	2	Several	several	JJ
cord-308095-mehmk49a	238	3	metaanalyses	metaanalyse	NNS
cord-308095-mehmk49a	238	4	have	have	VBP
cord-308095-mehmk49a	238	5	shown	show	VBN
cord-308095-mehmk49a	238	6	that	that	IN
cord-308095-mehmk49a	238	7	industry	industry	NN
cord-308095-mehmk49a	238	8	funding	funding	NN
cord-308095-mehmk49a	238	9	of	of	IN
cord-308095-mehmk49a	238	10	medical	medical	JJ
cord-308095-mehmk49a	238	11	research	research	NN
cord-308095-mehmk49a	238	12	tends	tend	VBZ
cord-308095-mehmk49a	238	13	to	to	TO
cord-308095-mehmk49a	238	14	produce	produce	VB
cord-308095-mehmk49a	238	15	more	more	RBR
cord-308095-mehmk49a	238	16	favourable	favourable	JJ
cord-308095-mehmk49a	238	17	findings	finding	NNS
cord-308095-mehmk49a	238	18	for	for	IN
cord-308095-mehmk49a	238	19	the	the	DT
cord-308095-mehmk49a	238	20	industry	industry	NN
cord-308095-mehmk49a	238	21	sponsor	sponsor	NN
cord-308095-mehmk49a	238	22	(	(	-LRB-
cord-308095-mehmk49a	238	23	see	see	VB
cord-308095-mehmk49a	238	24	,	,	,
cord-308095-mehmk49a	238	25	e.g.	e.g.	RB
cord-308095-mehmk49a	238	26	,	,	,
cord-308095-mehmk49a	238	27	Lundh	Lundh	NNP
cord-308095-mehmk49a	238	28	et	et	NNP
cord-308095-mehmk49a	238	29	al	al	NNP
cord-308095-mehmk49a	238	30	.	.	.
cord-308095-mehmk49a	238	31	2017	2017	CD
cord-308095-mehmk49a	238	32	;	;	:
cord-308095-mehmk49a	238	33	Bekelman	Bekelman	NNP
cord-308095-mehmk49a	238	34	,	,	,
cord-308095-mehmk49a	238	35	Li	Li	NNP
cord-308095-mehmk49a	238	36	,	,	,
cord-308095-mehmk49a	238	37	and	and	CC
cord-308095-mehmk49a	238	38	Gross	Gross	NNP
cord-308095-mehmk49a	238	39	2003	2003	CD
cord-308095-mehmk49a	238	40	)	)	-RRB-
cord-308095-mehmk49a	238	41	.	.	.
cord-308095-mehmk49a	239	1	Given	give	VBN
cord-308095-mehmk49a	239	2	that	that	IN
cord-308095-mehmk49a	239	3	these	these	DT
cord-308095-mehmk49a	239	4	analyses	analysis	NNS
cord-308095-mehmk49a	239	5	are	be	VBP
cord-308095-mehmk49a	239	6	based	base	VBN
cord-308095-mehmk49a	239	7	on	on	IN
cord-308095-mehmk49a	239	8	studies	study	NNS
cord-308095-mehmk49a	239	9	that	that	WDT
cord-308095-mehmk49a	239	10	disclose	disclose	VBP
cord-308095-mehmk49a	239	11	their	-PRON-	PRP$
cord-308095-mehmk49a	239	12	industry	industry	NN
cord-308095-mehmk49a	239	13	funding	funding	NN
cord-308095-mehmk49a	239	14	,	,	,
cord-308095-mehmk49a	239	15	it	-PRON-	PRP
cord-308095-mehmk49a	239	16	is	be	VBZ
cord-308095-mehmk49a	239	17	clear	clear	JJ
cord-308095-mehmk49a	239	18	that	that	IN
cord-308095-mehmk49a	239	19	disclosure	disclosure	NN
cord-308095-mehmk49a	239	20	in	in	IN
cord-308095-mehmk49a	239	21	this	this	DT
cord-308095-mehmk49a	239	22	context	context	NN
cord-308095-mehmk49a	239	23	does	do	VBZ
cord-308095-mehmk49a	239	24	not	not	RB
cord-308095-mehmk49a	239	25	serve	serve	VB
cord-308095-mehmk49a	239	26	to	to	TO
cord-308095-mehmk49a	239	27	neutralize	neutralize	VB
cord-308095-mehmk49a	239	28	the	the	DT
cord-308095-mehmk49a	239	29	bias	bias	NN
cord-308095-mehmk49a	239	30	.	.	.
cord-308095-mehmk49a	240	1	In	in	IN
cord-308095-mehmk49a	240	2	addition	addition	NN
cord-308095-mehmk49a	240	3	to	to	IN
cord-308095-mehmk49a	240	4	the	the	DT
cord-308095-mehmk49a	240	5	impact	impact	NN
cord-308095-mehmk49a	240	6	on	on	IN
cord-308095-mehmk49a	240	7	research	research	NN
cord-308095-mehmk49a	240	8	findings	finding	NNS
cord-308095-mehmk49a	240	9	and	and	CC
cord-308095-mehmk49a	240	10	the	the	DT
cord-308095-mehmk49a	240	11	interpretations	interpretation	NNS
cord-308095-mehmk49a	240	12	of	of	IN
cord-308095-mehmk49a	240	13	those	those	DT
cord-308095-mehmk49a	240	14	findings	finding	NNS
cord-308095-mehmk49a	240	15	,	,	,
cord-308095-mehmk49a	240	16	industrysponsored	industrysponsored	JJ
cord-308095-mehmk49a	240	17	research	research	NN
cord-308095-mehmk49a	240	18	influences	influence	VBZ
cord-308095-mehmk49a	240	19	the	the	DT
cord-308095-mehmk49a	240	20	kinds	kind	NNS
cord-308095-mehmk49a	240	21	of	of	IN
cord-308095-mehmk49a	240	22	questions	question	NNS
cord-308095-mehmk49a	240	23	that	that	WDT
cord-308095-mehmk49a	240	24	researchers	researcher	NNS
cord-308095-mehmk49a	240	25	explore	explore	VBP
cord-308095-mehmk49a	240	26	(	(	-LRB-
cord-308095-mehmk49a	240	27	and	and	CC
cord-308095-mehmk49a	240	28	those	those	DT
cord-308095-mehmk49a	240	29	they	-PRON-	PRP
cord-308095-mehmk49a	240	30	neglect	neglect	VBP
cord-308095-mehmk49a	240	31	or	or	CC
cord-308095-mehmk49a	240	32	ignore	ignore	VBP
cord-308095-mehmk49a	240	33	)	)	-RRB-
cord-308095-mehmk49a	240	34	and	and	CC
cord-308095-mehmk49a	240	35	the	the	DT
cord-308095-mehmk49a	240	36	ways	way	NNS
cord-308095-mehmk49a	240	37	in	in	IN
cord-308095-mehmk49a	240	38	which	which	WDT
cord-308095-mehmk49a	240	39	those	those	DT
cord-308095-mehmk49a	240	40	questions	question	NNS
cord-308095-mehmk49a	240	41	are	be	VBP
cord-308095-mehmk49a	240	42	explored	explore	VBN
cord-308095-mehmk49a	240	43	(	(	-LRB-
cord-308095-mehmk49a	240	44	Marks	Marks	NNP
cord-308095-mehmk49a	240	45	2019a	2019a	CD
cord-308095-mehmk49a	240	46	,	,	,
cord-308095-mehmk49a	240	47	75	75	CD
cord-308095-mehmk49a	240	48	-	-	SYM
cord-308095-mehmk49a	240	49	78	78	CD
cord-308095-mehmk49a	240	50	)	)	-RRB-
cord-308095-mehmk49a	240	51	.	.	.
cord-308095-mehmk49a	241	1	Research	research	NN
cord-308095-mehmk49a	241	2	agenda	agenda	NN
cord-308095-mehmk49a	241	3	distortion	distortion	NN
cord-308095-mehmk49a	241	4	-	-	:
cord-308095-mehmk49a	241	5	which	which	WDT
cord-308095-mehmk49a	241	6	is	be	VBZ
cord-308095-mehmk49a	241	7	not	not	RB
cord-308095-mehmk49a	241	8	eliminated	eliminate	VBN
cord-308095-mehmk49a	241	9	by	by	IN
cord-308095-mehmk49a	241	10	the	the	DT
cord-308095-mehmk49a	241	11	disclosure	disclosure	NN
cord-308095-mehmk49a	241	12	of	of	IN
cord-308095-mehmk49a	241	13	the	the	DT
cord-308095-mehmk49a	241	14	relationships	relationship	NNS
cord-308095-mehmk49a	241	15	that	that	WDT
cord-308095-mehmk49a	241	16	contribute	contribute	VBP
cord-308095-mehmk49a	241	17	to	to	IN
cord-308095-mehmk49a	241	18	the	the	DT
cord-308095-mehmk49a	241	19	distortioncan	distortioncan	NN
cord-308095-mehmk49a	241	20	be	be	VB
cord-308095-mehmk49a	241	21	both	both	DT
cord-308095-mehmk49a	241	22	subtle	subtle	JJ
cord-308095-mehmk49a	241	23	and	and	CC
cord-308095-mehmk49a	241	24	profound	profound	JJ
cord-308095-mehmk49a	241	25	.	.	.
cord-308095-mehmk49a	242	1	In	in	IN
cord-308095-mehmk49a	242	2	the	the	DT
cord-308095-mehmk49a	242	3	case	case	NN
cord-308095-mehmk49a	242	4	of	of	IN
cord-308095-mehmk49a	242	5	the	the	DT
cord-308095-mehmk49a	242	6	opioid	opioid	JJ
cord-308095-mehmk49a	242	7	crisis	crisis	NN
cord-308095-mehmk49a	242	8	,	,	,
cord-308095-mehmk49a	242	9	it	-PRON-	PRP
cord-308095-mehmk49a	242	10	triggered	trigger	VBD
cord-308095-mehmk49a	242	11	an	an	DT
cord-308095-mehmk49a	242	12	expansion	expansion	NN
cord-308095-mehmk49a	242	13	of	of	IN
cord-308095-mehmk49a	242	14	the	the	DT
cord-308095-mehmk49a	242	15	use	use	NN
cord-308095-mehmk49a	242	16	of	of	IN
cord-308095-mehmk49a	242	17	opioids	opioid	NNS
cord-308095-mehmk49a	242	18	to	to	IN
cord-308095-mehmk49a	242	19	non	non	JJ
cord-308095-mehmk49a	242	20	-	-	JJ
cord-308095-mehmk49a	242	21	cancer	cancer	JJ
cord-308095-mehmk49a	242	22	patients	patient	NNS
cord-308095-mehmk49a	242	23	,	,	,
cord-308095-mehmk49a	242	24	and	and	CC
cord-308095-mehmk49a	242	25	it	-PRON-	PRP
cord-308095-mehmk49a	242	26	continues	continue	VBZ
cord-308095-mehmk49a	242	27	to	to	TO
cord-308095-mehmk49a	242	28	lead	lead	VB
cord-308095-mehmk49a	242	29	to	to	IN
cord-308095-mehmk49a	242	30	an	an	DT
cord-308095-mehmk49a	242	31	emphasis	emphasis	NN
cord-308095-mehmk49a	242	32	on	on	IN
cord-308095-mehmk49a	242	33	pharmacological	pharmacological	JJ
cord-308095-mehmk49a	242	34	solutions	solution	NNS
cord-308095-mehmk49a	242	35	to	to	IN
cord-308095-mehmk49a	242	36	both	both	DT
cord-308095-mehmk49a	242	37	pain	pain	NN
cord-308095-mehmk49a	242	38	management	management	NN
cord-308095-mehmk49a	242	39	and	and	CC
cord-308095-mehmk49a	242	40	addiction	addiction	NN
cord-308095-mehmk49a	242	41	.	.	.
cord-308095-mehmk49a	243	1	I	-PRON-	PRP
cord-308095-mehmk49a	243	2	am	be	VBP
cord-308095-mehmk49a	243	3	not	not	RB
cord-308095-mehmk49a	243	4	suggesting	suggest	VBG
cord-308095-mehmk49a	243	5	that	that	IN
cord-308095-mehmk49a	243	6	pharmacological	pharmacological	JJ
cord-308095-mehmk49a	243	7	solutions	solution	NNS
cord-308095-mehmk49a	243	8	have	have	VBP
cord-308095-mehmk49a	243	9	no	no	DT
cord-308095-mehmk49a	243	10	place	place	NN
cord-308095-mehmk49a	243	11	.	.	.
cord-308095-mehmk49a	244	1	But	but	CC
cord-308095-mehmk49a	244	2	,	,	,
cord-308095-mehmk49a	244	3	if	if	IN
cord-308095-mehmk49a	244	4	we	-PRON-	PRP
cord-308095-mehmk49a	244	5	are	be	VBP
cord-308095-mehmk49a	244	6	serious	serious	JJ
cord-308095-mehmk49a	244	7	about	about	IN
cord-308095-mehmk49a	244	8	solving	solve	VBG
cord-308095-mehmk49a	244	9	these	these	DT
cord-308095-mehmk49a	244	10	public	public	JJ
cord-308095-mehmk49a	244	11	health	health	NN
cord-308095-mehmk49a	244	12	challenges	challenge	NNS
cord-308095-mehmk49a	244	13	,	,	,
cord-308095-mehmk49a	244	14	we	-PRON-	PRP
cord-308095-mehmk49a	244	15	must	must	MD
cord-308095-mehmk49a	244	16	be	be	VB
cord-308095-mehmk49a	244	17	prepared	prepared	JJ
cord-308095-mehmk49a	244	18	to	to	TO
cord-308095-mehmk49a	244	19	explore	explore	VB
cord-308095-mehmk49a	244	20	all	all	DT
cord-308095-mehmk49a	244	21	potential	potential	JJ
cord-308095-mehmk49a	244	22	solutions	solution	NNS
cord-308095-mehmk49a	244	23	,	,	,
cord-308095-mehmk49a	244	24	including	include	VBG
cord-308095-mehmk49a	244	25	those	those	DT
cord-308095-mehmk49a	244	26	that	that	WDT
cord-308095-mehmk49a	244	27	may	may	MD
cord-308095-mehmk49a	244	28	be	be	VB
cord-308095-mehmk49a	244	29	inimical	inimical	JJ
cord-308095-mehmk49a	244	30	to	to	IN
cord-308095-mehmk49a	244	31	the	the	DT
cord-308095-mehmk49a	244	32	commercial	commercial	JJ
cord-308095-mehmk49a	244	33	interests	interest	NNS
cord-308095-mehmk49a	244	34	of	of	IN
cord-308095-mehmk49a	244	35	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	244	36	companies	company	NNS
cord-308095-mehmk49a	244	37	.	.	.
cord-308095-mehmk49a	245	1	It	-PRON-	PRP
cord-308095-mehmk49a	245	2	would	would	MD
cord-308095-mehmk49a	245	3	certainly	certainly	RB
cord-308095-mehmk49a	245	4	have	have	VB
cord-308095-mehmk49a	245	5	been	be	VBN
cord-308095-mehmk49a	245	6	important	important	JJ
cord-308095-mehmk49a	245	7	for	for	IN
cord-308095-mehmk49a	245	8	the	the	DT
cord-308095-mehmk49a	245	9	CDC	CDC	NNP
cord-308095-mehmk49a	245	10	to	to	TO
cord-308095-mehmk49a	245	11	know	know	VB
cord-308095-mehmk49a	245	12	that	that	IN
cord-308095-mehmk49a	245	13	many	many	JJ
cord-308095-mehmk49a	245	14	of	of	IN
cord-308095-mehmk49a	245	15	the	the	DT
cord-308095-mehmk49a	245	16	patient	patient	JJ
cord-308095-mehmk49a	245	17	advocacy	advocacy	NN
cord-308095-mehmk49a	245	18	organizations	organization	NNS
cord-308095-mehmk49a	245	19	and	and	CC
cord-308095-mehmk49a	245	20	medical	medical	JJ
cord-308095-mehmk49a	245	21	professional	professional	JJ
cord-308095-mehmk49a	245	22	associations	association	NNS
cord-308095-mehmk49a	245	23	that	that	WDT
cord-308095-mehmk49a	245	24	were	be	VBD
cord-308095-mehmk49a	245	25	objecting	object	VBG
cord-308095-mehmk49a	245	26	to	to	IN
cord-308095-mehmk49a	245	27	its	-PRON-	PRP$
cord-308095-mehmk49a	245	28	draft	draft	NN
cord-308095-mehmk49a	245	29	guidelines	guideline	NNS
cord-308095-mehmk49a	245	30	(	(	-LRB-
cord-308095-mehmk49a	245	31	calling	call	VBG
cord-308095-mehmk49a	245	32	for	for	IN
cord-308095-mehmk49a	245	33	more	more	JJR
cord-308095-mehmk49a	245	34	restraint	restraint	NN
cord-308095-mehmk49a	245	35	on	on	IN
cord-308095-mehmk49a	245	36	opioid	opioid	JJ
cord-308095-mehmk49a	245	37	prescribing	prescribe	VBG
cord-308095-mehmk49a	245	38	)	)	-RRB-
cord-308095-mehmk49a	245	39	had	have	VBD
cord-308095-mehmk49a	245	40	received	receive	VBN
cord-308095-mehmk49a	245	41	funding	funding	NN
cord-308095-mehmk49a	245	42	from	from	IN
cord-308095-mehmk49a	245	43	opioid	opioid	JJ
cord-308095-mehmk49a	245	44	companies	company	NNS
cord-308095-mehmk49a	245	45	.	.	.
cord-308095-mehmk49a	246	1	This	this	DT
cord-308095-mehmk49a	246	2	was	be	VBD
cord-308095-mehmk49a	246	3	significant	significant	JJ
cord-308095-mehmk49a	246	4	information	information	NN
cord-308095-mehmk49a	246	5	,	,	,
cord-308095-mehmk49a	246	6	whether	whether	IN
cord-308095-mehmk49a	246	7	or	or	CC
cord-308095-mehmk49a	246	8	not	not	RB
cord-308095-mehmk49a	246	9	the	the	DT
cord-308095-mehmk49a	246	10	groups	group	NNS
cord-308095-mehmk49a	246	11	were	be	VBD
cord-308095-mehmk49a	246	12	dependent	dependent	JJ
cord-308095-mehmk49a	246	13	on	on	IN
cord-308095-mehmk49a	246	14	industry	industry	NN
cord-308095-mehmk49a	246	15	funding	funding	NN
cord-308095-mehmk49a	246	16	(	(	-LRB-
cord-308095-mehmk49a	246	17	and	and	CC
cord-308095-mehmk49a	246	18	some	some	DT
cord-308095-mehmk49a	246	19	clearly	clearly	RB
cord-308095-mehmk49a	246	20	were	be	VBD
cord-308095-mehmk49a	246	21	)	)	-RRB-
cord-308095-mehmk49a	246	22	.	.	.
cord-308095-mehmk49a	247	1	Lack	lack	NN
cord-308095-mehmk49a	247	2	of	of	IN
cord-308095-mehmk49a	247	3	dependence	dependence	NN
cord-308095-mehmk49a	247	4	is	be	VBZ
cord-308095-mehmk49a	247	5	not	not	RB
cord-308095-mehmk49a	247	6	the	the	DT
cord-308095-mehmk49a	247	7	same	same	JJ
cord-308095-mehmk49a	247	8	as	as	IN
cord-308095-mehmk49a	247	9	independence	independence	NN
cord-308095-mehmk49a	247	10	.	.	.
cord-308095-mehmk49a	248	1	4	4	LS
cord-308095-mehmk49a	249	1	So	so	RB
cord-308095-mehmk49a	249	2	the	the	DT
cord-308095-mehmk49a	249	3	disclosure	disclosure	NN
cord-308095-mehmk49a	249	4	of	of	IN
cord-308095-mehmk49a	249	5	patient	patient	JJ
cord-308095-mehmk49a	249	6	advocacy	advocacy	NN
cord-308095-mehmk49a	249	7	groups	group	NNS
cord-308095-mehmk49a	249	8	'	'	POS
cord-308095-mehmk49a	249	9	and	and	CC
cord-308095-mehmk49a	249	10	medical	medical	JJ
cord-308095-mehmk49a	249	11	professional	professional	JJ
cord-308095-mehmk49a	249	12	associations	association	NNS
cord-308095-mehmk49a	249	13	'	'	POS
cord-308095-mehmk49a	249	14	financial	financial	JJ
cord-308095-mehmk49a	249	15	relationships	relationship	NNS
cord-308095-mehmk49a	249	16	is	be	VBZ
cord-308095-mehmk49a	249	17	clearly	clearly	RB
cord-308095-mehmk49a	249	18	necessary	necessary	JJ
cord-308095-mehmk49a	249	19	.	.	.
cord-308095-mehmk49a	250	1	But	but	CC
cord-308095-mehmk49a	250	2	disclosure	disclosure	NN
cord-308095-mehmk49a	250	3	alone	alone	RB
cord-308095-mehmk49a	250	4	will	will	MD
cord-308095-mehmk49a	250	5	not	not	RB
cord-308095-mehmk49a	250	6	address	address	VB
cord-308095-mehmk49a	250	7	the	the	DT
cord-308095-mehmk49a	250	8	systemic	systemic	JJ
cord-308095-mehmk49a	250	9	problem	problem	NN
cord-308095-mehmk49a	250	10	that	that	WDT
cord-308095-mehmk49a	250	11	arises	arise	VBZ
cord-308095-mehmk49a	250	12	when	when	WRB
cord-308095-mehmk49a	250	13	,	,	,
cord-308095-mehmk49a	250	14	as	as	IN
cord-308095-mehmk49a	250	15	is	be	VBZ
cord-308095-mehmk49a	250	16	so	so	RB
cord-308095-mehmk49a	250	17	often	often	RB
cord-308095-mehmk49a	250	18	the	the	DT
cord-308095-mehmk49a	250	19	case	case	NN
cord-308095-mehmk49a	250	20	,	,	,
cord-308095-mehmk49a	250	21	most	most	JJS
cord-308095-mehmk49a	250	22	of	of	IN
cord-308095-mehmk49a	250	23	the	the	DT
cord-308095-mehmk49a	250	24	relevant	relevant	JJ
cord-308095-mehmk49a	250	25	public	public	JJ
cord-308095-mehmk49a	250	26	health	health	NN
cord-308095-mehmk49a	250	27	NGOs	NGOs	NNPS
cord-308095-mehmk49a	250	28	related	relate	VBN
cord-308095-mehmk49a	250	29	to	to	IN
cord-308095-mehmk49a	250	30	a	a	DT
cord-308095-mehmk49a	250	31	particular	particular	JJ
cord-308095-mehmk49a	250	32	health	health	NN
cord-308095-mehmk49a	250	33	problem	problem	NN
cord-308095-mehmk49a	250	34	receive	receive	VBP
cord-308095-mehmk49a	250	35	funding	funding	NN
cord-308095-mehmk49a	250	36	from	from	IN
cord-308095-mehmk49a	250	37	industry	industry	NN
cord-308095-mehmk49a	250	38	actors	actor	NNS
cord-308095-mehmk49a	250	39	with	with	IN
cord-308095-mehmk49a	250	40	a	a	DT
cord-308095-mehmk49a	250	41	vested	vested	JJ
cord-308095-mehmk49a	250	42	interest	interest	NN
cord-308095-mehmk49a	250	43	in	in	IN
cord-308095-mehmk49a	250	44	the	the	DT
cord-308095-mehmk49a	250	45	solution	solution	NN
cord-308095-mehmk49a	250	46	to	to	IN
cord-308095-mehmk49a	250	47	that	that	DT
cord-308095-mehmk49a	250	48	problem	problem	NN
cord-308095-mehmk49a	250	49	.	.	.
cord-308095-mehmk49a	251	1	5	5	LS
cord-308095-mehmk49a	251	2	Policymakers	policymaker	NNS
cord-308095-mehmk49a	251	3	are	be	VBP
cord-308095-mehmk49a	251	4	then	then	RB
cord-308095-mehmk49a	251	5	left	leave	VBN
cord-308095-mehmk49a	251	6	with	with	IN
cord-308095-mehmk49a	251	7	the	the	DT
cord-308095-mehmk49a	251	8	unenviable	unenviable	JJ
cord-308095-mehmk49a	251	9	task	task	NN
cord-308095-mehmk49a	251	10	of	of	IN
cord-308095-mehmk49a	251	11	having	have	VBG
cord-308095-mehmk49a	251	12	to	to	TO
cord-308095-mehmk49a	251	13	decide	decide	VB
cord-308095-mehmk49a	251	14	whether	whether	IN
cord-308095-mehmk49a	251	15	to	to	TO
cord-308095-mehmk49a	251	16	ignore	ignore	VB
cord-308095-mehmk49a	251	17	these	these	DT
cord-308095-mehmk49a	251	18	entities	entity	NNS
cord-308095-mehmk49a	251	19	'	'	POS
cord-308095-mehmk49a	251	20	representations	representation	NNS
cord-308095-mehmk49a	251	21	entirely	entirely	RB
cord-308095-mehmk49a	251	22	or	or	CC
cord-308095-mehmk49a	251	23	to	to	TO
cord-308095-mehmk49a	251	24	accord	accord	VB
cord-308095-mehmk49a	251	25	them	-PRON-	PRP
cord-308095-mehmk49a	251	26	less	less	JJR
cord-308095-mehmk49a	251	27	weight	weight	NN
cord-308095-mehmk49a	251	28	-	-	HYPH
cord-308095-mehmk49a	251	29	and	and	CC
cord-308095-mehmk49a	251	30	,	,	,
cord-308095-mehmk49a	251	31	in	in	IN
cord-308095-mehmk49a	251	32	either	either	DT
cord-308095-mehmk49a	251	33	case	case	NN
cord-308095-mehmk49a	251	34	,	,	,
cord-308095-mehmk49a	251	35	whether	whether	IN
cord-308095-mehmk49a	251	36	to	to	TO
cord-308095-mehmk49a	251	37	do	do	VB
cord-308095-mehmk49a	251	38	so	so	RB
cord-308095-mehmk49a	251	39	across	across	IN
cord-308095-mehmk49a	251	40	the	the	DT
cord-308095-mehmk49a	251	41	board	board	NN
cord-308095-mehmk49a	251	42	,	,	,
cord-308095-mehmk49a	251	43	or	or	CC
cord-308095-mehmk49a	251	44	only	only	RB
cord-308095-mehmk49a	251	45	when	when	WRB
cord-308095-mehmk49a	251	46	these	these	DT
cord-308095-mehmk49a	251	47	groups	group	NNS
cord-308095-mehmk49a	251	48	'	'	POS
cord-308095-mehmk49a	251	49	representations	representation	NNS
cord-308095-mehmk49a	251	50	align	align	VBP
cord-308095-mehmk49a	251	51	with	with	IN
cord-308095-mehmk49a	251	52	the	the	DT
cord-308095-mehmk49a	251	53	interests	interest	NNS
cord-308095-mehmk49a	251	54	of	of	IN
cord-308095-mehmk49a	251	55	powerful	powerful	JJ
cord-308095-mehmk49a	251	56	corporate	corporate	JJ
cord-308095-mehmk49a	251	57	actors	actor	NNS
cord-308095-mehmk49a	251	58	operating	operate	VBG
cord-308095-mehmk49a	251	59	in	in	IN
cord-308095-mehmk49a	251	60	the	the	DT
cord-308095-mehmk49a	251	61	same	same	JJ
cord-308095-mehmk49a	251	62	space	space	NN
cord-308095-mehmk49a	251	63	.	.	.
cord-308095-mehmk49a	252	1	And	and	CC
cord-308095-mehmk49a	252	2	,	,	,
cord-308095-mehmk49a	252	3	more	more	RBR
cord-308095-mehmk49a	252	4	fundamentally	fundamentally	RB
cord-308095-mehmk49a	252	5	,	,	,
cord-308095-mehmk49a	252	6	policymakers	policymaker	NNS
cord-308095-mehmk49a	252	7	lack	lack	VBP
cord-308095-mehmk49a	252	8	what	what	WP
cord-308095-mehmk49a	252	9	they	-PRON-	PRP
cord-308095-mehmk49a	252	10	really	really	RB
cord-308095-mehmk49a	252	11	need	need	VBP
cord-308095-mehmk49a	252	12	-	-	HYPH
cord-308095-mehmk49a	252	13	access	access	NN
cord-308095-mehmk49a	252	14	to	to	IN
cord-308095-mehmk49a	252	15	the	the	DT
cord-308095-mehmk49a	252	16	full	full	JJ
cord-308095-mehmk49a	252	17	range	range	NN
cord-308095-mehmk49a	252	18	of	of	IN
cord-308095-mehmk49a	252	19	views	view	NNS
cord-308095-mehmk49a	252	20	and	and	CC
cord-308095-mehmk49a	252	21	interests	interest	NNS
cord-308095-mehmk49a	252	22	of	of	IN
cord-308095-mehmk49a	252	23	patients	patient	NNS
cord-308095-mehmk49a	252	24	that	that	WDT
cord-308095-mehmk49a	252	25	are	be	VBP
cord-308095-mehmk49a	252	26	truly	truly	RB
cord-308095-mehmk49a	252	27	independent	independent	JJ
cord-308095-mehmk49a	252	28	of	of	IN
cord-308095-mehmk49a	252	29	the	the	DT
cord-308095-mehmk49a	252	30	views	view	NNS
cord-308095-mehmk49a	252	31	and	and	CC
cord-308095-mehmk49a	252	32	interests	interest	NNS
cord-308095-mehmk49a	252	33	of	of	IN
cord-308095-mehmk49a	252	34	industry	industry	NN
cord-308095-mehmk49a	252	35	.	.	.
cord-308095-mehmk49a	253	1	Turning	turn	VBG
cord-308095-mehmk49a	253	2	now	now	RB
cord-308095-mehmk49a	253	3	to	to	IN
cord-308095-mehmk49a	253	4	public	public	JJ
cord-308095-mehmk49a	253	5	health	health	NN
cord-308095-mehmk49a	253	6	agencies	agency	NNS
cord-308095-mehmk49a	253	7	and	and	CC
cord-308095-mehmk49a	253	8	legislators	legislator	NNS
cord-308095-mehmk49a	253	9	,	,	,
cord-308095-mehmk49a	253	10	once	once	RB
cord-308095-mehmk49a	253	11	again	again	RB
cord-308095-mehmk49a	253	12	we	-PRON-	PRP
cord-308095-mehmk49a	253	13	see	see	VBP
cord-308095-mehmk49a	253	14	that	that	DT
cord-308095-mehmk49a	253	15	disclosure	disclosure	NN
cord-308095-mehmk49a	253	16	of	of	IN
cord-308095-mehmk49a	253	17	financial	financial	JJ
cord-308095-mehmk49a	253	18	relationships	relationship	NNS
cord-308095-mehmk49a	253	19	is	be	VBZ
cord-308095-mehmk49a	253	20	necessary	necessary	JJ
cord-308095-mehmk49a	253	21	but	but	CC
cord-308095-mehmk49a	253	22	not	not	RB
cord-308095-mehmk49a	253	23	sufficient	sufficient	JJ
cord-308095-mehmk49a	253	24	to	to	TO
cord-308095-mehmk49a	253	25	address	address	VB
cord-308095-mehmk49a	253	26	the	the	DT
cord-308095-mehmk49a	253	27	problem	problem	NN
cord-308095-mehmk49a	253	28	of	of	IN
cord-308095-mehmk49a	253	29	corporate	corporate	JJ
cord-308095-mehmk49a	253	30	influence	influence	NN
cord-308095-mehmk49a	253	31	.	.	.
cord-308095-mehmk49a	254	1	Some	some	DT
cord-308095-mehmk49a	254	2	information	information	NN
cord-308095-mehmk49a	254	3	on	on	IN
cord-308095-mehmk49a	254	4	campaign	campaign	NN
cord-308095-mehmk49a	254	5	contributions	contribution	NNS
cord-308095-mehmk49a	254	6	is	be	VBZ
cord-308095-mehmk49a	254	7	already	already	RB
cord-308095-mehmk49a	254	8	in	in	IN
cord-308095-mehmk49a	254	9	the	the	DT
cord-308095-mehmk49a	254	10	public	public	JJ
cord-308095-mehmk49a	254	11	domain	domain	NN
cord-308095-mehmk49a	254	12	.	.	.
cord-308095-mehmk49a	255	1	For	for	IN
cord-308095-mehmk49a	255	2	example	example	NN
cord-308095-mehmk49a	255	3	,	,	,
cord-308095-mehmk49a	255	4	the	the	DT
cord-308095-mehmk49a	255	5	Federal	Federal	NNP
cord-308095-mehmk49a	255	6	Elections	Elections	NNPS
cord-308095-mehmk49a	255	7	Commission	Commission	NNP
cord-308095-mehmk49a	255	8	in	in	IN
cord-308095-mehmk49a	255	9	the	the	DT
cord-308095-mehmk49a	255	10	United	United	NNP
cord-308095-mehmk49a	255	11	States	States	NNP
cord-308095-mehmk49a	255	12	maintains	maintain	VBZ
cord-308095-mehmk49a	255	13	a	a	DT
cord-308095-mehmk49a	255	14	database	database	NN
cord-308095-mehmk49a	255	15	of	of	IN
cord-308095-mehmk49a	255	16	campaign	campaign	NN
cord-308095-mehmk49a	255	17	finance	finance	NN
cord-308095-mehmk49a	255	18	contributions	contribution	NNS
cord-308095-mehmk49a	255	19	from	from	IN
cord-308095-mehmk49a	255	20	political	political	JJ
cord-308095-mehmk49a	255	21	action	action	NN
cord-308095-mehmk49a	255	22	committees	committee	NNS
cord-308095-mehmk49a	255	23	(	(	-LRB-
cord-308095-mehmk49a	255	24	PACs	PACs	NNPS
cord-308095-mehmk49a	255	25	)	)	-RRB-
cord-308095-mehmk49a	255	26	.	.	.
cord-308095-mehmk49a	256	1	(	(	-LRB-
cord-308095-mehmk49a	256	2	This	this	DT
cord-308095-mehmk49a	256	3	database	database	NN
cord-308095-mehmk49a	256	4	,	,	,
cord-308095-mehmk49a	256	5	available	available	JJ
cord-308095-mehmk49a	256	6	at	at	IN
cord-308095-mehmk49a	256	7	https://www.fec.gov	https://www.fec.gov	NNP
cord-308095-mehmk49a	256	8	,	,	,
cord-308095-mehmk49a	256	9	is	be	VBZ
cord-308095-mehmk49a	256	10	the	the	DT
cord-308095-mehmk49a	256	11	one	one	NN
cord-308095-mehmk49a	256	12	on	on	IN
cord-308095-mehmk49a	256	13	which	which	WDT
cord-308095-mehmk49a	256	14	McCoy	McCoy	NNP
cord-308095-mehmk49a	256	15	and	and	CC
cord-308095-mehmk49a	256	16	Kanter	Kanter	NNP
cord-308095-mehmk49a	256	17	2018	2018	CD
cord-308095-mehmk49a	256	18	relied	rely	VBD
cord-308095-mehmk49a	256	19	to	to	TO
cord-308095-mehmk49a	256	20	assess	assess	VB
cord-308095-mehmk49a	256	21	the	the	DT
cord-308095-mehmk49a	256	22	industry	industry	NN
cord-308095-mehmk49a	256	23	ties	tie	NNS
cord-308095-mehmk49a	256	24	of	of	IN
cord-308095-mehmk49a	256	25	the	the	DT
cord-308095-mehmk49a	256	26	House	House	NNP
cord-308095-mehmk49a	256	27	and	and	CC
cord-308095-mehmk49a	256	28	Senate	Senate	NNP
cord-308095-mehmk49a	256	29	Committees	Committees	NNPS
cord-308095-mehmk49a	256	30	charged	charge	VBN
cord-308095-mehmk49a	256	31	with	with	IN
cord-308095-mehmk49a	256	32	leading	lead	VBG
cord-308095-mehmk49a	256	33	the	the	DT
cord-308095-mehmk49a	256	34	4	4	CD
cord-308095-mehmk49a	256	35	Physicians	Physicians	NNPS
cord-308095-mehmk49a	256	36	are	be	VBP
cord-308095-mehmk49a	256	37	not	not	RB
cord-308095-mehmk49a	256	38	dependent	dependent	JJ
cord-308095-mehmk49a	256	39	on	on	IN
cord-308095-mehmk49a	256	40	drug	drug	NN
cord-308095-mehmk49a	256	41	companies	company	NNS
cord-308095-mehmk49a	256	42	for	for	IN
cord-308095-mehmk49a	256	43	pens	pen	NNS
cord-308095-mehmk49a	256	44	and	and	CC
cord-308095-mehmk49a	256	45	mugs	mug	NNS
cord-308095-mehmk49a	256	46	-	-	:
cord-308095-mehmk49a	256	47	they	-PRON-	PRP
cord-308095-mehmk49a	256	48	can	can	MD
cord-308095-mehmk49a	256	49	afford	afford	VB
cord-308095-mehmk49a	256	50	to	to	TO
cord-308095-mehmk49a	256	51	buy	buy	VB
cord-308095-mehmk49a	256	52	their	-PRON-	PRP$
cord-308095-mehmk49a	256	53	own	own	JJ
cord-308095-mehmk49a	256	54	!	!	.
cord-308095-mehmk49a	257	1	But	but	CC
cord-308095-mehmk49a	257	2	these	these	DT
cord-308095-mehmk49a	257	3	small	small	JJ
cord-308095-mehmk49a	257	4	gifts	gift	NNS
cord-308095-mehmk49a	257	5	influence	influence	VBP
cord-308095-mehmk49a	257	6	them	-PRON-	PRP
cord-308095-mehmk49a	257	7	nonetheless	nonetheless	RB
cord-308095-mehmk49a	257	8	.	.	.
cord-308095-mehmk49a	258	1	See	see	VB
cord-308095-mehmk49a	258	2	,	,	,
cord-308095-mehmk49a	258	3	e.g.	e.g.	RB
cord-308095-mehmk49a	258	4	,	,	,
cord-308095-mehmk49a	258	5	Sah	Sah	NNP
cord-308095-mehmk49a	258	6	and	and	CC
cord-308095-mehmk49a	258	7	Fugh	Fugh	NNP
cord-308095-mehmk49a	258	8	-	-	HYPH
cord-308095-mehmk49a	258	9	Berman	Berman	NNP
cord-308095-mehmk49a	258	10	2013	2013	CD
cord-308095-mehmk49a	258	11	;	;	:
cord-308095-mehmk49a	258	12	Lo	Lo	NNP
cord-308095-mehmk49a	258	13	and	and	CC
cord-308095-mehmk49a	258	14	Grady	Grady	NNP
cord-308095-mehmk49a	258	15	2017	2017	CD
cord-308095-mehmk49a	258	16	.	.	.
cord-308095-mehmk49a	259	1	5	5	LS
cord-308095-mehmk49a	260	1	Although	although	IN
cord-308095-mehmk49a	260	2	widely	widely	RB
cord-308095-mehmk49a	260	3	publicized	publicize	VBN
cord-308095-mehmk49a	260	4	investigations	investigation	NNS
cord-308095-mehmk49a	260	5	revealing	reveal	VBG
cord-308095-mehmk49a	260	6	opioid	opioid	JJ
cord-308095-mehmk49a	260	7	company	company	NN
cord-308095-mehmk49a	260	8	payments	payment	NNS
cord-308095-mehmk49a	260	9	to	to	IN
cord-308095-mehmk49a	260	10	PAOs	pao	NNS
cord-308095-mehmk49a	260	11	and	and	CC
cord-308095-mehmk49a	260	12	health	health	NN
cord-308095-mehmk49a	260	13	professional	professional	JJ
cord-308095-mehmk49a	260	14	associations	association	NNS
cord-308095-mehmk49a	260	15	led	lead	VBD
cord-308095-mehmk49a	260	16	to	to	IN
cord-308095-mehmk49a	260	17	withdrawals	withdrawal	NNS
cord-308095-mehmk49a	260	18	of	of	IN
cord-308095-mehmk49a	260	19	funding	funding	NN
cord-308095-mehmk49a	260	20	and	and	CC
cord-308095-mehmk49a	260	21	,	,	,
cord-308095-mehmk49a	260	22	in	in	IN
cord-308095-mehmk49a	260	23	a	a	DT
cord-308095-mehmk49a	260	24	few	few	JJ
cord-308095-mehmk49a	260	25	cases	case	NNS
cord-308095-mehmk49a	260	26	,	,	,
cord-308095-mehmk49a	260	27	to	to	IN
cord-308095-mehmk49a	260	28	the	the	DT
cord-308095-mehmk49a	260	29	recipient	recipient	NN
cord-308095-mehmk49a	260	30	organizations	organization	NNS
cord-308095-mehmk49a	260	31	ceasing	cease	VBG
cord-308095-mehmk49a	260	32	to	to	TO
cord-308095-mehmk49a	260	33	operate	operate	VB
cord-308095-mehmk49a	260	34	,	,	,
cord-308095-mehmk49a	260	35	industry	industry	NN
cord-308095-mehmk49a	260	36	funding	funding	NN
cord-308095-mehmk49a	260	37	of	of	IN
cord-308095-mehmk49a	260	38	patient	patient	JJ
cord-308095-mehmk49a	260	39	advocacy	advocacy	NN
cord-308095-mehmk49a	260	40	groups	group	NNS
cord-308095-mehmk49a	260	41	remains	remain	VBZ
cord-308095-mehmk49a	260	42	pervasive	pervasive	JJ
cord-308095-mehmk49a	260	43	.	.	.
cord-308095-mehmk49a	261	1	One	one	CD
cord-308095-mehmk49a	261	2	recent	recent	JJ
cord-308095-mehmk49a	261	3	study	study	NN
cord-308095-mehmk49a	261	4	found	find	VBD
cord-308095-mehmk49a	261	5	that	that	IN
cord-308095-mehmk49a	261	6	83	83	CD
cord-308095-mehmk49a	261	7	per	per	NN
cord-308095-mehmk49a	261	8	cent	cent	NN
cord-308095-mehmk49a	261	9	of	of	IN
cord-308095-mehmk49a	261	10	the	the	DT
cord-308095-mehmk49a	261	11	104	104	CD
cord-308095-mehmk49a	261	12	largest	large	JJS
cord-308095-mehmk49a	261	13	groups	group	NNS
cord-308095-mehmk49a	261	14	received	receive	VBD
cord-308095-mehmk49a	261	15	funding	funding	NN
cord-308095-mehmk49a	261	16	from	from	IN
cord-308095-mehmk49a	261	17	drug	drug	NN
cord-308095-mehmk49a	261	18	,	,	,
cord-308095-mehmk49a	261	19	device	device	NN
cord-308095-mehmk49a	261	20	,	,	,
cord-308095-mehmk49a	261	21	or	or	CC
cord-308095-mehmk49a	261	22	biotechnology	biotechnology	NN
cord-308095-mehmk49a	261	23	companies	company	NNS
cord-308095-mehmk49a	261	24	(	(	-LRB-
cord-308095-mehmk49a	261	25	McCoy	McCoy	NNP
cord-308095-mehmk49a	261	26	et	et	NNP
cord-308095-mehmk49a	261	27	al	al	NNP
cord-308095-mehmk49a	261	28	.	.	.
cord-308095-mehmk49a	261	29	2017	2017	CD
cord-308095-mehmk49a	261	30	)	)	-RRB-
cord-308095-mehmk49a	261	31	.	.	.
cord-308095-mehmk49a	262	1	We	-PRON-	PRP
cord-308095-mehmk49a	262	2	should	should	MD
cord-308095-mehmk49a	262	3	not	not	RB
cord-308095-mehmk49a	262	4	expect	expect	VB
cord-308095-mehmk49a	262	5	disclosure	disclosure	NN
cord-308095-mehmk49a	262	6	alone	alone	RB
cord-308095-mehmk49a	262	7	to	to	TO
cord-308095-mehmk49a	262	8	lead	lead	VB
cord-308095-mehmk49a	262	9	to	to	IN
cord-308095-mehmk49a	262	10	the	the	DT
cord-308095-mehmk49a	262	11	widespread	widespread	JJ
cord-308095-mehmk49a	262	12	elimination	elimination	NN
cord-308095-mehmk49a	262	13	of	of	IN
cord-308095-mehmk49a	262	14	these	these	DT
cord-308095-mehmk49a	262	15	relationships	relationship	NNS
cord-308095-mehmk49a	262	16	,	,	,
cord-308095-mehmk49a	262	17	especially	especially	RB
cord-308095-mehmk49a	262	18	if	if	IN
cord-308095-mehmk49a	262	19	the	the	DT
cord-308095-mehmk49a	262	20	pervasiveness	pervasiveness	NN
cord-308095-mehmk49a	262	21	of	of	IN
cord-308095-mehmk49a	262	22	these	these	DT
cord-308095-mehmk49a	262	23	relationships	relationship	NNS
cord-308095-mehmk49a	262	24	reinforces	reinforce	VBZ
cord-308095-mehmk49a	262	25	the	the	DT
cord-308095-mehmk49a	262	26	(	(	-LRB-
cord-308095-mehmk49a	262	27	problematic	problematic	JJ
cord-308095-mehmk49a	262	28	)	)	-RRB-
cord-308095-mehmk49a	262	29	view	view	NN
cord-308095-mehmk49a	262	30	that	that	IN
cord-308095-mehmk49a	262	31	they	-PRON-	PRP
cord-308095-mehmk49a	262	32	are	be	VBP
cord-308095-mehmk49a	262	33	acceptable	acceptable	JJ
cord-308095-mehmk49a	262	34	or	or	CC
cord-308095-mehmk49a	262	35	unavoidable	unavoidable	JJ
cord-308095-mehmk49a	262	36	.	.	.
cord-308095-mehmk49a	263	1	response	response	NN
cord-308095-mehmk49a	263	2	to	to	IN
cord-308095-mehmk49a	263	3	the	the	DT
cord-308095-mehmk49a	263	4	opioid	opioid	JJ
cord-308095-mehmk49a	263	5	crisis	crisis	NN
cord-308095-mehmk49a	263	6	.	.	.
cord-308095-mehmk49a	263	7	)	)	-RRB-
cord-308095-mehmk49a	264	1	We	-PRON-	PRP
cord-308095-mehmk49a	264	2	do	do	VBP
cord-308095-mehmk49a	264	3	not	not	RB
cord-308095-mehmk49a	264	4	know	know	VB
cord-308095-mehmk49a	264	5	the	the	DT
cord-308095-mehmk49a	264	6	full	full	JJ
cord-308095-mehmk49a	264	7	extent	extent	NN
cord-308095-mehmk49a	264	8	of	of	IN
cord-308095-mehmk49a	264	9	campaign	campaign	NN
cord-308095-mehmk49a	264	10	contributions	contribution	NNS
cord-308095-mehmk49a	264	11	by	by	IN
cord-308095-mehmk49a	264	12	opioid	opioid	JJ
cord-308095-mehmk49a	264	13	companies	company	NNS
cord-308095-mehmk49a	264	14	because	because	IN
cord-308095-mehmk49a	264	15	hundreds	hundred	NNS
cord-308095-mehmk49a	264	16	of	of	IN
cord-308095-mehmk49a	264	17	millions	million	NNS
cord-308095-mehmk49a	264	18	of	of	IN
cord-308095-mehmk49a	264	19	dollars	dollar	NNS
cord-308095-mehmk49a	264	20	in	in	IN
cord-308095-mehmk49a	264	21	campaign	campaign	NN
cord-308095-mehmk49a	264	22	contributions	contribution	NNS
cord-308095-mehmk49a	264	23	are	be	VBP
cord-308095-mehmk49a	264	24	made	make	VBN
cord-308095-mehmk49a	264	25	via	via	IN
cord-308095-mehmk49a	264	26	"	"	``
cord-308095-mehmk49a	264	27	superPACs	superpac	NNS
cord-308095-mehmk49a	264	28	"	"	''
cord-308095-mehmk49a	264	29	that	that	WDT
cord-308095-mehmk49a	264	30	shroud	shroud	VBP
cord-308095-mehmk49a	264	31	the	the	DT
cord-308095-mehmk49a	264	32	origin	origin	NN
cord-308095-mehmk49a	264	33	of	of	IN
cord-308095-mehmk49a	264	34	the	the	DT
cord-308095-mehmk49a	264	35	funds	fund	NNS
cord-308095-mehmk49a	264	36	.	.	.
cord-308095-mehmk49a	265	1	Greater	great	JJR
cord-308095-mehmk49a	265	2	transparency	transparency	NN
cord-308095-mehmk49a	265	3	in	in	IN
cord-308095-mehmk49a	265	4	relation	relation	NN
cord-308095-mehmk49a	265	5	to	to	IN
cord-308095-mehmk49a	265	6	"	"	``
cord-308095-mehmk49a	265	7	dark	dark	JJ
cord-308095-mehmk49a	265	8	money	money	NN
cord-308095-mehmk49a	265	9	"	"	''
cord-308095-mehmk49a	265	10	is	be	VBZ
cord-308095-mehmk49a	265	11	clearly	clearly	RB
cord-308095-mehmk49a	265	12	important	important	JJ
cord-308095-mehmk49a	265	13	,	,	,
cord-308095-mehmk49a	265	14	but	but	CC
cord-308095-mehmk49a	265	15	campaign	campaign	NN
cord-308095-mehmk49a	265	16	contributions	contribution	NNS
cord-308095-mehmk49a	265	17	and	and	CC
cord-308095-mehmk49a	265	18	lobbying	lobbying	NN
cord-308095-mehmk49a	265	19	can	can	MD
cord-308095-mehmk49a	265	20	still	still	RB
cord-308095-mehmk49a	265	21	influence	influence	VB
cord-308095-mehmk49a	265	22	legislators	legislator	NNS
cord-308095-mehmk49a	265	23	even	even	RB
cord-308095-mehmk49a	265	24	when	when	WRB
cord-308095-mehmk49a	265	25	they	-PRON-	PRP
cord-308095-mehmk49a	265	26	are	be	VBP
cord-308095-mehmk49a	265	27	disclosed	disclose	VBN
cord-308095-mehmk49a	265	28	-	-	:
cord-308095-mehmk49a	265	29	as	as	IN
cord-308095-mehmk49a	265	30	congressional	congressional	JJ
cord-308095-mehmk49a	265	31	voting	voting	NN
cord-308095-mehmk49a	265	32	records	record	NNS
cord-308095-mehmk49a	265	33	make	make	VBP
cord-308095-mehmk49a	265	34	clear	clear	JJ
cord-308095-mehmk49a	265	35	(	(	-LRB-
cord-308095-mehmk49a	265	36	see	see	VB
cord-308095-mehmk49a	265	37	,	,	,
cord-308095-mehmk49a	265	38	e.g.	e.g.	RB
cord-308095-mehmk49a	265	39	,	,	,
cord-308095-mehmk49a	265	40	the	the	DT
cord-308095-mehmk49a	265	41	website	website	NN
cord-308095-mehmk49a	265	42	of	of	IN
cord-308095-mehmk49a	265	43	the	the	DT
cord-308095-mehmk49a	265	44	Center	Center	NNP
cord-308095-mehmk49a	265	45	for	for	IN
cord-308095-mehmk49a	265	46	Responsive	Responsive	NNP
cord-308095-mehmk49a	265	47	Politics	Politics	NNPS
cord-308095-mehmk49a	265	48	,	,	,
cord-308095-mehmk49a	265	49	https://www.opensecrets.org	https://www.opensecrets.org	ADD
cord-308095-mehmk49a	265	50	)	)	-RRB-
cord-308095-mehmk49a	265	51	.	.	.
cord-308095-mehmk49a	266	1	The	the	DT
cord-308095-mehmk49a	266	2	solution	solution	NN
cord-308095-mehmk49a	266	3	,	,	,
cord-308095-mehmk49a	266	4	of	of	IN
cord-308095-mehmk49a	266	5	course	course	NN
cord-308095-mehmk49a	266	6	,	,	,
cord-308095-mehmk49a	266	7	would	would	MD
cord-308095-mehmk49a	266	8	be	be	VB
cord-308095-mehmk49a	266	9	to	to	TO
cord-308095-mehmk49a	266	10	take	take	VB
cord-308095-mehmk49a	266	11	corporate	corporate	JJ
cord-308095-mehmk49a	266	12	money	money	NN
cord-308095-mehmk49a	266	13	-	-	:
cord-308095-mehmk49a	266	14	including	include	VBG
cord-308095-mehmk49a	266	15	opioid	opioid	JJ
cord-308095-mehmk49a	266	16	industry	industry	NN
cord-308095-mehmk49a	266	17	funds	fund	NNS
cord-308095-mehmk49a	266	18	-	-	:
cord-308095-mehmk49a	266	19	out	out	IN
cord-308095-mehmk49a	266	20	of	of	IN
cord-308095-mehmk49a	266	21	politics	politic	NNS
cord-308095-mehmk49a	266	22	(	(	-LRB-
cord-308095-mehmk49a	266	23	see	see	VB
cord-308095-mehmk49a	266	24	,	,	,
cord-308095-mehmk49a	266	25	e.g.	e.g.	RB
cord-308095-mehmk49a	266	26	,	,	,
cord-308095-mehmk49a	266	27	Lessig	Lessig	NNP
cord-308095-mehmk49a	266	28	2015	2015	CD
cord-308095-mehmk49a	266	29	)	)	-RRB-
cord-308095-mehmk49a	266	30	.	.	.
cord-308095-mehmk49a	267	1	A	a	DT
cord-308095-mehmk49a	267	2	detailed	detailed	JJ
cord-308095-mehmk49a	267	3	consideration	consideration	NN
cord-308095-mehmk49a	267	4	of	of	IN
cord-308095-mehmk49a	267	5	campaign	campaign	NN
cord-308095-mehmk49a	267	6	finance	finance	NN
cord-308095-mehmk49a	267	7	reform	reform	NN
cord-308095-mehmk49a	267	8	is	be	VBZ
cord-308095-mehmk49a	267	9	,	,	,
cord-308095-mehmk49a	267	10	of	of	IN
cord-308095-mehmk49a	267	11	course	course	NN
cord-308095-mehmk49a	267	12	,	,	,
cord-308095-mehmk49a	267	13	beyond	beyond	IN
cord-308095-mehmk49a	267	14	the	the	DT
cord-308095-mehmk49a	267	15	scope	scope	NN
cord-308095-mehmk49a	267	16	of	of	IN
cord-308095-mehmk49a	267	17	this	this	DT
cord-308095-mehmk49a	267	18	paper	paper	NN
cord-308095-mehmk49a	267	19	.	.	.
cord-308095-mehmk49a	268	1	But	but	CC
cord-308095-mehmk49a	268	2	I	-PRON-	PRP
cord-308095-mehmk49a	268	3	will	will	MD
cord-308095-mehmk49a	268	4	address	address	VB
cord-308095-mehmk49a	268	5	another	another	DT
cord-308095-mehmk49a	268	6	powerful	powerful	JJ
cord-308095-mehmk49a	268	7	vehicle	vehicle	NN
cord-308095-mehmk49a	268	8	for	for	IN
cord-308095-mehmk49a	268	9	corporate	corporate	JJ
cord-308095-mehmk49a	268	10	influence	influence	NN
cord-308095-mehmk49a	268	11	:	:	:
cord-308095-mehmk49a	268	12	close	close	JJ
cord-308095-mehmk49a	268	13	relationships	relationship	NNS
cord-308095-mehmk49a	268	14	between	between	IN
cord-308095-mehmk49a	268	15	public	public	JJ
cord-308095-mehmk49a	268	16	health	health	NN
cord-308095-mehmk49a	268	17	agencies	agency	NNS
cord-308095-mehmk49a	268	18	and	and	CC
cord-308095-mehmk49a	268	19	opioid	opioid	JJ
cord-308095-mehmk49a	268	20	companies	company	NNS
cord-308095-mehmk49a	268	21	.	.	.
cord-308095-mehmk49a	269	1	After	after	IN
cord-308095-mehmk49a	269	2	the	the	DT
cord-308095-mehmk49a	269	3	director	director	NN
cord-308095-mehmk49a	269	4	of	of	IN
cord-308095-mehmk49a	269	5	the	the	DT
cord-308095-mehmk49a	269	6	NIH	NIH	NNP
cord-308095-mehmk49a	269	7	announced	announce	VBD
cord-308095-mehmk49a	269	8	the	the	DT
cord-308095-mehmk49a	269	9	"	"	``
cord-308095-mehmk49a	269	10	publicprivate	publicprivate	NNP
cord-308095-mehmk49a	269	11	initiative	initiative	NN
cord-308095-mehmk49a	269	12	"	"	''
cord-308095-mehmk49a	269	13	to	to	TO
cord-308095-mehmk49a	269	14	address	address	VB
cord-308095-mehmk49a	269	15	the	the	DT
cord-308095-mehmk49a	269	16	opioid	opioid	JJ
cord-308095-mehmk49a	269	17	epidemic	epidemic	NN
cord-308095-mehmk49a	269	18	(	(	-LRB-
cord-308095-mehmk49a	269	19	discussed	discuss	VBN
cord-308095-mehmk49a	269	20	above	above	RB
cord-308095-mehmk49a	269	21	)	)	-RRB-
cord-308095-mehmk49a	269	22	,	,	,
cord-308095-mehmk49a	269	23	he	-PRON-	PRP
cord-308095-mehmk49a	269	24	commissioned	commission	VBD
cord-308095-mehmk49a	269	25	a	a	DT
cord-308095-mehmk49a	269	26	working	work	VBG
cord-308095-mehmk49a	269	27	group	group	NN
cord-308095-mehmk49a	269	28	to	to	TO
cord-308095-mehmk49a	269	29	explore	explore	VB
cord-308095-mehmk49a	269	30	the	the	DT
cord-308095-mehmk49a	269	31	ethical	ethical	JJ
cord-308095-mehmk49a	269	32	issues	issue	NNS
cord-308095-mehmk49a	269	33	.	.	.
cord-308095-mehmk49a	270	1	The	the	DT
cord-308095-mehmk49a	270	2	working	work	VBG
cord-308095-mehmk49a	270	3	group	group	NN
cord-308095-mehmk49a	270	4	based	base	VBD
cord-308095-mehmk49a	270	5	its	-PRON-	PRP$
cord-308095-mehmk49a	270	6	recommendations	recommendation	NNS
cord-308095-mehmk49a	270	7	on	on	IN
cord-308095-mehmk49a	270	8	concerns	concern	NNS
cord-308095-mehmk49a	270	9	about	about	IN
cord-308095-mehmk49a	270	10	"	"	``
cord-308095-mehmk49a	270	11	real	real	JJ
cord-308095-mehmk49a	270	12	or	or	CC
cord-308095-mehmk49a	270	13	perceived	perceive	VBN
cord-308095-mehmk49a	270	14	conflicts	conflict	NNS
cord-308095-mehmk49a	270	15	of	of	IN
cord-308095-mehmk49a	270	16	interest	interest	NN
cord-308095-mehmk49a	270	17	"	"	''
cord-308095-mehmk49a	270	18	(	(	-LRB-
cord-308095-mehmk49a	270	19	NIH	NIH	NNP
cord-308095-mehmk49a	270	20	Working	Working	NNP
cord-308095-mehmk49a	270	21	Group	Group	NNP
cord-308095-mehmk49a	270	22	2018	2018	CD
cord-308095-mehmk49a	270	23	)	)	-RRB-
cord-308095-mehmk49a	270	24	.	.	.
cord-308095-mehmk49a	271	1	The	the	DT
cord-308095-mehmk49a	271	2	group	group	NN
cord-308095-mehmk49a	271	3	stated	state	VBD
cord-308095-mehmk49a	271	4	that	that	IN
cord-308095-mehmk49a	271	5	it	-PRON-	PRP
cord-308095-mehmk49a	271	6	was	be	VBD
cord-308095-mehmk49a	271	7	"	"	``
cord-308095-mehmk49a	271	8	preferable	preferable	JJ
cord-308095-mehmk49a	271	9	"	"	''
cord-308095-mehmk49a	271	10	that	that	IN
cord-308095-mehmk49a	271	11	public	public	JJ
cord-308095-mehmk49a	271	12	funds	fund	NNS
cord-308095-mehmk49a	271	13	be	be	VB
cord-308095-mehmk49a	271	14	used	use	VBN
cord-308095-mehmk49a	271	15	from	from	IN
cord-308095-mehmk49a	271	16	this	this	DT
cord-308095-mehmk49a	271	17	initiative	initiative	NN
cord-308095-mehmk49a	271	18	,	,	,
cord-308095-mehmk49a	271	19	but	but	CC
cord-308095-mehmk49a	271	20	it	-PRON-	PRP
cord-308095-mehmk49a	271	21	only	only	RB
cord-308095-mehmk49a	271	22	recommended	recommend	VBD
cord-308095-mehmk49a	271	23	a	a	DT
cord-308095-mehmk49a	271	24	bar	bar	NN
cord-308095-mehmk49a	271	25	on	on	IN
cord-308095-mehmk49a	271	26	industry	industry	NN
cord-308095-mehmk49a	271	27	funding	funding	NN
cord-308095-mehmk49a	271	28	where	where	WRB
cord-308095-mehmk49a	271	29	an	an	DT
cord-308095-mehmk49a	271	30	opioid	opioid	JJ
cord-308095-mehmk49a	271	31	company	company	NN
cord-308095-mehmk49a	271	32	was	be	VBD
cord-308095-mehmk49a	271	33	engaged	engage	VBN
cord-308095-mehmk49a	271	34	in	in	IN
cord-308095-mehmk49a	271	35	"	"	``
cord-308095-mehmk49a	271	36	litigation	litigation	NN
cord-308095-mehmk49a	271	37	of	of	IN
cord-308095-mehmk49a	271	38	concern	concern	NN
cord-308095-mehmk49a	271	39	"	"	``
cord-308095-mehmk49a	271	40	related	relate	VBN
cord-308095-mehmk49a	271	41	to	to	IN
cord-308095-mehmk49a	271	42	the	the	DT
cord-308095-mehmk49a	271	43	opioid	opioid	JJ
cord-308095-mehmk49a	271	44	crisis	crisis	NN
cord-308095-mehmk49a	271	45	.	.	.
cord-308095-mehmk49a	272	1	The	the	DT
cord-308095-mehmk49a	272	2	advisory	advisory	JJ
cord-308095-mehmk49a	272	3	group	group	NN
cord-308095-mehmk49a	272	4	recommended	recommend	VBD
cord-308095-mehmk49a	272	5	that	that	IN
cord-308095-mehmk49a	272	6	,	,	,
cord-308095-mehmk49a	272	7	in	in	IN
cord-308095-mehmk49a	272	8	other	other	JJ
cord-308095-mehmk49a	272	9	cases	case	NNS
cord-308095-mehmk49a	272	10	,	,	,
cord-308095-mehmk49a	272	11	money	money	NN
cord-308095-mehmk49a	272	12	provided	provide	VBN
cord-308095-mehmk49a	272	13	by	by	IN
cord-308095-mehmk49a	272	14	industry	industry	NN
cord-308095-mehmk49a	272	15	actors	actor	NNS
cord-308095-mehmk49a	272	16	should	should	MD
cord-308095-mehmk49a	272	17	be	be	VB
cord-308095-mehmk49a	272	18	"	"	``
cord-308095-mehmk49a	272	19	without	without	IN
cord-308095-mehmk49a	272	20	conditions	condition	NNS
cord-308095-mehmk49a	272	21	.	.	.
cord-308095-mehmk49a	273	1	"	"	``
cord-308095-mehmk49a	273	2	Even	even	RB
cord-308095-mehmk49a	273	3	when	when	WRB
cord-308095-mehmk49a	273	4	companies	company	NNS
cord-308095-mehmk49a	273	5	are	be	VBP
cord-308095-mehmk49a	273	6	excluded	exclude	VBN
cord-308095-mehmk49a	273	7	from	from	IN
cord-308095-mehmk49a	273	8	funding	funding	NN
cord-308095-mehmk49a	273	9	due	due	IN
cord-308095-mehmk49a	273	10	to	to	IN
cord-308095-mehmk49a	273	11	litigation	litigation	NN
cord-308095-mehmk49a	273	12	,	,	,
cord-308095-mehmk49a	273	13	the	the	DT
cord-308095-mehmk49a	273	14	working	work	VBG
cord-308095-mehmk49a	273	15	group	group	NN
cord-308095-mehmk49a	273	16	said	say	VBD
cord-308095-mehmk49a	273	17	it	-PRON-	PRP
cord-308095-mehmk49a	273	18	would	would	MD
cord-308095-mehmk49a	273	19	not	not	RB
cord-308095-mehmk49a	273	20	only	only	RB
cord-308095-mehmk49a	273	21	permit	permit	VB
cord-308095-mehmk49a	273	22	but	but	CC
cord-308095-mehmk49a	273	23	encourage	encourage	VB
cord-308095-mehmk49a	273	24	"	"	''
cord-308095-mehmk49a	273	25	in	in	IN
cord-308095-mehmk49a	273	26	-	-	HYPH
cord-308095-mehmk49a	273	27	kind	kind	NN
cord-308095-mehmk49a	273	28	"	"	''
cord-308095-mehmk49a	273	29	industry	industry	NN
cord-308095-mehmk49a	273	30	contributions	contribution	NNS
cord-308095-mehmk49a	273	31	to	to	IN
cord-308095-mehmk49a	273	32	the	the	DT
cord-308095-mehmk49a	273	33	partnership	partnership	NN
cord-308095-mehmk49a	273	34	.	.	.
cord-308095-mehmk49a	274	1	In	in	IN
cord-308095-mehmk49a	274	2	response	response	NN
cord-308095-mehmk49a	274	3	to	to	IN
cord-308095-mehmk49a	274	4	the	the	DT
cord-308095-mehmk49a	274	5	group	group	NN
cord-308095-mehmk49a	274	6	's	's	POS
cord-308095-mehmk49a	274	7	report	report	NN
cord-308095-mehmk49a	274	8	,	,	,
cord-308095-mehmk49a	274	9	the	the	DT
cord-308095-mehmk49a	274	10	director	director	NN
cord-308095-mehmk49a	274	11	of	of	IN
cord-308095-mehmk49a	274	12	the	the	DT
cord-308095-mehmk49a	274	13	NIH	NIH	NNP
cord-308095-mehmk49a	274	14	said	say	VBD
cord-308095-mehmk49a	274	15	that	that	IN
cord-308095-mehmk49a	274	16	he	-PRON-	PRP
cord-308095-mehmk49a	274	17	"	"	``
cord-308095-mehmk49a	274	18	fully	fully	RB
cord-308095-mehmk49a	274	19	embrace[d	embrace[d	NNP
cord-308095-mehmk49a	274	20	]	]	-RRB-
cord-308095-mehmk49a	275	1	"	"	``
cord-308095-mehmk49a	275	2	the	the	DT
cord-308095-mehmk49a	275	3	recommendation	recommendation	NN
cord-308095-mehmk49a	275	4	that	that	IN
cord-308095-mehmk49a	275	5	the	the	DT
cord-308095-mehmk49a	275	6	NIH	NIH	NNP
cord-308095-mehmk49a	275	7	should	should	MD
cord-308095-mehmk49a	275	8	address	address	VB
cord-308095-mehmk49a	275	9	the	the	DT
cord-308095-mehmk49a	275	10	crisis	crisis	NN
cord-308095-mehmk49a	275	11	with	with	IN
cord-308095-mehmk49a	275	12	government	government	NN
cord-308095-mehmk49a	275	13	,	,	,
cord-308095-mehmk49a	275	14	not	not	RB
cord-308095-mehmk49a	275	15	industry	industry	NN
cord-308095-mehmk49a	275	16	,	,	,
cord-308095-mehmk49a	275	17	funds	fund	NNS
cord-308095-mehmk49a	275	18	(	(	-LRB-
cord-308095-mehmk49a	275	19	Collins	Collins	NNP
cord-308095-mehmk49a	275	20	2018	2018	CD
cord-308095-mehmk49a	275	21	)	)	-RRB-
cord-308095-mehmk49a	275	22	.	.	.
cord-308095-mehmk49a	276	1	He	-PRON-	PRP
cord-308095-mehmk49a	276	2	also	also	RB
cord-308095-mehmk49a	276	3	said	say	VBD
cord-308095-mehmk49a	276	4	that	that	IN
cord-308095-mehmk49a	276	5	any	any	DT
cord-308095-mehmk49a	276	6	partnerships	partnership	NNS
cord-308095-mehmk49a	276	7	in	in	IN
cord-308095-mehmk49a	276	8	this	this	DT
cord-308095-mehmk49a	276	9	initiative	initiative	NN
cord-308095-mehmk49a	276	10	would	would	MD
cord-308095-mehmk49a	276	11	be	be	VB
cord-308095-mehmk49a	276	12	"	"	``
cord-308095-mehmk49a	276	13	done	do	VBN
cord-308095-mehmk49a	276	14	with	with	IN
cord-308095-mehmk49a	276	15	the	the	DT
cord-308095-mehmk49a	276	16	utmost	utmost	JJ
cord-308095-mehmk49a	276	17	transparency	transparency	NN
cord-308095-mehmk49a	276	18	.	.	.
cord-308095-mehmk49a	276	19	"	"	''
cord-308095-mehmk49a	277	1	These	these	DT
cord-308095-mehmk49a	277	2	assurances	assurance	NNS
cord-308095-mehmk49a	277	3	,	,	,
cord-308095-mehmk49a	277	4	however	however	RB
cord-308095-mehmk49a	277	5	,	,	,
cord-308095-mehmk49a	277	6	do	do	VBP
cord-308095-mehmk49a	277	7	not	not	RB
cord-308095-mehmk49a	277	8	address	address	VB
cord-308095-mehmk49a	277	9	all	all	PDT
cord-308095-mehmk49a	277	10	the	the	DT
cord-308095-mehmk49a	277	11	ethical	ethical	JJ
cord-308095-mehmk49a	277	12	concerns	concern	NNS
cord-308095-mehmk49a	277	13	.	.	.
cord-308095-mehmk49a	278	1	First	first	RB
cord-308095-mehmk49a	278	2	,	,	,
cord-308095-mehmk49a	278	3	influence	influence	NN
cord-308095-mehmk49a	278	4	can	can	MD
cord-308095-mehmk49a	278	5	occur	occur	VB
cord-308095-mehmk49a	279	1	when	when	WRB
cord-308095-mehmk49a	279	2	there	there	EX
cord-308095-mehmk49a	279	3	are	be	VBP
cord-308095-mehmk49a	279	4	no	no	DT
cord-308095-mehmk49a	279	5	formal	formal	JJ
cord-308095-mehmk49a	279	6	conditions	condition	NNS
cord-308095-mehmk49a	279	7	(	(	-LRB-
cord-308095-mehmk49a	279	8	or	or	CC
cord-308095-mehmk49a	279	9	"	"	``
cord-308095-mehmk49a	279	10	strings	string	NNS
cord-308095-mehmk49a	279	11	"	"	''
cord-308095-mehmk49a	279	12	)	)	-RRB-
cord-308095-mehmk49a	279	13	attached	attach	VBN
cord-308095-mehmk49a	279	14	-	-	:
cord-308095-mehmk49a	279	15	in	in	RP
cord-308095-mehmk49a	279	16	fact	fact	NN
cord-308095-mehmk49a	279	17	,	,	,
cord-308095-mehmk49a	279	18	reciprocity	reciprocity	NN
cord-308095-mehmk49a	279	19	often	often	RB
cord-308095-mehmk49a	279	20	makes	make	VBZ
cord-308095-mehmk49a	279	21	such	such	JJ
cord-308095-mehmk49a	279	22	conditions	condition	NNS
cord-308095-mehmk49a	279	23	entirely	entirely	RB
cord-308095-mehmk49a	279	24	unnecessary	unnecessary	JJ
cord-308095-mehmk49a	279	25	.	.	.
cord-308095-mehmk49a	280	1	Second	second	JJ
cord-308095-mehmk49a	280	2	,	,	,
cord-308095-mehmk49a	280	3	reciprocal	reciprocal	JJ
cord-308095-mehmk49a	280	4	effects	effect	NNS
cord-308095-mehmk49a	280	5	are	be	VBP
cord-308095-mehmk49a	280	6	not	not	RB
cord-308095-mehmk49a	280	7	confined	confine	VBN
cord-308095-mehmk49a	280	8	to	to	IN
cord-308095-mehmk49a	280	9	cash	cash	NN
cord-308095-mehmk49a	280	10	payments	payment	NNS
cord-308095-mehmk49a	280	11	;	;	:
cord-308095-mehmk49a	280	12	they	-PRON-	PRP
cord-308095-mehmk49a	280	13	may	may	MD
cord-308095-mehmk49a	280	14	be	be	VB
cord-308095-mehmk49a	280	15	triggered	trigger	VBN
cord-308095-mehmk49a	280	16	by	by	IN
cord-308095-mehmk49a	280	17	the	the	DT
cord-308095-mehmk49a	280	18	receipt	receipt	NN
cord-308095-mehmk49a	280	19	-	-	HYPH
cord-308095-mehmk49a	280	20	or	or	CC
cord-308095-mehmk49a	280	21	mere	mere	JJ
cord-308095-mehmk49a	280	22	anticipation	anticipation	NN
cord-308095-mehmk49a	280	23	of	of	IN
cord-308095-mehmk49a	280	24	the	the	DT
cord-308095-mehmk49a	280	25	receipt	receipt	NN
cord-308095-mehmk49a	280	26	-	-	:
cord-308095-mehmk49a	280	27	of	of	IN
cord-308095-mehmk49a	280	28	"	"	``
cord-308095-mehmk49a	280	29	in	in	IN
cord-308095-mehmk49a	280	30	-	-	HYPH
cord-308095-mehmk49a	280	31	kind	kind	NN
cord-308095-mehmk49a	280	32	contributions	contribution	NNS
cord-308095-mehmk49a	280	33	,	,	,
cord-308095-mehmk49a	280	34	"	"	''
cord-308095-mehmk49a	280	35	whether	whether	IN
cord-308095-mehmk49a	280	36	goods	good	NNS
cord-308095-mehmk49a	280	37	,	,	,
cord-308095-mehmk49a	280	38	services	service	NNS
cord-308095-mehmk49a	280	39	,	,	,
cord-308095-mehmk49a	280	40	or	or	CC
cord-308095-mehmk49a	280	41	anything	anything	NN
cord-308095-mehmk49a	280	42	else	else	RB
cord-308095-mehmk49a	280	43	of	of	IN
cord-308095-mehmk49a	280	44	value	value	NN
cord-308095-mehmk49a	280	45	(	(	-LRB-
cord-308095-mehmk49a	280	46	Marks	Marks	NNP
cord-308095-mehmk49a	280	47	2019a	2019a	CD
cord-308095-mehmk49a	280	48	)	)	-RRB-
cord-308095-mehmk49a	280	49	.	.	.
cord-308095-mehmk49a	281	1	And	and	CC
cord-308095-mehmk49a	281	2	third	third	JJ
cord-308095-mehmk49a	281	3	,	,	,
cord-308095-mehmk49a	281	4	transparent	transparent	JJ
cord-308095-mehmk49a	281	5	relationships	relationship	NNS
cord-308095-mehmk49a	281	6	may	may	MD
cord-308095-mehmk49a	281	7	still	still	RB
cord-308095-mehmk49a	281	8	be	be	VB
cord-308095-mehmk49a	281	9	extremely	extremely	RB
cord-308095-mehmk49a	281	10	influential	influential	JJ
cord-308095-mehmk49a	281	11	.	.	.
cord-308095-mehmk49a	282	1	As	as	IN
cord-308095-mehmk49a	282	2	I	-PRON-	PRP
cord-308095-mehmk49a	282	3	emphasized	emphasize	VBD
cord-308095-mehmk49a	282	4	above	above	RB
cord-308095-mehmk49a	282	5	,	,	,
cord-308095-mehmk49a	282	6	policymakers	policymaker	NNS
cord-308095-mehmk49a	282	7	can	can	MD
cord-308095-mehmk49a	282	8	not	not	RB
cord-308095-mehmk49a	282	9	and	and	CC
cord-308095-mehmk49a	282	10	should	should	MD
cord-308095-mehmk49a	282	11	not	not	RB
cord-308095-mehmk49a	282	12	rely	rely	VB
cord-308095-mehmk49a	282	13	on	on	IN
cord-308095-mehmk49a	282	14	transparency	transparency	NN
cord-308095-mehmk49a	282	15	to	to	TO
cord-308095-mehmk49a	282	16	eliminate	eliminate	VB
cord-308095-mehmk49a	282	17	corporate	corporate	JJ
cord-308095-mehmk49a	282	18	influence	influence	NN
cord-308095-mehmk49a	282	19	.	.	.
cord-308095-mehmk49a	283	1	In	in	IN
cord-308095-mehmk49a	283	2	addition	addition	NN
cord-308095-mehmk49a	283	3	,	,	,
cord-308095-mehmk49a	283	4	such	such	JJ
cord-308095-mehmk49a	283	5	influence	influence	NN
cord-308095-mehmk49a	283	6	can	can	MD
cord-308095-mehmk49a	283	7	distort	distort	VB
cord-308095-mehmk49a	283	8	policy	policy	NN
cord-308095-mehmk49a	283	9	agendas	agenda	NNS
cord-308095-mehmk49a	283	10	and	and	CC
cord-308095-mehmk49a	283	11	reinforce	reinforce	VB
cord-308095-mehmk49a	283	12	the	the	DT
cord-308095-mehmk49a	283	13	framing	framing	NN
cord-308095-mehmk49a	283	14	of	of	IN
cord-308095-mehmk49a	283	15	two	two	CD
cord-308095-mehmk49a	283	16	of	of	IN
cord-308095-mehmk49a	283	17	our	-PRON-	PRP$
cord-308095-mehmk49a	283	18	most	most	RBS
cord-308095-mehmk49a	283	19	pressing	pressing	JJ
cord-308095-mehmk49a	283	20	public	public	JJ
cord-308095-mehmk49a	283	21	health	health	NN
cord-308095-mehmk49a	283	22	challenges	challenge	NNS
cord-308095-mehmk49a	283	23	,	,	,
cord-308095-mehmk49a	283	24	pain	pain	NN
cord-308095-mehmk49a	283	25	management	management	NN
cord-308095-mehmk49a	283	26	and	and	CC
cord-308095-mehmk49a	283	27	opioid	opioid	JJ
cord-308095-mehmk49a	283	28	addiction	addiction	NN
cord-308095-mehmk49a	283	29	,	,	,
cord-308095-mehmk49a	283	30	in	in	IN
cord-308095-mehmk49a	283	31	ways	way	NNS
cord-308095-mehmk49a	283	32	that	that	WDT
cord-308095-mehmk49a	283	33	are	be	VBP
cord-308095-mehmk49a	283	34	most	most	RBS
cord-308095-mehmk49a	283	35	likely	likely	JJ
cord-308095-mehmk49a	283	36	to	to	TO
cord-308095-mehmk49a	283	37	promote	promote	VB
cord-308095-mehmk49a	283	38	the	the	DT
cord-308095-mehmk49a	283	39	commercial	commercial	JJ
cord-308095-mehmk49a	283	40	interests	interest	NNS
cord-308095-mehmk49a	283	41	of	of	IN
cord-308095-mehmk49a	283	42	the	the	DT
cord-308095-mehmk49a	283	43	opioid	opioid	JJ
cord-308095-mehmk49a	283	44	industry	industry	NN
cord-308095-mehmk49a	283	45	and	and	CC
cord-308095-mehmk49a	283	46	pharmaceutical	pharmaceutical	NN
cord-308095-mehmk49a	283	47	companies	company	NNS
cord-308095-mehmk49a	283	48	more	more	RBR
cord-308095-mehmk49a	283	49	broadly	broadly	RB
cord-308095-mehmk49a	284	1	(	(	-LRB-
cord-308095-mehmk49a	284	2	Marks	Marks	NNP
cord-308095-mehmk49a	284	3	2019a	2019a	CD
cord-308095-mehmk49a	284	4	,	,	,
cord-308095-mehmk49a	284	5	78	78	CD
cord-308095-mehmk49a	284	6	-	-	SYM
cord-308095-mehmk49a	284	7	81	81	CD
cord-308095-mehmk49a	284	8	)	)	-RRB-
cord-308095-mehmk49a	284	9	.	.	.
cord-308095-mehmk49a	285	1	This	this	DT
cord-308095-mehmk49a	285	2	may	may	MD
cord-308095-mehmk49a	285	3	explain	explain	VB
cord-308095-mehmk49a	285	4	the	the	DT
cord-308095-mehmk49a	285	5	NIH	NIH	NNP
cord-308095-mehmk49a	285	6	's	's	POS
cord-308095-mehmk49a	285	7	emphasis	emphasis	NN
cord-308095-mehmk49a	285	8	on	on	IN
cord-308095-mehmk49a	285	9	the	the	DT
cord-308095-mehmk49a	285	10	development	development	NN
cord-308095-mehmk49a	285	11	of	of	IN
cord-308095-mehmk49a	285	12	new	new	JJ
cord-308095-mehmk49a	285	13	pharmaceuticals	pharmaceutical	NNS
cord-308095-mehmk49a	285	14	to	to	TO
cord-308095-mehmk49a	285	15	address	address	VB
cord-308095-mehmk49a	285	16	pain	pain	NN
cord-308095-mehmk49a	285	17	management	management	NN
cord-308095-mehmk49a	285	18	and	and	CC
cord-308095-mehmk49a	285	19	addiction	addiction	NN
cord-308095-mehmk49a	285	20	(	(	-LRB-
cord-308095-mehmk49a	285	21	Collins	Collins	NNP
cord-308095-mehmk49a	285	22	2017	2017	CD
cord-308095-mehmk49a	285	23	(	(	-LRB-
cord-308095-mehmk49a	285	24	Collins	Collins	NNP
cord-308095-mehmk49a	285	25	,	,	,
cord-308095-mehmk49a	285	26	2018	2018	CD
cord-308095-mehmk49a	285	27	.	.	.
cord-308095-mehmk49a	286	1	It	-PRON-	PRP
cord-308095-mehmk49a	286	2	is	be	VBZ
cord-308095-mehmk49a	286	3	tempting	tempting	JJ
cord-308095-mehmk49a	286	4	for	for	IN
cord-308095-mehmk49a	286	5	public	public	JJ
cord-308095-mehmk49a	286	6	health	health	NN
cord-308095-mehmk49a	286	7	officials	official	NNS
cord-308095-mehmk49a	286	8	to	to	TO
cord-308095-mehmk49a	286	9	perceive	perceive	VB
cord-308095-mehmk49a	286	10	an	an	DT
cord-308095-mehmk49a	286	11	alignment	alignment	NN
cord-308095-mehmk49a	286	12	of	of	IN
cord-308095-mehmk49a	286	13	interests	interest	NNS
cord-308095-mehmk49a	286	14	.	.	.
cord-308095-mehmk49a	287	1	At	at	IN
cord-308095-mehmk49a	287	2	first	first	JJ
cord-308095-mehmk49a	287	3	glance	glance	NN
cord-308095-mehmk49a	287	4	,	,	,
cord-308095-mehmk49a	287	5	both	both	CC
cord-308095-mehmk49a	287	6	the	the	DT
cord-308095-mehmk49a	287	7	NIH	NIH	NNP
cord-308095-mehmk49a	287	8	and	and	CC
cord-308095-mehmk49a	287	9	pharmaceutical	pharmaceutical	NN
cord-308095-mehmk49a	287	10	companies	company	NNS
cord-308095-mehmk49a	287	11	might	may	MD
cord-308095-mehmk49a	287	12	appear	appear	VB
cord-308095-mehmk49a	287	13	to	to	TO
cord-308095-mehmk49a	287	14	have	have	VB
cord-308095-mehmk49a	287	15	a	a	DT
cord-308095-mehmk49a	287	16	shared	share	VBN
cord-308095-mehmk49a	287	17	interest	interest	NN
cord-308095-mehmk49a	287	18	in	in	IN
cord-308095-mehmk49a	287	19	the	the	DT
cord-308095-mehmk49a	287	20	development	development	NN
cord-308095-mehmk49a	287	21	of	of	IN
cord-308095-mehmk49a	287	22	effective	effective	JJ
cord-308095-mehmk49a	287	23	nonaddictive	nonaddictive	JJ
cord-308095-mehmk49a	287	24	pain	pain	NN
cord-308095-mehmk49a	287	25	medications	medication	NNS
cord-308095-mehmk49a	287	26	.	.	.
cord-308095-mehmk49a	288	1	But	but	CC
cord-308095-mehmk49a	288	2	that	that	DT
cord-308095-mehmk49a	288	3	apparent	apparent	JJ
cord-308095-mehmk49a	288	4	alignment	alignment	NN
cord-308095-mehmk49a	288	5	warrants	warrant	NNS
cord-308095-mehmk49a	288	6	interrogation	interrogation	NN
cord-308095-mehmk49a	288	7	(	(	-LRB-
cord-308095-mehmk49a	288	8	Marks	Marks	NNP
cord-308095-mehmk49a	288	9	2019a	2019a	CD
cord-308095-mehmk49a	288	10	)	)	-RRB-
cord-308095-mehmk49a	288	11	.	.	.
cord-308095-mehmk49a	289	1	Even	even	RB
cord-308095-mehmk49a	289	2	when	when	WRB
cord-308095-mehmk49a	289	3	a	a	DT
cord-308095-mehmk49a	289	4	corporation	corporation	NN
cord-308095-mehmk49a	289	5	engages	engage	VBZ
cord-308095-mehmk49a	289	6	in	in	IN
cord-308095-mehmk49a	289	7	a	a	DT
cord-308095-mehmk49a	289	8	business	business	NN
cord-308095-mehmk49a	289	9	activity	activity	NN
cord-308095-mehmk49a	289	10	with	with	IN
cord-308095-mehmk49a	289	11	the	the	DT
cord-308095-mehmk49a	289	12	express	express	JJ
cord-308095-mehmk49a	289	13	aim	aim	NN
cord-308095-mehmk49a	289	14	of	of	IN
cord-308095-mehmk49a	289	15	promoting	promote	VBG
cord-308095-mehmk49a	289	16	health	health	NN
cord-308095-mehmk49a	289	17	,	,	,
cord-308095-mehmk49a	289	18	its	-PRON-	PRP$
cord-308095-mehmk49a	289	19	primary	primary	JJ
cord-308095-mehmk49a	289	20	objective	objective	NN
cord-308095-mehmk49a	289	21	is	be	VBZ
cord-308095-mehmk49a	289	22	the	the	DT
cord-308095-mehmk49a	289	23	generation	generation	NN
cord-308095-mehmk49a	289	24	of	of	IN
cord-308095-mehmk49a	289	25	profits	profit	NNS
cord-308095-mehmk49a	289	26	from	from	IN
cord-308095-mehmk49a	289	27	the	the	DT
cord-308095-mehmk49a	289	28	sale	sale	NN
cord-308095-mehmk49a	289	29	of	of	IN
cord-308095-mehmk49a	289	30	goods	good	NNS
cord-308095-mehmk49a	289	31	or	or	CC
cord-308095-mehmk49a	289	32	services	service	NNS
cord-308095-mehmk49a	289	33	.	.	.
cord-308095-mehmk49a	290	1	The	the	DT
cord-308095-mehmk49a	290	2	primary	primary	JJ
cord-308095-mehmk49a	290	3	obligation	obligation	NN
cord-308095-mehmk49a	290	4	of	of	IN
cord-308095-mehmk49a	290	5	public	public	JJ
cord-308095-mehmk49a	290	6	health	health	NN
cord-308095-mehmk49a	290	7	agencies	agency	NNS
cord-308095-mehmk49a	290	8	is	be	VBZ
cord-308095-mehmk49a	290	9	to	to	TO
cord-308095-mehmk49a	290	10	protect	protect	VB
cord-308095-mehmk49a	290	11	and	and	CC
cord-308095-mehmk49a	290	12	promote	promote	VB
cord-308095-mehmk49a	290	13	public	public	JJ
cord-308095-mehmk49a	290	14	health	health	NN
cord-308095-mehmk49a	290	15	.	.	.
cord-308095-mehmk49a	291	1	Divergence	divergence	NN
cord-308095-mehmk49a	291	2	between	between	IN
cord-308095-mehmk49a	291	3	these	these	DT
cord-308095-mehmk49a	291	4	objectives	objective	NNS
cord-308095-mehmk49a	291	5	is	be	VBZ
cord-308095-mehmk49a	291	6	inevitable	inevitable	JJ
cord-308095-mehmk49a	291	7	and	and	CC
cord-308095-mehmk49a	291	8	,	,	,
cord-308095-mehmk49a	291	9	at	at	IN
cord-308095-mehmk49a	291	10	times	time	NNS
cord-308095-mehmk49a	291	11	,	,	,
cord-308095-mehmk49a	291	12	acute	acute	JJ
cord-308095-mehmk49a	291	13	.	.	.
cord-308095-mehmk49a	292	1	A	a	DT
cord-308095-mehmk49a	292	2	drug	drug	NN
cord-308095-mehmk49a	292	3	formulated	formulate	VBN
cord-308095-mehmk49a	292	4	to	to	TO
cord-308095-mehmk49a	292	5	promote	promote	VB
cord-308095-mehmk49a	292	6	health	health	NN
cord-308095-mehmk49a	292	7	(	(	-LRB-
cord-308095-mehmk49a	292	8	for	for	IN
cord-308095-mehmk49a	292	9	example	example	NN
cord-308095-mehmk49a	292	10	,	,	,
cord-308095-mehmk49a	292	11	by	by	IN
cord-308095-mehmk49a	292	12	alleviating	alleviate	VBG
cord-308095-mehmk49a	292	13	pain	pain	NN
cord-308095-mehmk49a	292	14	)	)	-RRB-
cord-308095-mehmk49a	292	15	may	may	MD
cord-308095-mehmk49a	292	16	turn	turn	VB
cord-308095-mehmk49a	292	17	out	out	RP
cord-308095-mehmk49a	292	18	to	to	TO
cord-308095-mehmk49a	292	19	be	be	VB
cord-308095-mehmk49a	292	20	less	less	RBR
cord-308095-mehmk49a	292	21	effective	effective	JJ
cord-308095-mehmk49a	292	22	than	than	IN
cord-308095-mehmk49a	292	23	anticipated	anticipate	VBN
cord-308095-mehmk49a	292	24	or	or	CC
cord-308095-mehmk49a	292	25	to	to	TO
cord-308095-mehmk49a	292	26	have	have	VB
cord-308095-mehmk49a	292	27	dangerous	dangerous	JJ
cord-308095-mehmk49a	292	28	side	side	NN
cord-308095-mehmk49a	292	29	-	-	HYPH
cord-308095-mehmk49a	292	30	effects	effect	NNS
cord-308095-mehmk49a	292	31	.	.	.
cord-308095-mehmk49a	293	1	In	in	IN
cord-308095-mehmk49a	293	2	such	such	JJ
cord-308095-mehmk49a	293	3	cases	case	NNS
cord-308095-mehmk49a	293	4	,	,	,
cord-308095-mehmk49a	293	5	public	public	JJ
cord-308095-mehmk49a	293	6	health	health	NN
cord-308095-mehmk49a	293	7	agencies	agency	NNS
cord-308095-mehmk49a	293	8	have	have	VBP
cord-308095-mehmk49a	293	9	an	an	DT
cord-308095-mehmk49a	293	10	obligation	obligation	NN
cord-308095-mehmk49a	293	11	to	to	TO
cord-308095-mehmk49a	293	12	ensure	ensure	VB
cord-308095-mehmk49a	293	13	,	,	,
cord-308095-mehmk49a	293	14	at	at	IN
cord-308095-mehmk49a	293	15	the	the	DT
cord-308095-mehmk49a	293	16	very	very	RB
cord-308095-mehmk49a	293	17	least	least	JJS
cord-308095-mehmk49a	293	18	,	,	,
cord-308095-mehmk49a	293	19	that	that	IN
cord-308095-mehmk49a	293	20	health	health	NN
cord-308095-mehmk49a	293	21	professionals	professional	NNS
cord-308095-mehmk49a	293	22	and	and	CC
cord-308095-mehmk49a	293	23	patients	patient	NNS
cord-308095-mehmk49a	293	24	are	be	VBP
cord-308095-mehmk49a	293	25	made	make	VBN
cord-308095-mehmk49a	293	26	aware	aware	JJ
cord-308095-mehmk49a	293	27	of	of	IN
cord-308095-mehmk49a	293	28	these	these	DT
cord-308095-mehmk49a	293	29	concerns	concern	NNS
cord-308095-mehmk49a	293	30	.	.	.
cord-308095-mehmk49a	294	1	However	however	RB
cord-308095-mehmk49a	294	2	,	,	,
cord-308095-mehmk49a	294	3	the	the	DT
cord-308095-mehmk49a	294	4	drug	drug	NN
cord-308095-mehmk49a	294	5	company	company	NN
cord-308095-mehmk49a	294	6	will	will	MD
cord-308095-mehmk49a	294	7	have	have	VB
cord-308095-mehmk49a	294	8	a	a	DT
cord-308095-mehmk49a	294	9	powerful	powerful	JJ
cord-308095-mehmk49a	294	10	economic	economic	JJ
cord-308095-mehmk49a	294	11	incentive	incentive	NN
cord-308095-mehmk49a	294	12	to	to	TO
cord-308095-mehmk49a	294	13	exaggerate	exaggerate	VB
cord-308095-mehmk49a	294	14	the	the	DT
cord-308095-mehmk49a	294	15	benefits	benefit	NNS
cord-308095-mehmk49a	294	16	of	of	IN
cord-308095-mehmk49a	294	17	the	the	DT
cord-308095-mehmk49a	294	18	drug	drug	NN
cord-308095-mehmk49a	294	19	,	,	,
cord-308095-mehmk49a	294	20	downplay	downplay	VB
cord-308095-mehmk49a	294	21	the	the	DT
cord-308095-mehmk49a	294	22	adverse	adverse	JJ
cord-308095-mehmk49a	294	23	effects	effect	NNS
cord-308095-mehmk49a	294	24	,	,	,
cord-308095-mehmk49a	294	25	and	and	CC
cord-308095-mehmk49a	294	26	promote	promote	VB
cord-308095-mehmk49a	294	27	sales	sale	NNS
cord-308095-mehmk49a	294	28	for	for	IN
cord-308095-mehmk49a	294	29	as	as	RB
cord-308095-mehmk49a	294	30	long	long	RB
cord-308095-mehmk49a	294	31	as	as	IN
cord-308095-mehmk49a	294	32	possible	possible	JJ
cord-308095-mehmk49a	294	33	to	to	TO
cord-308095-mehmk49a	294	34	protect	protect	VB
cord-308095-mehmk49a	294	35	revenues	revenue	NNS
cord-308095-mehmk49a	294	36	-	-	:
cord-308095-mehmk49a	294	37	especially	especially	RB
cord-308095-mehmk49a	294	38	when	when	WRB
cord-308095-mehmk49a	294	39	profits	profit	NNS
cord-308095-mehmk49a	294	40	dwarf	dwarf	VBP
cord-308095-mehmk49a	294	41	potential	potential	JJ
cord-308095-mehmk49a	294	42	financial	financial	JJ
cord-308095-mehmk49a	294	43	penalties	penalty	NNS
cord-308095-mehmk49a	294	44	.	.	.
cord-308095-mehmk49a	295	1	We	-PRON-	PRP
cord-308095-mehmk49a	295	2	have	have	VBP
cord-308095-mehmk49a	295	3	seen	see	VBN
cord-308095-mehmk49a	295	4	precisely	precisely	RB
cord-308095-mehmk49a	295	5	this	this	DT
cord-308095-mehmk49a	295	6	scenario	scenario	NN
cord-308095-mehmk49a	295	7	play	play	VBP
cord-308095-mehmk49a	295	8	out	out	RP
cord-308095-mehmk49a	295	9	in	in	IN
cord-308095-mehmk49a	295	10	the	the	DT
cord-308095-mehmk49a	295	11	opioid	opioid	JJ
cord-308095-mehmk49a	295	12	crisis	crisis	NN
cord-308095-mehmk49a	295	13	,	,	,
cord-308095-mehmk49a	295	14	and	and	CC
cord-308095-mehmk49a	295	15	policymakers	policymaker	NNS
cord-308095-mehmk49a	295	16	should	should	MD
cord-308095-mehmk49a	295	17	be	be	VB
cord-308095-mehmk49a	295	18	at	at	IN
cord-308095-mehmk49a	295	19	pains	pain	NNS
cord-308095-mehmk49a	295	20	to	to	TO
cord-308095-mehmk49a	295	21	avoid	avoid	VB
cord-308095-mehmk49a	295	22	its	-PRON-	PRP$
cord-308095-mehmk49a	295	23	repetition	repetition	NN
cord-308095-mehmk49a	295	24	.	.	.
cord-308095-mehmk49a	296	1	Partnering	partner	VBG
cord-308095-mehmk49a	296	2	with	with	IN
cord-308095-mehmk49a	296	3	the	the	DT
cord-308095-mehmk49a	296	4	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	296	5	industry	industry	NN
cord-308095-mehmk49a	296	6	to	to	TO
cord-308095-mehmk49a	296	7	address	address	VB
cord-308095-mehmk49a	296	8	the	the	DT
cord-308095-mehmk49a	296	9	opioid	opioid	JJ
cord-308095-mehmk49a	296	10	crisis	crisis	NN
cord-308095-mehmk49a	296	11	courts	court	NNS
cord-308095-mehmk49a	296	12	serious	serious	JJ
cord-308095-mehmk49a	296	13	public	public	JJ
cord-308095-mehmk49a	296	14	health	health	NN
cord-308095-mehmk49a	296	15	hazards	hazard	NNS
cord-308095-mehmk49a	296	16	.	.	.
cord-308095-mehmk49a	297	1	The	the	DT
cord-308095-mehmk49a	297	2	threat	threat	NN
cord-308095-mehmk49a	297	3	to	to	IN
cord-308095-mehmk49a	297	4	public	public	JJ
cord-308095-mehmk49a	297	5	trust	trust	NN
cord-308095-mehmk49a	297	6	in	in	IN
cord-308095-mehmk49a	297	7	government	government	NN
cord-308095-mehmk49a	297	8	,	,	,
cord-308095-mehmk49a	297	9	the	the	DT
cord-308095-mehmk49a	297	10	academy	academy	NN
cord-308095-mehmk49a	297	11	,	,	,
cord-308095-mehmk49a	297	12	and	and	CC
cord-308095-mehmk49a	297	13	civil	civil	JJ
cord-308095-mehmk49a	297	14	society	society	NN
cord-308095-mehmk49a	297	15	groups	group	NNS
cord-308095-mehmk49a	297	16	is	be	VBZ
cord-308095-mehmk49a	297	17	now	now	RB
cord-308095-mehmk49a	297	18	readily	readily	RB
cord-308095-mehmk49a	297	19	apparent	apparent	JJ
cord-308095-mehmk49a	297	20	,	,	,
cord-308095-mehmk49a	297	21	too	too	RB
cord-308095-mehmk49a	297	22	(	(	-LRB-
cord-308095-mehmk49a	297	23	Rose	Rose	NNP
cord-308095-mehmk49a	297	24	2013	2013	CD
cord-308095-mehmk49a	297	25	;	;	:
cord-308095-mehmk49a	297	26	Marks	Marks	NNP
cord-308095-mehmk49a	297	27	2019a	2019a	CD
cord-308095-mehmk49a	297	28	)	)	-RRB-
cord-308095-mehmk49a	297	29	.	.	.
cord-308095-mehmk49a	298	1	But	but	CC
cord-308095-mehmk49a	298	2	there	there	EX
cord-308095-mehmk49a	298	3	is	be	VBZ
cord-308095-mehmk49a	298	4	another	another	DT
cord-308095-mehmk49a	298	5	important	important	JJ
cord-308095-mehmk49a	298	6	reason	reason	NN
cord-308095-mehmk49a	298	7	for	for	IN
cord-308095-mehmk49a	298	8	public	public	JJ
cord-308095-mehmk49a	298	9	health	health	NN
cord-308095-mehmk49a	298	10	bodies	body	NNS
cord-308095-mehmk49a	298	11	to	to	TO
cord-308095-mehmk49a	298	12	be	be	VB
cord-308095-mehmk49a	298	13	wary	wary	JJ
cord-308095-mehmk49a	298	14	of	of	IN
cord-308095-mehmk49a	298	15	close	close	JJ
cord-308095-mehmk49a	298	16	relationships	relationship	NNS
cord-308095-mehmk49a	298	17	with	with	IN
cord-308095-mehmk49a	298	18	the	the	DT
cord-308095-mehmk49a	298	19	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	298	20	industry	industry	NN
cord-308095-mehmk49a	298	21	:	:	:
cord-308095-mehmk49a	298	22	institutional	institutional	JJ
cord-308095-mehmk49a	298	23	integrity	integrity	NN
cord-308095-mehmk49a	298	24	.	.	.
cord-308095-mehmk49a	299	1	A	a	DT
cord-308095-mehmk49a	299	2	key	key	JJ
cord-308095-mehmk49a	299	3	component	component	NN
cord-308095-mehmk49a	299	4	of	of	IN
cord-308095-mehmk49a	299	5	institutional	institutional	JJ
cord-308095-mehmk49a	299	6	integrity	integrity	NN
cord-308095-mehmk49a	299	7	is	be	VBZ
cord-308095-mehmk49a	299	8	consistency	consistency	NN
cord-308095-mehmk49a	299	9	-	-	:
cord-308095-mehmk49a	299	10	in	in	IN
cord-308095-mehmk49a	299	11	particular	particular	JJ
cord-308095-mehmk49a	299	12	,	,	,
cord-308095-mehmk49a	299	13	consistency	consistency	NN
cord-308095-mehmk49a	299	14	among	among	IN
cord-308095-mehmk49a	299	15	what	what	WP
cord-308095-mehmk49a	299	16	an	an	DT
cord-308095-mehmk49a	299	17	institution	institution	NN
cord-308095-mehmk49a	299	18	does	do	VBZ
cord-308095-mehmk49a	299	19	(	(	-LRB-
cord-308095-mehmk49a	299	20	its	-PRON-	PRP$
cord-308095-mehmk49a	299	21	practices	practice	NNS
cord-308095-mehmk49a	299	22	)	)	-RRB-
cord-308095-mehmk49a	299	23	,	,	,
cord-308095-mehmk49a	299	24	what	what	WP
cord-308095-mehmk49a	299	25	it	-PRON-	PRP
cord-308095-mehmk49a	299	26	says	say	VBZ
cord-308095-mehmk49a	299	27	it	-PRON-	PRP
cord-308095-mehmk49a	299	28	does	do	VBZ
cord-308095-mehmk49a	299	29	(	(	-LRB-
cord-308095-mehmk49a	299	30	its	-PRON-	PRP$
cord-308095-mehmk49a	299	31	mission	mission	NN
cord-308095-mehmk49a	299	32	)	)	-RRB-
cord-308095-mehmk49a	299	33	,	,	,
cord-308095-mehmk49a	299	34	and	and	CC
cord-308095-mehmk49a	299	35	what	what	WP
cord-308095-mehmk49a	299	36	it	-PRON-	PRP
cord-308095-mehmk49a	299	37	is	be	VBZ
cord-308095-mehmk49a	299	38	obligated	obligate	VBN
cord-308095-mehmk49a	299	39	to	to	TO
cord-308095-mehmk49a	299	40	do	do	VB
cord-308095-mehmk49a	299	41	(	(	-LRB-
cord-308095-mehmk49a	299	42	its	-PRON-	PRP$
cord-308095-mehmk49a	299	43	purpose	purpose	NN
cord-308095-mehmk49a	299	44	)	)	-RRB-
cord-308095-mehmk49a	300	1	(	(	-LRB-
cord-308095-mehmk49a	300	2	Marks	mark	NNS
cord-308095-mehmk49a	300	3	2017	2017	CD
cord-308095-mehmk49a	300	4	(	(	-LRB-
cord-308095-mehmk49a	300	5	Marks	Marks	NNP
cord-308095-mehmk49a	300	6	,	,	,
cord-308095-mehmk49a	300	7	2019a	2019a	CD
cord-308095-mehmk49a	300	8	.	.	.
cord-308095-mehmk49a	301	1	Public	public	JJ
cord-308095-mehmk49a	301	2	health	health	NN
cord-308095-mehmk49a	301	3	agencies	agency	NNS
cord-308095-mehmk49a	301	4	'	'	POS
cord-308095-mehmk49a	301	5	and	and	CC
cord-308095-mehmk49a	301	6	NGOs	NGOs	NNPS
cord-308095-mehmk49a	301	7	'	'	POS
cord-308095-mehmk49a	301	8	relationships	relationship	NNS
cord-308095-mehmk49a	301	9	with	with	IN
cord-308095-mehmk49a	301	10	the	the	DT
cord-308095-mehmk49a	301	11	opioid	opioid	NN
cord-308095-mehmk49a	301	12	industry	industry	NN
cord-308095-mehmk49a	301	13	have	have	VBP
cord-308095-mehmk49a	301	14	clearly	clearly	RB
cord-308095-mehmk49a	301	15	served	serve	VBN
cord-308095-mehmk49a	301	16	to	to	TO
cord-308095-mehmk49a	301	17	undermine	undermine	VB
cord-308095-mehmk49a	301	18	their	-PRON-	PRP$
cord-308095-mehmk49a	301	19	public	public	JJ
cord-308095-mehmk49a	301	20	health	health	NN
cord-308095-mehmk49a	301	21	mission	mission	NN
cord-308095-mehmk49a	301	22	and	and	CC
cord-308095-mehmk49a	301	23	purpose	purpose	NN
cord-308095-mehmk49a	301	24	-	-	:
cord-308095-mehmk49a	301	25	and	and	CC
cord-308095-mehmk49a	301	26	,	,	,
cord-308095-mehmk49a	301	27	in	in	IN
cord-308095-mehmk49a	301	28	turn	turn	NN
cord-308095-mehmk49a	301	29	,	,	,
cord-308095-mehmk49a	301	30	their	-PRON-	PRP$
cord-308095-mehmk49a	301	31	integrity	integrity	NN
cord-308095-mehmk49a	301	32	.	.	.
cord-308095-mehmk49a	302	1	The	the	DT
cord-308095-mehmk49a	302	2	crisis	crisis	NN
cord-308095-mehmk49a	302	3	is	be	VBZ
cord-308095-mehmk49a	302	4	yet	yet	RB
cord-308095-mehmk49a	302	5	another	another	DT
cord-308095-mehmk49a	302	6	painful	painful	JJ
cord-308095-mehmk49a	302	7	reminder	reminder	NN
cord-308095-mehmk49a	302	8	of	of	IN
cord-308095-mehmk49a	302	9	the	the	DT
cord-308095-mehmk49a	302	10	perils	peril	NNS
cord-308095-mehmk49a	302	11	of	of	IN
cord-308095-mehmk49a	302	12	partnership	partnership	NN
cord-308095-mehmk49a	302	13	with	with	IN
cord-308095-mehmk49a	302	14	any	any	DT
cord-308095-mehmk49a	302	15	entity	entity	NN
cord-308095-mehmk49a	302	16	whose	whose	WP$
cord-308095-mehmk49a	302	17	mission	mission	NN
cord-308095-mehmk49a	302	18	,	,	,
cord-308095-mehmk49a	302	19	purpose	purpose	NN
cord-308095-mehmk49a	302	20	,	,	,
cord-308095-mehmk49a	302	21	or	or	CC
cord-308095-mehmk49a	302	22	practices	practice	NNS
cord-308095-mehmk49a	302	23	diverge	diverge	VBP
cord-308095-mehmk49a	302	24	fundamentally	fundamentally	RB
cord-308095-mehmk49a	302	25	from	from	IN
cord-308095-mehmk49a	302	26	those	those	DT
cord-308095-mehmk49a	302	27	of	of	IN
cord-308095-mehmk49a	302	28	one	one	PRP
cord-308095-mehmk49a	302	29	's	's	POS
cord-308095-mehmk49a	302	30	own	own	JJ
cord-308095-mehmk49a	302	31	institution	institution	NN
cord-308095-mehmk49a	302	32	(	(	-LRB-
cord-308095-mehmk49a	302	33	Marks	Marks	NNP
cord-308095-mehmk49a	302	34	2019a	2019a	CD
cord-308095-mehmk49a	302	35	)	)	-RRB-
cord-308095-mehmk49a	302	36	.	.	.
cord-308095-mehmk49a	303	1	What	what	WP
cord-308095-mehmk49a	303	2	the	the	DT
cord-308095-mehmk49a	303	3	opioid	opioid	JJ
cord-308095-mehmk49a	303	4	crisis	crisis	NN
cord-308095-mehmk49a	303	5	has	have	VBZ
cord-308095-mehmk49a	303	6	also	also	RB
cord-308095-mehmk49a	303	7	made	make	VBN
cord-308095-mehmk49a	303	8	clear	clear	JJ
cord-308095-mehmk49a	303	9	,	,	,
cord-308095-mehmk49a	303	10	moreover	moreover	RB
cord-308095-mehmk49a	303	11	,	,	,
cord-308095-mehmk49a	303	12	is	be	VBZ
cord-308095-mehmk49a	303	13	that	that	DT
cord-308095-mehmk49a	303	14	looking	look	VBG
cord-308095-mehmk49a	303	15	solely	solely	RB
cord-308095-mehmk49a	303	16	at	at	IN
cord-308095-mehmk49a	303	17	the	the	DT
cord-308095-mehmk49a	303	18	ethical	ethical	JJ
cord-308095-mehmk49a	303	19	implications	implication	NNS
cord-308095-mehmk49a	303	20	of	of	IN
cord-308095-mehmk49a	303	21	a	a	DT
cord-308095-mehmk49a	303	22	single	single	JJ
cord-308095-mehmk49a	303	23	relationship	relationship	NN
cord-308095-mehmk49a	303	24	between	between	IN
cord-308095-mehmk49a	303	25	a	a	DT
cord-308095-mehmk49a	303	26	public	public	JJ
cord-308095-mehmk49a	303	27	health	health	NN
cord-308095-mehmk49a	303	28	agency	agency	NN
cord-308095-mehmk49a	303	29	,	,	,
cord-308095-mehmk49a	303	30	university	university	NN
cord-308095-mehmk49a	303	31	,	,	,
cord-308095-mehmk49a	303	32	or	or	CC
cord-308095-mehmk49a	303	33	public	public	JJ
cord-308095-mehmk49a	303	34	health	health	NN
cord-308095-mehmk49a	303	35	NGO	NGO	NNP
cord-308095-mehmk49a	303	36	on	on	IN
cord-308095-mehmk49a	303	37	the	the	DT
cord-308095-mehmk49a	303	38	one	one	CD
cord-308095-mehmk49a	303	39	hand	hand	NN
cord-308095-mehmk49a	303	40	,	,	,
cord-308095-mehmk49a	303	41	and	and	CC
cord-308095-mehmk49a	303	42	a	a	DT
cord-308095-mehmk49a	303	43	private	private	JJ
cord-308095-mehmk49a	303	44	-	-	HYPH
cord-308095-mehmk49a	303	45	sector	sector	NN
cord-308095-mehmk49a	303	46	entity	entity	NN
cord-308095-mehmk49a	303	47	on	on	IN
cord-308095-mehmk49a	303	48	the	the	DT
cord-308095-mehmk49a	303	49	other	other	JJ
cord-308095-mehmk49a	303	50	,	,	,
cord-308095-mehmk49a	303	51	fails	fail	VBZ
cord-308095-mehmk49a	303	52	to	to	TO
cord-308095-mehmk49a	303	53	take	take	VB
cord-308095-mehmk49a	303	54	into	into	IN
cord-308095-mehmk49a	303	55	account	account	NN
cord-308095-mehmk49a	303	56	the	the	DT
cord-308095-mehmk49a	303	57	systemic	systemic	JJ
cord-308095-mehmk49a	303	58	problem	problem	NN
cord-308095-mehmk49a	303	59	arising	arise	VBG
cord-308095-mehmk49a	303	60	from	from	IN
cord-308095-mehmk49a	303	61	corporate	corporate	JJ
cord-308095-mehmk49a	303	62	strategies	strategy	NNS
cord-308095-mehmk49a	303	63	that	that	WDT
cord-308095-mehmk49a	303	64	involve	involve	VBP
cord-308095-mehmk49a	303	65	(	(	-LRB-
cord-308095-mehmk49a	303	66	as	as	IN
cord-308095-mehmk49a	303	67	they	-PRON-	PRP
cord-308095-mehmk49a	303	68	almost	almost	RB
cord-308095-mehmk49a	303	69	invariably	invariably	RB
cord-308095-mehmk49a	303	70	do	do	VBP
cord-308095-mehmk49a	303	71	)	)	-RRB-
cord-308095-mehmk49a	303	72	webs	web	NNS
cord-308095-mehmk49a	303	73	of	of	IN
cord-308095-mehmk49a	303	74	influence	influence	NN
cord-308095-mehmk49a	303	75	with	with	IN
cord-308095-mehmk49a	303	76	a	a	DT
cord-308095-mehmk49a	303	77	variety	variety	NN
cord-308095-mehmk49a	303	78	of	of	IN
cord-308095-mehmk49a	303	79	institutions	institution	NNS
cord-308095-mehmk49a	303	80	in	in	IN
cord-308095-mehmk49a	303	81	government	government	NN
cord-308095-mehmk49a	303	82	,	,	,
cord-308095-mehmk49a	303	83	the	the	DT
cord-308095-mehmk49a	303	84	academy	academy	NN
cord-308095-mehmk49a	303	85	,	,	,
cord-308095-mehmk49a	303	86	and	and	CC
cord-308095-mehmk49a	303	87	civil	civil	JJ
cord-308095-mehmk49a	303	88	society	society	NN
cord-308095-mehmk49a	303	89	.	.	.
cord-308095-mehmk49a	304	1	Corporations	corporation	NNS
cord-308095-mehmk49a	304	2	do	do	VBP
cord-308095-mehmk49a	304	3	not	not	RB
cord-308095-mehmk49a	304	4	build	build	VB
cord-308095-mehmk49a	304	5	individual	individual	JJ
cord-308095-mehmk49a	304	6	relationships	relationship	NNS
cord-308095-mehmk49a	304	7	in	in	IN
cord-308095-mehmk49a	304	8	isolation	isolation	NN
cord-308095-mehmk49a	304	9	;	;	:
cord-308095-mehmk49a	304	10	they	-PRON-	PRP
cord-308095-mehmk49a	304	11	develop	develop	VBP
cord-308095-mehmk49a	304	12	strategies	strategy	NNS
cord-308095-mehmk49a	304	13	to	to	TO
cord-308095-mehmk49a	304	14	engage	engage	VB
cord-308095-mehmk49a	304	15	with	with	IN
cord-308095-mehmk49a	304	16	all	all	PDT
cord-308095-mehmk49a	304	17	these	these	DT
cord-308095-mehmk49a	304	18	actors	actor	NNS
cord-308095-mehmk49a	304	19	.	.	.
cord-308095-mehmk49a	305	1	But	but	CC
cord-308095-mehmk49a	305	2	when	when	WRB
cord-308095-mehmk49a	305	3	each	each	DT
cord-308095-mehmk49a	305	4	of	of	IN
cord-308095-mehmk49a	305	5	these	these	DT
cord-308095-mehmk49a	305	6	actors	actor	NNS
cord-308095-mehmk49a	305	7	considers	consider	VBZ
cord-308095-mehmk49a	305	8	the	the	DT
cord-308095-mehmk49a	305	9	ethics	ethic	NNS
cord-308095-mehmk49a	305	10	of	of	IN
cord-308095-mehmk49a	305	11	"	"	``
cord-308095-mehmk49a	305	12	engagement	engagement	NN
cord-308095-mehmk49a	305	13	,	,	,
cord-308095-mehmk49a	305	14	"	"	''
cord-308095-mehmk49a	305	15	they	-PRON-	PRP
cord-308095-mehmk49a	305	16	tend	tend	VBP
cord-308095-mehmk49a	305	17	only	only	RB
cord-308095-mehmk49a	305	18	to	to	TO
cord-308095-mehmk49a	305	19	focus	focus	VB
cord-308095-mehmk49a	305	20	on	on	IN
cord-308095-mehmk49a	305	21	their	-PRON-	PRP$
cord-308095-mehmk49a	305	22	own	own	JJ
cord-308095-mehmk49a	305	23	proposed	propose	VBN
cord-308095-mehmk49a	305	24	relationship	relationship	NN
cord-308095-mehmk49a	305	25	.	.	.
cord-308095-mehmk49a	306	1	Public	public	JJ
cord-308095-mehmk49a	306	2	health	health	NN
cord-308095-mehmk49a	306	3	agencies	agency	NNS
cord-308095-mehmk49a	306	4	,	,	,
cord-308095-mehmk49a	306	5	universities	university	NNS
cord-308095-mehmk49a	306	6	,	,	,
cord-308095-mehmk49a	306	7	and	and	CC
cord-308095-mehmk49a	306	8	public	public	JJ
cord-308095-mehmk49a	306	9	health	health	NN
cord-308095-mehmk49a	306	10	NGOs	NGOs	NNPS
cord-308095-mehmk49a	306	11	contemplating	contemplate	VBG
cord-308095-mehmk49a	306	12	partnerships	partnership	NNS
cord-308095-mehmk49a	306	13	should	should	MD
cord-308095-mehmk49a	306	14	be	be	VB
cord-308095-mehmk49a	306	15	as	as	RB
cord-308095-mehmk49a	306	16	attentive	attentive	JJ
cord-308095-mehmk49a	306	17	to	to	IN
cord-308095-mehmk49a	306	18	webs	web	NNS
cord-308095-mehmk49a	306	19	of	of	IN
cord-308095-mehmk49a	306	20	influence	influence	NN
cord-308095-mehmk49a	306	21	as	as	IN
cord-308095-mehmk49a	306	22	the	the	DT
cord-308095-mehmk49a	306	23	corporations	corporation	NNS
cord-308095-mehmk49a	306	24	that	that	WDT
cord-308095-mehmk49a	306	25	weave	weave	VBP
cord-308095-mehmk49a	306	26	them	-PRON-	PRP
cord-308095-mehmk49a	306	27	.	.	.
cord-308095-mehmk49a	307	1	Of	of	RB
cord-308095-mehmk49a	307	2	course	course	RB
cord-308095-mehmk49a	307	3	,	,	,
cord-308095-mehmk49a	307	4	being	be	VBG
cord-308095-mehmk49a	307	5	attentive	attentive	JJ
cord-308095-mehmk49a	307	6	to	to	IN
cord-308095-mehmk49a	307	7	the	the	DT
cord-308095-mehmk49a	307	8	webs	web	NNS
cord-308095-mehmk49a	307	9	of	of	IN
cord-308095-mehmk49a	307	10	influence	influence	NN
cord-308095-mehmk49a	307	11	and	and	CC
cord-308095-mehmk49a	307	12	their	-PRON-	PRP$
cord-308095-mehmk49a	307	13	ethical	ethical	JJ
cord-308095-mehmk49a	307	14	and	and	CC
cord-308095-mehmk49a	307	15	policy	policy	NN
cord-308095-mehmk49a	307	16	implications	implication	NNS
cord-308095-mehmk49a	307	17	is	be	VBZ
cord-308095-mehmk49a	307	18	resource	resource	NN
cord-308095-mehmk49a	307	19	intensive	intensive	JJ
cord-308095-mehmk49a	307	20	,	,	,
cord-308095-mehmk49a	307	21	and	and	CC
cord-308095-mehmk49a	307	22	it	-PRON-	PRP
cord-308095-mehmk49a	307	23	can	can	MD
cord-308095-mehmk49a	307	24	not	not	RB
cord-308095-mehmk49a	307	25	be	be	VB
cord-308095-mehmk49a	307	26	a	a	DT
cord-308095-mehmk49a	307	27	one	one	CD
cord-308095-mehmk49a	307	28	-	-	HYPH
cord-308095-mehmk49a	307	29	off	off	NN
cord-308095-mehmk49a	307	30	enterprise	enterprise	NN
cord-308095-mehmk49a	307	31	either	either	RB
cord-308095-mehmk49a	307	32	.	.	.
cord-308095-mehmk49a	308	1	Imagine	imagine	VBP
cord-308095-mehmk49a	308	2	you	-PRON-	PRP
cord-308095-mehmk49a	308	3	are	be	VBP
cord-308095-mehmk49a	308	4	the	the	DT
cord-308095-mehmk49a	308	5	head	head	NN
cord-308095-mehmk49a	308	6	of	of	IN
cord-308095-mehmk49a	308	7	a	a	DT
cord-308095-mehmk49a	308	8	public	public	JJ
cord-308095-mehmk49a	308	9	health	health	NN
cord-308095-mehmk49a	308	10	agency	agency	NN
cord-308095-mehmk49a	308	11	.	.	.
cord-308095-mehmk49a	309	1	Yours	-PRON-	PRP
cord-308095-mehmk49a	309	2	may	may	MD
cord-308095-mehmk49a	309	3	be	be	VB
cord-308095-mehmk49a	309	4	the	the	DT
cord-308095-mehmk49a	309	5	first	first	JJ
cord-308095-mehmk49a	309	6	public	public	JJ
cord-308095-mehmk49a	309	7	health	health	NN
cord-308095-mehmk49a	309	8	agency	agency	NN
cord-308095-mehmk49a	309	9	to	to	IN
cord-308095-mehmk49a	309	10	partner	partner	NN
cord-308095-mehmk49a	309	11	with	with	IN
cord-308095-mehmk49a	309	12	corporation	corporation	NN
cord-308095-mehmk49a	309	13	X.	X.	NNP
cord-308095-mehmk49a	310	1	But	but	CC
cord-308095-mehmk49a	310	2	that	that	DT
cord-308095-mehmk49a	310	3	corporation	corporation	NN
cord-308095-mehmk49a	310	4	may	may	MD
cord-308095-mehmk49a	310	5	be	be	VB
cord-308095-mehmk49a	310	6	using	use	VBG
cord-308095-mehmk49a	310	7	its	-PRON-	PRP$
cord-308095-mehmk49a	310	8	partnership	partnership	NN
cord-308095-mehmk49a	310	9	with	with	IN
cord-308095-mehmk49a	310	10	you	-PRON-	PRP
cord-308095-mehmk49a	310	11	as	as	IN
cord-308095-mehmk49a	310	12	a	a	DT
cord-308095-mehmk49a	310	13	pilot	pilot	NN
cord-308095-mehmk49a	310	14	or	or	CC
cord-308095-mehmk49a	310	15	test	test	NN
cord-308095-mehmk49a	310	16	case	case	NN
cord-308095-mehmk49a	310	17	that	that	IN
cord-308095-mehmk49a	310	18	it	-PRON-	PRP
cord-308095-mehmk49a	310	19	will	will	MD
cord-308095-mehmk49a	310	20	then	then	RB
cord-308095-mehmk49a	310	21	use	use	VB
cord-308095-mehmk49a	310	22	to	to	TO
cord-308095-mehmk49a	310	23	"	"	``
cord-308095-mehmk49a	310	24	sell	sell	VB
cord-308095-mehmk49a	310	25	"	"	''
cord-308095-mehmk49a	310	26	the	the	DT
cord-308095-mehmk49a	310	27	idea	idea	NN
cord-308095-mehmk49a	310	28	of	of	IN
cord-308095-mehmk49a	310	29	partnership	partnership	NN
cord-308095-mehmk49a	310	30	to	to	IN
cord-308095-mehmk49a	310	31	another	another	DT
cord-308095-mehmk49a	310	32	public	public	JJ
cord-308095-mehmk49a	310	33	health	health	NN
cord-308095-mehmk49a	310	34	agency	agency	NN
cord-308095-mehmk49a	310	35	.	.	.
cord-308095-mehmk49a	311	1	Your	-PRON-	PRP$
cord-308095-mehmk49a	311	2	public	public	JJ
cord-308095-mehmk49a	311	3	health	health	NN
cord-308095-mehmk49a	311	4	agency	agency	NN
cord-308095-mehmk49a	311	5	would	would	MD
cord-308095-mehmk49a	311	6	need	need	VB
cord-308095-mehmk49a	311	7	to	to	TO
cord-308095-mehmk49a	311	8	continue	continue	VB
cord-308095-mehmk49a	311	9	to	to	TO
cord-308095-mehmk49a	311	10	be	be	VB
cord-308095-mehmk49a	311	11	attentive	attentive	JJ
cord-308095-mehmk49a	311	12	to	to	IN
cord-308095-mehmk49a	311	13	the	the	DT
cord-308095-mehmk49a	311	14	relationships	relationship	NNS
cord-308095-mehmk49a	311	15	that	that	WDT
cord-308095-mehmk49a	311	16	corporation	corporation	NN
cord-308095-mehmk49a	311	17	X	x	NN
cord-308095-mehmk49a	311	18	is	be	VBZ
cord-308095-mehmk49a	311	19	weaving	weave	VBG
cord-308095-mehmk49a	311	20	with	with	IN
cord-308095-mehmk49a	311	21	other	other	JJ
cord-308095-mehmk49a	311	22	public	public	JJ
cord-308095-mehmk49a	311	23	health	health	NN
cord-308095-mehmk49a	311	24	agencies	agency	NNS
cord-308095-mehmk49a	311	25	,	,	,
cord-308095-mehmk49a	311	26	universities	university	NNS
cord-308095-mehmk49a	311	27	,	,	,
cord-308095-mehmk49a	311	28	and	and	CC
cord-308095-mehmk49a	311	29	NGOs-	ngos-	JJ
cord-308095-mehmk49a	312	1	in	in	IN
cord-308095-mehmk49a	312	2	addition	addition	NN
cord-308095-mehmk49a	312	3	to	to	IN
cord-308095-mehmk49a	312	4	other	other	JJ
cord-308095-mehmk49a	312	5	private	private	JJ
cord-308095-mehmk49a	312	6	-	-	HYPH
cord-308095-mehmk49a	312	7	sector	sector	NN
cord-308095-mehmk49a	312	8	entities	entity	NNS
cord-308095-mehmk49a	312	9	(	(	-LRB-
cord-308095-mehmk49a	312	10	including	include	VBG
cord-308095-mehmk49a	312	11	trade	trade	NN
cord-308095-mehmk49a	312	12	associations	association	NNS
cord-308095-mehmk49a	312	13	and	and	CC
cord-308095-mehmk49a	312	14	consultancy	consultancy	NN
cord-308095-mehmk49a	312	15	firms	firm	NNS
cord-308095-mehmk49a	312	16	)	)	-RRB-
cord-308095-mehmk49a	312	17	with	with	IN
cord-308095-mehmk49a	312	18	whom	whom	WP
cord-308095-mehmk49a	312	19	the	the	DT
cord-308095-mehmk49a	312	20	corporation	corporation	NN
cord-308095-mehmk49a	312	21	is	be	VBZ
cord-308095-mehmk49a	312	22	collaborating	collaborate	VBG
cord-308095-mehmk49a	312	23	in	in	IN
cord-308095-mehmk49a	312	24	order	order	NN
cord-308095-mehmk49a	312	25	to	to	TO
cord-308095-mehmk49a	312	26	exercise	exercise	VB
cord-308095-mehmk49a	312	27	influence	influence	NN
cord-308095-mehmk49a	312	28	.	.	.
cord-308095-mehmk49a	313	1	And	and	CC
cord-308095-mehmk49a	313	2	your	-PRON-	PRP$
cord-308095-mehmk49a	313	3	agency	agency	NN
cord-308095-mehmk49a	313	4	would	would	MD
cord-308095-mehmk49a	313	5	need	need	VB
cord-308095-mehmk49a	313	6	to	to	TO
cord-308095-mehmk49a	313	7	be	be	VB
cord-308095-mehmk49a	313	8	attentive	attentive	JJ
cord-308095-mehmk49a	313	9	to	to	IN
cord-308095-mehmk49a	313	10	these	these	DT
cord-308095-mehmk49a	313	11	relationships	relationship	NNS
cord-308095-mehmk49a	313	12	throughout	throughout	IN
cord-308095-mehmk49a	313	13	its	-PRON-	PRP$
cord-308095-mehmk49a	313	14	own	own	JJ
cord-308095-mehmk49a	313	15	relationship	relationship	NN
cord-308095-mehmk49a	313	16	with	with	IN
cord-308095-mehmk49a	313	17	the	the	DT
cord-308095-mehmk49a	313	18	corporation	corporation	NN
cord-308095-mehmk49a	313	19	.	.	.
cord-308095-mehmk49a	314	1	Such	such	JJ
cord-308095-mehmk49a	314	2	constant	constant	NN
cord-308095-mehmk49a	314	3	(	(	-LRB-
cord-308095-mehmk49a	314	4	or	or	CC
cord-308095-mehmk49a	314	5	,	,	,
cord-308095-mehmk49a	314	6	at	at	IN
cord-308095-mehmk49a	314	7	least	least	JJS
cord-308095-mehmk49a	314	8	,	,	,
cord-308095-mehmk49a	314	9	periodic	periodic	JJ
cord-308095-mehmk49a	314	10	)	)	-RRB-
cord-308095-mehmk49a	314	11	vigilance	vigilance	NN
cord-308095-mehmk49a	314	12	would	would	MD
cord-308095-mehmk49a	314	13	require	require	VB
cord-308095-mehmk49a	314	14	considerable	considerable	JJ
cord-308095-mehmk49a	314	15	additional	additional	JJ
cord-308095-mehmk49a	314	16	resources	resource	NNS
cord-308095-mehmk49a	314	17	.	.	.
cord-308095-mehmk49a	315	1	But	but	CC
cord-308095-mehmk49a	315	2	the	the	DT
cord-308095-mehmk49a	315	3	full	full	JJ
cord-308095-mehmk49a	315	4	extent	extent	NN
cord-308095-mehmk49a	315	5	of	of	IN
cord-308095-mehmk49a	315	6	the	the	DT
cord-308095-mehmk49a	315	7	webs	webs	NNP
cord-308095-mehmk49a	315	8	of	of	IN
cord-308095-mehmk49a	315	9	relations	relation	NNS
cord-308095-mehmk49a	315	10	may	may	MD
cord-308095-mehmk49a	315	11	not	not	RB
cord-308095-mehmk49a	315	12	be	be	VB
cord-308095-mehmk49a	315	13	apparent	apparent	JJ
cord-308095-mehmk49a	315	14	until	until	IN
cord-308095-mehmk49a	315	15	far	far	RB
cord-308095-mehmk49a	315	16	too	too	RB
cord-308095-mehmk49a	315	17	late	late	JJ
cord-308095-mehmk49a	315	18	-	-	:
cord-308095-mehmk49a	315	19	as	as	IN
cord-308095-mehmk49a	315	20	in	in	IN
cord-308095-mehmk49a	315	21	the	the	DT
cord-308095-mehmk49a	315	22	case	case	NN
cord-308095-mehmk49a	315	23	of	of	IN
cord-308095-mehmk49a	315	24	the	the	DT
cord-308095-mehmk49a	315	25	opioid	opioid	JJ
cord-308095-mehmk49a	315	26	crisis	crisis	NN
cord-308095-mehmk49a	315	27	.	.	.
cord-308095-mehmk49a	316	1	The	the	DT
cord-308095-mehmk49a	316	2	safer	safe	JJR
cord-308095-mehmk49a	316	3	and	and	CC
cord-308095-mehmk49a	316	4	far	far	RB
cord-308095-mehmk49a	316	5	more	more	RBR
cord-308095-mehmk49a	316	6	advisable	advisable	JJ
cord-308095-mehmk49a	316	7	course	course	NN
cord-308095-mehmk49a	316	8	of	of	IN
cord-308095-mehmk49a	316	9	action	action	NN
cord-308095-mehmk49a	316	10	is	be	VBZ
cord-308095-mehmk49a	316	11	simply	simply	RB
cord-308095-mehmk49a	316	12	to	to	TO
cord-308095-mehmk49a	316	13	avoid	avoid	VB
cord-308095-mehmk49a	316	14	these	these	DT
cord-308095-mehmk49a	316	15	relationships	relationship	NNS
cord-308095-mehmk49a	316	16	-	-	:
cord-308095-mehmk49a	316	17	to	to	TO
cord-308095-mehmk49a	316	18	move	move	VB
cord-308095-mehmk49a	316	19	from	from	IN
cord-308095-mehmk49a	316	20	the	the	DT
cord-308095-mehmk49a	316	21	corporate	corporate	JJ
cord-308095-mehmk49a	316	22	partnership	partnership	NN
cord-308095-mehmk49a	316	23	paradigm	paradigm	NN
cord-308095-mehmk49a	316	24	to	to	IN
cord-308095-mehmk49a	316	25	a	a	DT
cord-308095-mehmk49a	316	26	new	new	JJ
cord-308095-mehmk49a	316	27	norm	norm	NN
cord-308095-mehmk49a	316	28	:	:	:
cord-308095-mehmk49a	316	29	separation	separation	NN
cord-308095-mehmk49a	316	30	,	,	,
cord-308095-mehmk49a	316	31	instead	instead	RB
cord-308095-mehmk49a	316	32	of	of	IN
cord-308095-mehmk49a	316	33	collaboration	collaboration	NN
cord-308095-mehmk49a	316	34	.	.	.
cord-308095-mehmk49a	317	1	For	for	IN
cord-308095-mehmk49a	317	2	years	year	NNS
cord-308095-mehmk49a	317	3	,	,	,
cord-308095-mehmk49a	317	4	courts	court	NNS
cord-308095-mehmk49a	317	5	sealed	seal	VBD
cord-308095-mehmk49a	317	6	documents	document	NNS
cord-308095-mehmk49a	317	7	that	that	WDT
cord-308095-mehmk49a	317	8	would	would	MD
cord-308095-mehmk49a	317	9	have	have	VB
cord-308095-mehmk49a	317	10	revealed	reveal	VBN
cord-308095-mehmk49a	317	11	the	the	DT
cord-308095-mehmk49a	317	12	role	role	NN
cord-308095-mehmk49a	317	13	of	of	IN
cord-308095-mehmk49a	317	14	corporate	corporate	JJ
cord-308095-mehmk49a	317	15	strategies	strategy	NNS
cord-308095-mehmk49a	317	16	of	of	IN
cord-308095-mehmk49a	317	17	influence	influence	NN
cord-308095-mehmk49a	317	18	in	in	IN
cord-308095-mehmk49a	317	19	the	the	DT
cord-308095-mehmk49a	317	20	opioid	opioid	JJ
cord-308095-mehmk49a	317	21	epidemic	epidemic	NN
cord-308095-mehmk49a	317	22	(	(	-LRB-
cord-308095-mehmk49a	317	23	Lesser	less	JJR
cord-308095-mehmk49a	317	24	et	et	FW
cord-308095-mehmk49a	317	25	al	al	NNP
cord-308095-mehmk49a	317	26	.	.	.
cord-308095-mehmk49a	317	27	2019	2019	CD
cord-308095-mehmk49a	317	28	)	)	-RRB-
cord-308095-mehmk49a	317	29	.	.	.
cord-308095-mehmk49a	318	1	News	news	NN
cord-308095-mehmk49a	318	2	outlets	outlet	NNS
cord-308095-mehmk49a	318	3	have	have	VBP
cord-308095-mehmk49a	318	4	been	be	VBN
cord-308095-mehmk49a	318	5	challenging	challenge	VBG
cord-308095-mehmk49a	318	6	this	this	DT
cord-308095-mehmk49a	318	7	practice	practice	NN
cord-308095-mehmk49a	318	8	,	,	,
cord-308095-mehmk49a	318	9	and	and	CC
cord-308095-mehmk49a	318	10	the	the	DT
cord-308095-mehmk49a	318	11	courts	court	NNS
cord-308095-mehmk49a	318	12	are	be	VBP
cord-308095-mehmk49a	318	13	finally	finally	RB
cord-308095-mehmk49a	318	14	unsealing	unseal	VBG
cord-308095-mehmk49a	318	15	documents	document	NNS
cord-308095-mehmk49a	318	16	from	from	IN
cord-308095-mehmk49a	318	17	earlier	early	JJR
cord-308095-mehmk49a	318	18	opioid	opioid	JJ
cord-308095-mehmk49a	318	19	cases	case	NNS
cord-308095-mehmk49a	318	20	(	(	-LRB-
cord-308095-mehmk49a	318	21	Ross	Ross	NNP
cord-308095-mehmk49a	318	22	2019	2019	CD
cord-308095-mehmk49a	318	23	)	)	-RRB-
cord-308095-mehmk49a	318	24	.	.	.
cord-308095-mehmk49a	319	1	There	there	EX
cord-308095-mehmk49a	319	2	has	have	VBZ
cord-308095-mehmk49a	319	3	also	also	RB
cord-308095-mehmk49a	319	4	been	be	VBN
cord-308095-mehmk49a	319	5	a	a	DT
cord-308095-mehmk49a	319	6	plethora	plethora	NN
cord-308095-mehmk49a	319	7	of	of	IN
cord-308095-mehmk49a	319	8	new	new	JJ
cord-308095-mehmk49a	319	9	litigation	litigation	NN
cord-308095-mehmk49a	319	10	against	against	IN
cord-308095-mehmk49a	319	11	not	not	RB
cord-308095-mehmk49a	319	12	only	only	JJ
cord-308095-mehmk49a	319	13	opioid	opioid	JJ
cord-308095-mehmk49a	319	14	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	319	15	but	but	CC
cord-308095-mehmk49a	319	16	also	also	RB
cord-308095-mehmk49a	319	17	opioid	opioid	JJ
cord-308095-mehmk49a	319	18	distributorsincluding	distributorsinclude	VBG
cord-308095-mehmk49a	319	19	several	several	JJ
cord-308095-mehmk49a	319	20	high	high	JJ
cord-308095-mehmk49a	319	21	-	-	HYPH
cord-308095-mehmk49a	319	22	street	street	NN
cord-308095-mehmk49a	319	23	pharmacy	pharmacy	NN
cord-308095-mehmk49a	319	24	chains	chain	NNS
cord-308095-mehmk49a	319	25	as	as	RB
cord-308095-mehmk49a	319	26	well	well	RB
cord-308095-mehmk49a	319	27	as	as	IN
cord-308095-mehmk49a	319	28	commercial	commercial	JJ
cord-308095-mehmk49a	319	29	distributors	distributor	NNS
cord-308095-mehmk49a	319	30	.	.	.
cord-308095-mehmk49a	320	1	In	in	IN
cord-308095-mehmk49a	320	2	addition	addition	NN
cord-308095-mehmk49a	320	3	to	to	IN
cord-308095-mehmk49a	320	4	thousands	thousand	NNS
cord-308095-mehmk49a	320	5	of	of	IN
cord-308095-mehmk49a	320	6	civil	civil	JJ
cord-308095-mehmk49a	320	7	cases	case	NNS
cord-308095-mehmk49a	320	8	against	against	IN
cord-308095-mehmk49a	320	9	opioid	opioid	JJ
cord-308095-mehmk49a	320	10	companies	company	NNS
cord-308095-mehmk49a	320	11	(	(	-LRB-
cord-308095-mehmk49a	320	12	Gluck	Gluck	NNP
cord-308095-mehmk49a	320	13	,	,	,
cord-308095-mehmk49a	320	14	Hall	Hall	NNP
cord-308095-mehmk49a	320	15	,	,	,
cord-308095-mehmk49a	320	16	and	and	CC
cord-308095-mehmk49a	320	17	Curfman	Curfman	NNP
cord-308095-mehmk49a	320	18	2018	2018	CD
cord-308095-mehmk49a	320	19	)	)	-RRB-
cord-308095-mehmk49a	320	20	,	,	,
cord-308095-mehmk49a	320	21	a	a	DT
cord-308095-mehmk49a	320	22	few	few	JJ
cord-308095-mehmk49a	320	23	individuals	individual	NNS
cord-308095-mehmk49a	320	24	have	have	VBP
cord-308095-mehmk49a	320	25	faced	face	VBN
cord-308095-mehmk49a	320	26	criminal	criminal	JJ
cord-308095-mehmk49a	320	27	charges	charge	NNS
cord-308095-mehmk49a	320	28	(	(	-LRB-
cord-308095-mehmk49a	320	29	Gonzales	Gonzales	NNP
cord-308095-mehmk49a	320	30	2019	2019	CD
cord-308095-mehmk49a	320	31	)	)	-RRB-
cord-308095-mehmk49a	320	32	.	.	.
cord-308095-mehmk49a	321	1	Several	several	JJ
cord-308095-mehmk49a	321	2	former	former	JJ
cord-308095-mehmk49a	321	3	executives	executive	NNS
cord-308095-mehmk49a	321	4	of	of	IN
cord-308095-mehmk49a	321	5	one	one	CD
cord-308095-mehmk49a	321	6	opioid	opioid	NN
cord-308095-mehmk49a	321	7	manufacturer	manufacturer	NN
cord-308095-mehmk49a	321	8	,	,	,
cord-308095-mehmk49a	321	9	Insys	Insys	NNP
cord-308095-mehmk49a	321	10	,	,	,
cord-308095-mehmk49a	321	11	were	be	VBD
cord-308095-mehmk49a	321	12	convicted	convict	VBN
cord-308095-mehmk49a	321	13	of	of	IN
cord-308095-mehmk49a	321	14	fraud	fraud	NN
cord-308095-mehmk49a	321	15	,	,	,
cord-308095-mehmk49a	321	16	and	and	CC
cord-308095-mehmk49a	321	17	recently	recently	RB
cord-308095-mehmk49a	321	18	received	receive	VBD
cord-308095-mehmk49a	321	19	prison	prison	NN
cord-308095-mehmk49a	321	20	sentences	sentence	NNS
cord-308095-mehmk49a	321	21	(	(	-LRB-
cord-308095-mehmk49a	321	22	Thomas	Thomas	NNP
cord-308095-mehmk49a	321	23	2020	2020	CD
cord-308095-mehmk49a	321	24	)	)	-RRB-
cord-308095-mehmk49a	321	25	.	.	.
cord-308095-mehmk49a	322	1	The	the	DT
cord-308095-mehmk49a	322	2	verdict	verdict	NN
cord-308095-mehmk49a	322	3	was	be	VBD
cord-308095-mehmk49a	322	4	swiftly	swiftly	RB
cord-308095-mehmk49a	322	5	followed	follow	VBN
cord-308095-mehmk49a	322	6	by	by	IN
cord-308095-mehmk49a	322	7	the	the	DT
cord-308095-mehmk49a	322	8	company	company	NN
cord-308095-mehmk49a	322	9	's	's	POS
cord-308095-mehmk49a	322	10	agreement	agreement	NN
cord-308095-mehmk49a	322	11	to	to	TO
cord-308095-mehmk49a	322	12	pay	pay	VB
cord-308095-mehmk49a	322	13	$	$	$
cord-308095-mehmk49a	322	14	225	225	CD
cord-308095-mehmk49a	322	15	million	million	CD
cord-308095-mehmk49a	322	16	to	to	TO
cord-308095-mehmk49a	322	17	settle	settle	VB
cord-308095-mehmk49a	322	18	its	-PRON-	PRP$
cord-308095-mehmk49a	322	19	own	own	JJ
cord-308095-mehmk49a	322	20	fraud	fraud	NN
cord-308095-mehmk49a	322	21	charges	charge	NNS
cord-308095-mehmk49a	322	22	(	(	-LRB-
cord-308095-mehmk49a	322	23	Thomas	Thomas	NNP
cord-308095-mehmk49a	322	24	2019	2019	CD
cord-308095-mehmk49a	322	25	)	)	-RRB-
cord-308095-mehmk49a	322	26	.	.	.
cord-308095-mehmk49a	323	1	In	in	IN
cord-308095-mehmk49a	323	2	Oklahoma	Oklahoma	NNP
cord-308095-mehmk49a	323	3	,	,	,
cord-308095-mehmk49a	323	4	a	a	DT
cord-308095-mehmk49a	323	5	judgment	judgment	NN
cord-308095-mehmk49a	323	6	of	of	IN
cord-308095-mehmk49a	323	7	$	$	$
cord-308095-mehmk49a	323	8	465	465	CD
cord-308095-mehmk49a	323	9	million	million	CD
cord-308095-mehmk49a	323	10	was	be	VBD
cord-308095-mehmk49a	323	11	entered	enter	VBN
cord-308095-mehmk49a	323	12	against	against	IN
cord-308095-mehmk49a	323	13	the	the	DT
cord-308095-mehmk49a	323	14	Johnson	Johnson	NNP
cord-308095-mehmk49a	323	15	&	&	CC
cord-308095-mehmk49a	323	16	Johnson	Johnson	NNP
cord-308095-mehmk49a	323	17	companies	company	NNS
cord-308095-mehmk49a	323	18	for	for	IN
cord-308095-mehmk49a	323	19	creating	create	VBG
cord-308095-mehmk49a	323	20	a	a	DT
cord-308095-mehmk49a	323	21	"	"	``
cord-308095-mehmk49a	323	22	public	public	JJ
cord-308095-mehmk49a	323	23	nuisance	nuisance	NN
cord-308095-mehmk49a	323	24	"	"	''
cord-308095-mehmk49a	323	25	that	that	WDT
cord-308095-mehmk49a	323	26	resulted	result	VBD
cord-308095-mehmk49a	323	27	not	not	RB
cord-308095-mehmk49a	323	28	only	only	RB
cord-308095-mehmk49a	323	29	from	from	IN
cord-308095-mehmk49a	323	30	the	the	DT
cord-308095-mehmk49a	323	31	group	group	NN
cord-308095-mehmk49a	323	32	's	's	POS
cord-308095-mehmk49a	323	33	promotion	promotion	NN
cord-308095-mehmk49a	323	34	of	of	IN
cord-308095-mehmk49a	323	35	its	-PRON-	PRP$
cord-308095-mehmk49a	323	36	own	own	JJ
cord-308095-mehmk49a	323	37	brands	brand	NNS
cord-308095-mehmk49a	323	38	of	of	IN
cord-308095-mehmk49a	323	39	opioids	opioid	NNS
cord-308095-mehmk49a	323	40	but	but	CC
cord-308095-mehmk49a	323	41	also	also	RB
cord-308095-mehmk49a	323	42	from	from	IN
cord-308095-mehmk49a	323	43	its	-PRON-	PRP$
cord-308095-mehmk49a	323	44	promotion	promotion	NN
cord-308095-mehmk49a	323	45	of	of	IN
cord-308095-mehmk49a	323	46	opioids	opioid	NNS
cord-308095-mehmk49a	323	47	more	more	RBR
cord-308095-mehmk49a	323	48	generally	generally	RB
cord-308095-mehmk49a	323	49	and	and	CC
cord-308095-mehmk49a	323	50	its	-PRON-	PRP$
cord-308095-mehmk49a	323	51	supply	supply	NN
cord-308095-mehmk49a	323	52	of	of	IN
cord-308095-mehmk49a	323	53	active	active	JJ
cord-308095-mehmk49a	323	54	ingredients	ingredient	NNS
cord-308095-mehmk49a	323	55	to	to	IN
cord-308095-mehmk49a	323	56	other	other	JJ
cord-308095-mehmk49a	323	57	opioid	opioid	JJ
cord-308095-mehmk49a	323	58	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	323	59	(	(	-LRB-
cord-308095-mehmk49a	323	60	Hofman	Hofman	NNP
cord-308095-mehmk49a	323	61	2019a	2019a	CD
cord-308095-mehmk49a	323	62	,	,	,
cord-308095-mehmk49a	323	63	2019b	2019b	CD
cord-308095-mehmk49a	323	64	)	)	-RRB-
cord-308095-mehmk49a	323	65	.	.	.
cord-308095-mehmk49a	324	1	Purdue	Purdue	NNP
cord-308095-mehmk49a	324	2	Pharma	Pharma	NNP
cord-308095-mehmk49a	324	3	and	and	CC
cord-308095-mehmk49a	324	4	Teva	Teva	NNP
cord-308095-mehmk49a	324	5	,	,	,
cord-308095-mehmk49a	324	6	which	which	WDT
cord-308095-mehmk49a	324	7	were	be	VBD
cord-308095-mehmk49a	324	8	also	also	RB
cord-308095-mehmk49a	324	9	defendants	defendant	NNS
cord-308095-mehmk49a	324	10	in	in	IN
cord-308095-mehmk49a	324	11	that	that	DT
cord-308095-mehmk49a	324	12	case	case	NN
cord-308095-mehmk49a	324	13	,	,	,
cord-308095-mehmk49a	324	14	settled	settle	VBN
cord-308095-mehmk49a	324	15	shortly	shortly	RB
cord-308095-mehmk49a	324	16	before	before	IN
cord-308095-mehmk49a	324	17	the	the	DT
cord-308095-mehmk49a	324	18	trial	trial	NN
cord-308095-mehmk49a	324	19	for	for	IN
cord-308095-mehmk49a	324	20	$	$	$
cord-308095-mehmk49a	324	21	270	270	CD
cord-308095-mehmk49a	324	22	million	million	CD
cord-308095-mehmk49a	324	23	and	and	CC
cord-308095-mehmk49a	324	24	$	$	$
cord-308095-mehmk49a	324	25	85	85	CD
cord-308095-mehmk49a	324	26	million	million	CD
cord-308095-mehmk49a	324	27	respectively	respectively	RB
cord-308095-mehmk49a	324	28	(	(	-LRB-
cord-308095-mehmk49a	324	29	Silverman	Silverman	NNP
cord-308095-mehmk49a	324	30	2019	2019	CD
cord-308095-mehmk49a	324	31	)	)	-RRB-
cord-308095-mehmk49a	324	32	.	.	.
cord-308095-mehmk49a	325	1	In	in	IN
cord-308095-mehmk49a	325	2	order	order	NN
cord-308095-mehmk49a	325	3	to	to	TO
cord-308095-mehmk49a	325	4	avoid	avoid	VB
cord-308095-mehmk49a	325	5	the	the	DT
cord-308095-mehmk49a	325	6	landmark	landmark	NN
cord-308095-mehmk49a	325	7	first	first	JJ
cord-308095-mehmk49a	325	8	federal	federal	JJ
cord-308095-mehmk49a	325	9	trial	trial	NN
cord-308095-mehmk49a	325	10	,	,	,
cord-308095-mehmk49a	325	11	three	three	CD
cord-308095-mehmk49a	325	12	commercial	commercial	JJ
cord-308095-mehmk49a	325	13	distributors	distributor	NNS
cord-308095-mehmk49a	325	14	and	and	CC
cord-308095-mehmk49a	325	15	one	one	CD
cord-308095-mehmk49a	325	16	manufacturer	manufacturer	NN
cord-308095-mehmk49a	325	17	(	(	-LRB-
cord-308095-mehmk49a	325	18	again	again	RB
cord-308095-mehmk49a	325	19	,	,	,
cord-308095-mehmk49a	325	20	Teva	Teva	NNP
cord-308095-mehmk49a	325	21	)	)	-RRB-
cord-308095-mehmk49a	325	22	also	also	RB
cord-308095-mehmk49a	325	23	agreed	agree	VBD
cord-308095-mehmk49a	325	24	in	in	IN
cord-308095-mehmk49a	325	25	October	October	NNP
cord-308095-mehmk49a	325	26	2019	2019	CD
cord-308095-mehmk49a	325	27	to	to	TO
cord-308095-mehmk49a	325	28	pay	pay	VB
cord-308095-mehmk49a	325	29	two	two	CD
cord-308095-mehmk49a	325	30	Ohio	Ohio	NNP
cord-308095-mehmk49a	325	31	counties	county	NNS
cord-308095-mehmk49a	325	32	$	$	$
cord-308095-mehmk49a	325	33	260	260	CD
cord-308095-mehmk49a	325	34	million	million	CD
cord-308095-mehmk49a	325	35	(	(	-LRB-
cord-308095-mehmk49a	325	36	Hofman	Hofman	NNP
cord-308095-mehmk49a	325	37	2019c	2019c	CD
cord-308095-mehmk49a	325	38	)	)	-RRB-
cord-308095-mehmk49a	325	39	.	.	.
cord-308095-mehmk49a	326	1	And	and	CC
cord-308095-mehmk49a	326	2	in	in	IN
cord-308095-mehmk49a	326	3	February	February	NNP
cord-308095-mehmk49a	326	4	2020	2020	CD
cord-308095-mehmk49a	326	5	,	,	,
cord-308095-mehmk49a	326	6	Mallinckrodt	Mallinckrodt	NNP
cord-308095-mehmk49a	326	7	Pharmaceuticals	Pharmaceuticals	NNP
cord-308095-mehmk49a	326	8	,	,	,
cord-308095-mehmk49a	326	9	the	the	DT
cord-308095-mehmk49a	326	10	largest	large	JJS
cord-308095-mehmk49a	326	11	opioid	opioid	JJ
cord-308095-mehmk49a	326	12	manufacturer	manufacturer	NN
cord-308095-mehmk49a	326	13	in	in	IN
cord-308095-mehmk49a	326	14	the	the	DT
cord-308095-mehmk49a	326	15	United	United	NNP
cord-308095-mehmk49a	326	16	States	States	NNP
cord-308095-mehmk49a	326	17	,	,	,
cord-308095-mehmk49a	326	18	announced	announce	VBD
cord-308095-mehmk49a	326	19	a	a	DT
cord-308095-mehmk49a	326	20	tentative	tentative	JJ
cord-308095-mehmk49a	326	21	agreement	agreement	NN
cord-308095-mehmk49a	326	22	to	to	TO
cord-308095-mehmk49a	326	23	pay	pay	VB
cord-308095-mehmk49a	326	24	$	$	$
cord-308095-mehmk49a	326	25	1.6	1.6	CD
cord-308095-mehmk49a	326	26	billion	billion	CD
cord-308095-mehmk49a	326	27	to	to	TO
cord-308095-mehmk49a	326	28	settle	settle	VB
cord-308095-mehmk49a	326	29	lawsuits	lawsuit	NNS
cord-308095-mehmk49a	326	30	brought	bring	VBN
cord-308095-mehmk49a	326	31	by	by	IN
cord-308095-mehmk49a	326	32	state	state	NN
cord-308095-mehmk49a	326	33	and	and	CC
cord-308095-mehmk49a	326	34	local	local	JJ
cord-308095-mehmk49a	326	35	governments	government	NNS
cord-308095-mehmk49a	326	36	for	for	IN
cord-308095-mehmk49a	326	37	its	-PRON-	PRP$
cord-308095-mehmk49a	326	38	role	role	NN
cord-308095-mehmk49a	326	39	in	in	IN
cord-308095-mehmk49a	326	40	the	the	DT
cord-308095-mehmk49a	326	41	opioid	opioid	JJ
cord-308095-mehmk49a	326	42	crisis	crisis	NN
cord-308095-mehmk49a	326	43	(	(	-LRB-
cord-308095-mehmk49a	326	44	Kaplan	Kaplan	NNP
cord-308095-mehmk49a	326	45	and	and	CC
cord-308095-mehmk49a	326	46	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	326	47	2020	2020	CD
cord-308095-mehmk49a	326	48	)	)	-RRB-
cord-308095-mehmk49a	326	49	.	.	.
cord-308095-mehmk49a	327	1	Amid	amid	IN
cord-308095-mehmk49a	327	2	discussions	discussion	NNS
cord-308095-mehmk49a	327	3	of	of	IN
cord-308095-mehmk49a	327	4	further	further	JJ
cord-308095-mehmk49a	327	5	settlements	settlement	NNS
cord-308095-mehmk49a	327	6	,	,	,
cord-308095-mehmk49a	327	7	two	two	CD
cord-308095-mehmk49a	327	8	thousand	thousand	CD
cord-308095-mehmk49a	327	9	cases	case	NNS
cord-308095-mehmk49a	327	10	wait	wait	VBP
cord-308095-mehmk49a	327	11	in	in	IN
cord-308095-mehmk49a	327	12	the	the	DT
cord-308095-mehmk49a	327	13	wings	wing	NNS
cord-308095-mehmk49a	327	14	(	(	-LRB-
cord-308095-mehmk49a	327	15	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	327	16	2020b	2020b	CD
cord-308095-mehmk49a	327	17	)	)	-RRB-
cord-308095-mehmk49a	327	18	.	.	.
cord-308095-mehmk49a	328	1	But	but	CC
cord-308095-mehmk49a	328	2	we	-PRON-	PRP
cord-308095-mehmk49a	328	3	should	should	MD
cord-308095-mehmk49a	328	4	not	not	RB
cord-308095-mehmk49a	328	5	expect	expect	VB
cord-308095-mehmk49a	328	6	these	these	DT
cord-308095-mehmk49a	328	7	cases	case	NNS
cord-308095-mehmk49a	328	8	and	and	CC
cord-308095-mehmk49a	328	9	settlements	settlement	NNS
cord-308095-mehmk49a	328	10	to	to	TO
cord-308095-mehmk49a	328	11	make	make	VB
cord-308095-mehmk49a	328	12	good	good	JJ
cord-308095-mehmk49a	328	13	the	the	DT
cord-308095-mehmk49a	328	14	economic	economic	JJ
cord-308095-mehmk49a	328	15	losses	loss	NNS
cord-308095-mehmk49a	328	16	resulting	result	VBG
cord-308095-mehmk49a	328	17	from	from	IN
cord-308095-mehmk49a	328	18	the	the	DT
cord-308095-mehmk49a	328	19	opioid	opioid	JJ
cord-308095-mehmk49a	328	20	epidemic	epidemic	NN
cord-308095-mehmk49a	328	21	(	(	-LRB-
cord-308095-mehmk49a	328	22	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	328	23	2019d	2019d	CD
cord-308095-mehmk49a	328	24	(	(	-LRB-
cord-308095-mehmk49a	328	25	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	328	26	,	,	,
cord-308095-mehmk49a	328	27	2020a	2020a	NNS
cord-308095-mehmk49a	328	28	.	.	.
cord-308095-mehmk49a	329	1	Purdue	Purdue	NNP
cord-308095-mehmk49a	329	2	Pharma	Pharma	NNP
cord-308095-mehmk49a	329	3	and	and	CC
cord-308095-mehmk49a	329	4	Insys	Insys	NNP
cord-308095-mehmk49a	329	5	have	have	VBP
cord-308095-mehmk49a	329	6	already	already	RB
cord-308095-mehmk49a	329	7	filed	file	VBN
cord-308095-mehmk49a	329	8	for	for	IN
cord-308095-mehmk49a	329	9	bankruptcy	bankruptcy	NN
cord-308095-mehmk49a	329	10	(	(	-LRB-
cord-308095-mehmk49a	329	11	Hals	Hals	NNP
cord-308095-mehmk49a	329	12	2019a	2019a	CD
cord-308095-mehmk49a	329	13	(	(	-LRB-
cord-308095-mehmk49a	329	14	Hals	Hals	NNP
cord-308095-mehmk49a	329	15	,	,	,
cord-308095-mehmk49a	329	16	2019b	2019b	CD
cord-308095-mehmk49a	329	17	.	.	.
cord-308095-mehmk49a	330	1	The	the	DT
cord-308095-mehmk49a	330	2	judgement	judgement	NN
cord-308095-mehmk49a	330	3	against	against	IN
cord-308095-mehmk49a	330	4	Johnson	Johnson	NNP
cord-308095-mehmk49a	330	5	&	&	CC
cord-308095-mehmk49a	330	6	Johnson	Johnson	NNP
cord-308095-mehmk49a	330	7	will	will	MD
cord-308095-mehmk49a	330	8	only	only	RB
cord-308095-mehmk49a	330	9	cover	cover	VB
cord-308095-mehmk49a	330	10	one	one	CD
cord-308095-mehmk49a	330	11	year	year	NN
cord-308095-mehmk49a	330	12	of	of	IN
cord-308095-mehmk49a	330	13	one	one	CD
cord-308095-mehmk49a	330	14	state	state	NN
cord-308095-mehmk49a	330	15	's	's	POS
cord-308095-mehmk49a	330	16	abatement	abatement	NN
cord-308095-mehmk49a	330	17	costs	cost	VBZ
cord-308095-mehmk49a	330	18	for	for	IN
cord-308095-mehmk49a	330	19	an	an	DT
cord-308095-mehmk49a	330	20	epidemic	epidemic	NN
cord-308095-mehmk49a	330	21	that	that	WDT
cord-308095-mehmk49a	330	22	will	will	MD
cord-308095-mehmk49a	330	23	take	take	VB
cord-308095-mehmk49a	330	24	decades	decade	NNS
cord-308095-mehmk49a	330	25	to	to	TO
cord-308095-mehmk49a	330	26	address	address	VB
cord-308095-mehmk49a	330	27	.	.	.
cord-308095-mehmk49a	331	1	If	if	IN
cord-308095-mehmk49a	331	2	efforts	effort	NNS
cord-308095-mehmk49a	331	3	to	to	TO
cord-308095-mehmk49a	331	4	reach	reach	VB
cord-308095-mehmk49a	331	5	a	a	DT
cord-308095-mehmk49a	331	6	larger	large	JJR
cord-308095-mehmk49a	331	7	coordinated	coordinated	JJ
cord-308095-mehmk49a	331	8	settlement	settlement	NN
cord-308095-mehmk49a	331	9	are	be	VBP
cord-308095-mehmk49a	331	10	successful	successful	JJ
cord-308095-mehmk49a	331	11	,	,	,
cord-308095-mehmk49a	331	12	they	-PRON-	PRP
cord-308095-mehmk49a	331	13	would	would	MD
cord-308095-mehmk49a	331	14	be	be	VB
cord-308095-mehmk49a	331	15	measured	measure	VBN
cord-308095-mehmk49a	331	16	in	in	IN
cord-308095-mehmk49a	331	17	the	the	DT
cord-308095-mehmk49a	331	18	billions	billion	NNS
cord-308095-mehmk49a	331	19	of	of	IN
cord-308095-mehmk49a	331	20	dollars	dollar	NNS
cord-308095-mehmk49a	331	21	-	-	:
cord-308095-mehmk49a	331	22	far	far	RB
cord-308095-mehmk49a	331	23	short	short	JJ
cord-308095-mehmk49a	331	24	of	of	IN
cord-308095-mehmk49a	331	25	the	the	DT
cord-308095-mehmk49a	331	26	trillions	trillion	NNS
cord-308095-mehmk49a	331	27	of	of	IN
cord-308095-mehmk49a	331	28	dollars	dollar	NNS
cord-308095-mehmk49a	331	29	in	in	IN
cord-308095-mehmk49a	331	30	the	the	DT
cord-308095-mehmk49a	331	31	most	most	RBS
cord-308095-mehmk49a	331	32	recent	recent	JJ
cord-308095-mehmk49a	331	33	cost	cost	NN
cord-308095-mehmk49a	331	34	estimates	estimate	NNS
cord-308095-mehmk49a	331	35	(	(	-LRB-
cord-308095-mehmk49a	331	36	Hoffman	Hoffman	NNP
cord-308095-mehmk49a	331	37	2019c	2019c	CD
cord-308095-mehmk49a	331	38	;	;	:
cord-308095-mehmk49a	331	39	CEA	CEA	NNP
cord-308095-mehmk49a	331	40	2019	2019	CD
cord-308095-mehmk49a	331	41	)	)	-RRB-
cord-308095-mehmk49a	331	42	.	.	.
cord-308095-mehmk49a	332	1	And	and	CC
cord-308095-mehmk49a	332	2	any	any	DT
cord-308095-mehmk49a	332	3	settlement	settlement	NN
cord-308095-mehmk49a	332	4	would	would	MD
cord-308095-mehmk49a	332	5	,	,	,
cord-308095-mehmk49a	332	6	of	of	IN
cord-308095-mehmk49a	332	7	course	course	NN
cord-308095-mehmk49a	332	8	,	,	,
cord-308095-mehmk49a	332	9	not	not	RB
cord-308095-mehmk49a	332	10	bring	bring	VB
cord-308095-mehmk49a	332	11	back	back	RB
cord-308095-mehmk49a	332	12	the	the	DT
cord-308095-mehmk49a	332	13	hundreds	hundred	NNS
cord-308095-mehmk49a	332	14	of	of	IN
cord-308095-mehmk49a	332	15	thousands	thousand	NNS
cord-308095-mehmk49a	332	16	of	of	IN
cord-308095-mehmk49a	332	17	Americans	Americans	NNPS
cord-308095-mehmk49a	332	18	who	who	WP
cord-308095-mehmk49a	332	19	have	have	VBP
cord-308095-mehmk49a	332	20	died	die	VBN
cord-308095-mehmk49a	332	21	,	,	,
cord-308095-mehmk49a	332	22	nor	nor	CC
cord-308095-mehmk49a	332	23	would	would	MD
cord-308095-mehmk49a	332	24	it	-PRON-	PRP
cord-308095-mehmk49a	332	25	restore	restore	VB
cord-308095-mehmk49a	332	26	the	the	DT
cord-308095-mehmk49a	332	27	lives	life	NNS
cord-308095-mehmk49a	332	28	of	of	IN
cord-308095-mehmk49a	332	29	the	the	DT
cord-308095-mehmk49a	332	30	families	family	NNS
cord-308095-mehmk49a	332	31	and	and	CC
cord-308095-mehmk49a	332	32	communities	community	NNS
cord-308095-mehmk49a	332	33	destroyed	destroy	VBN
cord-308095-mehmk49a	332	34	by	by	IN
cord-308095-mehmk49a	332	35	the	the	DT
cord-308095-mehmk49a	332	36	epidemic	epidemic	NN
cord-308095-mehmk49a	332	37	.	.	.
cord-308095-mehmk49a	333	1	If	if	IN
cord-308095-mehmk49a	333	2	we	-PRON-	PRP
cord-308095-mehmk49a	333	3	are	be	VBP
cord-308095-mehmk49a	333	4	to	to	TO
cord-308095-mehmk49a	333	5	prevent	prevent	VB
cord-308095-mehmk49a	333	6	future	future	JJ
cord-308095-mehmk49a	333	7	loss	loss	NN
cord-308095-mehmk49a	333	8	of	of	IN
cord-308095-mehmk49a	333	9	life	life	NN
cord-308095-mehmk49a	333	10	,	,	,
cord-308095-mehmk49a	333	11	we	-PRON-	PRP
cord-308095-mehmk49a	333	12	need	need	VBP
cord-308095-mehmk49a	333	13	to	to	TO
cord-308095-mehmk49a	333	14	supplement	supplement	VB
cord-308095-mehmk49a	333	15	"	"	``
cord-308095-mehmk49a	333	16	backwardlooking	backwardlooke	VBG
cord-308095-mehmk49a	333	17	"	"	''
cord-308095-mehmk49a	333	18	strategies	strategy	NNS
cord-308095-mehmk49a	333	19	based	base	VBN
cord-308095-mehmk49a	333	20	on	on	IN
cord-308095-mehmk49a	333	21	establishing	establish	VBG
cord-308095-mehmk49a	333	22	legal	legal	JJ
cord-308095-mehmk49a	333	23	liability	liability	NN
cord-308095-mehmk49a	333	24	with	with	IN
cord-308095-mehmk49a	333	25	some	some	DT
cord-308095-mehmk49a	333	26	forward	forward	RB
cord-308095-mehmk49a	333	27	-	-	HYPH
cord-308095-mehmk49a	333	28	looking	look	VBG
cord-308095-mehmk49a	333	29	ones	one	NNS
cord-308095-mehmk49a	333	30	(	(	-LRB-
cord-308095-mehmk49a	333	31	Young	young	JJ
cord-308095-mehmk49a	333	32	2011	2011	CD
cord-308095-mehmk49a	333	33	;	;	:
cord-308095-mehmk49a	333	34	Marks	Marks	NNP
cord-308095-mehmk49a	333	35	2017	2017	CD
cord-308095-mehmk49a	333	36	)	)	-RRB-
cord-308095-mehmk49a	333	37	.	.	.
cord-308095-mehmk49a	334	1	Such	such	JJ
cord-308095-mehmk49a	334	2	forward	forward	RB
cord-308095-mehmk49a	334	3	-	-	HYPH
cord-308095-mehmk49a	334	4	looking	look	VBG
cord-308095-mehmk49a	334	5	strategies	strategy	NNS
cord-308095-mehmk49a	334	6	must	must	MD
cord-308095-mehmk49a	334	7	address	address	VB
cord-308095-mehmk49a	334	8	the	the	DT
cord-308095-mehmk49a	334	9	webs	web	NNS
cord-308095-mehmk49a	334	10	of	of	IN
cord-308095-mehmk49a	334	11	relationships	relationship	NNS
cord-308095-mehmk49a	334	12	that	that	WDT
cord-308095-mehmk49a	334	13	served	serve	VBD
cord-308095-mehmk49a	334	14	as	as	IN
cord-308095-mehmk49a	334	15	vehicles	vehicle	NNS
cord-308095-mehmk49a	334	16	for	for	IN
cord-308095-mehmk49a	334	17	corporate	corporate	JJ
cord-308095-mehmk49a	334	18	influence	influence	NN
cord-308095-mehmk49a	334	19	and	and	CC
cord-308095-mehmk49a	334	20	severely	severely	RB
cord-308095-mehmk49a	334	21	exacerbated	exacerbate	VBD
cord-308095-mehmk49a	334	22	the	the	DT
cord-308095-mehmk49a	334	23	current	current	JJ
cord-308095-mehmk49a	334	24	crisis	crisis	NN
cord-308095-mehmk49a	334	25	.	.	.
cord-308095-mehmk49a	335	1	If	if	IN
cord-308095-mehmk49a	335	2	the	the	DT
cord-308095-mehmk49a	335	3	opioid	opioid	JJ
cord-308095-mehmk49a	335	4	epidemic	epidemic	NN
cord-308095-mehmk49a	335	5	has	have	VBZ
cord-308095-mehmk49a	335	6	taught	teach	VBN
cord-308095-mehmk49a	335	7	us	-PRON-	PRP
cord-308095-mehmk49a	335	8	anything	anything	NN
cord-308095-mehmk49a	335	9	,	,	,
cord-308095-mehmk49a	335	10	it	-PRON-	PRP
cord-308095-mehmk49a	335	11	is	be	VBZ
cord-308095-mehmk49a	335	12	that	that	IN
cord-308095-mehmk49a	335	13	governments	government	NNS
cord-308095-mehmk49a	335	14	,	,	,
cord-308095-mehmk49a	335	15	intergovernmental	intergovernmental	JJ
cord-308095-mehmk49a	335	16	organizations	organization	NNS
cord-308095-mehmk49a	335	17	,	,	,
cord-308095-mehmk49a	335	18	the	the	DT
cord-308095-mehmk49a	335	19	academy	academy	NN
cord-308095-mehmk49a	335	20	,	,	,
cord-308095-mehmk49a	335	21	and	and	CC
cord-308095-mehmk49a	335	22	public	public	JJ
cord-308095-mehmk49a	335	23	health	health	NN
cord-308095-mehmk49a	335	24	NGOs	NGOs	NNPS
cord-308095-mehmk49a	335	25	need	need	VBP
cord-308095-mehmk49a	335	26	to	to	TO
cord-308095-mehmk49a	335	27	be	be	VB
cord-308095-mehmk49a	335	28	pre	pre	JJ
cord-308095-mehmk49a	335	29	-	-	JJ
cord-308095-mehmk49a	335	30	emptive	emptive	JJ
cord-308095-mehmk49a	335	31	and	and	CC
cord-308095-mehmk49a	335	32	proactive	proactive	JJ
cord-308095-mehmk49a	335	33	,	,	,
cord-308095-mehmk49a	335	34	developing	develop	VBG
cord-308095-mehmk49a	335	35	comprehensive	comprehensive	JJ
cord-308095-mehmk49a	335	36	counterstrategies	counterstrategie	NNS
cord-308095-mehmk49a	335	37	to	to	TO
cord-308095-mehmk49a	335	38	insulate	insulate	VB
cord-308095-mehmk49a	335	39	themselves	-PRON-	PRP
cord-308095-mehmk49a	335	40	from	from	IN
cord-308095-mehmk49a	335	41	corporate	corporate	JJ
cord-308095-mehmk49a	335	42	influence	influence	NN
cord-308095-mehmk49a	335	43	.	.	.
cord-308095-mehmk49a	336	1	Whatever	whatever	WDT
cord-308095-mehmk49a	336	2	metaphor	metaphor	NN
cord-308095-mehmk49a	336	3	we	-PRON-	PRP
cord-308095-mehmk49a	336	4	use	use	VBP
cord-308095-mehmk49a	336	5	to	to	TO
cord-308095-mehmk49a	336	6	describe	describe	VB
cord-308095-mehmk49a	336	7	corporate	corporate	JJ
cord-308095-mehmk49a	336	8	strategieswhether	strategieswhether	NN
cord-308095-mehmk49a	336	9	we	-PRON-	PRP
cord-308095-mehmk49a	336	10	characterize	characterize	VBP
cord-308095-mehmk49a	336	11	them	-PRON-	PRP
cord-308095-mehmk49a	336	12	as	as	IN
cord-308095-mehmk49a	336	13	"	"	``
cord-308095-mehmk49a	336	14	webs	webs	NNP
cord-308095-mehmk49a	336	15	"	"	''
cord-308095-mehmk49a	336	16	(	(	-LRB-
cord-308095-mehmk49a	336	17	Freudenberg	Freudenberg	NNP
cord-308095-mehmk49a	336	18	2014	2014	CD
cord-308095-mehmk49a	336	19	;	;	:
cord-308095-mehmk49a	336	20	Gornall	Gornall	NNP
cord-308095-mehmk49a	336	21	2015	2015	CD
cord-308095-mehmk49a	336	22	;	;	:
cord-308095-mehmk49a	336	23	Marks	Marks	NNP
cord-308095-mehmk49a	336	24	2019a	2019a	CD
cord-308095-mehmk49a	336	25	)	)	-RRB-
cord-308095-mehmk49a	336	26	or	or	CC
cord-308095-mehmk49a	336	27	"	"	``
cord-308095-mehmk49a	336	28	tentacular	tentacular	JJ
cord-308095-mehmk49a	336	29	"	"	''
cord-308095-mehmk49a	336	30	(	(	-LRB-
cord-308095-mehmk49a	336	31	Joseph	Joseph	NNP
cord-308095-mehmk49a	336	32	2019c	2019c	CD
cord-308095-mehmk49a	336	33	)	)	-RRB-
cord-308095-mehmk49a	337	1	-the	-the	DT
cord-308095-mehmk49a	337	2	implications	implication	NNS
cord-308095-mehmk49a	337	3	are	be	VBP
cord-308095-mehmk49a	337	4	the	the	DT
cord-308095-mehmk49a	337	5	same	same	JJ
cord-308095-mehmk49a	337	6	:	:	:
cord-308095-mehmk49a	338	1	in	in	IN
cord-308095-mehmk49a	338	2	order	order	NN
cord-308095-mehmk49a	338	3	for	for	IN
cord-308095-mehmk49a	338	4	counterstrategies	counterstrategie	NNS
cord-308095-mehmk49a	338	5	to	to	TO
cord-308095-mehmk49a	338	6	be	be	VB
cord-308095-mehmk49a	338	7	effective	effective	JJ
cord-308095-mehmk49a	338	8	,	,	,
cord-308095-mehmk49a	338	9	they	-PRON-	PRP
cord-308095-mehmk49a	338	10	can	can	MD
cord-308095-mehmk49a	338	11	not	not	RB
cord-308095-mehmk49a	338	12	address	address	VB
cord-308095-mehmk49a	338	13	individual	individual	JJ
cord-308095-mehmk49a	338	14	relationships	relationship	NNS
cord-308095-mehmk49a	338	15	with	with	IN
cord-308095-mehmk49a	338	16	industry	industry	NN
cord-308095-mehmk49a	338	17	actors	actor	NNS
cord-308095-mehmk49a	338	18	in	in	IN
cord-308095-mehmk49a	338	19	isolation	isolation	NN
cord-308095-mehmk49a	338	20	.	.	.
cord-308095-mehmk49a	339	1	The	the	DT
cord-308095-mehmk49a	339	2	opioid	opioid	JJ
cord-308095-mehmk49a	339	3	epidemic	epidemic	NN
cord-308095-mehmk49a	339	4	makes	make	VBZ
cord-308095-mehmk49a	339	5	clear	clear	JJ
cord-308095-mehmk49a	339	6	that	that	IN
cord-308095-mehmk49a	339	7	individual	individual	JJ
cord-308095-mehmk49a	339	8	institutions	institution	NNS
cord-308095-mehmk49a	339	9	-	-	:
cord-308095-mehmk49a	339	10	whether	whether	IN
cord-308095-mehmk49a	339	11	governments	government	NNS
cord-308095-mehmk49a	339	12	,	,	,
cord-308095-mehmk49a	339	13	universities	university	NNS
cord-308095-mehmk49a	339	14	,	,	,
cord-308095-mehmk49a	339	15	or	or	CC
cord-308095-mehmk49a	339	16	public	public	JJ
cord-308095-mehmk49a	339	17	health	health	NN
cord-308095-mehmk49a	339	18	NGOs	NGOs	NNPS
cord-308095-mehmk49a	339	19	-	-	:
cord-308095-mehmk49a	339	20	are	be	VBP
cord-308095-mehmk49a	339	21	unlikely	unlikely	JJ
cord-308095-mehmk49a	339	22	to	to	TO
cord-308095-mehmk49a	339	23	be	be	VB
cord-308095-mehmk49a	339	24	fully	fully	RB
cord-308095-mehmk49a	339	25	aware	aware	JJ
cord-308095-mehmk49a	339	26	of	of	IN
cord-308095-mehmk49a	339	27	the	the	DT
cord-308095-mehmk49a	339	28	networks	network	NNS
cord-308095-mehmk49a	339	29	of	of	IN
cord-308095-mehmk49a	339	30	relationships	relationship	NNS
cord-308095-mehmk49a	339	31	in	in	IN
cord-308095-mehmk49a	339	32	which	which	WDT
cord-308095-mehmk49a	339	33	they	-PRON-	PRP
cord-308095-mehmk49a	339	34	are	be	VBP
cord-308095-mehmk49a	339	35	implicated	implicate	VBN
cord-308095-mehmk49a	339	36	until	until	IN
cord-308095-mehmk49a	339	37	many	many	JJ
cord-308095-mehmk49a	339	38	years	year	NNS
cord-308095-mehmk49a	339	39	later	later	RB
cord-308095-mehmk49a	339	40	.	.	.
cord-308095-mehmk49a	340	1	By	by	IN
cord-308095-mehmk49a	340	2	that	that	DT
cord-308095-mehmk49a	340	3	time	time	NN
cord-308095-mehmk49a	340	4	,	,	,
cord-308095-mehmk49a	340	5	the	the	DT
cord-308095-mehmk49a	340	6	damage	damage	NN
cord-308095-mehmk49a	340	7	may	may	MD
cord-308095-mehmk49a	340	8	already	already	RB
cord-308095-mehmk49a	340	9	have	have	VB
cord-308095-mehmk49a	340	10	been	be	VBN
cord-308095-mehmk49a	340	11	done	do	VBN
cord-308095-mehmk49a	340	12	-	-	:
cord-308095-mehmk49a	340	13	as	as	IN
cord-308095-mehmk49a	340	14	was	be	VBD
cord-308095-mehmk49a	340	15	undoubtedly	undoubtedly	RB
cord-308095-mehmk49a	340	16	the	the	DT
cord-308095-mehmk49a	340	17	case	case	NN
cord-308095-mehmk49a	340	18	with	with	IN
cord-308095-mehmk49a	340	19	the	the	DT
cord-308095-mehmk49a	340	20	opioid	opioid	JJ
cord-308095-mehmk49a	340	21	crisis	crisis	NN
cord-308095-mehmk49a	340	22	.	.	.
cord-308095-mehmk49a	341	1	If	if	IN
cord-308095-mehmk49a	341	2	we	-PRON-	PRP
cord-308095-mehmk49a	341	3	are	be	VBP
cord-308095-mehmk49a	341	4	to	to	TO
cord-308095-mehmk49a	341	5	protect	protect	VB
cord-308095-mehmk49a	341	6	and	and	CC
cord-308095-mehmk49a	341	7	promote	promote	VB
cord-308095-mehmk49a	341	8	public	public	JJ
cord-308095-mehmk49a	341	9	health	health	NN
cord-308095-mehmk49a	341	10	,	,	,
cord-308095-mehmk49a	341	11	we	-PRON-	PRP
cord-308095-mehmk49a	341	12	will	will	MD
cord-308095-mehmk49a	341	13	need	need	VB
cord-308095-mehmk49a	341	14	a	a	DT
cord-308095-mehmk49a	341	15	paradigm	paradigm	NN
cord-308095-mehmk49a	341	16	shift	shift	NN
cord-308095-mehmk49a	341	17	.	.	.
cord-308095-mehmk49a	342	1	In	in	IN
cord-308095-mehmk49a	342	2	order	order	NN
cord-308095-mehmk49a	342	3	to	to	TO
cord-308095-mehmk49a	342	4	bring	bring	VB
cord-308095-mehmk49a	342	5	about	about	RB
cord-308095-mehmk49a	342	6	such	such	PDT
cord-308095-mehmk49a	342	7	a	a	DT
cord-308095-mehmk49a	342	8	shift	shift	NN
cord-308095-mehmk49a	342	9	,	,	,
cord-308095-mehmk49a	342	10	we	-PRON-	PRP
cord-308095-mehmk49a	342	11	must	must	MD
cord-308095-mehmk49a	342	12	first	first	RB
cord-308095-mehmk49a	342	13	recognize	recognize	VB
cord-308095-mehmk49a	342	14	that	that	IN
cord-308095-mehmk49a	342	15	medicine	medicine	NN
cord-308095-mehmk49a	342	16	and	and	CC
cord-308095-mehmk49a	342	17	public	public	JJ
cord-308095-mehmk49a	342	18	health	health	NN
cord-308095-mehmk49a	342	19	were	be	VBD
cord-308095-mehmk49a	342	20	not	not	RB
cord-308095-mehmk49a	342	21	always	always	RB
cord-308095-mehmk49a	342	22	so	so	RB
cord-308095-mehmk49a	342	23	heavily	heavily	RB
cord-308095-mehmk49a	342	24	dependent	dependent	JJ
cord-308095-mehmk49a	342	25	on	on	IN
cord-308095-mehmk49a	342	26	corporate	corporate	JJ
cord-308095-mehmk49a	342	27	funding	funding	NN
cord-308095-mehmk49a	342	28	.	.	.
cord-308095-mehmk49a	343	1	The	the	DT
cord-308095-mehmk49a	343	2	influx	influx	NN
cord-308095-mehmk49a	343	3	of	of	IN
cord-308095-mehmk49a	343	4	this	this	DT
cord-308095-mehmk49a	343	5	funding	funding	NN
cord-308095-mehmk49a	343	6	has	have	VBZ
cord-308095-mehmk49a	343	7	burgeoned	burgeon	VBN
cord-308095-mehmk49a	343	8	in	in	IN
cord-308095-mehmk49a	343	9	the	the	DT
cord-308095-mehmk49a	343	10	last	last	JJ
cord-308095-mehmk49a	343	11	few	few	JJ
cord-308095-mehmk49a	343	12	decades	decade	NNS
cord-308095-mehmk49a	343	13	,	,	,
cord-308095-mehmk49a	343	14	as	as	IN
cord-308095-mehmk49a	343	15	corporations	corporation	NNS
cord-308095-mehmk49a	343	16	increasingly	increasingly	RB
cord-308095-mehmk49a	343	17	and	and	CC
cord-308095-mehmk49a	343	18	understandably	understandably	RB
cord-308095-mehmk49a	343	19	recognized	recognize	VBD
cord-308095-mehmk49a	343	20	the	the	DT
cord-308095-mehmk49a	343	21	opportunities	opportunity	NNS
cord-308095-mehmk49a	343	22	for	for	IN
cord-308095-mehmk49a	343	23	the	the	DT
cord-308095-mehmk49a	343	24	promotion	promotion	NN
cord-308095-mehmk49a	343	25	of	of	IN
cord-308095-mehmk49a	343	26	their	-PRON-	PRP$
cord-308095-mehmk49a	343	27	commercial	commercial	JJ
cord-308095-mehmk49a	343	28	interests	interest	NNS
cord-308095-mehmk49a	343	29	that	that	WDT
cord-308095-mehmk49a	343	30	this	this	DT
cord-308095-mehmk49a	343	31	affords	afford	VBZ
cord-308095-mehmk49a	343	32	them	-PRON-	PRP
cord-308095-mehmk49a	343	33	.	.	.
cord-308095-mehmk49a	344	1	But	but	CC
cord-308095-mehmk49a	344	2	the	the	DT
cord-308095-mehmk49a	344	3	relationships	relationship	NNS
cord-308095-mehmk49a	344	4	with	with	IN
cord-308095-mehmk49a	344	5	industry	industry	NN
cord-308095-mehmk49a	344	6	that	that	WDT
cord-308095-mehmk49a	344	7	are	be	VBP
cord-308095-mehmk49a	344	8	now	now	RB
cord-308095-mehmk49a	344	9	the	the	DT
cord-308095-mehmk49a	344	10	norm	norm	NN
cord-308095-mehmk49a	344	11	were	be	VBD
cord-308095-mehmk49a	344	12	once	once	RB
cord-308095-mehmk49a	344	13	frowned	frown	VBN
cord-308095-mehmk49a	344	14	upon	upon	IN
cord-308095-mehmk49a	344	15	.	.	.
cord-308095-mehmk49a	345	1	This	this	DT
cord-308095-mehmk49a	345	2	may	may	MD
cord-308095-mehmk49a	345	3	not	not	RB
cord-308095-mehmk49a	345	4	be	be	VB
cord-308095-mehmk49a	345	5	readily	readily	RB
cord-308095-mehmk49a	345	6	apparent	apparent	JJ
cord-308095-mehmk49a	345	7	to	to	IN
cord-308095-mehmk49a	345	8	the	the	DT
cord-308095-mehmk49a	345	9	current	current	JJ
cord-308095-mehmk49a	345	10	generation	generation	NN
cord-308095-mehmk49a	345	11	of	of	IN
cord-308095-mehmk49a	345	12	policymakers	policymaker	NNS
cord-308095-mehmk49a	345	13	,	,	,
cord-308095-mehmk49a	345	14	researchers	researcher	NNS
cord-308095-mehmk49a	345	15	,	,	,
cord-308095-mehmk49a	345	16	practitioners	practitioner	NNS
cord-308095-mehmk49a	345	17	,	,	,
cord-308095-mehmk49a	345	18	and	and	CC
cord-308095-mehmk49a	345	19	others	other	NNS
cord-308095-mehmk49a	345	20	in	in	IN
cord-308095-mehmk49a	345	21	medicine	medicine	NN
cord-308095-mehmk49a	345	22	and	and	CC
cord-308095-mehmk49a	345	23	public	public	JJ
cord-308095-mehmk49a	345	24	health	health	NN
cord-308095-mehmk49a	345	25	-	-	:
cord-308095-mehmk49a	345	26	it	-PRON-	PRP
cord-308095-mehmk49a	345	27	may	may	MD
cord-308095-mehmk49a	345	28	seem	seem	VB
cord-308095-mehmk49a	345	29	as	as	IN
cord-308095-mehmk49a	345	30	though	though	IN
cord-308095-mehmk49a	345	31	things	thing	NNS
cord-308095-mehmk49a	345	32	have	have	VBP
cord-308095-mehmk49a	345	33	always	always	RB
cord-308095-mehmk49a	345	34	been	be	VBN
cord-308095-mehmk49a	345	35	this	this	DT
cord-308095-mehmk49a	345	36	way	way	NN
cord-308095-mehmk49a	345	37	.	.	.
cord-308095-mehmk49a	346	1	But	but	CC
cord-308095-mehmk49a	346	2	we	-PRON-	PRP
cord-308095-mehmk49a	346	3	need	need	VBP
cord-308095-mehmk49a	346	4	only	only	RB
cord-308095-mehmk49a	346	5	turn	turn	VB
cord-308095-mehmk49a	346	6	to	to	IN
cord-308095-mehmk49a	346	7	the	the	DT
cord-308095-mehmk49a	346	8	work	work	NN
cord-308095-mehmk49a	346	9	of	of	IN
cord-308095-mehmk49a	346	10	the	the	DT
cord-308095-mehmk49a	346	11	late	late	JJ
cord-308095-mehmk49a	346	12	Arnold	Arnold	NNP
cord-308095-mehmk49a	346	13	Relman	Relman	NNP
cord-308095-mehmk49a	346	14	,	,	,
cord-308095-mehmk49a	346	15	former	former	JJ
cord-308095-mehmk49a	346	16	editor	editor	NN
cord-308095-mehmk49a	346	17	of	of	IN
cord-308095-mehmk49a	346	18	the	the	DT
cord-308095-mehmk49a	346	19	New	New	NNP
cord-308095-mehmk49a	346	20	England	England	NNP
cord-308095-mehmk49a	346	21	Journal	Journal	NNP
cord-308095-mehmk49a	346	22	of	of	IN
cord-308095-mehmk49a	346	23	Medicine	Medicine	NNP
cord-308095-mehmk49a	346	24	,	,	,
cord-308095-mehmk49a	346	25	in	in	IN
cord-308095-mehmk49a	346	26	the	the	DT
cord-308095-mehmk49a	346	27	early	early	JJ
cord-308095-mehmk49a	346	28	1980s	1980s	CD
cord-308095-mehmk49a	346	29	to	to	TO
cord-308095-mehmk49a	346	30	be	be	VB
cord-308095-mehmk49a	346	31	reminded	remind	VBN
cord-308095-mehmk49a	346	32	that	that	IN
cord-308095-mehmk49a	346	33	this	this	DT
cord-308095-mehmk49a	346	34	is	be	VBZ
cord-308095-mehmk49a	346	35	not	not	RB
cord-308095-mehmk49a	346	36	the	the	DT
cord-308095-mehmk49a	346	37	case	case	NN
cord-308095-mehmk49a	346	38	.	.	.
cord-308095-mehmk49a	347	1	Drawing	draw	VBG
cord-308095-mehmk49a	347	2	on	on	IN
cord-308095-mehmk49a	347	3	President	President	NNP
cord-308095-mehmk49a	347	4	Eisenhower	Eisenhower	NNP
cord-308095-mehmk49a	347	5	's	's	POS
cord-308095-mehmk49a	347	6	warning	warning	NN
cord-308095-mehmk49a	347	7	about	about	IN
cord-308095-mehmk49a	347	8	the	the	DT
cord-308095-mehmk49a	347	9	"	"	``
cord-308095-mehmk49a	347	10	military	military	JJ
cord-308095-mehmk49a	347	11	-	-	HYPH
cord-308095-mehmk49a	347	12	industrial	industrial	JJ
cord-308095-mehmk49a	347	13	complex	complex	NN
cord-308095-mehmk49a	347	14	,	,	,
cord-308095-mehmk49a	347	15	"	"	''
cord-308095-mehmk49a	347	16	Relman	Relman	NNP
cord-308095-mehmk49a	347	17	expressed	express	VBD
cord-308095-mehmk49a	347	18	concern	concern	NN
cord-308095-mehmk49a	347	19	about	about	IN
cord-308095-mehmk49a	347	20	the	the	DT
cord-308095-mehmk49a	347	21	"	"	``
cord-308095-mehmk49a	347	22	new	new	JJ
cord-308095-mehmk49a	347	23	medicalindustrial	medicalindustrial	JJ
cord-308095-mehmk49a	347	24	complex	complex	NN
cord-308095-mehmk49a	347	25	,	,	,
cord-308095-mehmk49a	347	26	"	"	''
cord-308095-mehmk49a	347	27	and	and	CC
cord-308095-mehmk49a	347	28	cautioned	caution	VBD
cord-308095-mehmk49a	347	29	that	that	IN
cord-308095-mehmk49a	347	30	relationships	relationship	NNS
cord-308095-mehmk49a	347	31	with	with	IN
cord-308095-mehmk49a	347	32	drug	drug	NN
cord-308095-mehmk49a	347	33	and	and	CC
cord-308095-mehmk49a	347	34	device	device	NN
cord-308095-mehmk49a	347	35	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	347	36	had	have	VBD
cord-308095-mehmk49a	347	37	become	become	VBN
cord-308095-mehmk49a	347	38	"	"	``
cord-308095-mehmk49a	347	39	more	more	RBR
cord-308095-mehmk49a	347	40	pervasive	pervasive	JJ
cord-308095-mehmk49a	347	41	,	,	,
cord-308095-mehmk49a	347	42	complex	complex	JJ
cord-308095-mehmk49a	347	43	,	,	,
cord-308095-mehmk49a	347	44	and	and	CC
cord-308095-mehmk49a	347	45	problematic	problematic	JJ
cord-308095-mehmk49a	347	46	"	"	''
cord-308095-mehmk49a	347	47	(	(	-LRB-
cord-308095-mehmk49a	347	48	Relman	Relman	NNP
cord-308095-mehmk49a	347	49	1980	1980	CD
cord-308095-mehmk49a	347	50	,	,	,
cord-308095-mehmk49a	347	51	963	963	CD
cord-308095-mehmk49a	347	52	;	;	:
cord-308095-mehmk49a	347	53	Relman	Relman	NNP
cord-308095-mehmk49a	347	54	1984	1984	CD
cord-308095-mehmk49a	347	55	Relman	Relman	NNP
cord-308095-mehmk49a	347	56	,	,	,
cord-308095-mehmk49a	347	57	1182	1182	CD
cord-308095-mehmk49a	347	58	.	.	.
cord-308095-mehmk49a	348	1	Despite	despite	IN
cord-308095-mehmk49a	348	2	Relman	Relman	NNP
cord-308095-mehmk49a	348	3	's	's	POS
cord-308095-mehmk49a	348	4	warnings	warning	NNS
cord-308095-mehmk49a	348	5	,	,	,
cord-308095-mehmk49a	348	6	that	that	DT
cord-308095-mehmk49a	348	7	trajectory	trajectory	NN
cord-308095-mehmk49a	348	8	has	have	VBZ
cord-308095-mehmk49a	348	9	only	only	RB
cord-308095-mehmk49a	348	10	increased	increase	VBN
cord-308095-mehmk49a	348	11	during	during	IN
cord-308095-mehmk49a	348	12	the	the	DT
cord-308095-mehmk49a	348	13	last	last	JJ
cord-308095-mehmk49a	348	14	four	four	CD
cord-308095-mehmk49a	348	15	decades	decade	NNS
cord-308095-mehmk49a	348	16	.	.	.
cord-308095-mehmk49a	349	1	But	but	CC
cord-308095-mehmk49a	349	2	it	-PRON-	PRP
cord-308095-mehmk49a	349	3	is	be	VBZ
cord-308095-mehmk49a	349	4	not	not	RB
cord-308095-mehmk49a	349	5	too	too	RB
cord-308095-mehmk49a	349	6	late	late	JJ
cord-308095-mehmk49a	349	7	to	to	TO
cord-308095-mehmk49a	349	8	change	change	VB
cord-308095-mehmk49a	349	9	direction	direction	NN
cord-308095-mehmk49a	349	10	.	.	.
cord-308095-mehmk49a	350	1	Changing	change	VBG
cord-308095-mehmk49a	350	2	direction	direction	NN
cord-308095-mehmk49a	350	3	will	will	MD
cord-308095-mehmk49a	350	4	require	require	VB
cord-308095-mehmk49a	350	5	more	more	JJR
cord-308095-mehmk49a	350	6	than	than	IN
cord-308095-mehmk49a	350	7	the	the	DT
cord-308095-mehmk49a	350	8	withdrawal	withdrawal	NN
cord-308095-mehmk49a	350	9	of	of	IN
cord-308095-mehmk49a	350	10	donors	donor	NNS
cord-308095-mehmk49a	350	11	'	'	POS
cord-308095-mehmk49a	350	12	naming	naming	NN
cord-308095-mehmk49a	350	13	rights	right	NNS
cord-308095-mehmk49a	350	14	in	in	IN
cord-308095-mehmk49a	350	15	response	response	NN
cord-308095-mehmk49a	350	16	to	to	IN
cord-308095-mehmk49a	350	17	criminal	criminal	JJ
cord-308095-mehmk49a	350	18	convictions	conviction	NNS
cord-308095-mehmk49a	350	19	,	,	,
cord-308095-mehmk49a	350	20	public	public	JJ
cord-308095-mehmk49a	350	21	outrage	outrage	NN
cord-308095-mehmk49a	350	22	,	,	,
cord-308095-mehmk49a	350	23	or	or	CC
cord-308095-mehmk49a	350	24	opprobrium	opprobrium	NN
cord-308095-mehmk49a	350	25	(	(	-LRB-
cord-308095-mehmk49a	350	26	Barry	Barry	NNP
cord-308095-mehmk49a	350	27	2019	2019	CD
cord-308095-mehmk49a	350	28	;	;	:
cord-308095-mehmk49a	350	29	McNeil	McNeil	NNP
cord-308095-mehmk49a	350	30	2019	2019	CD
cord-308095-mehmk49a	350	31	)	)	-RRB-
cord-308095-mehmk49a	350	32	.	.	.
cord-308095-mehmk49a	351	1	First	first	RB
cord-308095-mehmk49a	351	2	,	,	,
cord-308095-mehmk49a	351	3	public	public	JJ
cord-308095-mehmk49a	351	4	officials	official	NNS
cord-308095-mehmk49a	351	5	,	,	,
cord-308095-mehmk49a	351	6	academic	academic	JJ
cord-308095-mehmk49a	351	7	administrators	administrator	NNS
cord-308095-mehmk49a	351	8	,	,	,
cord-308095-mehmk49a	351	9	and	and	CC
cord-308095-mehmk49a	351	10	the	the	DT
cord-308095-mehmk49a	351	11	leaders	leader	NNS
cord-308095-mehmk49a	351	12	of	of	IN
cord-308095-mehmk49a	351	13	public	public	JJ
cord-308095-mehmk49a	351	14	health	health	NN
cord-308095-mehmk49a	351	15	NGOs	NGOs	NNPS
cord-308095-mehmk49a	351	16	must	must	MD
cord-308095-mehmk49a	351	17	recognize	recognize	VB
cord-308095-mehmk49a	351	18	that	that	IN
cord-308095-mehmk49a	351	19	corporate	corporate	JJ
cord-308095-mehmk49a	351	20	influence	influence	NN
cord-308095-mehmk49a	351	21	in	in	IN
cord-308095-mehmk49a	351	22	public	public	JJ
cord-308095-mehmk49a	351	23	health	health	NN
cord-308095-mehmk49a	351	24	is	be	VBZ
cord-308095-mehmk49a	351	25	a	a	DT
cord-308095-mehmk49a	351	26	systemic	systemic	JJ
cord-308095-mehmk49a	351	27	problem	problem	NN
cord-308095-mehmk49a	351	28	,	,	,
cord-308095-mehmk49a	351	29	and	and	CC
cord-308095-mehmk49a	351	30	they	-PRON-	PRP
cord-308095-mehmk49a	351	31	must	must	MD
cord-308095-mehmk49a	351	32	speak	speak	VB
cord-308095-mehmk49a	351	33	out	out	RP
cord-308095-mehmk49a	351	34	about	about	IN
cord-308095-mehmk49a	351	35	that	that	DT
cord-308095-mehmk49a	351	36	problem	problem	NN
cord-308095-mehmk49a	351	37	.	.	.
cord-308095-mehmk49a	352	1	If	if	IN
cord-308095-mehmk49a	352	2	it	-PRON-	PRP
cord-308095-mehmk49a	352	3	is	be	VBZ
cord-308095-mehmk49a	352	4	difficult	difficult	JJ
cord-308095-mehmk49a	352	5	for	for	IN
cord-308095-mehmk49a	352	6	individual	individual	JJ
cord-308095-mehmk49a	352	7	public	public	JJ
cord-308095-mehmk49a	352	8	officials	official	NNS
cord-308095-mehmk49a	352	9	or	or	CC
cord-308095-mehmk49a	352	10	academic	academic	JJ
cord-308095-mehmk49a	352	11	administrators	administrator	NNS
cord-308095-mehmk49a	352	12	to	to	TO
cord-308095-mehmk49a	352	13	speak	speak	VB
cord-308095-mehmk49a	352	14	out	out	RP
cord-308095-mehmk49a	352	15	on	on	IN
cord-308095-mehmk49a	352	16	their	-PRON-	PRP$
cord-308095-mehmk49a	352	17	own	own	JJ
cord-308095-mehmk49a	352	18	,	,	,
cord-308095-mehmk49a	352	19	they	-PRON-	PRP
cord-308095-mehmk49a	352	20	can	can	MD
cord-308095-mehmk49a	352	21	collaborate	collaborate	VB
cord-308095-mehmk49a	352	22	with	with	IN
cord-308095-mehmk49a	352	23	others	other	NNS
cord-308095-mehmk49a	352	24	by	by	IN
cord-308095-mehmk49a	352	25	making	make	VBG
cord-308095-mehmk49a	352	26	a	a	DT
cord-308095-mehmk49a	352	27	joint	joint	JJ
cord-308095-mehmk49a	352	28	statement	statement	NN
cord-308095-mehmk49a	352	29	-	-	:
cord-308095-mehmk49a	352	30	for	for	IN
cord-308095-mehmk49a	352	31	example	example	NN
cord-308095-mehmk49a	352	32	,	,	,
cord-308095-mehmk49a	352	33	an	an	DT
cord-308095-mehmk49a	352	34	open	open	JJ
cord-308095-mehmk49a	352	35	letter	letter	NN
cord-308095-mehmk49a	352	36	to	to	IN
cord-308095-mehmk49a	352	37	the	the	DT
cord-308095-mehmk49a	352	38	New	New	NNP
cord-308095-mehmk49a	352	39	York	York	NNP
cord-308095-mehmk49a	352	40	Times	Times	NNP
cord-308095-mehmk49a	352	41	that	that	WDT
cord-308095-mehmk49a	352	42	makes	make	VBZ
cord-308095-mehmk49a	352	43	clear	clear	JJ
cord-308095-mehmk49a	352	44	why	why	WRB
cord-308095-mehmk49a	352	45	corporate	corporate	JJ
cord-308095-mehmk49a	352	46	partnerships	partnership	NNS
cord-308095-mehmk49a	352	47	are	be	VBP
cord-308095-mehmk49a	352	48	problematic	problematic	JJ
cord-308095-mehmk49a	352	49	and	and	CC
cord-308095-mehmk49a	352	50	why	why	WRB
cord-308095-mehmk49a	352	51	more	more	JJR
cord-308095-mehmk49a	352	52	public	public	JJ
cord-308095-mehmk49a	352	53	funding	funding	NN
cord-308095-mehmk49a	352	54	to	to	TO
cord-308095-mehmk49a	352	55	protect	protect	VB
cord-308095-mehmk49a	352	56	and	and	CC
cord-308095-mehmk49a	352	57	promote	promote	VB
cord-308095-mehmk49a	352	58	public	public	JJ
cord-308095-mehmk49a	352	59	health	health	NN
cord-308095-mehmk49a	352	60	is	be	VBZ
cord-308095-mehmk49a	352	61	necessary	necessary	JJ
cord-308095-mehmk49a	352	62	.	.	.
cord-308095-mehmk49a	353	1	Government	government	NN
cord-308095-mehmk49a	353	2	agencies	agency	NNS
cord-308095-mehmk49a	353	3	may	may	MD
cord-308095-mehmk49a	353	4	also	also	RB
cord-308095-mehmk49a	353	5	collaborate	collaborate	VB
cord-308095-mehmk49a	353	6	with	with	IN
cord-308095-mehmk49a	353	7	each	each	DT
cord-308095-mehmk49a	353	8	other	other	JJ
cord-308095-mehmk49a	353	9	,	,	,
cord-308095-mehmk49a	353	10	instead	instead	RB
cord-308095-mehmk49a	353	11	of	of	IN
cord-308095-mehmk49a	353	12	collaborating	collaborate	VBG
cord-308095-mehmk49a	353	13	with	with	IN
cord-308095-mehmk49a	353	14	industry	industry	NN
cord-308095-mehmk49a	353	15	,	,	,
cord-308095-mehmk49a	353	16	to	to	TO
cord-308095-mehmk49a	353	17	address	address	VB
cord-308095-mehmk49a	353	18	public	public	JJ
cord-308095-mehmk49a	353	19	health	health	NN
cord-308095-mehmk49a	353	20	problems	problem	NNS
cord-308095-mehmk49a	353	21	(	(	-LRB-
cord-308095-mehmk49a	353	22	Marks	Marks	NNP
cord-308095-mehmk49a	353	23	2019a	2019a	CD
cord-308095-mehmk49a	353	24	)	)	-RRB-
cord-308095-mehmk49a	353	25	.	.	.
cord-308095-mehmk49a	354	1	Notably	notably	RB
cord-308095-mehmk49a	354	2	,	,	,
cord-308095-mehmk49a	354	3	the	the	DT
cord-308095-mehmk49a	354	4	opioid	opioid	JJ
cord-308095-mehmk49a	354	5	litigation	litigation	NN
cord-308095-mehmk49a	354	6	has	have	VBZ
cord-308095-mehmk49a	354	7	involved	involve	VBN
cord-308095-mehmk49a	354	8	considerable	considerable	JJ
cord-308095-mehmk49a	354	9	collaboration	collaboration	NN
cord-308095-mehmk49a	354	10	among	among	IN
cord-308095-mehmk49a	354	11	states	state	NNS
cord-308095-mehmk49a	354	12	'	'	POS
cord-308095-mehmk49a	354	13	attorneys	attorney	NNS
cord-308095-mehmk49a	354	14	-	-	:
cord-308095-mehmk49a	354	15	general	general	JJ
cord-308095-mehmk49a	354	16	.	.	.
cord-308095-mehmk49a	355	1	Working	work	VBG
cord-308095-mehmk49a	355	2	together	together	RB
cord-308095-mehmk49a	355	3	,	,	,
cord-308095-mehmk49a	355	4	public	public	JJ
cord-308095-mehmk49a	355	5	health	health	NN
cord-308095-mehmk49a	355	6	agencies	agency	NNS
cord-308095-mehmk49a	355	7	can	can	MD
cord-308095-mehmk49a	355	8	not	not	RB
cord-308095-mehmk49a	355	9	only	only	RB
cord-308095-mehmk49a	355	10	collaborate	collaborate	VB
cord-308095-mehmk49a	355	11	on	on	IN
cord-308095-mehmk49a	355	12	addressing	address	VBG
cord-308095-mehmk49a	355	13	individual	individual	JJ
cord-308095-mehmk49a	355	14	public	public	JJ
cord-308095-mehmk49a	355	15	health	health	NN
cord-308095-mehmk49a	355	16	challenges	challenge	NNS
cord-308095-mehmk49a	355	17	,	,	,
cord-308095-mehmk49a	355	18	they	-PRON-	PRP
cord-308095-mehmk49a	355	19	can	can	MD
cord-308095-mehmk49a	355	20	also	also	RB
cord-308095-mehmk49a	355	21	develop	develop	VB
cord-308095-mehmk49a	355	22	strategies	strategy	NNS
cord-308095-mehmk49a	355	23	to	to	TO
cord-308095-mehmk49a	355	24	wean	wean	VB
cord-308095-mehmk49a	355	25	themselves	-PRON-	PRP
cord-308095-mehmk49a	355	26	from	from	IN
cord-308095-mehmk49a	355	27	industry	industry	NN
cord-308095-mehmk49a	355	28	funding	funding	NN
cord-308095-mehmk49a	355	29	.	.	.
cord-308095-mehmk49a	356	1	The	the	DT
cord-308095-mehmk49a	356	2	same	same	JJ
cord-308095-mehmk49a	356	3	may	may	MD
cord-308095-mehmk49a	356	4	be	be	VB
cord-308095-mehmk49a	356	5	said	say	VBN
cord-308095-mehmk49a	356	6	for	for	IN
cord-308095-mehmk49a	356	7	the	the	DT
cord-308095-mehmk49a	356	8	academy	academy	NN
cord-308095-mehmk49a	356	9	and	and	CC
cord-308095-mehmk49a	356	10	public	public	JJ
cord-308095-mehmk49a	356	11	health	health	NN
cord-308095-mehmk49a	356	12	NGOs	NGOs	NNPS
cord-308095-mehmk49a	356	13	-	-	:
cord-308095-mehmk49a	356	14	including	include	VBG
cord-308095-mehmk49a	356	15	health	health	NN
cord-308095-mehmk49a	356	16	professional	professional	JJ
cord-308095-mehmk49a	356	17	associations	association	NNS
cord-308095-mehmk49a	356	18	(	(	-LRB-
cord-308095-mehmk49a	356	19	which	which	WDT
cord-308095-mehmk49a	356	20	have	have	VBP
cord-308095-mehmk49a	356	21	the	the	DT
cord-308095-mehmk49a	356	22	power	power	NN
cord-308095-mehmk49a	356	23	to	to	TO
cord-308095-mehmk49a	356	24	influence	influence	VB
cord-308095-mehmk49a	356	25	norms	norm	NNS
cord-308095-mehmk49a	356	26	and	and	CC
cord-308095-mehmk49a	356	27	expectations	expectation	NNS
cord-308095-mehmk49a	356	28	for	for	IN
cord-308095-mehmk49a	356	29	other	other	JJ
cord-308095-mehmk49a	356	30	institutions	institution	NNS
cord-308095-mehmk49a	356	31	,	,	,
cord-308095-mehmk49a	356	32	as	as	RB
cord-308095-mehmk49a	356	33	well	well	RB
cord-308095-mehmk49a	356	34	as	as	IN
cord-308095-mehmk49a	356	35	individual	individual	JJ
cord-308095-mehmk49a	356	36	professionals	professional	NNS
cord-308095-mehmk49a	356	37	)	)	-RRB-
cord-308095-mehmk49a	356	38	.	.	.
cord-308095-mehmk49a	357	1	Although	although	IN
cord-308095-mehmk49a	357	2	these	these	DT
cord-308095-mehmk49a	357	3	institutions	institution	NNS
cord-308095-mehmk49a	357	4	may	may	MD
cord-308095-mehmk49a	357	5	not	not	RB
cord-308095-mehmk49a	357	6	be	be	VB
cord-308095-mehmk49a	357	7	able	able	JJ
cord-308095-mehmk49a	357	8	to	to	TO
cord-308095-mehmk49a	357	9	restructure	restructure	VB
cord-308095-mehmk49a	357	10	their	-PRON-	PRP$
cord-308095-mehmk49a	357	11	funding	funding	NN
cord-308095-mehmk49a	357	12	strategies	strategy	NNS
cord-308095-mehmk49a	357	13	overnight	overnight	RB
cord-308095-mehmk49a	357	14	,	,	,
cord-308095-mehmk49a	357	15	it	-PRON-	PRP
cord-308095-mehmk49a	357	16	is	be	VBZ
cord-308095-mehmk49a	357	17	not	not	RB
cord-308095-mehmk49a	357	18	unrealistic	unrealistic	JJ
cord-308095-mehmk49a	357	19	to	to	TO
cord-308095-mehmk49a	357	20	expect	expect	VB
cord-308095-mehmk49a	357	21	them	-PRON-	PRP
cord-308095-mehmk49a	357	22	to	to	TO
cord-308095-mehmk49a	357	23	develop	develop	VB
cord-308095-mehmk49a	357	24	a	a	DT
cord-308095-mehmk49a	357	25	five	five	CD
cord-308095-mehmk49a	357	26	-	-	HYPH
cord-308095-mehmk49a	357	27	or	or	CC
cord-308095-mehmk49a	357	28	ten	ten	CD
cord-308095-mehmk49a	357	29	-	-	HYPH
cord-308095-mehmk49a	357	30	year	year	NN
cord-308095-mehmk49a	357	31	plan	plan	NN
cord-308095-mehmk49a	357	32	.	.	.
cord-308095-mehmk49a	358	1	Many	many	JJ
cord-308095-mehmk49a	358	2	proponents	proponent	NNS
cord-308095-mehmk49a	358	3	of	of	IN
cord-308095-mehmk49a	358	4	corporate	corporate	JJ
cord-308095-mehmk49a	358	5	partnerships	partnership	NNS
cord-308095-mehmk49a	358	6	argue	argue	VBP
cord-308095-mehmk49a	358	7	that	that	IN
cord-308095-mehmk49a	358	8	we	-PRON-	PRP
cord-308095-mehmk49a	358	9	can	can	MD
cord-308095-mehmk49a	358	10	not	not	RB
cord-308095-mehmk49a	358	11	afford	afford	VB
cord-308095-mehmk49a	358	12	to	to	TO
cord-308095-mehmk49a	358	13	tackle	tackle	VB
cord-308095-mehmk49a	358	14	the	the	DT
cord-308095-mehmk49a	358	15	major	major	JJ
cord-308095-mehmk49a	358	16	challenges	challenge	NNS
cord-308095-mehmk49a	358	17	in	in	IN
cord-308095-mehmk49a	358	18	public	public	JJ
cord-308095-mehmk49a	358	19	health	health	NN
cord-308095-mehmk49a	358	20	without	without	IN
cord-308095-mehmk49a	358	21	industry	industry	NN
cord-308095-mehmk49a	358	22	funding	funding	NN
cord-308095-mehmk49a	358	23	.	.	.
cord-308095-mehmk49a	359	1	But	but	CC
cord-308095-mehmk49a	359	2	the	the	DT
cord-308095-mehmk49a	359	3	opioid	opioid	JJ
cord-308095-mehmk49a	359	4	epidemic	epidemic	NN
cord-308095-mehmk49a	359	5	was	be	VBD
cord-308095-mehmk49a	359	6	fuelled	fuel	VBN
cord-308095-mehmk49a	359	7	by	by	IN
cord-308095-mehmk49a	359	8	these	these	DT
cord-308095-mehmk49a	359	9	very	very	JJ
cord-308095-mehmk49a	359	10	relationships	relationship	NNS
cord-308095-mehmk49a	359	11	,	,	,
cord-308095-mehmk49a	359	12	and	and	CC
cord-308095-mehmk49a	359	13	it	-PRON-	PRP
cord-308095-mehmk49a	359	14	has	have	VBZ
cord-308095-mehmk49a	359	15	cost	cost	VBN
cord-308095-mehmk49a	359	16	us	-PRON-	PRP
cord-308095-mehmk49a	359	17	trillions	trillion	NNS
cord-308095-mehmk49a	359	18	of	of	IN
cord-308095-mehmk49a	359	19	dollars	dollar	NNS
cord-308095-mehmk49a	359	20	.	.	.
cord-308095-mehmk49a	360	1	Given	give	VBN
cord-308095-mehmk49a	360	2	the	the	DT
cord-308095-mehmk49a	360	3	human	human	JJ
cord-308095-mehmk49a	360	4	and	and	CC
cord-308095-mehmk49a	360	5	financial	financial	JJ
cord-308095-mehmk49a	360	6	toll	toll	NN
cord-308095-mehmk49a	360	7	,	,	,
cord-308095-mehmk49a	360	8	we	-PRON-	PRP
cord-308095-mehmk49a	360	9	simply	simply	RB
cord-308095-mehmk49a	360	10	can	can	MD
cord-308095-mehmk49a	360	11	not	not	RB
cord-308095-mehmk49a	360	12	afford	afford	VB
cord-308095-mehmk49a	360	13	to	to	TO
cord-308095-mehmk49a	360	14	carry	carry	VB
cord-308095-mehmk49a	360	15	on	on	RP
cord-308095-mehmk49a	360	16	doing	do	VBG
cord-308095-mehmk49a	360	17	"	"	``
cord-308095-mehmk49a	360	18	business	business	NN
cord-308095-mehmk49a	360	19	as	as	IN
cord-308095-mehmk49a	360	20	usual	usual	JJ
cord-308095-mehmk49a	360	21	"	"	''
cord-308095-mehmk49a	360	22	in	in	IN
cord-308095-mehmk49a	360	23	public	public	JJ
cord-308095-mehmk49a	360	24	health	health	NN
cord-308095-mehmk49a	360	25	.	.	.
cord-308095-mehmk49a	361	1	Sponsorship	sponsorship	NN
cord-308095-mehmk49a	361	2	of	of	IN
cord-308095-mehmk49a	361	3	national	national	JJ
cord-308095-mehmk49a	361	4	health	health	NN
cord-308095-mehmk49a	361	5	organizations	organization	NNS
cord-308095-mehmk49a	361	6	by	by	IN
cord-308095-mehmk49a	361	7	two	two	CD
cord-308095-mehmk49a	361	8	major	major	JJ
cord-308095-mehmk49a	361	9	soda	soda	NN
cord-308095-mehmk49a	361	10	companies	company	NNS
cord-308095-mehmk49a	361	11	$	$	$
cord-308095-mehmk49a	361	12	3	3	CD
cord-308095-mehmk49a	361	13	million	million	CD
cord-308095-mehmk49a	361	14	gift	gift	NN
cord-308095-mehmk49a	361	15	from	from	IN
cord-308095-mehmk49a	361	16	Purdue	Purdue	NNP
cord-308095-mehmk49a	361	17	Pharma	Pharma	NNP
cord-308095-mehmk49a	361	18	to	to	TO
cord-308095-mehmk49a	361	19	support	support	VB
cord-308095-mehmk49a	361	20	MGH	MGH	NNP
cord-308095-mehmk49a	361	21	pain	pain	NN
cord-308095-mehmk49a	361	22	program	program	NN
cord-308095-mehmk49a	361	23	Pain	Pain	NNP
cord-308095-mehmk49a	361	24	Management	Management	NNP
cord-308095-mehmk49a	361	25	Association	Association	NNP
cord-308095-mehmk49a	361	26	shutting	shut	VBG
cord-308095-mehmk49a	361	27	down	down	RP
cord-308095-mehmk49a	361	28	.	.	.
cord-308095-mehmk49a	362	1	Pain	Pain	NNP
cord-308095-mehmk49a	362	2	News	News	NNP
cord-308095-mehmk49a	362	3	Network	Network	NNP
cord-308095-mehmk49a	363	1	Getting	get	VBG
cord-308095-mehmk49a	363	2	to	to	IN
cord-308095-mehmk49a	363	3	yes	yes	UH
cord-308095-mehmk49a	363	4	:	:	:
cord-308095-mehmk49a	364	1	Corporate	corporate	JJ
cord-308095-mehmk49a	364	2	power	power	NN
cord-308095-mehmk49a	364	3	and	and	CC
cord-308095-mehmk49a	364	4	the	the	DT
cord-308095-mehmk49a	364	5	creation	creation	NN
cord-308095-mehmk49a	364	6	of	of	IN
cord-308095-mehmk49a	364	7	a	a	DT
cord-308095-mehmk49a	364	8	psychopharmaceutical	psychopharmaceutical	JJ
cord-308095-mehmk49a	364	9	blockbuster	blockbuster	JJ
cord-308095-mehmk49a	364	10	Commonwealth	Commonwealth	NNP
cord-308095-mehmk49a	364	11	of	of	IN
cord-308095-mehmk49a	364	12	Massachusetts	Massachusetts	NNP
cord-308095-mehmk49a	364	13	v.	v.	IN
cord-308095-mehmk49a	364	14	Purdue	Purdue	NNP
cord-308095-mehmk49a	364	15	Pharma	Pharma	NNP
cord-308095-mehmk49a	364	16	L.P.	L.P.	NNP
cord-308095-mehmk49a	364	17	et	et	NNP
cord-308095-mehmk49a	364	18	al	al	NNP
cord-308095-mehmk49a	364	19	.	.	.
cord-308095-mehmk49a	365	1	First	first	RB
cord-308095-mehmk49a	365	2	Amended	amend	VBN
cord-308095-mehmk49a	365	3	Complaint	Complaint	NNP
cord-308095-mehmk49a	365	4	Time	Time	NNP
cord-308095-mehmk49a	365	5	out	out	RP
cord-308095-mehmk49a	366	1	:	:	:
cord-308095-mehmk49a	366	2	NFL	NFL	NNP
cord-308095-mehmk49a	366	3	conflicts	conflict	NNS
cord-308095-mehmk49a	366	4	of	of	IN
cord-308095-mehmk49a	366	5	interest	interest	NN
cord-308095-mehmk49a	366	6	with	with	IN
cord-308095-mehmk49a	366	7	public	public	JJ
cord-308095-mehmk49a	366	8	health	health	NN
cord-308095-mehmk49a	366	9	efforts	effort	NNS
cord-308095-mehmk49a	366	10	to	to	TO
cord-308095-mehmk49a	366	11	prevent	prevent	VB
cord-308095-mehmk49a	366	12	TBI	TBI	NNP
cord-308095-mehmk49a	366	13	Tufts	Tufts	NNP
cord-308095-mehmk49a	366	14	removes	remove	VBZ
cord-308095-mehmk49a	366	15	Sackler	Sackler	NNP
cord-308095-mehmk49a	366	16	name	name	NN
cord-308095-mehmk49a	366	17	over	over	IN
cord-308095-mehmk49a	366	18	opioids	opioid	NNS
cord-308095-mehmk49a	366	19	Scope	scope	NN
cord-308095-mehmk49a	366	20	and	and	CC
cord-308095-mehmk49a	366	21	impact	impact	NN
cord-308095-mehmk49a	366	22	of	of	IN
cord-308095-mehmk49a	366	23	financial	financial	JJ
cord-308095-mehmk49a	366	24	conflicts	conflict	NNS
cord-308095-mehmk49a	366	25	of	of	IN
cord-308095-mehmk49a	366	26	interest	interest	NN
cord-308095-mehmk49a	366	27	in	in	IN
cord-308095-mehmk49a	366	28	biomedical	biomedical	JJ
cord-308095-mehmk49a	366	29	research	research	NN
cord-308095-mehmk49a	366	30	:	:	:
cord-308095-mehmk49a	366	31	A	a	DT
cord-308095-mehmk49a	366	32	systematic	systematic	JJ
cord-308095-mehmk49a	366	33	review	review	NN
cord-308095-mehmk49a	366	34	Hall	Hall	NNP
cord-308095-mehmk49a	366	35	of	of	IN
cord-308095-mehmk49a	366	36	mirrors	mirror	NNS
cord-308095-mehmk49a	366	37	:	:	:
cord-308095-mehmk49a	366	38	Corporate	corporate	JJ
cord-308095-mehmk49a	366	39	philanthropy	philanthropy	NN
cord-308095-mehmk49a	366	40	and	and	CC
cord-308095-mehmk49a	366	41	strategic	strategic	JJ
cord-308095-mehmk49a	366	42	advocacy	advocacy	NN
cord-308095-mehmk49a	366	43	.	.	.
cord-308095-mehmk49a	367	1	NBER	NBER	NNP
cord-308095-mehmk49a	367	2	Working	Working	NNP
cord-308095-mehmk49a	367	3	paper	paper	NN
cord-308095-mehmk49a	367	4	25329	25329	CD
cord-308095-mehmk49a	368	1	The	the	DT
cord-308095-mehmk49a	368	2	dirt	dirt	NN
cord-308095-mehmk49a	368	3	on	on	IN
cord-308095-mehmk49a	368	4	coming	come	VBG
cord-308095-mehmk49a	368	5	clean	clean	JJ
cord-308095-mehmk49a	368	6	:	:	:
cord-308095-mehmk49a	368	7	Perverse	perverse	JJ
cord-308095-mehmk49a	368	8	effects	effect	NNS
cord-308095-mehmk49a	368	9	of	of	IN
cord-308095-mehmk49a	368	10	disclosing	disclose	VBG
cord-308095-mehmk49a	368	11	conflicts	conflict	NNS
cord-308095-mehmk49a	368	12	of	of	IN
cord-308095-mehmk49a	368	13	interest	interest	NN
cord-308095-mehmk49a	368	14	Politics	politic	NNS
cord-308095-mehmk49a	368	15	of	of	IN
cord-308095-mehmk49a	368	16	pain	pain	NN
cord-308095-mehmk49a	369	1	:	:	:
cord-308095-mehmk49a	369	2	Drugmakers	Drugmakers	NNP
cord-308095-mehmk49a	369	3	fought	fight	VBD
cord-308095-mehmk49a	369	4	state	state	NN
cord-308095-mehmk49a	369	5	opioid	opioid	JJ
cord-308095-mehmk49a	369	6	limits	limit	NNS
cord-308095-mehmk49a	369	7	amid	amid	IN
cord-308095-mehmk49a	369	8	crisis	crisis	NN
cord-308095-mehmk49a	370	1	The	the	DT
cord-308095-mehmk49a	370	2	illusion	illusion	NN
cord-308095-mehmk49a	370	3	of	of	IN
cord-308095-mehmk49a	370	4	transparency	transparency	NN
cord-308095-mehmk49a	370	5	Statement	statement	NN
cord-308095-mehmk49a	370	6	from	from	IN
cord-308095-mehmk49a	370	7	NIH	NIH	NNP
cord-308095-mehmk49a	370	8	Director	Director	NNP
cord-308095-mehmk49a	370	9	on	on	IN
cord-308095-mehmk49a	370	10	public	public	JJ
cord-308095-mehmk49a	370	11	-	-	HYPH
cord-308095-mehmk49a	370	12	private	private	JJ
cord-308095-mehmk49a	370	13	partnerships	partnership	NNS
cord-308095-mehmk49a	370	14	as	as	IN
cord-308095-mehmk49a	370	15	part	part	NN
cord-308095-mehmk49a	370	16	of	of	IN
cord-308095-mehmk49a	370	17	the	the	DT
cord-308095-mehmk49a	370	18	NIH	NIH	NNP
cord-308095-mehmk49a	370	19	HEAL	HEAL	NNP
cord-308095-mehmk49a	370	20	initiative	initiative	NN
cord-308095-mehmk49a	370	21	.	.	.
cord-308095-mehmk49a	371	1	NIH.gov	nih.gov	JJ
cord-308095-mehmk49a	371	2	Corporate	corporate	JJ
cord-308095-mehmk49a	371	3	influence	influence	NN
cord-308095-mehmk49a	371	4	:	:	:
cord-308095-mehmk49a	371	5	Purdue	Purdue	NNP
cord-308095-mehmk49a	371	6	and	and	CC
cord-308095-mehmk49a	371	7	the	the	DT
cord-308095-mehmk49a	371	8	WHO	WHO	NNP
cord-308095-mehmk49a	371	9	.	.	.
cord-308095-mehmk49a	372	1	Offices	office	NNS
cord-308095-mehmk49a	372	2	of	of	IN
cord-308095-mehmk49a	372	3	the	the	DT
cord-308095-mehmk49a	372	4	19-who	19-who	CD
cord-308095-mehmk49a	372	5	-	-	HYPH
cord-308095-mehmk49a	372	6	purdue	purdue	NNP
cord-308095-mehmk49a	372	7	-	-	HYPH
cord-308095-mehmk49a	372	8	report	report	NN
cord-308095-mehmk49a	372	9	-	-	HYPH
cord-308095-mehmk49a	372	10	final	final	JJ
cord-308095-mehmk49a	372	11	Council	Council	NNP
cord-308095-mehmk49a	372	12	of	of	IN
cord-308095-mehmk49a	372	13	Economic	Economic	NNP
cord-308095-mehmk49a	372	14	Advisors	Advisors	NNPS
cord-308095-mehmk49a	372	15	(	(	-LRB-
cord-308095-mehmk49a	372	16	CEA	CEA	NNP
cord-308095-mehmk49a	372	17	)	)	-RRB-
cord-308095-mehmk49a	372	18	.	.	.
cord-308095-mehmk49a	373	1	2017	2017	CD
cord-308095-mehmk49a	373	2	.	.	.
cord-308095-mehmk49a	374	1	The	the	DT
cord-308095-mehmk49a	374	2	underestimated	underestimated	JJ
cord-308095-mehmk49a	374	3	costs	cost	NNS
cord-308095-mehmk49a	374	4	of	of	IN
cord-308095-mehmk49a	374	5	the	the	DT
cord-308095-mehmk49a	374	6	opioid	opioid	JJ
cord-308095-mehmk49a	374	7	crisis	crisis	NN
cord-308095-mehmk49a	374	8	Top	top	JJ
cord-308095-mehmk49a	374	9	executives	executive	NNS
cord-308095-mehmk49a	374	10	of	of	IN
cord-308095-mehmk49a	374	11	Insys	Insys	NNP
cord-308095-mehmk49a	374	12	,	,	,
cord-308095-mehmk49a	374	13	an	an	DT
cord-308095-mehmk49a	374	14	opioid	opioid	JJ
cord-308095-mehmk49a	374	15	company	company	NN
cord-308095-mehmk49a	374	16	,	,	,
cord-308095-mehmk49a	374	17	are	be	VBP
cord-308095-mehmk49a	374	18	found	find	VBN
cord-308095-mehmk49a	374	19	guilty	guilty	JJ
cord-308095-mehmk49a	374	20	of	of	IN
cord-308095-mehmk49a	374	21	racketeering	racketeering	NN
cord-308095-mehmk49a	374	22	/health	/health	.
cord-308095-mehmk49a	375	1	/insys	/insys	JJ
cord-308095-mehmk49a	375	2	-	-	HYPH
cord-308095-mehmk49a	375	3	trial	trial	NN
cord-308095-mehmk49a	375	4	-	-	HYPH
cord-308095-mehmk49a	375	5	verdict-	verdict-	NN
cord-308095-mehmk49a	376	1	kapoor.html	kapoor.html	NNP
cord-308095-mehmk49a	376	2	A	a	DT
cord-308095-mehmk49a	376	3	tech	tech	NN
cord-308095-mehmk49a	376	4	company	company	NN
cord-308095-mehmk49a	376	5	gave	give	VBD
cord-308095-mehmk49a	376	6	doctors	doctor	NNS
cord-308095-mehmk49a	376	7	free	free	JJ
cord-308095-mehmk49a	376	8	softwarerigged	softwarerigge	VBN
cord-308095-mehmk49a	376	9	to	to	TO
cord-308095-mehmk49a	376	10	encourage	encourage	VB
cord-308095-mehmk49a	376	11	them	-PRON-	PRP
cord-308095-mehmk49a	376	12	to	to	TO
cord-308095-mehmk49a	376	13	prescribe	prescribe	VB
cord-308095-mehmk49a	376	14	opioids	opioid	NNS
cord-308095-mehmk49a	376	15	,	,	,
cord-308095-mehmk49a	376	16	prosecutors	prosecutor	NNS
cord-308095-mehmk49a	376	17	say	say	VBP
cord-308095-mehmk49a	376	18	Lethal	lethal	JJ
cord-308095-mehmk49a	376	19	but	but	CC
cord-308095-mehmk49a	376	20	legal	legal	JJ
cord-308095-mehmk49a	376	21	:	:	:
cord-308095-mehmk49a	376	22	Corporations	corporation	NNS
cord-308095-mehmk49a	376	23	,	,	,
cord-308095-mehmk49a	376	24	consumption	consumption	NN
cord-308095-mehmk49a	376	25	,	,	,
cord-308095-mehmk49a	376	26	and	and	CC
cord-308095-mehmk49a	376	27	protecting	protect	VBG
cord-308095-mehmk49a	376	28	public	public	JJ
cord-308095-mehmk49a	376	29	health	health	NN
cord-308095-mehmk49a	376	30	Civil	civil	JJ
cord-308095-mehmk49a	376	31	litigation	litigation	NN
cord-308095-mehmk49a	376	32	and	and	CC
cord-308095-mehmk49a	376	33	the	the	DT
cord-308095-mehmk49a	376	34	opioid	opioid	JJ
cord-308095-mehmk49a	376	35	crisis	crisis	NN
cord-308095-mehmk49a	376	36	:	:	:
cord-308095-mehmk49a	376	37	The	the	DT
cord-308095-mehmk49a	376	38	role	role	NN
cord-308095-mehmk49a	376	39	of	of	IN
cord-308095-mehmk49a	376	40	courts	court	NNS
cord-308095-mehmk49a	376	41	in	in	IN
cord-308095-mehmk49a	376	42	a	a	DT
cord-308095-mehmk49a	376	43	national	national	JJ
cord-308095-mehmk49a	376	44	health	health	NN
cord-308095-mehmk49a	376	45	crisis	crisis	NN
cord-308095-mehmk49a	377	1	The	the	DT
cord-308095-mehmk49a	377	2	Shadows	shadow	NNS
cord-308095-mehmk49a	377	3	of	of	IN
cord-308095-mehmk49a	377	4	sunlight	sunlight	NN
cord-308095-mehmk49a	378	1	:	:	:
cord-308095-mehmk49a	378	2	Why	why	WRB
cord-308095-mehmk49a	378	3	disclosure	disclosure	NN
cord-308095-mehmk49a	378	4	should	should	MD
cord-308095-mehmk49a	378	5	not	not	RB
cord-308095-mehmk49a	378	6	be	be	VB
cord-308095-mehmk49a	378	7	a	a	DT
cord-308095-mehmk49a	378	8	priority	priority	NN
cord-308095-mehmk49a	378	9	in	in	IN
cord-308095-mehmk49a	378	10	addressing	address	VBG
cord-308095-mehmk49a	378	11	conflicts	conflict	NNS
cord-308095-mehmk49a	378	12	of	of	IN
cord-308095-mehmk49a	378	13	interest	interest	NN
cord-308095-mehmk49a	378	14	Bioethical	Bioethical	NNP
cord-308095-mehmk49a	378	15	Inquiry	Inquiry	NNP
cord-308095-mehmk49a	378	16	Drug	Drug	NNP
cord-308095-mehmk49a	378	17	distributor	distributor	NN
cord-308095-mehmk49a	378	18	and	and	CC
cord-308095-mehmk49a	378	19	former	former	JJ
cord-308095-mehmk49a	378	20	execs	exec	NNS
cord-308095-mehmk49a	378	21	face	face	VBP
cord-308095-mehmk49a	378	22	first	first	JJ
cord-308095-mehmk49a	378	23	criminal	criminal	JJ
cord-308095-mehmk49a	378	24	charges	charge	NNS
cord-308095-mehmk49a	378	25	in	in	IN
cord-308095-mehmk49a	378	26	opioid	opioid	JJ
cord-308095-mehmk49a	378	27	crisis	crisis	NN
cord-308095-mehmk49a	378	28	.	.	.
cord-308095-mehmk49a	379	1	NPR	NPR	NNP
cord-308095-mehmk49a	379	2	Sugar	Sugar	NNP
cord-308095-mehmk49a	379	3	:	:	:
cord-308095-mehmk49a	380	1	A	a	DT
cord-308095-mehmk49a	380	2	web	web	NN
cord-308095-mehmk49a	380	3	of	of	IN
cord-308095-mehmk49a	380	4	influence	influence	NN
cord-308095-mehmk49a	380	5	Keeping	keep	VBG
cord-308095-mehmk49a	380	6	modern	modern	JJ
cord-308095-mehmk49a	380	7	in	in	IN
cord-308095-mehmk49a	380	8	medicine	medicine	NN
cord-308095-mehmk49a	380	9	:	:	:
cord-308095-mehmk49a	380	10	Pharmaceutical	pharmaceutical	NN
cord-308095-mehmk49a	380	11	promotion	promotion	NN
cord-308095-mehmk49a	380	12	and	and	CC
cord-308095-mehmk49a	380	13	physician	physician	NN
cord-308095-mehmk49a	380	14	education	education	NN
cord-308095-mehmk49a	380	15	in	in	IN
cord-308095-mehmk49a	380	16	postwar	postwar	JJ
cord-308095-mehmk49a	380	17	America	America	NNP
cord-308095-mehmk49a	380	18	Industry	Industry	NNP
cord-308095-mehmk49a	380	19	payments	payment	NNS
cord-308095-mehmk49a	380	20	to	to	IN
cord-308095-mehmk49a	380	21	physicians	physician	NNS
cord-308095-mehmk49a	380	22	for	for	IN
cord-308095-mehmk49a	380	23	opioid	opioid	JJ
cord-308095-mehmk49a	380	24	products	products	NNPS
cord-308095-mehmk49a	380	25	Association	Association	NNP
cord-308095-mehmk49a	380	26	of	of	IN
cord-308095-mehmk49a	380	27	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	380	28	industry	industry	NN
cord-308095-mehmk49a	380	29	marketing	marketing	NN
cord-308095-mehmk49a	380	30	of	of	IN
cord-308095-mehmk49a	380	31	opioid	opioid	JJ
cord-308095-mehmk49a	380	32	products	product	NNS
cord-308095-mehmk49a	380	33	to	to	IN
cord-308095-mehmk49a	380	34	physicians	physician	NNS
cord-308095-mehmk49a	380	35	with	with	IN
cord-308095-mehmk49a	380	36	subsequent	subsequent	JJ
cord-308095-mehmk49a	380	37	opioid	opioid	NN
cord-308095-mehmk49a	380	38	prescribing	prescribe	VBG
cord-308095-mehmk49a	380	39	Association	Association	NNP
cord-308095-mehmk49a	380	40	of	of	IN
cord-308095-mehmk49a	380	41	Pharmaceutical	Pharmaceutical	NNP
cord-308095-mehmk49a	380	42	Industry	Industry	NNP
cord-308095-mehmk49a	380	43	marketing	marketing	NN
cord-308095-mehmk49a	380	44	of	of	IN
cord-308095-mehmk49a	380	45	opioid	opioid	JJ
cord-308095-mehmk49a	380	46	products	product	NNS
cord-308095-mehmk49a	380	47	with	with	IN
cord-308095-mehmk49a	380	48	mortality	mortality	NN
cord-308095-mehmk49a	380	49	from	from	IN
cord-308095-mehmk49a	380	50	opioid	opioid	NN
cord-308095-mehmk49a	380	51	-	-	HYPH
cord-308095-mehmk49a	380	52	related	relate	VBN
cord-308095-mehmk49a	380	53	overdoses	overdose	NNS
cord-308095-mehmk49a	380	54	OxyContin	oxycontin	NN
cord-308095-mehmk49a	380	55	maker	maker	NN
cord-308095-mehmk49a	380	56	Purdue	Purdue	NNP
cord-308095-mehmk49a	380	57	Pharma	Pharma	NNP
cord-308095-mehmk49a	380	58	to	to	TO
cord-308095-mehmk49a	380	59	pay	pay	VB
cord-308095-mehmk49a	380	60	states	state	NNS
cord-308095-mehmk49a	380	61	'	'	POS
cord-308095-mehmk49a	380	62	lawyers	lawyer	NNS
cord-308095-mehmk49a	380	63	,	,	,
cord-308095-mehmk49a	380	64	urged	urge	VBD
cord-308095-mehmk49a	380	65	to	to	TO
cord-308095-mehmk49a	380	66	help	help	VB
cord-308095-mehmk49a	380	67	victims	victim	NNS
cord-308095-mehmk49a	380	68	$	$	$
cord-308095-mehmk49a	380	69	260	260	CD
cord-308095-mehmk49a	380	70	million	million	CD
cord-308095-mehmk49a	380	71	opioid	opioid	NN
cord-308095-mehmk49a	380	72	settlement	settlement	NN
cord-308095-mehmk49a	380	73	reached	reach	VBD
cord-308095-mehmk49a	380	74	at	at	IN
cord-308095-mehmk49a	380	75	last	last	JJ
cord-308095-mehmk49a	380	76	minute	minute	NN
cord-308095-mehmk49a	380	77	with	with	IN
cord-308095-mehmk49a	380	78	big	big	JJ
cord-308095-mehmk49a	380	79	drug	drug	NN
cord-308095-mehmk49a	380	80	companies	company	NNS
cord-308095-mehmk49a	380	81	Association	Association	NNP
cord-308095-mehmk49a	380	82	between	between	IN
cord-308095-mehmk49a	380	83	opioid	opioid	NN
cord-308095-mehmk49a	380	84	prescribing	prescribing	NN
cord-308095-mehmk49a	380	85	in	in	IN
cord-308095-mehmk49a	380	86	Medicare	Medicare	NNP
cord-308095-mehmk49a	380	87	and	and	CC
cord-308095-mehmk49a	380	88	pharmaceutical	pharmaceutical	JJ
cord-308095-mehmk49a	380	89	company	company	NN
cord-308095-mehmk49a	380	90	gifts	gift	NNS
cord-308095-mehmk49a	380	91	by	by	IN
cord-308095-mehmk49a	380	92	physician	physician	NN
cord-308095-mehmk49a	380	93	specialty	specialty	NN
cord-308095-mehmk49a	380	94	Fueling	fuel	VBG
cord-308095-mehmk49a	380	95	an	an	DT
cord-308095-mehmk49a	380	96	epidemic	epidemic	NN
cord-308095-mehmk49a	380	97	-	-	HYPH
cord-308095-mehmk49a	380	98	Report	report	NN
cord-308095-mehmk49a	380	99	Two	two	CD
cord-308095-mehmk49a	380	100	:	:	:
cord-308095-mehmk49a	380	101	Exposing	expose	VBG
cord-308095-mehmk49a	380	102	financial	financial	JJ
cord-308095-mehmk49a	380	103	ties	tie	NNS
cord-308095-mehmk49a	380	104	between	between	IN
cord-308095-mehmk49a	380	105	opioid	opioid	NN
cord-308095-mehmk49a	380	106	manufacturers	manufacturer	NNS
cord-308095-mehmk49a	380	107	and	and	CC
cord-308095-mehmk49a	380	108	third	third	JJ
cord-308095-mehmk49a	380	109	party	party	NN
cord-308095-mehmk49a	380	110	advocacy	advocacy	NN
cord-308095-mehmk49a	380	111	groups	group	NNS
cord-308095-mehmk49a	380	112	Inside	inside	IN
cord-308095-mehmk49a	380	113	the	the	DT
cord-308095-mehmk49a	380	114	opioid	opioid	JJ
cord-308095-mehmk49a	380	115	industry	industry	NN
cord-308095-mehmk49a	380	116	's	's	POS
cord-308095-mehmk49a	380	117	marketing	marketing	NN
cord-308095-mehmk49a	380	118	machine	machine	NN
cord-308095-mehmk49a	380	119	:	:	:
cord-308095-mehmk49a	380	120	Unsealed	unsealed	JJ
cord-308095-mehmk49a	380	121	court	court	NN
cord-308095-mehmk49a	380	122	documents	document	NNS
cord-308095-mehmk49a	380	123	reveal	reveal	VBP
cord-308095-mehmk49a	380	124	how	how	WRB
cord-308095-mehmk49a	380	125	drug	drug	NN
cord-308095-mehmk49a	380	126	companies	company	NNS
cord-308095-mehmk49a	380	127	ramped	ramp	VBD
cord-308095-mehmk49a	380	128	up	up	RP
cord-308095-mehmk49a	380	129	sales	sale	NNS
cord-308095-mehmk49a	380	130	during	during	IN
cord-308095-mehmk49a	380	131	the	the	DT
cord-308095-mehmk49a	380	132	epidemic	epidemic	NN
cord-308095-mehmk49a	380	133	We	-PRON-	PRP
cord-308095-mehmk49a	380	134	owe	owe	VBP
cord-308095-mehmk49a	380	135	much	much	JJ
cord-308095-mehmk49a	380	136	to	to	IN
cord-308095-mehmk49a	380	137	the	the	DT
cord-308095-mehmk49a	380	138	Sackler	Sackler	NNP
cord-308095-mehmk49a	380	139	family	family	NN
cord-308095-mehmk49a	380	140	"	"	''
cord-308095-mehmk49a	380	141	:	:	:
cord-308095-mehmk49a	380	142	How	how	WRB
cord-308095-mehmk49a	380	143	gifts	gift	NNS
cord-308095-mehmk49a	380	144	to	to	IN
cord-308095-mehmk49a	380	145	a	a	DT
cord-308095-mehmk49a	380	146	top	top	JJ
cord-308095-mehmk49a	380	147	medical	medical	JJ
cord-308095-mehmk49a	380	148	school	school	NN
cord-308095-mehmk49a	380	149	advanced	advance	VBD
cord-308095-mehmk49a	380	150	the	the	DT
cord-308095-mehmk49a	380	151	interests	interest	NNS
cord-308095-mehmk49a	380	152	of	of	IN
cord-308095-mehmk49a	380	153	Purdue	Purdue	NNP
cord-308095-mehmk49a	380	154	Pharma	Pharma	NNP
cord-308095-mehmk49a	380	155	Extending	extend	VBG
cord-308095-mehmk49a	380	156	the	the	DT
cord-308095-mehmk49a	380	157	Sunshine	Sunshine	NNP
cord-308095-mehmk49a	380	158	Act	Act	NNP
cord-308095-mehmk49a	380	159	from	from	IN
cord-308095-mehmk49a	380	160	physicians	physician	NNS
cord-308095-mehmk49a	380	161	to	to	IN
cord-308095-mehmk49a	380	162	patient	patient	JJ
cord-308095-mehmk49a	380	163	advocacy	advocacy	NN
cord-308095-mehmk49a	380	164	organizations	organization	NNS
cord-308095-mehmk49a	380	165	Evaluating	evaluate	VBG
cord-308095-mehmk49a	380	166	open	open	JJ
cord-308095-mehmk49a	380	167	payments	payment	NNS
cord-308095-mehmk49a	380	168	Effect	effect	NN
cord-308095-mehmk49a	380	169	of	of	IN
cord-308095-mehmk49a	380	170	the	the	DT
cord-308095-mehmk49a	380	171	public	public	JJ
cord-308095-mehmk49a	380	172	disclosure	disclosure	NN
cord-308095-mehmk49a	380	173	of	of	IN
cord-308095-mehmk49a	380	174	industry	industry	NN
cord-308095-mehmk49a	380	175	payments	payment	NNS
cord-308095-mehmk49a	380	176	information	information	NN
cord-308095-mehmk49a	380	177	on	on	IN
cord-308095-mehmk49a	380	178	patients	patient	NNS
cord-308095-mehmk49a	380	179	:	:	:
cord-308095-mehmk49a	381	1	Results	result	NNS
cord-308095-mehmk49a	381	2	from	from	IN
cord-308095-mehmk49a	381	3	a	a	DT
cord-308095-mehmk49a	381	4	population	population	NN
cord-308095-mehmk49a	381	5	-	-	HYPH
cord-308095-mehmk49a	381	6	based	base	VBN
cord-308095-mehmk49a	381	7	natural	natural	JJ
cord-308095-mehmk49a	381	8	experiment	experiment	NN
cord-308095-mehmk49a	381	9	Mallinckrodt	Mallinckrodt	NNP
cord-308095-mehmk49a	381	10	reaches	reach	VBZ
cord-308095-mehmk49a	381	11	$	$	$
cord-308095-mehmk49a	381	12	1.6	1.6	CD
cord-308095-mehmk49a	381	13	billion	billion	CD
cord-308095-mehmk49a	381	14	deal	deal	NN
cord-308095-mehmk49a	381	15	to	to	TO
cord-308095-mehmk49a	381	16	settle	settle	VB
cord-308095-mehmk49a	381	17	opioid	opioid	JJ
cord-308095-mehmk49a	381	18	lawsuits	lawsuit	NNS
cord-308095-mehmk49a	382	1	The	the	DT
cord-308095-mehmk49a	382	2	family	family	NN
cord-308095-mehmk49a	382	3	that	that	WDT
cord-308095-mehmk49a	382	4	built	build	VBD
cord-308095-mehmk49a	382	5	an	an	DT
cord-308095-mehmk49a	382	6	empire	empire	NN
cord-308095-mehmk49a	382	7	of	of	IN
cord-308095-mehmk49a	382	8	pain	pain	NN
cord-308095-mehmk49a	382	9	Fake	fake	JJ
cord-308095-mehmk49a	382	10	doctors	doctor	NNS
cord-308095-mehmk49a	382	11	,	,	,
cord-308095-mehmk49a	382	12	pilfered	pilfer	VBD
cord-308095-mehmk49a	382	13	medical	medical	JJ
cord-308095-mehmk49a	382	14	records	record	NNS
cord-308095-mehmk49a	382	15	drive	drive	VBP
cord-308095-mehmk49a	382	16	Oxy	Oxy	NNP
cord-308095-mehmk49a	382	17	China	China	NNP
cord-308095-mehmk49a	382	18	sales	sale	NNS
cord-308095-mehmk49a	383	1	How	how	WRB
cord-308095-mehmk49a	383	2	judges	judge	NNS
cord-308095-mehmk49a	383	3	added	add	VBD
cord-308095-mehmk49a	383	4	to	to	IN
cord-308095-mehmk49a	383	5	the	the	DT
cord-308095-mehmk49a	383	6	grim	grim	JJ
cord-308095-mehmk49a	383	7	toll	toll	NN
cord-308095-mehmk49a	383	8	of	of	IN
cord-308095-mehmk49a	383	9	opioids	opioid	NNS
cord-308095-mehmk49a	383	10	Republic	Republic	NNP
cord-308095-mehmk49a	383	11	,	,	,
cord-308095-mehmk49a	383	12	lost	lose	VBD
cord-308095-mehmk49a	383	13	:	:	:
cord-308095-mehmk49a	384	1	The	the	DT
cord-308095-mehmk49a	384	2	corruption	corruption	NN
cord-308095-mehmk49a	384	3	of	of	IN
cord-308095-mehmk49a	384	4	equality	equality	NN
cord-308095-mehmk49a	384	5	and	and	CC
cord-308095-mehmk49a	384	6	the	the	DT
cord-308095-mehmk49a	384	7	steps	step	NNS
cord-308095-mehmk49a	384	8	to	to	TO
cord-308095-mehmk49a	384	9	end	end	VB
cord-308095-mehmk49a	384	10	it	-PRON-	PRP
cord-308095-mehmk49a	384	11	Financial	financial	JJ
cord-308095-mehmk49a	384	12	conflicts	conflict	NNS
cord-308095-mehmk49a	384	13	of	of	IN
cord-308095-mehmk49a	384	14	interest	interest	NN
cord-308095-mehmk49a	384	15	and	and	CC
cord-308095-mehmk49a	384	16	the	the	DT
cord-308095-mehmk49a	384	17	Centers	Centers	NNPS
cord-308095-mehmk49a	384	18	for	for	IN
cord-308095-mehmk49a	384	19	Disease	Disease	NNP
cord-308095-mehmk49a	384	20	Control	Control	NNP
cord-308095-mehmk49a	384	21	and	and	CC
cord-308095-mehmk49a	384	22	Prevention	Prevention	NNP
cord-308095-mehmk49a	384	23	's	's	POS
cord-308095-mehmk49a	384	24	2016	2016	CD
cord-308095-mehmk49a	384	25	guideline	guideline	NN
cord-308095-mehmk49a	384	26	for	for	IN
cord-308095-mehmk49a	384	27	prescribing	prescribe	VBG
cord-308095-mehmk49a	384	28	opioids	opioid	NNS
cord-308095-mehmk49a	384	29	for	for	IN
cord-308095-mehmk49a	384	30	chronic	chronic	JJ
cord-308095-mehmk49a	384	31	pain	pain	NN
cord-308095-mehmk49a	384	32	Conflict	conflict	NN
cord-308095-mehmk49a	384	33	of	of	IN
cord-308095-mehmk49a	384	34	interest	interest	NN
cord-308095-mehmk49a	384	35	in	in	IN
cord-308095-mehmk49a	384	36	medical	medical	JJ
cord-308095-mehmk49a	384	37	research	research	NN
cord-308095-mehmk49a	384	38	,	,	,
cord-308095-mehmk49a	384	39	education	education	NN
cord-308095-mehmk49a	384	40	,	,	,
cord-308095-mehmk49a	384	41	and	and	CC
cord-308095-mehmk49a	384	42	practice	practice	VB
cord-308095-mehmk49a	384	43	Payments	payment	NNS
cord-308095-mehmk49a	384	44	to	to	IN
cord-308095-mehmk49a	384	45	physicians	physician	NNS
cord-308095-mehmk49a	384	46	:	:	:
cord-308095-mehmk49a	384	47	Does	do	VBZ
cord-308095-mehmk49a	384	48	the	the	DT
cord-308095-mehmk49a	384	49	amount	amount	NN
cord-308095-mehmk49a	384	50	of	of	IN
cord-308095-mehmk49a	384	51	money	money	NN
cord-308095-mehmk49a	384	52	make	make	VBP
cord-308095-mehmk49a	384	53	a	a	DT
cord-308095-mehmk49a	384	54	difference	difference	NN
cord-308095-mehmk49a	385	1	The	the	DT
cord-308095-mehmk49a	385	2	limits	limit	NNS
cord-308095-mehmk49a	385	3	of	of	IN
cord-308095-mehmk49a	385	4	transparency	transparency	NN
cord-308095-mehmk49a	385	5	:	:	:
cord-308095-mehmk49a	385	6	Pitfalls	pitfall	NNS
cord-308095-mehmk49a	385	7	and	and	CC
cord-308095-mehmk49a	385	8	potential	potential	NN
cord-308095-mehmk49a	385	9	of	of	IN
cord-308095-mehmk49a	385	10	disclosing	disclose	VBG
cord-308095-mehmk49a	385	11	conflicts	conflict	NNS
cord-308095-mehmk49a	385	12	of	of	IN
cord-308095-mehmk49a	385	13	interest	interest	NN
cord-308095-mehmk49a	386	1	The	the	DT
cord-308095-mehmk49a	386	2	unintended	unintended	JJ
cord-308095-mehmk49a	386	3	consequences	consequence	NNS
cord-308095-mehmk49a	386	4	of	of	IN
cord-308095-mehmk49a	386	5	conflict	conflict	NN
cord-308095-mehmk49a	386	6	of	of	IN
cord-308095-mehmk49a	386	7	interest	interest	NN
cord-308095-mehmk49a	386	8	disclosure	disclosure	NN
cord-308095-mehmk49a	386	9	Industry	Industry	NNP
cord-308095-mehmk49a	386	10	sponsorship	sponsorship	NN
cord-308095-mehmk49a	386	11	and	and	CC
cord-308095-mehmk49a	386	12	research	research	NN
cord-308095-mehmk49a	386	13	outcome	outcome	NN
cord-308095-mehmk49a	387	1	Dopesick	dopesick	NN
cord-308095-mehmk49a	387	2	:	:	:
cord-308095-mehmk49a	387	3	dealers	dealer	NNS
cord-308095-mehmk49a	387	4	,	,	,
cord-308095-mehmk49a	387	5	doctors	doctor	NNS
cord-308095-mehmk49a	387	6	,	,	,
cord-308095-mehmk49a	387	7	and	and	CC
cord-308095-mehmk49a	387	8	the	the	DT
cord-308095-mehmk49a	387	9	drug	drug	NN
cord-308095-mehmk49a	387	10	company	company	NN
cord-308095-mehmk49a	387	11	that	that	WDT
cord-308095-mehmk49a	387	12	addicted	addict	VBD
cord-308095-mehmk49a	387	13	America	America	NNP
cord-308095-mehmk49a	387	14	Caveat	Caveat	NNP
cord-308095-mehmk49a	387	15	partner	partner	NN
cord-308095-mehmk49a	387	16	:	:	:
cord-308095-mehmk49a	388	1	Sharing	share	VBG
cord-308095-mehmk49a	388	2	responsibility	responsibility	NN
cord-308095-mehmk49a	388	3	for	for	IN
cord-308095-mehmk49a	388	4	health	health	NN
cord-308095-mehmk49a	388	5	with	with	IN
cord-308095-mehmk49a	388	6	the	the	DT
cord-308095-mehmk49a	388	7	food	food	NN
cord-308095-mehmk49a	388	8	industry	industry	NN
cord-308095-mehmk49a	389	1	Opioid	opioid	JJ
cord-308095-mehmk49a	389	2	crisis	crisis	NN
cord-308095-mehmk49a	389	3	shows	show	VBZ
cord-308095-mehmk49a	389	4	partnering	partner	VBG
cord-308095-mehmk49a	389	5	with	with	IN
cord-308095-mehmk49a	389	6	industry	industry	NN
cord-308095-mehmk49a	389	7	can	can	MD
cord-308095-mehmk49a	389	8	be	be	VB
cord-308095-mehmk49a	389	9	bad	bad	JJ
cord-308095-mehmk49a	389	10	for	for	IN
cord-308095-mehmk49a	389	11	public	public	JJ
cord-308095-mehmk49a	389	12	health	health	NN
cord-308095-mehmk49a	389	13	.	.	.
cord-308095-mehmk49a	390	1	The	the	DT
cord-308095-mehmk49a	390	2	Conversation	Conversation	NNP
cord-308095-mehmk49a	390	3	Beyond	Beyond	NNP
cord-308095-mehmk49a	390	4	disclosure	disclosure	NN
cord-308095-mehmk49a	390	5	:	:	:
cord-308095-mehmk49a	391	1	Developing	develop	VBG
cord-308095-mehmk49a	391	2	law	law	NN
cord-308095-mehmk49a	391	3	and	and	CC
cord-308095-mehmk49a	391	4	policy	policy	NN
cord-308095-mehmk49a	391	5	to	to	TO
cord-308095-mehmk49a	391	6	tackle	tackle	VB
cord-308095-mehmk49a	391	7	corporate	corporate	JJ
cord-308095-mehmk49a	391	8	influence	influence	NN
cord-308095-mehmk49a	391	9	Conflict	conflict	NN
cord-308095-mehmk49a	391	10	of	of	IN
cord-308095-mehmk49a	391	11	interest	interest	NN
cord-308095-mehmk49a	391	12	for	for	IN
cord-308095-mehmk49a	391	13	patient	patient	JJ
cord-308095-mehmk49a	391	14	advocacy	advocacy	NN
cord-308095-mehmk49a	391	15	organizations	organization	NNS
cord-308095-mehmk49a	391	16	Industry	Industry	NNP
cord-308095-mehmk49a	391	17	support	support	NN
cord-308095-mehmk49a	391	18	of	of	IN
cord-308095-mehmk49a	391	19	patient	patient	JJ
cord-308095-mehmk49a	391	20	advocacy	advocacy	NN
cord-308095-mehmk49a	391	21	organizations	organization	NNS
cord-308095-mehmk49a	391	22	:	:	:
cord-308095-mehmk49a	391	23	The	the	DT
cord-308095-mehmk49a	391	24	case	case	NN
cord-308095-mehmk49a	391	25	for	for	IN
cord-308095-mehmk49a	391	26	an	an	DT
cord-308095-mehmk49a	391	27	extension	extension	NN
cord-308095-mehmk49a	391	28	of	of	IN
cord-308095-mehmk49a	391	29	the	the	DT
cord-308095-mehmk49a	391	30	Sunshine	Sunshine	NNP
cord-308095-mehmk49a	391	31	Act	Act	NNP
cord-308095-mehmk49a	391	32	provisions	provision	NNS
cord-308095-mehmk49a	391	33	of	of	IN
cord-308095-mehmk49a	391	34	the	the	DT
cord-308095-mehmk49a	391	35	Affordable	Affordable	NNP
cord-308095-mehmk49a	391	36	Care	Care	NNP
cord-308095-mehmk49a	391	37	Act	Act	NNP
cord-308095-mehmk49a	391	38	Campaign	Campaign	NNP
cord-308095-mehmk49a	391	39	contributions	contribution	NNS
cord-308095-mehmk49a	391	40	from	from	IN
cord-308095-mehmk49a	391	41	political	political	JJ
cord-308095-mehmk49a	391	42	action	action	NN
cord-308095-mehmk49a	391	43	committees	committee	NNS
cord-308095-mehmk49a	391	44	to	to	IN
cord-308095-mehmk49a	391	45	members	member	NNS
cord-308095-mehmk49a	391	46	of	of	IN
cord-308095-mehmk49a	391	47	congressional	congressional	JJ
cord-308095-mehmk49a	391	48	committees	committee	NNS
cord-308095-mehmk49a	391	49	responding	respond	VBG
cord-308095-mehmk49a	391	50	to	to	IN
cord-308095-mehmk49a	391	51	the	the	DT
cord-308095-mehmk49a	391	52	opioid	opioid	JJ
cord-308095-mehmk49a	391	53	crisis	crisis	NN
cord-308095-mehmk49a	391	54	US	US	NNP
cord-308095-mehmk49a	391	55	medical	medical	JJ
cord-308095-mehmk49a	391	56	group	group	NN
cord-308095-mehmk49a	391	57	that	that	WDT
cord-308095-mehmk49a	391	58	pushed	push	VBD
cord-308095-mehmk49a	391	59	doctors	doctor	NNS
cord-308095-mehmk49a	391	60	to	to	TO
cord-308095-mehmk49a	391	61	prescribe	prescribe	VB
cord-308095-mehmk49a	391	62	painkillers	painkiller	NNS
cord-308095-mehmk49a	391	63	forced	force	VBN
cord-308095-mehmk49a	391	64	to	to	TO
cord-308095-mehmk49a	391	65	close	close	VB
cord-308095-mehmk49a	391	66	.	.	.
cord-308095-mehmk49a	392	1	The	the	DT
cord-308095-mehmk49a	392	2	Guardian	Guardian	NNP
cord-308095-mehmk49a	392	3	UB	UB	NNP
cord-308095-mehmk49a	392	4	renames	rename	VBZ
cord-308095-mehmk49a	392	5	structure	structure	NN
cord-308095-mehmk49a	392	6	"	"	``
cord-308095-mehmk49a	392	7	Pharmacy	Pharmacy	NNP
cord-308095-mehmk49a	392	8	Building	Building	NNP
cord-308095-mehmk49a	392	9	"	"	''
cord-308095-mehmk49a	392	10	after	after	IN
cord-308095-mehmk49a	392	11	removing	remove	VBG
cord-308095-mehmk49a	392	12	convicted	convict	VBN
cord-308095-mehmk49a	392	13	alumnus	alumnus	NN
cord-308095-mehmk49a	392	14	'	'	POS
cord-308095-mehmk49a	392	15	name	name	NN
cord-308095-mehmk49a	392	16	.	.	.
cord-308095-mehmk49a	393	1	The	the	DT
cord-308095-mehmk49a	393	2	Buffalo	Buffalo	NNP
cord-308095-mehmk49a	393	3	News	News	NNP
cord-308095-mehmk49a	393	4	Pain	Pain	NNP
cord-308095-mehmk49a	393	5	killer	killer	NN
cord-308095-mehmk49a	393	6	:	:	:
cord-308095-mehmk49a	394	1	An	an	DT
cord-308095-mehmk49a	394	2	empire	empire	NN
cord-308095-mehmk49a	394	3	of	of	IN
cord-308095-mehmk49a	394	4	deceit	deceit	NN
cord-308095-mehmk49a	394	5	and	and	CC
cord-308095-mehmk49a	394	6	the	the	DT
cord-308095-mehmk49a	394	7	origin	origin	NN
cord-308095-mehmk49a	394	8	of	of	IN
cord-308095-mehmk49a	394	9	America	America	NNP
cord-308095-mehmk49a	394	10	's	's	POS
cord-308095-mehmk49a	394	11	opioid	opioid	JJ
cord-308095-mehmk49a	394	12	epidemic	epidemic	NN
cord-308095-mehmk49a	394	13	Ethical	ethical	JJ
cord-308095-mehmk49a	394	14	considerations	consideration	NNS
cord-308095-mehmk49a	394	15	for	for	IN
cord-308095-mehmk49a	394	16	industry	industry	NN
cord-308095-mehmk49a	394	17	partnership	partnership	NN
cord-308095-mehmk49a	394	18	on	on	IN
cord-308095-mehmk49a	394	19	research	research	NN
cord-308095-mehmk49a	394	20	to	to	TO
cord-308095-mehmk49a	394	21	help	help	VB
cord-308095-mehmk49a	394	22	end	end	VB
cord-308095-mehmk49a	394	23	the	the	DT
cord-308095-mehmk49a	394	24	opioid	opioid	JJ
cord-308095-mehmk49a	394	25	crisis	crisis	NN
cord-308095-mehmk49a	395	1	:	:	:
cord-308095-mehmk49a	395	2	Draft	draft	NN
cord-308095-mehmk49a	395	3	report	report	NN
cord-308095-mehmk49a	395	4	What	what	WP
cord-308095-mehmk49a	395	5	these	these	DT
cord-308095-mehmk49a	395	6	medical	medical	JJ
cord-308095-mehmk49a	395	7	journals	journal	NNS
cord-308095-mehmk49a	395	8	do	do	VBP
cord-308095-mehmk49a	395	9	n't	not	RB
cord-308095-mehmk49a	395	10	reveal	reveal	VB
cord-308095-mehmk49a	395	11	:	:	:
cord-308095-mehmk49a	395	12	Top	top	JJ
cord-308095-mehmk49a	395	13	doctors	doctor	NNS
cord-308095-mehmk49a	395	14	'	'	POS
cord-308095-mehmk49a	395	15	ties	tie	NNS
cord-308095-mehmk49a	395	16	to	to	IN
cord-308095-mehmk49a	395	17	industry	industry	NN
cord-308095-mehmk49a	395	18	/health	/health	.
cord-308095-mehmk49a	395	19	/	/	SYM
cord-308095-mehmk49a	395	20	medical	medical	JJ
cord-308095-mehmk49a	395	21	-	-	HYPH
cord-308095-mehmk49a	395	22	journals	journal	NNS
cord-308095-mehmk49a	395	23	-	-	HYPH
cord-308095-mehmk49a	395	24	conflicts	conflict	NNS
cord-308095-mehmk49a	395	25	-	-	HYPH
cord-308095-mehmk49a	395	26	of	of	IN
cord-308095-mehmk49a	395	27	-	-	HYPH
cord-308095-mehmk49a	395	28	interest.html	interest.html	NN
cord-308095-mehmk49a	395	29	Pharmaceutical	Pharmaceutical	NNP
cord-308095-mehmk49a	395	30	Research	Research	NNP
cord-308095-mehmk49a	395	31	and	and	CC
cord-308095-mehmk49a	395	32	Manufacturers	Manufacturers	NNPS
cord-308095-mehmk49a	395	33	of	of	IN
cord-308095-mehmk49a	395	34	America	America	NNP
cord-308095-mehmk49a	395	35	(	(	-LRB-
cord-308095-mehmk49a	395	36	PhRMA	PhRMA	NNP
cord-308095-mehmk49a	395	37	)	)	-RRB-
cord-308095-mehmk49a	395	38	.	.	.
cord-308095-mehmk49a	395	39	2017	2017	CD
cord-308095-mehmk49a	395	40	.	.	.
cord-308095-mehmk49a	396	1	PhRMA	PhRMA	NNP
cord-308095-mehmk49a	396	2	announces	announce	VBZ
cord-308095-mehmk49a	396	3	major	major	JJ
cord-308095-mehmk49a	396	4	commitment	commitment	NN
cord-308095-mehmk49a	396	5	to	to	TO
cord-308095-mehmk49a	396	6	address	address	VB
cord-308095-mehmk49a	396	7	the	the	DT
cord-308095-mehmk49a	396	8	opioid	opioid	JJ
cord-308095-mehmk49a	396	9	crisis	crisis	NN
cord-308095-mehmk49a	396	10	in	in	IN
cord-308095-mehmk49a	396	11	America	America	NNP
cord-308095-mehmk49a	396	12	.	.	.
cord-308095-mehmk49a	397	1	Press	press	NN
cord-308095-mehmk49a	397	2	release	release	VB
cord-308095-mehmk49a	397	3	The	the	DT
cord-308095-mehmk49a	397	4	antibiotic	antibiotic	JJ
cord-308095-mehmk49a	397	5	era	era	NN
cord-308095-mehmk49a	397	6	:	:	:
cord-308095-mehmk49a	397	7	Reform	reform	NN
cord-308095-mehmk49a	397	8	,	,	,
cord-308095-mehmk49a	397	9	resistance	resistance	NN
cord-308095-mehmk49a	397	10	,	,	,
cord-308095-mehmk49a	397	11	and	and	CC
cord-308095-mehmk49a	397	12	the	the	DT
cord-308095-mehmk49a	397	13	pursuit	pursuit	NN
cord-308095-mehmk49a	397	14	of	of	IN
cord-308095-mehmk49a	397	15	a	a	DT
cord-308095-mehmk49a	397	16	rational	rational	JJ
cord-308095-mehmk49a	397	17	therapeutics	therapeutic	NNS
cord-308095-mehmk49a	397	18	Preying	prey	VBG
cord-308095-mehmk49a	397	19	on	on	IN
cord-308095-mehmk49a	397	20	prescribers	prescriber	NNS
cord-308095-mehmk49a	397	21	(	(	-LRB-
cord-308095-mehmk49a	397	22	and	and	CC
cord-308095-mehmk49a	397	23	their	-PRON-	PRP$
cord-308095-mehmk49a	397	24	patients)-Pharmaceutical	patients)-pharmaceutical	JJ
cord-308095-mehmk49a	397	25	marketing	marketing	NN
cord-308095-mehmk49a	397	26	,	,	,
cord-308095-mehmk49a	397	27	iatrogenic	iatrogenic	JJ
cord-308095-mehmk49a	397	28	epidemics	epidemic	NNS
cord-308095-mehmk49a	397	29	,	,	,
cord-308095-mehmk49a	397	30	and	and	CC
cord-308095-mehmk49a	397	31	the	the	DT
cord-308095-mehmk49a	397	32	Sackler	Sackler	NNP
cord-308095-mehmk49a	397	33	legacy	legacy	NN
cord-308095-mehmk49a	397	34	Capping	capping	NN
cord-308095-mehmk49a	397	35	years	year	NNS
cord-308095-mehmk49a	397	36	of	of	IN
cord-308095-mehmk49a	397	37	criticism	criticism	NN
cord-308095-mehmk49a	397	38	,	,	,
cord-308095-mehmk49a	397	39	Purdue	Purdue	NNP
cord-308095-mehmk49a	397	40	Pharma	Pharma	NNP
cord-308095-mehmk49a	397	41	will	will	MD
cord-308095-mehmk49a	397	42	stop	stop	VB
cord-308095-mehmk49a	397	43	promoting	promote	VBG
cord-308095-mehmk49a	397	44	its	-PRON-	PRP$
cord-308095-mehmk49a	397	45	opioid	opioid	JJ
cord-308095-mehmk49a	397	46	drugs	drug	NNS
cord-308095-mehmk49a	397	47	to	to	IN
cord-308095-mehmk49a	397	48	doctors	doctor	NNS
cord-308095-mehmk49a	398	1	We	-PRON-	PRP
cord-308095-mehmk49a	398	2	manufacture	manufacture	VBP
cord-308095-mehmk49a	398	3	prescription	prescription	NN
cord-308095-mehmk49a	398	4	opioids	opioid	NNS
cord-308095-mehmk49a	398	5	.	.	.
cord-308095-mehmk49a	399	1	How	how	WRB
cord-308095-mehmk49a	399	2	could	could	MD
cord-308095-mehmk49a	399	3	we	-PRON-	PRP
cord-308095-mehmk49a	399	4	not	not	RB
cord-308095-mehmk49a	399	5	help	help	VB
cord-308095-mehmk49a	399	6	fight	fight	VB
cord-308095-mehmk49a	399	7	the	the	DT
cord-308095-mehmk49a	399	8	prescription	prescription	NN
cord-308095-mehmk49a	399	9	and	and	CC
cord-308095-mehmk49a	399	10	illicit	illicit	JJ
cord-308095-mehmk49a	399	11	opioid	opioid	JJ
cord-308095-mehmk49a	399	12	abuse	abuse	NN
cord-308095-mehmk49a	399	13	crisis	crisis	NN
cord-308095-mehmk49a	399	14	?	?	.
cord-308095-mehmk49a	400	1	New	New	NNP
cord-308095-mehmk49a	400	2	York	York	NNP
cord-308095-mehmk49a	400	3	Times	Times	NNP
cord-308095-mehmk49a	400	4	Dreamland	Dreamland	NNP
cord-308095-mehmk49a	400	5	:	:	:
cord-308095-mehmk49a	401	1	The	the	DT
cord-308095-mehmk49a	401	2	true	true	JJ
cord-308095-mehmk49a	401	3	tale	tale	NN
cord-308095-mehmk49a	401	4	of	of	IN
cord-308095-mehmk49a	401	5	America	America	NNP
cord-308095-mehmk49a	401	6	's	's	POS
cord-308095-mehmk49a	401	7	opiate	opiate	NN
cord-308095-mehmk49a	401	8	epidemic	epidemic	NN
cord-308095-mehmk49a	401	9	Judge	Judge	NNP
cord-308095-mehmk49a	401	10	partly	partly	RB
cord-308095-mehmk49a	401	11	vacates	vacate	VBZ
cord-308095-mehmk49a	401	12	convictions	conviction	NNS
cord-308095-mehmk49a	401	13	of	of	IN
cord-308095-mehmk49a	401	14	opioid	opioid	NN
cord-308095-mehmk49a	401	15	maker	maker	NN
cord-308095-mehmk49a	401	16	Insys	Insys	NNP
cord-308095-mehmk49a	401	17	'	'	POS
cord-308095-mehmk49a	401	18	founder	founder	NN
cord-308095-mehmk49a	401	19	,	,	,
cord-308095-mehmk49a	401	20	executives	executive	NNS
cord-308095-mehmk49a	401	21	The	the	DT
cord-308095-mehmk49a	401	22	new	new	JJ
cord-308095-mehmk49a	401	23	medical	medical	JJ
cord-308095-mehmk49a	401	24	-	-	HYPH
cord-308095-mehmk49a	401	25	industrial	industrial	JJ
cord-308095-mehmk49a	401	26	complex	complex	JJ
cord-308095-mehmk49a	401	27	Health	Health	NNP
cord-308095-mehmk49a	401	28	policy	policy	NN
cord-308095-mehmk49a	401	29	brief	brief	NN
cord-308095-mehmk49a	401	30	:	:	:
cord-308095-mehmk49a	401	31	The	the	DT
cord-308095-mehmk49a	401	32	Physician	Physician	NNP
cord-308095-mehmk49a	401	33	Payments	Payments	NNP
cord-308095-mehmk49a	401	34	Sunshine	Sunshine	NNP
cord-308095-mehmk49a	401	35	Act	Act	NNP
cord-308095-mehmk49a	401	36	Attempts	attempt	VBZ
cord-308095-mehmk49a	401	37	to	to	TO
cord-308095-mehmk49a	401	38	redefine	redefine	VB
cord-308095-mehmk49a	401	39	conflicts	conflict	NNS
cord-308095-mehmk49a	401	40	of	of	IN
cord-308095-mehmk49a	401	41	interest	interest	NN
cord-308095-mehmk49a	401	42	Patient	Patient	NNP
cord-308095-mehmk49a	401	43	advocacy	advocacy	NN
cord-308095-mehmk49a	401	44	organizations	organization	NNS
cord-308095-mehmk49a	401	45	:	:	:
cord-308095-mehmk49a	401	46	Institutional	institutional	JJ
cord-308095-mehmk49a	401	47	conflicts	conflict	NNS
cord-308095-mehmk49a	401	48	of	of	IN
cord-308095-mehmk49a	401	49	interest	interest	NN
cord-308095-mehmk49a	401	50	,	,	,
cord-308095-mehmk49a	401	51	trust	trust	NN
cord-308095-mehmk49a	401	52	,	,	,
cord-308095-mehmk49a	401	53	and	and	CC
cord-308095-mehmk49a	401	54	trustworthiness	trustworthiness	NN
cord-308095-mehmk49a	401	55	Patient	Patient	NNP
cord-308095-mehmk49a	401	56	advocacy	advocacy	NN
cord-308095-mehmk49a	401	57	organizations	organization	NNS
cord-308095-mehmk49a	401	58	,	,	,
cord-308095-mehmk49a	401	59	industry	industry	NN
cord-308095-mehmk49a	401	60	funding	funding	NN
cord-308095-mehmk49a	401	61	,	,	,
cord-308095-mehmk49a	401	62	and	and	CC
cord-308095-mehmk49a	401	63	conflicts	conflict	NNS
cord-308095-mehmk49a	401	64	of	of	IN
cord-308095-mehmk49a	401	65	interest	interest	NN
cord-308095-mehmk49a	401	66	Patient	Patient	NNP
cord-308095-mehmk49a	401	67	responses	response	NNS
cord-308095-mehmk49a	401	68	to	to	IN
cord-308095-mehmk49a	401	69	physician	physician	NN
cord-308095-mehmk49a	401	70	disclosures	disclosure	NNS
cord-308095-mehmk49a	401	71	of	of	IN
cord-308095-mehmk49a	401	72	industry	industry	NN
cord-308095-mehmk49a	401	73	conflicts	conflict	NNS
cord-308095-mehmk49a	401	74	of	of	IN
cord-308095-mehmk49a	401	75	interest	interest	NN
cord-308095-mehmk49a	401	76	:	:	:
cord-308095-mehmk49a	401	77	A	a	DT
cord-308095-mehmk49a	401	78	randomized	randomized	JJ
cord-308095-mehmk49a	401	79	field	field	NN
cord-308095-mehmk49a	401	80	experiment	experiment	NN
cord-308095-mehmk49a	401	81	.	.	.
cord-308095-mehmk49a	402	1	Organizational	Organizational	NNP
cord-308095-mehmk49a	402	2	Behavior	Behavior	NNP
cord-308095-mehmk49a	402	3	and	and	CC
cord-308095-mehmk49a	402	4	Human	Human	NNP
cord-308095-mehmk49a	402	5	Decision	Decision	NNP
cord-308095-mehmk49a	402	6	Processes	Processes	NNPS
cord-308095-mehmk49a	402	7	Purdue	Purdue	NNP
cord-308095-mehmk49a	402	8	's	's	POS
cord-308095-mehmk49a	402	9	Richard	Richard	NNP
cord-308095-mehmk49a	402	10	Sackler	Sackler	NNP
cord-308095-mehmk49a	402	11	proposed	propose	VBD
cord-308095-mehmk49a	402	12	plan	plan	NN
cord-308095-mehmk49a	402	13	to	to	TO
cord-308095-mehmk49a	402	14	play	play	VB
cord-308095-mehmk49a	402	15	down	down	RP
cord-308095-mehmk49a	402	16	OxyContin	OxyContin	NNP
cord-308095-mehmk49a	402	17	risks	risk	NNS
cord-308095-mehmk49a	402	18	,	,	,
cord-308095-mehmk49a	402	19	and	and	CC
cord-308095-mehmk49a	402	20	wanted	want	VBD
cord-308095-mehmk49a	402	21	drug	drug	NN
cord-308095-mehmk49a	402	22	maker	maker	NN
cord-308095-mehmk49a	402	23	feared	fear	VBD
cord-308095-mehmk49a	402	24	"	"	``
cord-308095-mehmk49a	402	25	like	like	IN
cord-308095-mehmk49a	402	26	a	a	DT
cord-308095-mehmk49a	402	27	tiger	tiger	NN
cord-308095-mehmk49a	402	28	,	,	,
cord-308095-mehmk49a	402	29	"	"	''
cord-308095-mehmk49a	402	30	files	file	NNS
cord-308095-mehmk49a	402	31	show	show	VBP
cord-308095-mehmk49a	402	32	Guest	guest	NN
cord-308095-mehmk49a	402	33	authorship	authorship	NN
cord-308095-mehmk49a	402	34	and	and	CC
cord-308095-mehmk49a	402	35	ghostwriting	ghostwriting	NN
cord-308095-mehmk49a	402	36	in	in	IN
cord-308095-mehmk49a	402	37	publications	publication	NNS
cord-308095-mehmk49a	402	38	related	relate	VBN
cord-308095-mehmk49a	402	39	to	to	IN
cord-308095-mehmk49a	402	40	Rofecoxib	Rofecoxib	NNP
cord-308095-mehmk49a	402	41	:	:	:
cord-308095-mehmk49a	403	1	A	a	DT
cord-308095-mehmk49a	403	2	case	case	NN
cord-308095-mehmk49a	403	3	study	study	NN
cord-308095-mehmk49a	403	4	of	of	IN
cord-308095-mehmk49a	403	5	industry	industry	NN
cord-308095-mehmk49a	403	6	documents	document	NNS
cord-308095-mehmk49a	403	7	from	from	IN
cord-308095-mehmk49a	403	8	Rofecoxib	Rofecoxib	NNP
cord-308095-mehmk49a	403	9	litigation	litigation	NN
cord-308095-mehmk49a	404	1	OxyContin	OxyContin	NNP
cord-308095-mehmk49a	404	2	goes	go	VBZ
cord-308095-mehmk49a	404	3	global-"We're	global-"We're	.
cord-308095-mehmk49a	405	1	only	only	RB
cord-308095-mehmk49a	405	2	just	just	RB
cord-308095-mehmk49a	405	3	getting	get	VBG
cord-308095-mehmk49a	405	4	started	start	VBN
cord-308095-mehmk49a	405	5	Conflict	conflict	NN
cord-308095-mehmk49a	405	6	of	of	IN
cord-308095-mehmk49a	405	7	interest	interest	NN
cord-308095-mehmk49a	405	8	disclosure	disclosure	NN
cord-308095-mehmk49a	405	9	as	as	IN
cord-308095-mehmk49a	405	10	a	a	DT
cord-308095-mehmk49a	405	11	reminder	reminder	NN
cord-308095-mehmk49a	405	12	of	of	IN
cord-308095-mehmk49a	405	13	professional	professional	JJ
cord-308095-mehmk49a	405	14	norms	norm	NNS
cord-308095-mehmk49a	405	15	:	:	:
cord-308095-mehmk49a	406	1	Clients	client	NNS
cord-308095-mehmk49a	406	2	first	first	RB
cord-308095-mehmk49a	406	3	!	!	.
cord-308095-mehmk49a	407	1	Physicians	physician	NNS
cord-308095-mehmk49a	407	2	under	under	IN
cord-308095-mehmk49a	407	3	the	the	DT
cord-308095-mehmk49a	407	4	influence	influence	NN
cord-308095-mehmk49a	407	5	:	:	:
cord-308095-mehmk49a	407	6	Social	social	JJ
cord-308095-mehmk49a	407	7	psychology	psychology	NN
cord-308095-mehmk49a	407	8	and	and	CC
cord-308095-mehmk49a	407	9	industry	industry	NN
cord-308095-mehmk49a	407	10	marketing	marketing	NN
cord-308095-mehmk49a	407	11	strategies	strategy	NNS
cord-308095-mehmk49a	408	1	Insinuation	insinuation	NN
cord-308095-mehmk49a	408	2	anxiety	anxiety	NN
cord-308095-mehmk49a	408	3	:	:	:
cord-308095-mehmk49a	408	4	Concern	concern	NN
cord-308095-mehmk49a	408	5	that	that	DT
cord-308095-mehmk49a	408	6	advice	advice	NN
cord-308095-mehmk49a	408	7	rejection	rejection	NN
cord-308095-mehmk49a	408	8	will	will	MD
cord-308095-mehmk49a	408	9	signal	signal	VB
cord-308095-mehmk49a	408	10	distrust	distrust	NN
cord-308095-mehmk49a	408	11	after	after	IN
cord-308095-mehmk49a	408	12	conflict	conflict	NN
cord-308095-mehmk49a	408	13	of	of	IN
cord-308095-mehmk49a	408	14	interest	interest	NN
cord-308095-mehmk49a	408	15	disclosure	disclosure	NN
cord-308095-mehmk49a	408	16	Purdue	Purdue	NNP
cord-308095-mehmk49a	408	17	Pharma	Pharma	NNP
cord-308095-mehmk49a	408	18	edits	edit	VBZ
cord-308095-mehmk49a	408	19	public	public	JJ
cord-308095-mehmk49a	408	20	service	service	NN
cord-308095-mehmk49a	408	21	ad	ad	NN
cord-308095-mehmk49a	408	22	in	in	IN
cord-308095-mehmk49a	408	23	Washington	Washington	NNP
cord-308095-mehmk49a	408	24	Post	Post	NNP
cord-308095-mehmk49a	408	25	US	US	NNP
cord-308095-mehmk49a	408	26	opioid	opioid	NN
cord-308095-mehmk49a	408	27	prescribing	prescribing	NN
cord-308095-mehmk49a	408	28	:	:	:
cord-308095-mehmk49a	409	1	The	the	DT
cord-308095-mehmk49a	409	2	federal	federal	JJ
cord-308095-mehmk49a	409	3	government	government	NN
cord-308095-mehmk49a	409	4	advisers	adviser	NNS
cord-308095-mehmk49a	409	5	with	with	IN
cord-308095-mehmk49a	409	6	recent	recent	JJ
cord-308095-mehmk49a	409	7	ties	tie	NNS
cord-308095-mehmk49a	409	8	to	to	IN
cord-308095-mehmk49a	409	9	big	big	JJ
cord-308095-mehmk49a	409	10	pharma	pharma	NNS
cord-308095-mehmk49a	410	1	Teva	Teva	NNP
cord-308095-mehmk49a	410	2	reaches	reach	VBZ
cord-308095-mehmk49a	410	3	$	$	$
cord-308095-mehmk49a	410	4	85	85	CD
cord-308095-mehmk49a	410	5	million	million	CD
cord-308095-mehmk49a	410	6	settlement	settlement	NN
cord-308095-mehmk49a	410	7	on	on	IN
cord-308095-mehmk49a	410	8	eve	eve	NNP
cord-308095-mehmk49a	410	9	of	of	IN
cord-308095-mehmk49a	410	10	opioid	opioid	JJ
cord-308095-mehmk49a	410	11	trial	trial	NN
cord-308095-mehmk49a	410	12	in	in	IN
cord-308095-mehmk49a	410	13	Oklahoma	Oklahoma	NNP
cord-308095-mehmk49a	410	14	Ghost	Ghost	NNP
cord-308095-mehmk49a	410	15	-	-	HYPH
cord-308095-mehmk49a	410	16	managed	manage	VBN
cord-308095-mehmk49a	410	17	medicine	medicine	NN
cord-308095-mehmk49a	410	18	:	:	:
cord-308095-mehmk49a	411	1	Big	big	JJ
cord-308095-mehmk49a	411	2	pharma	pharma	NNS
cord-308095-mehmk49a	411	3	's	's	POS
cord-308095-mehmk49a	411	4	invisible	invisible	JJ
cord-308095-mehmk49a	411	5	hands	hand	NNS
cord-308095-mehmk49a	412	1	Narrative	narrative	NN
cord-308095-mehmk49a	412	2	review	review	NN
cord-308095-mehmk49a	412	3	:	:	:
cord-308095-mehmk49a	413	1	The	the	DT
cord-308095-mehmk49a	413	2	promotion	promotion	NN
cord-308095-mehmk49a	413	3	of	of	IN
cord-308095-mehmk49a	413	4	gabapentin	gabapentin	NNP
cord-308095-mehmk49a	413	5	:	:	:
cord-308095-mehmk49a	413	6	An	an	DT
cord-308095-mehmk49a	413	7	analysis	analysis	NN
cord-308095-mehmk49a	413	8	of	of	IN
cord-308095-mehmk49a	413	9	internal	internal	JJ
cord-308095-mehmk49a	413	10	industry	industry	NN
cord-308095-mehmk49a	413	11	documents	document	NNS
cord-308095-mehmk49a	413	12	Insys	Insys	NNP
cord-308095-mehmk49a	413	13	,	,	,
cord-308095-mehmk49a	413	14	the	the	DT
cord-308095-mehmk49a	413	15	opioid	opioid	JJ
cord-308095-mehmk49a	413	16	drug	drug	NN
cord-308095-mehmk49a	413	17	maker	maker	NN
cord-308095-mehmk49a	413	18	,	,	,
cord-308095-mehmk49a	413	19	to	to	TO
cord-308095-mehmk49a	413	20	pay	pay	VB
cord-308095-mehmk49a	413	21	$	$	$
cord-308095-mehmk49a	413	22	225	225	CD
cord-308095-mehmk49a	413	23	million	million	CD
cord-308095-mehmk49a	413	24	to	to	TO
cord-308095-mehmk49a	413	25	settle	settle	VB
cord-308095-mehmk49a	413	26	fraud	fraud	NN
cord-308095-mehmk49a	413	27	charges	charge	NNS
cord-308095-mehmk49a	413	28	The	the	DT
cord-308095-mehmk49a	413	29	role	role	NN
cord-308095-mehmk49a	413	30	of	of	IN
cord-308095-mehmk49a	413	31	science	science	NN
cord-308095-mehmk49a	413	32	in	in	IN
cord-308095-mehmk49a	413	33	addressing	address	VBG
cord-308095-mehmk49a	413	34	the	the	DT
cord-308095-mehmk49a	413	35	opioid	opioid	JJ
cord-308095-mehmk49a	413	36	crisis	crisis	NN
cord-308095-mehmk49a	413	37	Ensuring	ensure	VBG
cord-308095-mehmk49a	413	38	balance	balance	NN
cord-308095-mehmk49a	413	39	in	in	IN
cord-308095-mehmk49a	413	40	national	national	JJ
cord-308095-mehmk49a	413	41	policies	policy	NNS
cord-308095-mehmk49a	413	42	on	on	IN
cord-308095-mehmk49a	413	43	controlled	control	VBN
cord-308095-mehmk49a	413	44	substances	substance	NNS
cord-308095-mehmk49a	413	45	:	:	:
cord-308095-mehmk49a	413	46	Guidance	guidance	NN
cord-308095-mehmk49a	413	47	for	for	IN
cord-308095-mehmk49a	413	48	availability	availability	NN
cord-308095-mehmk49a	413	49	and	and	CC
cord-308095-mehmk49a	413	50	accessibility	accessibility	NN
cord-308095-mehmk49a	413	51	of	of	IN
cord-308095-mehmk49a	413	52	controlled	control	VBN
cord-308095-mehmk49a	413	53	medicines	medicine	NNS
cord-308095-mehmk49a	413	54	Web	web	NN
cord-308095-mehmk49a	413	55	statement	statement	NN
cord-308095-mehmk49a	413	56	on	on	IN
cord-308095-mehmk49a	413	57	pain	pain	NN
cord-308095-mehmk49a	413	58	management	management	NN
cord-308095-mehmk49a	413	59	guidance	guidance	NN
cord-308095-mehmk49a	413	60	Responsibility	Responsibility	NNP
cord-308095-mehmk49a	413	61	for	for	IN
cord-308095-mehmk49a	413	62	justice	justice	NNP
cord-308095-mehmk49a	413	63	Report	Report	NNP
cord-308095-mehmk49a	413	64	and	and	CC
cord-308095-mehmk49a	413	65	recommendations	recommendation	NNS
cord-308095-mehmk49a	413	66	concerning	concern	VBG
cord-308095-mehmk49a	413	67	the	the	DT
cord-308095-mehmk49a	413	68	relationship	relationship	NN
cord-308095-mehmk49a	413	69	of	of	IN
cord-308095-mehmk49a	413	70	the	the	DT
cord-308095-mehmk49a	413	71	Sackler	Sackler	NNP
cord-308095-mehmk49a	413	72	family	family	NN
cord-308095-mehmk49a	413	73	and	and	CC
cord-308095-mehmk49a	413	74	Purdue	Purdue	NNP
cord-308095-mehmk49a	413	75	Pharma	Pharma	NNP
cord-308095-mehmk49a	413	76	with	with	IN
cord-308095-mehmk49a	413	77	Tufts	Tufts	NNP
cord-308095-mehmk49a	413	78	University	University	NNP
cord-308095-mehmk49a	413	79	Hammer	Hammer	NNP
cord-308095-mehmk49a	413	80	on	on	IN
cord-308095-mehmk49a	413	81	the	the	DT
cord-308095-mehmk49a	413	82	abusers	abuser	NNS
cord-308095-mehmk49a	413	83	"	"	''
cord-308095-mehmk49a	413	84	:	:	:
cord-308095-mehmk49a	414	1	Mass.	Massachusetts	NNP
cord-308095-mehmk49a	414	2	attorney	attorney	NN
cord-308095-mehmk49a	414	3	general	general	NN
cord-308095-mehmk49a	414	4	alleges	allege	VBZ
cord-308095-mehmk49a	414	5	Purdue	Purdue	NNP
cord-308095-mehmk49a	414	6	Pharma	Pharma	NNP
cord-308095-mehmk49a	414	7	tried	try	VBD
cord-308095-mehmk49a	414	8	to	to	TO
cord-308095-mehmk49a	414	9	shift	shift	VB
cord-308095-mehmk49a	414	10	blame	blame	NN
cord-308095-mehmk49a	414	11	for	for	IN
cord-308095-mehmk49a	414	12	opioid	opioid	JJ
cord-308095-mehmk49a	414	13	addiction	addiction	NN
cord-308095-mehmk49a	415	1	Publisher	publisher	NN
cord-308095-mehmk49a	415	2	's	's	POS
cord-308095-mehmk49a	415	3	note	note	NN
cord-308095-mehmk49a	415	4	Springer	Springer	NNP
cord-308095-mehmk49a	415	5	Nature	Nature	NNP
cord-308095-mehmk49a	415	6	remains	remain	VBZ
cord-308095-mehmk49a	415	7	neutral	neutral	JJ
cord-308095-mehmk49a	415	8	with	with	IN
cord-308095-mehmk49a	415	9	regard	regard	NN
cord-308095-mehmk49a	415	10	to	to	IN
cord-308095-mehmk49a	415	11	jurisdictional	jurisdictional	JJ
cord-308095-mehmk49a	415	12	claims	claim	NNS
cord-308095-mehmk49a	415	13	in	in	IN
cord-308095-mehmk49a	415	14	published	publish	VBN
cord-308095-mehmk49a	415	15	maps	map	NNS
cord-308095-mehmk49a	415	16	and	and	CC
cord-308095-mehmk49a	415	17	institutional	institutional	JJ
cord-308095-mehmk49a	415	18	affiliations	affiliation	NNS
cord-308095-mehmk49a	416	1	Acknowledgments	acknowledgment	NNS
cord-308095-mehmk49a	417	1	The	the	DT
cord-308095-mehmk49a	417	2	author	author	NN
cord-308095-mehmk49a	417	3	is	be	VBZ
cord-308095-mehmk49a	417	4	extremely	extremely	RB
cord-308095-mehmk49a	417	5	grateful	grateful	JJ
cord-308095-mehmk49a	417	6	to	to	IN
cord-308095-mehmk49a	417	7	Michele	Michele	NNP
cord-308095-mehmk49a	417	8	Mekel	Mekel	NNP
cord-308095-mehmk49a	417	9	and	and	CC
cord-308095-mehmk49a	417	10	to	to	IN
cord-308095-mehmk49a	417	11	all	all	PDT
cord-308095-mehmk49a	417	12	the	the	DT
cord-308095-mehmk49a	417	13	student	student	NN
cord-308095-mehmk49a	417	14	and	and	CC
cord-308095-mehmk49a	417	15	faculty	faculty	NN
cord-308095-mehmk49a	417	16	participants	participant	NNS
cord-308095-mehmk49a	417	17	in	in	IN
cord-308095-mehmk49a	417	18	the	the	DT
cord-308095-mehmk49a	417	19	Penn	Penn	NNP
cord-308095-mehmk49a	417	20	State	State	NNP
cord-308095-mehmk49a	417	21	Bioethics	Bioethics	NNP
cord-308095-mehmk49a	417	22	Colloquium	Colloquium	NNP
cord-308095-mehmk49a	417	23	for	for	IN
cord-308095-mehmk49a	417	24	their	-PRON-	PRP$
cord-308095-mehmk49a	417	25	invaluable	invaluable	JJ
cord-308095-mehmk49a	417	26	feedback	feedback	NN
cord-308095-mehmk49a	417	27	on	on	IN
cord-308095-mehmk49a	417	28	an	an	DT
cord-308095-mehmk49a	417	29	earlier	early	JJR
cord-308095-mehmk49a	417	30	draft	draft	NN
cord-308095-mehmk49a	417	31	.	.	.
cord-308095-mehmk49a	418	1	This	this	DT
cord-308095-mehmk49a	418	2	article	article	NN
cord-308095-mehmk49a	418	3	also	also	RB
cord-308095-mehmk49a	418	4	benefited	benefit	VBD
cord-308095-mehmk49a	418	5	from	from	IN
cord-308095-mehmk49a	418	6	the	the	DT
cord-308095-mehmk49a	418	7	author	author	NN
cord-308095-mehmk49a	418	8	's	's	POS
cord-308095-mehmk49a	418	9	discussions	discussion	NNS
cord-308095-mehmk49a	418	10	with	with	IN
cord-308095-mehmk49a	418	11	several	several	JJ
cord-308095-mehmk49a	418	12	colleagues	colleague	NNS
cord-308095-mehmk49a	418	13	at	at	IN
cord-308095-mehmk49a	418	14	other	other	JJ
cord-308095-mehmk49a	418	15	institutions	institution	NNS
cord-308095-mehmk49a	418	16	-	-	:
cord-308095-mehmk49a	418	17	among	among	IN
cord-308095-mehmk49a	418	18	them	-PRON-	PRP
cord-308095-mehmk49a	418	19	,	,	,
cord-308095-mehmk49a	418	20	Marc	Marc	NNP
cord-308095-mehmk49a	418	21	Rodwin	Rodwin	NNP
cord-308095-mehmk49a	418	22	,	,	,
cord-308095-mehmk49a	418	23	Sunita	Sunita	NNP
cord-308095-mehmk49a	418	24	Sah	Sah	NNP
cord-308095-mehmk49a	418	25	,	,	,
cord-308095-mehmk49a	418	26	Genny	Genny	NNP
cord-308095-mehmk49a	418	27	Pham	Pham	NNP
cord-308095-mehmk49a	418	28	Kanter	Kanter	NNP
cord-308095-mehmk49a	418	29	,	,	,
cord-308095-mehmk49a	418	30	Susannah	Susannah	NNP
cord-308095-mehmk49a	418	31	Rose	Rose	NNP
cord-308095-mehmk49a	418	32	,	,	,
cord-308095-mehmk49a	418	33	and	and	CC
cord-308095-mehmk49a	418	34	Lisa	Lisa	NNP
cord-308095-mehmk49a	418	35	Cosgrove	Cosgrove	NNP
cord-308095-mehmk49a	418	36	.	.	.
cord-308095-mehmk49a	419	1	He	-PRON-	PRP
cord-308095-mehmk49a	419	2	is	be	VBZ
cord-308095-mehmk49a	419	3	also	also	RB
cord-308095-mehmk49a	419	4	grateful	grateful	JJ
cord-308095-mehmk49a	419	5	to	to	IN
cord-308095-mehmk49a	419	6	Quinn	Quinn	NNP
cord-308095-mehmk49a	419	7	Grundy	Grundy	NNP
cord-308095-mehmk49a	419	8	and	and	CC
cord-308095-mehmk49a	419	9	another	another	DT
cord-308095-mehmk49a	419	10	(	(	-LRB-
cord-308095-mehmk49a	419	11	anonymous	anonymous	JJ
cord-308095-mehmk49a	419	12	)	)	-RRB-
cord-308095-mehmk49a	419	13	reviewer	reviewer	NN
cord-308095-mehmk49a	419	14	for	for	IN
cord-308095-mehmk49a	419	15	their	-PRON-	PRP$
cord-308095-mehmk49a	419	16	extremely	extremely	RB
cord-308095-mehmk49a	419	17	helpful	helpful	JJ
cord-308095-mehmk49a	419	18	comments	comment	NNS
cord-308095-mehmk49a	419	19	and	and	CC
cord-308095-mehmk49a	419	20	suggestions	suggestion	NNS
cord-308095-mehmk49a	419	21	.	.	.
cord-308095-mehmk49a	420	1	Please	please	UH
cord-308095-mehmk49a	420	2	excuse	excuse	VB
cord-308095-mehmk49a	420	3	any	any	DT
cord-308095-mehmk49a	420	4	errors	error	NNS
cord-308095-mehmk49a	420	5	and	and	CC
cord-308095-mehmk49a	420	6	omissions	omission	NNS
cord-308095-mehmk49a	420	7	-	-	HYPH
cord-308095-mehmk49a	420	8	final	final	JJ
cord-308095-mehmk49a	420	9	revisions	revision	NNS
cord-308095-mehmk49a	420	10	to	to	IN
cord-308095-mehmk49a	420	11	this	this	DT
cord-308095-mehmk49a	420	12	piece	piece	NN
cord-308095-mehmk49a	420	13	were	be	VBD
cord-308095-mehmk49a	420	14	made	make	VBN
cord-308095-mehmk49a	420	15	during	during	IN
cord-308095-mehmk49a	420	16	the	the	DT
cord-308095-mehmk49a	420	17	COVID-19	COVID-19	NNP
cord-308095-mehmk49a	420	18	pandemic	pandemic	NN
cord-308095-mehmk49a	420	19	.	.	.